0000105770-19-000045.txt : 20191029 0000105770-19-000045.hdr.sgml : 20191029 20191028185603 ACCESSION NUMBER: 0000105770-19-000045 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 89 CONFORMED PERIOD OF REPORT: 20190930 FILED AS OF DATE: 20191029 DATE AS OF CHANGE: 20191028 FILER: COMPANY DATA: COMPANY CONFORMED NAME: WEST PHARMACEUTICAL SERVICES INC CENTRAL INDEX KEY: 0000105770 STANDARD INDUSTRIAL CLASSIFICATION: FABRICATED RUBBER PRODUCTS, NEC [3060] IRS NUMBER: 231210010 STATE OF INCORPORATION: PA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-08036 FILM NUMBER: 191174130 BUSINESS ADDRESS: STREET 1: 530 HERMAN O. WEST DRIVE CITY: EXTON STATE: PA ZIP: 19341 BUSINESS PHONE: 6105942900 MAIL ADDRESS: STREET 1: 530 HERMAN O. WEST DRIVE CITY: EXTON STATE: PA ZIP: 19341 FORMER COMPANY: FORMER CONFORMED NAME: WEST CO INC DATE OF NAME CHANGE: 19990405 10-Q 1 wst10q93019.htm 10-Q Document
false--12-31Q3201900001057700.140.140.150.150.150.160.250.2510000000010000000075300000753000007410000074000000134000000.03820.04020.03670.008750.03820.04020.036726000002700000100000100000015000007000000100000700000700000100000030000003000000000012000001300000 0000105770 2019-01-01 2019-09-30 0000105770 2019-09-30 0000105770 2018-07-01 2018-09-30 0000105770 2018-01-01 2018-09-30 0000105770 2019-07-01 2019-09-30 0000105770 2018-12-31 0000105770 2017-12-31 0000105770 2018-09-30 0000105770 2019-04-01 0000105770 2019-01-01 2019-01-01 0000105770 wst:SmartDoseMember 2019-09-30 0000105770 wst:SmartDoseMember 2013-06-30 0000105770 2018-01-01 2018-12-31 0000105770 wst:ContractManufacturedCustomersMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2019-07-01 2019-09-30 0000105770 wst:BiologicsCustomersMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2018-07-01 2018-09-30 0000105770 wst:PharmaCustomersMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2018-07-01 2018-09-30 0000105770 wst:ContractManufacturedCustomersMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2018-01-01 2018-09-30 0000105770 wst:BiologicsCustomersMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2019-07-01 2019-09-30 0000105770 wst:PharmaCustomersMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2018-01-01 2018-09-30 0000105770 wst:ContractManufacturedCustomersMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2018-07-01 2018-09-30 0000105770 wst:PharmaCustomersMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2019-07-01 2019-09-30 0000105770 wst:GenericsCustomersMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2019-01-01 2019-09-30 0000105770 wst:PharmaCustomersMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2019-01-01 2019-09-30 0000105770 wst:GenericsCustomersMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2018-07-01 2018-09-30 0000105770 wst:GenericsCustomersMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2019-07-01 2019-09-30 0000105770 wst:BiologicsCustomersMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2018-01-01 2018-09-30 0000105770 wst:GenericsCustomersMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2018-01-01 2018-09-30 0000105770 wst:BiologicsCustomersMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2019-01-01 2019-09-30 0000105770 wst:ContractManufacturedCustomersMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2019-01-01 2019-09-30 0000105770 wst:ContractManufacturedProductsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2019-01-01 2019-09-30 0000105770 wst:StandardPackagingMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2019-01-01 2019-09-30 0000105770 wst:HighValueComponentsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2019-01-01 2019-09-30 0000105770 wst:ContractManufacturedProductsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2018-07-01 2018-09-30 0000105770 wst:HighValueComponentsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2018-01-01 2018-09-30 0000105770 wst:DeliveryDevicesMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2018-01-01 2018-09-30 0000105770 wst:HighValueComponentsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2018-07-01 2018-09-30 0000105770 wst:StandardPackagingMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2018-07-01 2018-09-30 0000105770 wst:StandardPackagingMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2019-07-01 2019-09-30 0000105770 wst:DeliveryDevicesMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2018-07-01 2018-09-30 0000105770 wst:DeliveryDevicesMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2019-01-01 2019-09-30 0000105770 wst:StandardPackagingMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2018-01-01 2018-09-30 0000105770 wst:ContractManufacturedProductsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2018-01-01 2018-09-30 0000105770 wst:HighValueComponentsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2019-07-01 2019-09-30 0000105770 wst:DeliveryDevicesMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2019-07-01 2019-09-30 0000105770 wst:ContractManufacturedProductsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2019-07-01 2019-09-30 0000105770 us-gaap:EMEAMember us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember 2019-01-01 2019-09-30 0000105770 srt:AsiaPacificMember us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember 2019-01-01 2019-09-30 0000105770 srt:AmericasMember us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember 2019-07-01 2019-09-30 0000105770 srt:AmericasMember us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember 2018-07-01 2018-09-30 0000105770 srt:AsiaPacificMember us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember 2019-07-01 2019-09-30 0000105770 srt:AmericasMember us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember 2018-01-01 2018-09-30 0000105770 us-gaap:EMEAMember us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember 2019-07-01 2019-09-30 0000105770 us-gaap:EMEAMember us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember 2018-07-01 2018-09-30 0000105770 srt:AmericasMember us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember 2019-01-01 2019-09-30 0000105770 srt:AsiaPacificMember us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember 2018-01-01 2018-09-30 0000105770 us-gaap:EMEAMember us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember 2018-01-01 2018-09-30 0000105770 srt:AsiaPacificMember us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember 2018-07-01 2018-09-30 0000105770 srt:MaximumMember 2019-01-01 2019-09-30 0000105770 us-gaap:AccountingStandardsUpdate201602Member 2019-01-01 0000105770 srt:MaximumMember 2019-09-30 0000105770 wst:SeniorCNotesDue2027Member 2018-12-31 0000105770 wst:Revolvingcreditfacilitydue2020Member 2018-12-31 0000105770 wst:SeniorBNotesDue2024Member 2019-09-30 0000105770 wst:SeniorCNotesDue2027Member 2019-09-30 0000105770 us-gaap:NotesPayableOtherPayablesMember 2018-12-31 0000105770 wst:Revolvingcreditfacilitydue2020Member 2019-09-30 0000105770 wst:SeniorNotesDue2022Member 2018-12-31 0000105770 us-gaap:NotesPayableOtherPayablesMember 2019-09-30 0000105770 wst:Revolvingcreditfacilitydue2024Member 2019-09-30 0000105770 wst:SeniorNotesDue2022Member 2019-09-30 0000105770 wst:SeniorBNotesDue2024Member 2018-12-31 0000105770 wst:Revolvingcreditfacilitydue2024Member 2018-01-01 2018-12-31 0000105770 us-gaap:FederalFundsEffectiveSwapRateMember wst:Revolvingcreditfacilitydue2024Member 2019-01-01 2019-09-30 0000105770 us-gaap:ForeignLineOfCreditMember wst:Revolvingcreditfacilitydue2024Member 2019-09-30 0000105770 srt:MinimumMember wst:Revolvingcreditfacilitydue2024Member 2019-01-01 2019-09-30 0000105770 us-gaap:LetterOfCreditMember wst:Revolvingcreditfacilitydue2024Member 2019-09-30 0000105770 srt:MaximumMember us-gaap:LondonInterbankOfferedRateLIBORMember wst:Revolvingcreditfacilitydue2024Member 2019-01-01 2019-09-30 0000105770 us-gaap:DomesticLineOfCreditMember wst:Revolvingcreditfacilitydue2024Member 2019-09-30 0000105770 srt:MinimumMember us-gaap:BaseRateMember wst:Revolvingcreditfacilitydue2024Member 2019-01-01 2019-09-30 0000105770 us-gaap:LondonInterbankOfferedRateLIBORMember wst:Revolvingcreditfacilitydue2024Member 2019-01-01 2019-09-30 0000105770 wst:Revolvingcreditfacilitydue2024Member 2019-01-01 2019-09-30 0000105770 srt:MaximumMember us-gaap:BaseRateMember wst:Revolvingcreditfacilitydue2024Member 2019-01-01 2019-09-30 0000105770 srt:MaximumMember wst:Revolvingcreditfacilitydue2024Member 2019-01-01 2019-09-30 0000105770 srt:MinimumMember us-gaap:LondonInterbankOfferedRateLIBORMember wst:Revolvingcreditfacilitydue2024Member 2019-01-01 2019-09-30 0000105770 currency:USD us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2019-09-30 0000105770 currency:JPY us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2019-09-30 0000105770 currency:USD us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:LongMember 2019-09-30 0000105770 currency:SGD us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2019-09-30 0000105770 currency:JPY us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:LongMember 2019-09-30 0000105770 currency:SGD us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:LongMember 2019-09-30 0000105770 us-gaap:NondesignatedMember 2019-01-01 2019-09-30 0000105770 us-gaap:CommodityOptionMember us-gaap:NondesignatedMember us-gaap:CostOfSalesMember 2018-01-01 2018-09-30 0000105770 us-gaap:NondesignatedMember 2019-07-01 2019-09-30 0000105770 us-gaap:CommodityOptionMember us-gaap:NondesignatedMember us-gaap:CostOfSalesMember 2019-07-01 2019-09-30 0000105770 us-gaap:CommodityOptionMember us-gaap:NondesignatedMember us-gaap:CostOfSalesMember 2019-01-01 2019-09-30 0000105770 us-gaap:NondesignatedMember 2018-01-01 2018-09-30 0000105770 us-gaap:CommodityOptionMember us-gaap:NondesignatedMember us-gaap:CostOfSalesMember 2018-07-01 2018-09-30 0000105770 us-gaap:NondesignatedMember 2018-07-01 2018-09-30 0000105770 wst:DebtYenDenominatedMember 2019-01-01 2019-09-30 0000105770 us-gaap:OptionMember 2017-11-22 0000105770 us-gaap:DebtMember 2019-01-01 2019-09-30 0000105770 currency:SGD us-gaap:ForwardContractsMember 2018-12-31 0000105770 us-gaap:OptionMember 2019-09-30 0000105770 currency:USD us-gaap:ForwardContractsMember 2018-12-31 0000105770 currency:EUR us-gaap:ForwardContractsMember 2018-12-31 0000105770 wst:DebtYenDenominatedMember 2019-09-30 0000105770 us-gaap:DebtMember 2019-09-30 0000105770 currency:SGD us-gaap:ForwardContractsMember 2019-09-30 0000105770 currency:USD us-gaap:ForwardContractsMember 2019-09-30 0000105770 us-gaap:FairValueHedgingMember 2019-07-01 2019-09-30 0000105770 us-gaap:CashFlowHedgingMember 2019-07-01 2019-09-30 0000105770 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember wst:NetSalesMember 2019-07-01 2019-09-30 0000105770 wst:ForeignCurrencyDenominatedDebtMember us-gaap:NetInvestmentHedgingMember us-gaap:ForeignCurrencyGainLossMember 2018-07-01 2018-09-30 0000105770 us-gaap:NetInvestmentHedgingMember 2018-07-01 2018-09-30 0000105770 us-gaap:ForeignExchangeContractMember us-gaap:FairValueHedgingMember us-gaap:ForeignCurrencyGainLossMember 2019-07-01 2019-09-30 0000105770 us-gaap:NetInvestmentHedgingMember 2019-07-01 2019-09-30 0000105770 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:CostOfSalesMember 2019-07-01 2019-09-30 0000105770 us-gaap:TreasuryLockMember us-gaap:CashFlowHedgingMember us-gaap:InterestExpenseMember 2019-07-01 2019-09-30 0000105770 wst:ForeignCurrencyDenominatedDebtMember us-gaap:NetInvestmentHedgingMember us-gaap:ForeignCurrencyGainLossMember 2019-07-01 2019-09-30 0000105770 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:CostOfSalesMember 2018-07-01 2018-09-30 0000105770 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember wst:NetSalesMember 2018-07-01 2018-09-30 0000105770 us-gaap:TreasuryLockMember us-gaap:CashFlowHedgingMember us-gaap:InterestExpenseMember 2018-07-01 2018-09-30 0000105770 us-gaap:CashFlowHedgingMember 2018-07-01 2018-09-30 0000105770 us-gaap:FairValueHedgingMember 2019-01-01 2019-09-30 0000105770 us-gaap:FairValueHedgingMember 2018-07-01 2018-09-30 0000105770 us-gaap:ForeignExchangeContractMember us-gaap:FairValueHedgingMember us-gaap:ForeignCurrencyGainLossMember 2019-01-01 2019-09-30 0000105770 us-gaap:ForeignExchangeContractMember us-gaap:FairValueHedgingMember us-gaap:ForeignCurrencyGainLossMember 2018-07-01 2018-09-30 0000105770 us-gaap:FairValueHedgingMember 2018-01-01 2018-09-30 0000105770 us-gaap:ForeignExchangeContractMember us-gaap:FairValueHedgingMember us-gaap:ForeignCurrencyGainLossMember 2018-01-01 2018-09-30 0000105770 us-gaap:CashFlowHedgingMember 2018-01-01 2018-09-30 0000105770 us-gaap:NetInvestmentHedgingMember 2019-01-01 2019-09-30 0000105770 us-gaap:TreasuryLockMember us-gaap:CashFlowHedgingMember us-gaap:InterestExpenseMember 2018-01-01 2018-09-30 0000105770 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:CostOfSalesMember 2019-01-01 2019-09-30 0000105770 wst:ForeignCurrencyDenominatedDebtMember us-gaap:NetInvestmentHedgingMember us-gaap:ForeignCurrencyGainLossMember 2019-01-01 2019-09-30 0000105770 us-gaap:TreasuryLockMember us-gaap:CashFlowHedgingMember us-gaap:InterestExpenseMember 2019-01-01 2019-09-30 0000105770 wst:ForeignCurrencyDenominatedDebtMember us-gaap:NetInvestmentHedgingMember us-gaap:ForeignCurrencyGainLossMember 2018-01-01 2018-09-30 0000105770 us-gaap:NetInvestmentHedgingMember 2018-01-01 2018-09-30 0000105770 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:CostOfSalesMember 2018-01-01 2018-09-30 0000105770 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember wst:NetSalesMember 2018-01-01 2018-09-30 0000105770 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember wst:NetSalesMember 2019-01-01 2019-09-30 0000105770 us-gaap:CashFlowHedgingMember 2019-01-01 2019-09-30 0000105770 us-gaap:FairValueInputsLevel2Member 2018-12-31 0000105770 us-gaap:FairValueInputsLevel1Member 2018-12-31 0000105770 us-gaap:FairValueInputsLevel3Member 2018-12-31 0000105770 us-gaap:FairValueInputsLevel3Member 2019-09-30 0000105770 us-gaap:FairValueInputsLevel2Member 2019-09-30 0000105770 us-gaap:FairValueInputsLevel1Member 2019-09-30 0000105770 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2019-07-01 2019-09-30 0000105770 us-gaap:InterestRateSwapMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2019-07-01 2019-09-30 0000105770 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2018-07-01 2018-09-30 0000105770 us-gaap:InterestRateSwapMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2019-01-01 2019-09-30 0000105770 us-gaap:TreasuryLockMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2018-07-01 2018-09-30 0000105770 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2018-01-01 2018-09-30 0000105770 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-01-01 2019-09-30 0000105770 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-07-01 2019-09-30 0000105770 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2018-01-01 2018-09-30 0000105770 us-gaap:TreasuryLockMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2019-07-01 2019-09-30 0000105770 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2019-01-01 2019-09-30 0000105770 us-gaap:ForeignExchangeContractMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2018-01-01 2018-09-30 0000105770 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2018-07-01 2018-09-30 0000105770 us-gaap:ForeignExchangeContractMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2019-07-01 2019-09-30 0000105770 us-gaap:TreasuryLockMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2018-01-01 2018-09-30 0000105770 us-gaap:ForeignExchangeContractMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2019-01-01 2019-09-30 0000105770 us-gaap:TreasuryLockMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2019-01-01 2019-09-30 0000105770 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2018-01-01 2018-09-30 0000105770 us-gaap:InterestRateSwapMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2018-07-01 2018-09-30 0000105770 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-09-30 0000105770 us-gaap:ForeignExchangeContractMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2018-07-01 2018-09-30 0000105770 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2018-07-01 2018-09-30 0000105770 us-gaap:InterestRateSwapMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2018-01-01 2018-09-30 0000105770 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2019-07-01 2019-09-30 0000105770 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2019-09-30 0000105770 us-gaap:AccumulatedTranslationAdjustmentMember 2019-01-01 2019-09-30 0000105770 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2018-12-31 0000105770 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2019-01-01 2019-09-30 0000105770 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2018-12-31 0000105770 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2019-09-30 0000105770 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-09-30 0000105770 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-01-01 2019-09-30 0000105770 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2019-01-01 2019-09-30 0000105770 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2018-12-31 0000105770 us-gaap:AccumulatedTranslationAdjustmentMember 2018-12-31 0000105770 us-gaap:AccumulatedTranslationAdjustmentMember 2019-09-30 0000105770 us-gaap:TreasuryStockMember 2019-01-01 2019-03-31 0000105770 us-gaap:RetainedEarningsMember 2019-03-31 0000105770 us-gaap:CommonStockMember 2019-01-01 2019-03-31 0000105770 2019-01-01 2019-03-31 0000105770 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-07-01 2019-09-30 0000105770 us-gaap:RetainedEarningsMember 2019-01-01 2019-03-31 0000105770 us-gaap:TreasuryStockMember 2019-04-01 2019-06-30 0000105770 2019-04-01 2019-06-30 0000105770 us-gaap:RetainedEarningsMember 2019-06-30 0000105770 us-gaap:CommonStockMember 2019-03-31 0000105770 us-gaap:RetainedEarningsMember 2019-07-01 2019-09-30 0000105770 us-gaap:CommonStockMember 2019-04-01 2019-06-30 0000105770 us-gaap:TreasuryStockMember 2019-06-30 0000105770 us-gaap:AdditionalPaidInCapitalMember 2019-04-01 2019-06-30 0000105770 2019-03-31 0000105770 us-gaap:CommonStockMember 2019-07-01 2019-09-30 0000105770 us-gaap:AdditionalPaidInCapitalMember 2019-06-30 0000105770 us-gaap:TreasuryStockMember 2018-12-31 0000105770 us-gaap:AdditionalPaidInCapitalMember 2019-03-31 0000105770 us-gaap:RetainedEarningsMember 2018-12-31 0000105770 us-gaap:RetainedEarningsMember 2019-09-30 0000105770 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-09-30 0000105770 us-gaap:CommonStockMember 2019-06-30 0000105770 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-03-31 0000105770 us-gaap:AdditionalPaidInCapitalMember 2019-09-30 0000105770 us-gaap:TreasuryStockMember 2019-09-30 0000105770 us-gaap:CommonStockMember 2019-09-30 0000105770 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-03-31 0000105770 us-gaap:AdditionalPaidInCapitalMember 2019-07-01 2019-09-30 0000105770 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-04-01 2019-06-30 0000105770 us-gaap:TreasuryStockMember 2019-07-01 2019-09-30 0000105770 us-gaap:CommonStockMember 2018-12-31 0000105770 2019-06-30 0000105770 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-03-31 0000105770 us-gaap:RetainedEarningsMember 2019-04-01 2019-06-30 0000105770 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-06-30 0000105770 us-gaap:TreasuryStockMember 2019-03-31 0000105770 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0000105770 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-12-31 0000105770 2018-03-31 0000105770 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-04-01 2018-06-30 0000105770 us-gaap:TreasuryStockMember 2018-01-01 2018-03-31 0000105770 2018-04-01 2018-06-30 0000105770 us-gaap:RetainedEarningsMember 2018-09-30 0000105770 us-gaap:RetainedEarningsMember 2018-06-30 0000105770 us-gaap:TreasuryStockMember 2017-12-31 0000105770 us-gaap:RetainedEarningsMember 2017-12-31 0000105770 us-gaap:RetainedEarningsMember 2018-03-31 0000105770 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-07-01 2018-09-30 0000105770 us-gaap:CommonStockMember 2018-06-30 0000105770 us-gaap:AdditionalPaidInCapitalMember 2018-01-01 2018-03-31 0000105770 us-gaap:TreasuryStockMember 2018-09-30 0000105770 2018-06-30 0000105770 us-gaap:TreasuryStockMember 2018-06-30 0000105770 us-gaap:TreasuryStockMember 2018-04-01 2018-06-30 0000105770 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-09-30 0000105770 2018-01-01 2018-03-31 0000105770 us-gaap:CommonStockMember 2018-04-01 2018-06-30 0000105770 us-gaap:RetainedEarningsMember 2018-07-01 2018-09-30 0000105770 us-gaap:RetainedEarningsMember 2018-01-01 2018-03-31 0000105770 us-gaap:AdditionalPaidInCapitalMember 2018-06-30 0000105770 us-gaap:CommonStockMember 2017-12-31 0000105770 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-06-30 0000105770 us-gaap:TreasuryStockMember 2018-07-01 2018-09-30 0000105770 us-gaap:TreasuryStockMember 2018-03-31 0000105770 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-01-01 2018-03-31 0000105770 us-gaap:CommonStockMember 2018-03-31 0000105770 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-12-31 0000105770 us-gaap:AdditionalPaidInCapitalMember 2018-04-01 2018-06-30 0000105770 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-03-31 0000105770 us-gaap:AdditionalPaidInCapitalMember 2018-07-01 2018-09-30 0000105770 us-gaap:AdditionalPaidInCapitalMember 2018-03-31 0000105770 us-gaap:AdditionalPaidInCapitalMember 2018-09-30 0000105770 us-gaap:CommonStockMember 2018-09-30 0000105770 us-gaap:CommonStockMember 2018-01-01 2018-03-31 0000105770 us-gaap:AdditionalPaidInCapitalMember 2017-12-31 0000105770 us-gaap:RetainedEarningsMember 2018-04-01 2018-06-30 0000105770 us-gaap:PerformanceSharesMember 2019-09-30 0000105770 us-gaap:PerformanceSharesMember 2019-01-01 2019-09-30 0000105770 us-gaap:RestrictedStockUnitsRSUMember 2019-01-01 2019-09-30 0000105770 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2019-07-01 2019-09-30 0000105770 us-gaap:PensionPlansDefinedBenefitMember 2018-07-01 2018-09-30 0000105770 us-gaap:PensionPlansDefinedBenefitMember 2019-07-01 2019-09-30 0000105770 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2018-07-01 2018-09-30 0000105770 us-gaap:OtherNonoperatingIncomeExpenseMember 2019-07-01 2019-09-30 0000105770 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2018-01-01 2018-09-30 0000105770 us-gaap:PensionPlansDefinedBenefitMember 2019-01-01 2019-09-30 0000105770 us-gaap:PensionPlansDefinedBenefitMember 2018-01-01 2018-09-30 0000105770 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2019-01-01 2019-09-30 0000105770 country:US us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2019-01-01 2019-09-30 0000105770 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-01-01 2018-09-30 0000105770 country:US 2019-01-01 2019-09-30 0000105770 us-gaap:ForeignPlanMember 2019-01-01 2019-09-30 0000105770 country:US us-gaap:PensionPlansDefinedBenefitMember 2018-01-01 2018-09-30 0000105770 country:US us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2018-01-01 2018-09-30 0000105770 us-gaap:ForeignPlanMember 2018-01-01 2018-09-30 0000105770 country:US us-gaap:PensionPlansDefinedBenefitMember 2019-01-01 2019-09-30 0000105770 country:US 2018-01-01 2018-09-30 0000105770 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-01-01 2019-09-30 0000105770 country:US us-gaap:PensionPlansDefinedBenefitMember 2019-07-01 2019-09-30 0000105770 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-07-01 2018-09-30 0000105770 country:US us-gaap:PensionPlansDefinedBenefitMember 2018-07-01 2018-09-30 0000105770 country:US us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2018-07-01 2018-09-30 0000105770 country:US us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2019-07-01 2019-09-30 0000105770 us-gaap:ForeignPlanMember 2018-07-01 2018-09-30 0000105770 country:US 2018-07-01 2018-09-30 0000105770 country:US 2019-07-01 2019-09-30 0000105770 us-gaap:ForeignPlanMember 2019-07-01 2019-09-30 0000105770 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-07-01 2019-09-30 0000105770 us-gaap:OtherNonoperatingIncomeExpenseMember 2019-01-01 2019-09-30 0000105770 wst:A2018RestructuringPlanMember 2018-01-01 2018-09-30 0000105770 wst:A2018RestructuringPlanMember 2019-07-01 2019-09-30 0000105770 wst:A2018RestructuringPlanMember 2019-01-01 2019-09-30 0000105770 wst:A2018RestructuringPlanMember 2018-07-01 2018-09-30 0000105770 wst:A2018RestructuringPlanMember 2019-09-30 0000105770 us-gaap:EmployeeSeveranceMember 2019-01-01 2019-09-30 0000105770 us-gaap:OtherRestructuringMember wst:A2018RestructuringPlanMember 2019-01-01 2019-09-30 0000105770 wst:AssetRelatedChargesMember wst:A2018RestructuringPlanMember 2019-09-30 0000105770 wst:AssetRelatedChargesMember wst:A2018RestructuringPlanMember 2019-01-01 2019-09-30 0000105770 wst:A2018RestructuringPlanMember 2018-12-31 0000105770 us-gaap:OtherRestructuringMember wst:A2018RestructuringPlanMember 2018-12-31 0000105770 us-gaap:EmployeeSeveranceMember 2018-12-31 0000105770 us-gaap:OtherRestructuringMember 2019-01-01 2019-09-30 0000105770 us-gaap:EmployeeSeveranceMember 2019-09-30 0000105770 us-gaap:OtherRestructuringMember wst:A2018RestructuringPlanMember 2019-09-30 0000105770 wst:AssetRelatedChargesMember wst:A2018RestructuringPlanMember 2018-12-31 0000105770 wst:AssetRelatedChargesMember 2019-01-01 2019-09-30 0000105770 wst:SmartDoseMember 2019-07-01 2019-09-30 0000105770 wst:SmartDoseMember 2019-01-01 2019-09-30 0000105770 srt:MaximumMember wst:A2018RestructuringPlanMember 2019-12-31 0000105770 wst:A2016RestructuringPlanMemberMember 2019-09-30 0000105770 wst:DeliverySystemsMember 2018-01-01 2018-09-30 0000105770 wst:DeliverySystemsMember 2018-07-01 2018-09-30 0000105770 wst:PackagingSystemsMember 2018-07-01 2018-09-30 0000105770 us-gaap:IntersegmentEliminationMember 2018-01-01 2018-09-30 0000105770 wst:CorporateAndEliminationsMember 2018-01-01 2018-09-30 0000105770 us-gaap:MaterialReconcilingItemsMember 2019-01-01 2019-09-30 0000105770 wst:PackagingSystemsMember 2019-01-01 2019-09-30 0000105770 wst:PackagingSystemsMember 2018-01-01 2018-09-30 0000105770 wst:DeliverySystemsMember 2019-07-01 2019-09-30 0000105770 wst:PackagingSystemsMember 2019-07-01 2019-09-30 0000105770 us-gaap:IntersegmentEliminationMember 2019-07-01 2019-09-30 0000105770 wst:DeliverySystemsMember 2019-01-01 2019-09-30 0000105770 us-gaap:MaterialReconcilingItemsMember 2019-07-01 2019-09-30 0000105770 wst:CorporateAndEliminationsMember 2019-07-01 2019-09-30 0000105770 wst:CorporateAndEliminationsMember 2019-01-01 2019-09-30 0000105770 us-gaap:IntersegmentEliminationMember 2019-01-01 2019-09-30 0000105770 wst:CorporateAndEliminationsMember 2018-07-01 2018-09-30 0000105770 us-gaap:MaterialReconcilingItemsMember 2018-01-01 2018-09-30 0000105770 us-gaap:IntersegmentEliminationMember 2018-07-01 2018-09-30 0000105770 us-gaap:MaterialReconcilingItemsMember 2018-07-01 2018-09-30 0000105770 2019-10-15 iso4217:EUR iso4217:USD xbrli:shares utreg:MBbls iso4217:SGD xbrli:shares xbrli:pure iso4217:JPY iso4217:USD iso4217:USD wst:bbl wst:segment
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549

FORM 10-Q
(Mark One)
☑
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended September 30, 2019
or
☐
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from            to

Commission File Number 1-8036

WEST PHARMACEUTICAL SERVICES, INC.
(Exact name of registrant as specified in its charter)
 
Pennsylvania
 
 
23-1210010
 
 (State or other jurisdiction of incorporation or organization)
 
(I.R.S. Employer Identification Number)
 
 
 
 
 
 
 
 
 
 
530 Herman O. West Drive,
Exton,
PA
 
 
19341-0645
 
 
(Address of principal executive offices)
 
 
(Zip Code)
 

Registrant’s telephone number, including area code: 610-594-2900
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol
Name of each exchange on which registered
Common Stock, par value $0.25 per share
WST
New York Stock Exchange
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.          Yes ☑ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).                      Yes ☑ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company.  See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer
☑
 
Accelerated filer
☐
Non-accelerated filer
☐
 
Smaller reporting company
☐
 
 
 
Emerging growth company
☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.                                                      ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes ☐ No ☑
As of September 30, 2019, there were 73,990,675 shares of the registrant’s common stock outstanding.


TABLE OF CONTENTS

 
 
Page
 
FINANCIAL STATEMENTS (UNAUDITED)
 
 
 
 
 
 
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
CONTROLS AND PROCEDURES
 
 
 
 
LEGAL PROCEEDINGS
RISK FACTORS
UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
EXHIBITS
 
 
 
 
 
 
 
 

2

PART I. FINANCIAL INFORMATION

ITEM 1.   FINANCIAL STATEMENTS

CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)
West Pharmaceutical Services, Inc. and Subsidiaries
(in millions, except per share data)


 
Three Months Ended
September 30,
 
Nine Months Ended
September 30,
 
2019
 
2018
 
2019
 
2018
Net sales
$
456.1

 
$
431.7

 
$
1,369.3

 
$
1,294.9

Cost of goods and services sold
308.3

 
296.1

 
916.8

 
882.7

Gross profit
147.8

 
135.6

 
452.5

 
412.2

Research and development
9.3

 
10.1

 
28.7

 
30.5

Selling, general and administrative expenses
64.8

 
64.9

 
203.7

 
203.2

Other expense (income) (Note 15)
6.4

 
(0.2
)
 
1.6

 
4.0

Operating profit
67.3

 
60.8

 
218.5

 
174.5

Interest expense
2.1

 
2.0

 
6.4

 
6.1

Interest income
(1.0
)
 
(0.5
)
 
(2.5
)
 
(1.4
)
Other nonoperating expense (income)
1.3

 
(1.8
)
 
0.2

 
(5.1
)
Income before income taxes
64.9

 
61.1

 
214.4

 
174.9

Income tax expense
10.9

 
8.0

 
42.5

 
26.5

Equity in net income of affiliated companies
(2.3
)
 
(2.1
)
 
(5.9
)
 
(6.5
)
Net income
$
56.3

 
$
55.2

 
$
177.8

 
$
154.9

 
 
 
 
 
 
 
 
Net income per share:
 
 
 

 
 

 
 

Basic
$
0.76

 
$
0.75

 
$
2.40

 
$
2.10

Diluted
$
0.75

 
$
0.73

 
$
2.36

 
$
2.05

 
 
 
 
 
 
 
 
Weighted average shares outstanding:
 

 
 

 
 

 
 

Basic
74.0

 
73.9

 
73.9

 
73.9

Diluted
75.5

 
75.7

 
75.3

 
75.4


See accompanying notes to condensed consolidated financial statements.

3

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED)
West Pharmaceutical Services, Inc. and Subsidiaries
(in millions)

 
Three Months Ended
September 30,
 
Nine Months Ended
September 30,
 
2019
 
2018
 
2019
 
2018
Net income
$
56.3

 
$
55.2

 
$
177.8

 
$
154.9

Other comprehensive (loss) income, net of tax:
 

 
 
 
 

 
 

Foreign currency translation adjustments
(23.8
)
 
(9.5
)
 
(20.1
)
 
(39.1
)
Defined benefit pension and other postretirement plan adjustments, net of tax of $0.7, $0, $0.7 and $0.1, respectively
2.4

 
(0.2
)
 
2.2

 
0.1

Net gain (loss) on derivatives, net of tax of $1.5, $(0.1), $0.7, and $1.0, respectively
3.2

 
(0.4
)
 
1.7

 
2.5

Other comprehensive loss, net of tax
(18.2
)
 
(10.1
)
 
(16.2
)
 
(36.5
)
Comprehensive income
$
38.1

 
$
45.1

 
$
161.6

 
$
118.4


See accompanying notes to condensed consolidated financial statements.

4

CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)
West Pharmaceutical Services, Inc. and Subsidiaries
(in millions, except per share data)
 
September 30,
2019
 
December 31,
2018
ASSETS
 
 
 
Current assets:
 
 
 
Cash and cash equivalents
$
396.0

 
$
337.4

Accounts receivable, net
316.1

 
288.2

Inventories
230.4

 
214.5

Other current assets
61.6

 
54.3

Total current assets
1,004.1

 
894.4

Property, plant and equipment
1,779.8

 
1,752.7

Less: accumulated depreciation and amortization
967.7

 
930.7

Property, plant and equipment, net
812.1

 
822.0

Operating lease right-of-use assets
71.3

 
—

Investments in affiliated companies
97.4

 
91.2

Goodwill
106.6

 
105.8

Deferred income taxes
33.8

 
24.7

Intangible assets, net
28.7

 
20.3

Other noncurrent assets
20.0

 
20.5

Total Assets
$
2,174.0

 
$
1,978.9

 
 
 
 
LIABILITIES AND EQUITY
 

 
 

Current liabilities:
 

 
 

Notes payable and other current debt
$
—

 
$
0.1

Accounts payable
145.3

 
130.4

Pension and other postretirement benefits
2.2

 
2.3

Accrued salaries, wages and benefits
72.6

 
64.5

Income taxes payable
19.1

 
9.8

Operating lease liabilities
9.8

 
—

Other current liabilities
86.0

 
76.6

Total current liabilities
335.0

 
283.7

Long-term debt
195.1

 
196.0

Deferred income taxes
10.3

 
13.1

Pension and other postretirement benefits
46.8

 
56.2

Operating lease liabilities
63.5

 
—

Other long-term liabilities
35.7

 
33.6

Total Liabilities
686.4

 
582.6

 
 
 
 
Commitments and contingencies (Note 17)


 


 
 
 
 
Equity:
 
 
 
Preferred stock, 3.0 million shares authorized; 0 shares issued and outstanding
—

 
—

Common stock, par value $0.25 per share; 100.0 million shares authorized; shares issued: 75.3 million and 75.3 million; shares outstanding: 74.0 million and 74.1 million
18.8

 
18.8

Capital in excess of par value
268.5

 
282.0

Retained earnings
1,497.3

 
1,353.4

Accumulated other comprehensive loss
(170.4
)
 
(154.2
)
Treasury stock, at cost (1.3 million and 1.2 million shares)
(126.6
)
 
(103.7
)
Total Equity
1,487.6

 
1,396.3

Total Liabilities and Equity
$
2,174.0

 
$
1,978.9


See accompanying notes to condensed consolidated financial statements.

5

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)
West Pharmaceutical Services, Inc. and Subsidiaries
(in millions)
 
Nine Months Ended
September 30,
 
2019
 
2018
Cash flows from operating activities:
 
 
 
Net income
$
177.8

 
$
154.9

Adjustments to reconcile net income to net cash provided by operating activities:
 
 
 
Depreciation
74.6

 
76.1

Amortization
2.5

 
2.0

Stock-based compensation
18.8

 
14.7

Non-cash restructuring charges
1.6

 
0.8

Pension settlement charge
2.7

 
—

Contingent consideration payments in excess of acquisition-date liability
(0.3
)
 
(0.5
)
Other non-cash items, net
(0.6
)
 
(4.0
)
Changes in assets and liabilities
(16.3
)
 
(28.6
)
Net cash provided by operating activities
260.8

 
215.4

 
 
 
 
Cash flows from investing activities:
 

 
 

Capital expenditures
(88.8
)
 
(74.7
)
Acquisition of business
(18.9
)
 
—

Other, net
0.3

 
2.5

Net cash used in investing activities
(107.4
)
 
(72.2
)
 
 
 
 
Cash flows from financing activities:
 

 
 

Borrowings under revolving credit agreements
28.0

 
—

Repayments under revolving credit agreements
(28.0
)
 
—

Debt issuance costs
(0.9
)
 
—

Dividend payments
(33.3
)
 
(31.0
)
Proceeds from stock-based compensation awards
25.5

 
25.7

Employee stock purchase plan contributions
4.0

 
3.6

Shares purchased under share repurchase programs
(83.1
)
 
(70.8
)
Net cash used in financing activities
(87.8
)
 
(72.5
)
Effect of exchange rates on cash
(7.0
)
 
(9.3
)
Net increase in cash and cash equivalents
58.6

 
61.4

 
 
 
 
Cash, including cash equivalents at beginning of period
337.4

 
235.9

Cash, including cash equivalents at end of period
$
396.0

 
$
297.3


See accompanying notes to condensed consolidated financial statements.

6

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

Note 1:  Summary of Significant Accounting Policies

Basis of Presentation: The condensed consolidated financial statements included in this report are unaudited and have been prepared in accordance with United States (“U.S.”) generally accepted accounting principles (“U.S. GAAP”) for interim financial reporting and U.S. Securities and Exchange Commission (“SEC”) regulations. The year-end condensed consolidated balance sheet data was derived from audited financial statements, but does not include all disclosures required by U.S. GAAP. Certain information and footnote disclosures normally included in annual financial statements prepared in accordance with U.S. GAAP have been condensed or omitted. In the opinion of management, these financial statements include all adjustments, which are of a normal recurring nature, necessary for a fair statement of the financial position, results of operations, cash flows and the change in equity for the periods presented. The condensed consolidated financial statements for the three and nine months ended September 30, 2019 should be read in conjunction with the consolidated financial statements and notes thereto of West Pharmaceutical Services, Inc. and its majority-owned subsidiaries (which may be referred to as “West”, the “Company”, “we”, “us” or “our”) appearing in our Annual Report on Form 10-K for the year ended December 31, 2018 (the “2018 Annual Report”). The results of operations for any interim period are not necessarily indicative of results for the full year.

In April 2019, we acquired the business of our distributor in South Korea for $18.9 million. As a result of the acquisition, we recorded inventories, property, plant and equipment, goodwill and a customer relationships intangible asset of $4.5 million, $0.6 million, $2.6 million and $11.2 million, respectively. The goodwill was recorded within our Proprietary Products reportable segment. The results of this acquisition have been included in our condensed consolidated financial statements since the acquisition date.

As of April 1, 2017, our consolidated financial statements exclude the results of our Venezuelan subsidiary. Please refer to Note 15, Other Expense, to the consolidated financial statements in our 2018 Annual Report for further discussion.

Note 2:  New Accounting Standards

Recently Adopted Standards

In August 2018, the SEC adopted a final release which would eliminate or modify certain disclosure requirements that are redundant, outdated, or duplicative of U.S. GAAP or other regulatory requirements. Among other changes, the amendments provide that disclosure requirements related to the analysis of shareholders’ equity are expanded for interim purposes. An analysis of the changes in each caption of shareholders’ equity presented in the balance sheet must be provided in a note or separate statement, as well as the amount of dividends per share for each class of shares. We provided this disclosure beginning in the first quarter of 2019. Please refer to Note 12, Shareholders’ Equity.

In June 2018, the Financial Accounting Standards Board (“FASB”) issued guidance which expands the scope of accounting for share-based payment arrangements to include share-based payment transactions for acquiring goods and services from nonemployees. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2018. Early adoption was permitted. We adopted this guidance as of January 1, 2019, on a prospective basis. The adoption did not have a material impact on our financial statements.

In February 2018, the FASB issued guidance to address a specific consequence of the Tax Cuts and Jobs Acts (the “2017 Tax Act”) by allowing a reclassification from accumulated other comprehensive income (loss) to retained earnings for stranded tax effects resulting from the 2017 Tax Act’s reduction of the U.S. federal corporate income tax rate. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2018. Early adoption was permitted. We adopted this guidance as of January 1, 2019, on a prospective basis, but elected to not reclassify from accumulated other comprehensive income (loss) to retained earnings the stranded tax effects resulting from the 2017 Tax Act’s reduction of the U.S. federal corporate income tax rate.

7


In August 2017, the FASB issued guidance which expands and refines hedge accounting for both nonfinancial and financial risk components and aligns the recognition and presentation of the effects of the hedging instrument and the hedged item in the financial statements. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2018. Early adoption was permitted. We adopted this guidance as of January 1, 2019, on a prospective basis. The adoption did not have a material impact on our financial statements.

In February 2016, the FASB issued guidance on the accounting for leases, Accounting Standards Codification (“ASC”) Topic 842 (“ASC 842”). This guidance requires lessees to recognize lease assets and lease liabilities on the balance sheet and to expand disclosures about leasing arrangements, both qualitative and quantitative. In terms of transition, the guidance requires adoption based upon a modified retrospective approach. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2018. Early adoption was permitted. We adopted this guidance as of January 1, 2019, using the modified retrospective approach that allows companies to apply ASC 842 as of the effective date and on a prospective basis. Please refer to Note 6, Leases, for additional information.

Standards Issued Not Yet Adopted

In April 2019, the FASB issued guidance which clarifies and improves areas of guidance related to the new credit losses, hedging, and recognition and measurement standards. This guidance is effective for the same fiscal years in which the original standards are effective or, if already implemented, annual periods beginning after the issuance of this guidance. Early adoption is permitted. We believe that the adoption of this guidance will not have a material impact on our financial statements.

In August 2018, the FASB issued guidance to align the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software (and hosting arrangements that include an internal-use software license). The accounting for the service element of a hosting arrangement that is a service contract is not affected by this update. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2019. Early adoption is permitted, including adoption in any interim period. We believe that the adoption of this guidance will not have a material impact on our financial statements.

In August 2018, the FASB issued guidance which modifies the disclosure requirements for defined benefit pension plans and other postretirement plans. The guidance removes disclosures that no longer are considered cost beneficial, clarifies the specific requirements of disclosures, and adds disclosure requirements identified as relevant. This guidance is effective for fiscal years ending after December 15, 2020. Early adoption is permitted. We believe that the adoption of this guidance will not have a material impact on our financial statements.

In August 2018, the FASB issued guidance which modifies the disclosure requirements on fair value measurements by removing, modifying, or adding certain disclosures. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2019. Early adoption is permitted. We believe that the adoption of this guidance will not have a material impact on our financial statements.

In June 2016, the FASB issued guidance which provides financial statement users with more decision-useful information about the expected credit losses on financial instruments and other commitments held by a reporting entity at each reporting date. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2019. Early adoption is permitted. We believe that the adoption of this guidance will not have a material impact on our financial statements.


8

Note 3:  Revenue

The following table presents the approximate percentage of our net sales by market group:
 
Three Months Ended
September 30,
 
Nine Months Ended
September 30,
 
2019
 
2018
 
2019
 
2018
Biologics
26
%
 
21
%
 
25
%
 
21
%
Generics
20
%
 
21
%
 
20
%
 
21
%
Pharma
30
%
 
34
%
 
31
%
 
35
%
Contract-Manufactured Products
24
%
 
24
%
 
24
%
 
23
%
 
100
%
 
100
%
 
100
%
 
100
%
The following table presents the approximate percentage of our net sales by product category:
 
Three Months Ended
September 30,
 
Nine Months Ended
September 30,
 
2019
 
2018
 
2019
 
2018
High-Value Components
42
%
 
41
%
 
43
%
 
42
%
Standard Packaging
28
%
 
31
%
 
29
%
 
32
%
Delivery Devices
6
%
 
4
%
 
4
%
 
3
%
Contract-Manufactured Products
24
%
 
24
%
 
24
%
 
23
%
 
100
%
 
100
%
 
100
%
 
100
%
The following table presents the approximate percentage of our net sales by geographic location:
 
Three Months Ended
September 30,
 
Nine Months Ended
September 30,
 
2019
 
2018
 
2019
 
2018
Americas
48
%
 
51
%
 
48
%
 
48
%
Europe, Middle East, Africa
44
%
 
41
%
 
44
%
 
44
%
Asia Pacific
8
%
 
8
%
 
8
%
 
8
%
 
100
%
 
100
%
 
100
%
 
100
%

Contract Assets and Liabilities
The following table summarizes our contract assets and liabilities, excluding contract assets included in accounts receivable, net:
 
($ in millions)
Contract assets, December 31, 2018
$
9.1

Contract assets, September 30, 2019
9.4

Change in contract assets - increase (decrease)
$
0.3

 
 
Deferred income, December 31, 2018
$
(33.4
)
Deferred income, September 30, 2019
(30.9
)
Change in deferred income - decrease (increase)
$
2.5



9

The decrease in deferred income during the nine months ended September 30, 2019 was primarily due to the recognition of revenue of $79.3 million, including $18.0 million of revenue that was included in deferred income at the beginning of the year, and $2.7 million in other adjustments, partially offset by additional cash payments of $79.5 million received in advance of satisfying future performance obligations.
The majority of the performance obligations within our contracts are satisfied within one year or less. Performance obligations satisfied beyond one year include those relating to a nonrefundable customer payment of $20.0 million received in June 2013 in return for the exclusive use of the SmartDose® technology platform within a specific therapeutic area. As of September 30, 2019, there was $5.9 million of unearned income related to this payment, of which $0.9 million was included in other current liabilities and $5.0 million was included in other long-term liabilities. The unearned income is being recognized as income on a straight-line basis over the remaining term of the agreement. The agreement does not include a future minimum purchase commitment from the customer.
Supply Chain Financing
We have entered into supply chain financing agreements with certain banks, pursuant to which we offer for sale certain accounts receivable to such banks from time to time, subject to the terms of the applicable agreements. These transactions result in a reduction in accounts receivable, as the agreements transfer effective control over, and credit risk related to, the receivables to the banks. These agreements do not allow for recourse in the event of uncollectibility, and we do not retain any interest in the underlying accounts receivable once sold. As of September 30, 2019, we derecognized $7.9 million of accounts receivable under these agreements. Discount fees related to the sale of such accounts receivable on our condensed consolidated income statements for the nine months ended September 30, 2019 were not material.

Voluntary Recall
On January 24, 2019, we issued a voluntary recall of our Vial2Bag® product line due to reports of potential unpredictable or variable dosing under certain conditions. Our fourth quarter 2018 results included an $11.3 million provision for product returns, recorded as a reduction of sales, partially offset by a reduction in cost of goods sold reflecting our inventory balance for these devices at December 31, 2018. During the three and nine months ended September 30, 2019, we recorded a net adjustment of $0.9 million and a net provision of $4.9 million, respectively, for potential inventory returns from our customers and related in-house inventory, partially offset by a reduction in our provision for product returns. We continue to work to get the products back on the market.

Note 4:  Net Income Per Share

The following table reconciles the shares used in the calculation of basic net income per share to those used for diluted net income per share:

 
Three Months Ended
September 30,
 
Nine Months Ended
September 30,
(in millions)
2019
 
2018
 
2019
 
2018
Net income
$
56.3

 
$
55.2

 
$
177.8

 
$
154.9

Weighted average common shares outstanding
74.0

 
73.9

 
73.9

 
73.9

Dilutive effect of equity awards, based on the treasury stock method
1.5

 
1.8

 
1.4

 
1.5

Weighted average shares assuming dilution
75.5

 
75.7

 
75.3

 
75.4



During the three months ended September 30, 2019 and 2018, there were 0.1 million and 0.1 million shares, respectively, from stock-based compensation plans not included in the computation of diluted net income per share because their impact was antidilutive. There were 0.3 million and 0.4 million antidilutive shares outstanding during the nine months ended September 30, 2019 and 2018, respectively.


10

In February 2019, we announced a share repurchase program for calendar-year 2019 authorizing the repurchase of up to 800,000 shares of our common stock from time to time on the open market or in privately-negotiated transactions as permitted under the Securities Exchange Act of 1934 Rule 10b-18. The number of shares repurchased and the timing of such transactions depended on a variety of factors, including market conditions. There were no shares purchased during the three months ended September 30, 2019. During the nine months ended September 30, 2019, we purchased 800,000 shares of our common stock under the now-completed program at a cost of $83.1 million, or an average price of $103.89 per share.

Note 5:  Inventories

Inventories are valued at the lower of cost (on a first-in, first-out basis) and net realizable value. Inventory balances were as follows:

($ in millions)
September 30,
2019
 
December 31,
2018
Raw materials
$
99.2

 
$
90.4

Work in process
38.3

 
42.2

Finished goods
92.9

 
81.9

 
$
230.4

 
$
214.5



Note 6:  Leases

Adoption of ASC 842

On January 1, 2019, we adopted ASC 842, using the modified retrospective approach that allows companies to apply ASC 842 as of the effective date and on a prospective basis. As a result, we were not required to adjust our comparative period financial information for effects of ASC 842 or present the new required lease disclosures for periods prior to the date of adoption. As of September 30, 2019, we had operating leases primarily related to land, buildings, and machinery and equipment, with lease terms through 2047. Certain of our operating leases include options to extend the lease term for up to five years, and certain of our operating leases include options to terminate the leases within one year. We had no finance leases as of September 30, 2019.

As a result of our adoption of ASC 842, we recorded operating lease right-of-use assets of $71.0 million and operating lease liabilities of $73.1 million for operating leases where we are the lessee in our condensed consolidated balance sheet as of January 1, 2019. The operating lease right-of-use assets are initially measured at cost, which comprises the initial amount of the lease liability adjusted for lease payments made at or before the lease commencement date, plus any initial direct costs incurred less any lease incentives received. The operating lease right-of-use assets are subsequently measured throughout the lease term at the carrying amount of the lease liability, plus initial direct costs, plus (minus) any prepaid (accrued) lease payments, less the unamortized balance of lease incentives received. Lease expense for lease payments is recognized on a straight-line basis over the lease term. The operating lease liabilities are initially measured at the present value of the unpaid lease payments at the lease commencement date.

Judgments used in applying ASC 842 include determining: i) whether a contract is, or contains, a lease; ii) the discount rate to be used to discount the unpaid lease payments to present value; iii) the lease term; and iv) the lease payments. We determine if a contract is, or contains, a lease at contract inception. A lease exists when a contract conveys to the customer the right to control the use of identified property, plant, or equipment for a period of time in exchange for consideration. The definition of a lease embodies two conditions: 1) there is an identified asset in the contract that is land or a depreciable asset (i.e., property, plant, and equipment); and 2) the customer has the right to control the use of the identified asset. ASC 842 requires a lessee to discount its unpaid lease payments using the interest rate implicit in the lease or, if that rate cannot be readily determined, its incremental borrowing rate. As all of our operating leases do not provide an implicit rate, we use our incremental borrowing rate based on the

11

information available at commencement date in determining the present value of lease payments. Our incremental borrowing rate for a lease is the rate of interest we would have to pay on a collateralized basis to borrow an amount equal to the lease payments under similar terms. The lease term for all of our operating leases includes the noncancellable period of the lease plus any additional periods covered by either a lessee option to extend (or not to terminate) the lease that the lessee is reasonably certain to exercise, or an option to extend (or not to terminate) the lease controlled by the lessor. Lease payments included in the measurement of the operating lease right-of-use assets and lease liabilities are comprised of fixed payments (including in-substance fixed payments), variable payments that depend on an index or rate, and the exercise price of a lessee option to purchase the underlying asset if the lessee is reasonably certain to exercise.

The components of lease expense were as follows:
($ in millions)
Three Months Ended
September 30, 2019
 
Nine Months Ended
September 30, 2019
Operating lease cost
$
3.4

 
$
9.7

Short-term lease cost
0.1

 
0.5

Variable lease cost
0.8

 
2.3

Total lease cost
$
4.3

 
$
12.5



Lease expense for the three and nine months ended September 30, 2018 was $3.3 million and $10.4 million, respectively.

Supplemental information related to leases was as follows:
($ in millions)
Three Months Ended
September 30, 2019
 
Nine Months Ended
September 30, 2019
Cash paid for amounts included in the measurement of lease liabilities:
 
 
 
Operating cash flows from operating leases
$
3.2

 
$
9.4

 
 
 
 
Right-of-use assets obtained in exchange for new operating lease liabilities
$
0.3

 
$
8.4



As of September 30, 2019, the weighted average remaining lease term for operating leases was 11.8 years, and the weighted average discount rate was 3.76%.

Maturities of lease liabilities as of September 30, 2019 were as follows:
($ in millions)
Operating
Year
Leases
2019 (remaining three months)
$
3.4

2020
12.0

2021
10.2

2022
8.3

2023
7.7

Thereafter
48.1

 
89.7

Less: imputed lease interest
(16.4
)
Total lease liabilities
$
73.3




12

Maturities of future minimum rental payments under non-cancelable operating leases as of December 31, 2018 were as follows:
($ in millions)
Operating
Year
Leases
2019
$
13.0

2020
10.5

2021
7.8

2022
6.9

2023
5.5

Thereafter
37.8

Total
$
81.5



Practical Expedients and Exemptions

We have elected to adopt the leasing package of practical expedients, which allows us to not retroactively reassess: i) any expired or existing contracts containing leases under the new definition of a lease; ii) the lease classification for any expired or existing leases; and iii) initial direct costs for any expired or existing leases. We have also elected to adopt practical expedients around land easements, the combination of lease and non-lease components, and the portfolio approach relating to discount rates. These practical expedients were applied consistently to all leases.

We have elected not to recognize operating lease right-of-use assets and operating lease liabilities for all short-term leases (leases with an initial lease term of 12 months or less). We recognize the lease payments associated with our short-term leases as an expense over the lease term.

Note 7:  Affiliated Companies

At September 30, 2019 and December 31, 2018, the aggregate carrying amount of our investment in affiliated companies that are accounted for under the equity method was $84.0 million and $77.8 million, respectively, and the aggregate carrying amount of our investment in affiliated companies that are not accounted for under the equity method was $13.4 million at both period-ends. We have elected to record these investments, for which fair value was not readily determinable, at cost, less impairment, adjusted for subsequent observable price changes. We test these investments for impairment whenever circumstances indicate that the carrying value of the investments may not be recoverable.

Our purchases from, and royalty payments made to, affiliates totaled $33.0 million and $85.2 million, respectively, for the three and nine months ended September 30, 2019, as compared to $16.3 million and $64.0 million, respectively, for the same periods in 2018. As of September 30, 2019 and December 31, 2018, the payable balance due to affiliates was $24.3 million and $12.9 million, respectively. The majority of these transactions related to a distributorship agreement with Daikyo Seiko, Ltd. (“Daikyo”) that allows us to purchase and re-sell Daikyo products.

Sales to affiliates were $2.2 million and $6.9 million, respectively, for the three and nine months ended September 30, 2019, as compared to $3.0 million and $8.0 million, respectively, for the same periods in 2018. As of September 30, 2019 and December 31, 2018, the receivable balance due from affiliates was $1.4 million and $1.6 million, respectively.

Please refer to Note 6, Affiliated Companies, to the consolidated financial statements in our 2018 Annual Report for additional details.


13

Note 8:  Debt

The following table summarizes our long-term debt obligations, net of unamortized debt issuance costs and current maturities. The interest rates shown in parentheses are as of September 30, 2019.

($ in millions)
September 30,
2019
 
December 31,
2018
Note payable, due December 31, 2019
$
—

 
$
0.1

Credit Facility, due October 15, 2020
—

 
28.6

Credit Facility, due March 28, 2024 (0.875%)
27.6

 
—

Series A notes, due July 5, 2022 (3.67%)
42.0

 
42.0

Series B notes, due July 5, 2024 (3.82%)
53.0

 
53.0

Series C notes, due July 5, 2027 (4.02%)
73.0

 
73.0

 
195.6

 
196.7

Less: unamortized debt issuance costs
0.5

 
0.6

Total debt
195.1

 
196.1

Less: current portion of long-term debt
—

 
0.1

Long-term debt, net
$
195.1

 
$
196.0



In March 2019, we entered into a new senior unsecured, multi-currency revolving credit facility agreement (the “Credit Agreement”) that replaced our prior revolving credit facility, which was scheduled to expire in October 2020. The Credit Agreement, which expires in March 2024, contains a senior unsecured, multi-currency revolving credit facility (the “Credit Facility”) of $300.0 million, with sublimits of up to $30.0 million for swing line loans for domestic borrowers in U.S. Dollars (“USD”) and a $20.0 million swing line loan for our German Holding Company and up to $30.0 million for the issuance of standby letters of credit, which Credit Facility may be increased from time-to-time by the greater of $350.0 million and earnings before interest, taxes, depreciation and amortization (“EBITDA”) for the preceding twelve month period in the aggregate through an increase in the Credit Facility, subject to the satisfaction of certain conditions. Borrowings under the Credit Facility bear interest at either the base rate (the per annum interest rate of the highest of the Prime Rate, the Federal Funds Rate plus 50 basis points or the daily London Interbank Offered Rate (“LIBOR”), plus 1.00%) or at the applicable LIBOR rate, plus a tiered margin based on the ratio of our net consolidated debt to our modified EBITDA, ranging from 0 to 37.5 basis points for base rate loans and 87.5 to 137.5 basis points for LIBOR rate loans. The Credit Agreement contains financial covenants providing that we shall not permit the ratio of our net consolidated debt to our modified EBITDA to be greater than 3.5 to 1; provided that, no more than three times during the term of the Credit Agreement, upon the occurrence of a qualified acquisition for each of our four fiscal quarters immediately following such qualified acquisition, the ratio shall be increased to 4.0 to 1. The Credit Agreement also contains customary limitations on liens securing our indebtedness, fundamental changes (mergers, consolidations, liquidations and dissolutions), asset sales, distributions and acquisitions. As of September 30, 2019 and December 31, 2018, total unamortized debt issuance costs of $1.1 million and $0.6 million, respectively, were recorded in other noncurrent assets and are being amortized as additional interest expense over the term of the Credit Facility. A portion of these costs relate to our prior revolving credit facility.

At September 30, 2019, we had $27.6 million in outstanding long-term borrowings under the Credit Facility, of which $4.6 million was denominated in Japanese Yen (“Yen”) and $23.0 million was denominated in Euro. These borrowings, together with outstanding letters of credit of $2.5 million, resulted in a borrowing capacity available under the Credit Facility of $269.9 million at September 30, 2019. Please refer to Note 9, Derivative Financial Instruments, for a discussion of the foreign currency hedges associated with the Credit Facility.

Please refer to Note 9, Debt, to the consolidated financial statements in our 2018 Annual Report for additional details regarding our debt agreements.

14


Note 9:  Derivative Financial Instruments

Our ongoing business operations expose us to various risks, such as fluctuating interest rates, foreign currency exchange rates and increasing commodity prices. To manage these market risks, we periodically enter into derivative financial instruments, such as interest rate swaps, options and foreign exchange contracts for periods consistent with, and for notional amounts equal to or less than, the related underlying exposures. We do not purchase or hold any derivative financial instruments for investment or trading purposes. All derivatives are recorded in our condensed consolidated balance sheet at fair value.

Foreign Exchange Rate Risk

We have entered into forward exchange contracts, designated as fair value hedges, to manage our exposure to fluctuating foreign exchange rates on cross-currency intercompany loans. As of September 30, 2019, the total amount of these forward exchange contracts was Singapore Dollar (“SGD”) 601.5 million and $13.4 million. As of December 31, 2018, the total amount of these forward exchange contracts was €10.0 million, SGD 601.5 million and $13.4 million.

In addition, we have entered into several foreign currency contracts, designated as cash flow hedges, for periods of up to eighteen months, intended to hedge the currency risk associated with a portion of our forecasted transactions denominated in foreign currencies. As of September 30, 2019, we had outstanding foreign currency contracts to purchase and sell certain pairs of currencies, as follows:
(in millions)
 
 
Sell
Currency
Purchase
 
USD
Euro
USD
39.3

 
—

34.2

Yen
5,921.1

 
31.8

20.2

SGD
31.9

 
18.7

4.3



At September 30, 2019, a portion of our debt consisted of borrowings denominated in currencies other than USD. We have designated our €21.0 million ($23.0 million) Euro-denominated borrowings under our Credit Facility as a hedge of our net investment in certain European subsidiaries. A cumulative foreign currency translation gain of $0.6 million pre-tax ($0.5 million after tax) on this debt was recorded within accumulated other comprehensive loss as of September 30, 2019. We have also designated our ¥500.0 million ($4.6 million) Yen-denominated borrowings under our Credit Facility as a hedge of our net investment in Daikyo. At September 30, 2019, there was a cumulative foreign currency translation loss of $0.5 million pre-tax ($0.4 million after tax) on this Yen-denominated debt, which was also included within accumulated other comprehensive loss.

Commodity Price Risk

Many of our proprietary products are made from synthetic elastomers, which are derived from the petroleum refining process. We purchase the majority of our elastomers via long-term supply contracts, some of which contain clauses that provide for surcharges related to fluctuations in crude oil prices. The following economic hedges did not qualify for hedge accounting treatment since they did not meet the highly effective requirement at inception.

From November 2017 through July 2019, we purchased several series of call options for a total of 301,326 barrels of crude oil to mitigate our exposure to such oil-based surcharges and protect operating cash flows with regards to a portion of our forecasted elastomer purchases.

As of September 30, 2019, we had outstanding contracts to purchase 107,909 barrels of crude oil from October 2019 to December 2020, at a weighted-average strike price of $71.15 per barrel.


15

Effects of Derivative Instruments on Financial Position and Results of Operations

Please refer to Note 10, Fair Value Measurements, for the balance sheet location and fair values of our derivative instruments as of September 30, 2019 and December 31, 2018.

The following table summarizes the effects of derivative instruments designated as fair value hedges on the condensed consolidated statements of income:
 
Amount of Loss (Gain) Recognized in Income for the
 
Amount of Gain Recognized in Income for the
 
 
 
Three Months Ended
September 30,
 
Nine Months Ended
September 30,
 
Location on Statement of Income
($ in millions)
2019
 
2018
 
2019
 
2018
 
 
Fair Value Hedges:
 
 
 
 
 
 
 
 
 
Foreign currency hedge contracts
$
4.3

 
$
(2.0
)
 
$
(5.0
)
 
$
(3.4
)
 
Other expense (income)
Total
$
4.3

 
$
(2.0
)
 
$
(5.0
)
 
$
(3.4
)
 
 

We recognize in earnings the initial value of forward point components on a straight-line basis over the life of the fair value hedge.

The following tables summarize the effects of derivative instruments designated as fair value, cash flow, and net investment hedges on other comprehensive income (“OCI”) and earnings, net of tax:
 
Amount of (Loss) Gain Recognized in OCI for the
 
Amount of Loss (Gain) Reclassified from Accumulated OCI into Income for the
 
Location of Loss (Gain) Reclassified from Accumulated OCI into Income
 
Three Months Ended
September 30,
 
Three Months Ended
September 30,
 
($ in millions)
2019
 
2018
 
2019
 
2018
 
 
Fair Value Hedges
 
 
 
 
 
 
 
 
 
Foreign currency hedge contracts
$
(0.6
)
 
$
—

 
$
2.9

 
$
—

 
Other expense (income)
Total
$
(0.6
)
 
$
—

 
$
2.9

 
$
—

 
 
Cash Flow Hedges:
 
 
 
 
 
 
 
 
 
Foreign currency hedge contracts
$
0.7

 
$
0.1

 
$
(0.3
)
 
$
—

 
Net sales
Foreign currency hedge contracts
0.6

 
(0.5
)
 
(0.2
)
 
(0.1
)
 
Cost of goods and services sold
Forward treasury locks
—

 
—

 
0.1

 
0.1

 
Interest expense
Total
$
1.3

 
$
(0.4
)
 
$
(0.4
)
 
$
—

 
 
Net Investment Hedges:
 

 
 

 
 

 
 

 
 
Foreign currency-denominated debt
$
0.7

 
$
0.2

 
$
—

 
$
—

 
Other expense (income)
Total
$
0.7

 
$
0.2

 
$
—

 
$
—

 
 


16

 
Amount of Gain (Loss) Recognized in OCI for the
 
Amount of (Gain) Loss Reclassified from Accumulated OCI into Income for the
 
Location of (Gain) Loss Reclassified from Accumulated OCI into Income
 
Nine Months Ended
September 30,
 
Nine Months Ended
September 30,
 
($ in millions)
2019
 
2018
 
2019
 
2018
 
 
Fair Value Hedges
 
 
 
 
 
 
 
 
 
Foreign currency hedge contracts
$
3.9

 
$
—

 
$
(3.3
)
 
$
—

 
Other expense (income)
Total
$
3.9

 
$
—

 
$
(3.3
)
 
$
—

 
 
Cash Flow Hedges:
 
 
 
 
 
 
 
 
 
Foreign currency hedge contracts
$
1.0

 
$
0.2

 
$
(0.7
)
 
$
0.8

 
Net sales
Foreign currency hedge contracts
1.1

 
0.9

 
(0.5
)
 
0.4

 
Cost of goods and services sold
Forward treasury locks
—

 
—

 
0.2

 
0.2

 
Interest expense
Total
$
2.1

 
$
1.1

 
$
(1.0
)
 
$
1.4

 
 
Net Investment Hedges:
 

 
 

 
 

 
 

 
 
Foreign currency-denominated debt
$
0.5

 
$
0.7

 
$
—

 
$
—

 
Other expense (income)
Total
$
0.5

 
$
0.7

 
$
—

 
$
—

 
 


The following table summarizes the effects of derivative instruments not designated as hedges on the condensed consolidated statements of income:
 
Amount of Loss Recognized in Income for the
 
Amount of Loss (Gain) Recognized in Income for the
 
 
 
Three Months Ended
September 30,
 
Nine Months Ended
September 30,
 
Location on Statement of Income
($ in millions)
2019
 
2018
 
2019
 
2018
 
 
Commodity call options
$
0.1

 
$
—

 
$
0.3

 
$
(0.5
)
 
Cost of goods and services sold
Total
$
0.1

 
$
—

 
$
0.3

 
$
(0.5
)
 
 


For the three and nine months ended September 30, 2019 and 2018, there was no material ineffectiveness related to our hedges.


17

Note 10:  Fair Value Measurements

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The following fair value hierarchy classifies the inputs to valuation techniques used to measure fair value into one of three levels:

•
Level 1: Unadjusted quoted prices in active markets for identical assets or liabilities.
•
Level 2: Inputs other than quoted prices that are observable for the asset or liability, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active.
•
Level 3: Unobservable inputs that reflect the reporting entity’s own assumptions.

The following tables present the assets and liabilities recorded at fair value on a recurring basis:
 
Balance at
 
Basis of Fair Value Measurements
($ in millions)
September 30,
2019
 
Level 1
 
Level 2
 
Level 3
Assets:
 
 
 
 
 
 
 
Deferred compensation assets
$
9.9

 
$
9.9

 
$
—

 
$
—

Foreign currency contracts
13.2

 
—

 
13.2

 
—

Commodity call options
0.1

 
—

 
0.1

 
—

 
$
23.2

 
$
9.9

 
$
13.3

 
$
—

Liabilities:
 

 
 

 
 

 
 

Contingent consideration
$
1.8

 
$
—

 
$
—

 
$
1.8

Deferred compensation liabilities
11.4

 
11.4

 
—

 
—

Foreign currency contracts
0.2

 
—

 
0.2

 
—

 
$
13.4

 
$
11.4

 
$
0.2

 
$
1.8


 
Balance at
 
Basis of Fair Value Measurements
($ in millions)
December 31,
2018
 
Level 1
 
Level 2
 
Level 3
Assets:
 
 
 
 
 
 
 
Deferred compensation assets
$
8.7

 
$
8.7

 
$
—

 
$
—

Foreign currency contracts
6.5

 
—

 
6.5

 
—

 
$
15.2

 
$
8.7

 
$
6.5

 
$
—

Liabilities:
 

 
 

 
 

 
 

Contingent consideration
$
1.7

 
$
—

 
$
—

 
$
1.7

Deferred compensation liabilities
9.8

 
9.8

 
—

 
—

Foreign currency contracts
0.2

 
—

 
0.2

 
—

 
$
11.7

 
$
9.8

 
$
0.2

 
$
1.7



Deferred compensation assets are included within other noncurrent assets and are valued using a market approach based on quoted market prices in an active market. The fair value of our foreign currency contracts, included within other current and other noncurrent assets, as well as other current and other long-term liabilities, is valued using an income approach based on quoted forward foreign exchange rates and spot rates at the reporting date. The fair value of our commodity call options, included within other current and other noncurrent assets, is valued using a market

18

approach. The fair value of our contingent consideration, included within other current and other long-term liabilities, is discussed further in the section related to Level 3 fair value measurements. The fair value of deferred compensation liabilities is based on quoted prices of the underlying employees’ investment selections and is included within other long-term liabilities. Please refer to Note 9, Derivative Financial Instruments, for further discussion of our derivatives.

Level 3 Fair Value Measurements

The fair value of the contingent consideration liability related to the SmartDose technology platform (the “SmartDose contingent consideration”) was initially determined using a probability-weighted income approach, and is revalued at each reporting date or more frequently if circumstances dictate. Changes in the fair value of this obligation are recorded as income or expense within other expense (income) in our condensed consolidated statements of income. The significant unobservable inputs used in the fair value measurement of the SmartDose contingent consideration are the sales projections, the probability of success factors, and the discount rate. Significant increases or decreases in any of those inputs in isolation would result in a significantly lower or higher fair value measurement. As development and commercialization of the SmartDose technology platform progresses, we may need to update the sales projections, the probability of success factors, and the discount rate used. This could result in a material increase or decrease to the SmartDose contingent consideration.

The following table provides a summary of changes in our Level 3 fair value measurements:
 
($ in millions)
Balance, December 31, 2017
$
4.9

Decrease in fair value recorded in earnings
(2.6
)
Payments
(0.6
)
Balance, December 31, 2018
1.7

Increase in fair value recorded in earnings
0.4

Payments
(0.3
)
Balance, September 30, 2019
$
1.8


Other Financial Instruments

We believe that the carrying amounts of our cash and cash equivalents and accounts receivable approximate their fair values due to their near-term maturities.

The estimated fair value of long-term debt is based on quoted market prices for debt issuances with similar terms and maturities and is classified as Level 2 within the fair value hierarchy. At September 30, 2019, the estimated fair value of long-term debt was $204.4 million compared to a carrying amount of $195.1 million. At December 31, 2018, the estimated fair value of long-term debt was $192.6 million and the carrying amount was $196.0 million.


19

Note 11:  Accumulated Other Comprehensive Loss
 
The following table presents the changes in the components of accumulated other comprehensive loss, net of tax, for the nine months ended September 30, 2019:

($ in millions)
(Losses) gains on
derivatives
 
Unrealized gains
on investment
securities
 
Defined benefit
pension and other
postretirement plans
 
Foreign
currency
translation
 
Total
Balance, December 31, 2018
$
(0.4
)
 
$
0.4

 
$
(40.4
)
 
$
(113.8
)
 
$
(154.2
)
Other comprehensive income (loss) before reclassifications
6.0

 
—

 
0.6

 
(20.1
)
 
(13.5
)
Amounts reclassified out
(4.3
)
 
—

 
1.6

 
—

 
(2.7
)
Other comprehensive income (loss), net of tax
1.7

 
—

 
2.2

 
(20.1
)
 
(16.2
)
Balance, September 30, 2019
$
1.3

 
$
0.4

 
$
(38.2
)
 
$
(133.9
)
 
$
(170.4
)


A summary of the reclassifications out of accumulated other comprehensive loss is presented in the following table:

($ in millions)
 
Three Months Ended
September 30,
 
Nine Months Ended
September 30,
 
Location on Statement of Income
Detail of components
 
2019
 
2018
 
2019
 
2018

 
Gains (losses) on derivatives:
 
 
 
 
 
 
 
 
 
 
Foreign currency contracts
 
$
0.3

 
$
0.1

 
$
0.8

 
$
(0.8
)
 
Net sales
Foreign currency contracts
 
0.3

 
—

 
0.8

 
(0.7
)
 
Cost of goods and services sold
Foreign currency contracts
 
(4.3
)
 
—

 
5.0

 
—

 
Other expense (income)
Forward treasury locks
 
(0.1
)
 
(0.1
)
 
(0.3
)
 
(0.3
)
 
Interest expense
Total before tax
 
(3.8
)
 
—

 
6.3

 
(1.8
)
 
 
Tax expense
 
1.3

 
—

 
(2.0
)
 
0.4

 
 
Net of tax
 
$
(2.5
)
 
$
—

 
$
4.3

 
$
(1.4
)
 
 
Amortization of defined benefit pension and other postretirement plans:
 
 
 
 
 
 
 
 
 
 
Prior service credit
 
$
0.1

 
$
0.5

 
$
0.4

 
$
1.6

 
(a)
Actuarial gains (losses)
 
0.2

 
(0.2
)
 
0.2

 
(1.0
)
 
(a)
Settlements
 
(2.7
)
 
—

 
(2.7
)
 
—

 
(a)
Total before tax
 
(2.4
)
 
0.3

 
(2.1
)
 
0.6

 
 
Tax expense
 
0.6

 
—

 
0.5

 
(0.1
)
 
 
Net of tax
 
$
(1.8
)
 
$
0.3

 
$
(1.6
)
 
$
0.5

 
 
Total reclassifications for the period, net of tax
 
$
(4.3
)
 
$
0.3

 
$
2.7

 
$
(0.9
)
 
 

(a) These components are included in the computation of net periodic benefit cost. Please refer to Note 14, Benefit Plans, for additional details.


20

Note 12: Shareholders’ Equity

The following table presents the changes in shareholders’ equity for the nine months ended September 30, 2019:

 
Common Shares Issued
 
Common Stock
 
Capital in Excess of Par Value
 
Number of Treasury Shares
 
Treasury Stock
 
Retained earnings
 
Accumulated other comprehensive loss
 
Total
($ in millions)
 
 
 
 
 
 
 
Balance, December 31, 2018
75.3

 
$
18.8

 
$
282.0

 
1.2

 
$
(103.7
)
 
$
1,353.4

 
$
(154.2
)
 
$
1,396.3

Net income
—

 
—

 
—

 
—

 
—

 
55.4

 
—

 
55.4

Activity related to stock-based compensation
—

 
—

 
(3.5
)
 
(0.2
)
 
14.2

 
—

 
—

 
10.7

Shares purchased under share repurchase program
—

 
—

 
—

 
0.8

 
(83.1
)
 
—

 
—

 
(83.1
)
Dividends declared ($0.15 per share)
—

 
—

 
—

 
—

 
—

 
(10.6
)
 
—

 
(10.6
)
Other comprehensive income, net of tax
—

 
—

 
—

 
—

 
—

 
—

 
0.8

 
0.8

Balance, March 31, 2019
75.3

 
$
18.8

 
$
278.5

 
1.8

 
$
(172.6
)
 
$
1,398.2

 
$
(153.4
)
 
$
1,369.5

Net income
—

 
—

 
—

 
—

 
—

 
66.1

 
—

 
66.1

Activity related to stock-based compensation
—

 
—

 
(5.1
)
 
(0.2
)
 
24.8

 
—

 
—

 
19.7

Dividends declared ($0.15 per share)
—

 
—

 
—

 
—

 
—

 
(11.4
)
 
—

 
(11.4
)
Other comprehensive income, net of tax
—

 
—

 
—

 
—

 
—

 
—

 
1.2

 
1.2

Balance, June 30, 2019
75.3

 
$
18.8

 
$
273.4

 
1.6

 
$
(147.8
)
 
$
1,452.9

 
$
(152.2
)
 
$
1,445.1

Net income
—

 
—

 
—

 
—

 
—

 
56.3

 
—

 
56.3

Activity related to stock-based compensation
—

 
—

 
(4.9
)
 
(0.3
)
 
21.2

 
—

 
—

 
16.3

Dividends declared ($0.16 per share)
—

 
—

 
—

 
—

 
—

 
(11.9
)
 
—

 
(11.9
)
Other comprehensive loss, net of tax
—

 
—

 
—

 
—

 
—

 
—

 
(18.2
)
 
(18.2
)
Balance, September 30, 2019
75.3

 
$
18.8

 
$
268.5

 
1.3

 
$
(126.6
)
 
$
1,497.3

 
$
(170.4
)
 
$
1,487.6




21

The following table presents the changes in shareholders’ equity for the nine months ended September 30, 2018:

 
Common Shares Issued
 
Common Stock
 
Capital in Excess of Par Value
 
Number of Treasury Shares
 
Treasury Stock
 
Retained earnings
 
Accumulated other comprehensive loss
 
Total
($ in millions)
 
 
 
 
 
 
 
Balance, December 31, 2017
75.2

 
$
18.8

 
$
309.3

 
1.3

 
$
(109.1
)
 
$
1,178.2

 
$
(117.3
)
 
$
1,279.9

Effect of modified retrospective application of a new accounting standard
—

 
—

 
—

 
—

 
—

 
11.4

 
—

 
11.4

Net income
—

 
—

 
—

 
—

 
—

 
43.6

 
—

 
43.6

Activity related to stock-based compensation
0.1

 
—

 
(0.8
)
 
(0.1
)
 
8.0

 
—

 
—

 
7.2

Shares purchased under share repurchase program
—

 
—

 
—

 
0.5

 
(47.9
)
 
—

 
—

 
(47.9
)
Dividends declared ($0.14 per share)
—

 
—

 
—

 
—

 
—

 
(10.4
)
 
—

 
(10.4
)
Other comprehensive income, net of tax
—

 
—

 
—

 
—

 
—

 
—

 
21.5

 
21.5

Balance, March 31, 2018
75.3

 
$
18.8

 
$
308.5

 
1.7

 
$
(149.0
)
 
$
1,222.8

 
$
(95.8
)
 
$
1,305.3

Net income
—

 
—

 
—

 
—

 
—

 
56.1

 
—

 
56.1

Activity related to stock-based compensation
—

 
—

 
(3.8
)
 
(0.2
)
 
16.0

 
—

 
—

 
12.2

Shares purchased under share repurchase program
—

 
—

 
—

 
0.3

 
(22.9
)
 
—

 
—

 
(22.9
)
Dividends declared ($0.14 per share)
—

 
—

 
—

 
—

 
—

 
(20.9
)
 
—

 
(20.9
)
Other comprehensive loss, net of tax
—

 
—

 
—

 
—

 
—

 
—

 
(47.9
)
 
(47.9
)
Balance, June 30, 2018
75.3

 
$
18.8

 
$
304.7

 
1.8

 
$
(155.9
)
 
$
1,258.0

 
$
(143.7
)
 
$
1,281.9

Net income
—

 
—

 
—

 
—

 
—

 
55.2

 
—

 
55.2

Activity related to stock-based compensation
—

 
—

 
(21.9
)
 
(0.6
)
 
47.2

 
—

 
—

 
25.3

Dividends declared ($0.15 per share)
—

 
—

 
—

 
—

 
—

 
(0.5
)
 
—

 
(0.5
)
Other comprehensive loss, net of tax
—

 
—

 
—

 
—

 
—

 
—

 
(10.1
)
 
(10.1
)
Balance, September 30, 2018
75.3

 
$
18.8

 
$
282.8

 
1.2

 
$
(108.7
)
 
$
1,312.7

 
$
(153.8
)
 
$
1,351.8




22

Note 13:  Stock-Based Compensation

The West Pharmaceutical Services, Inc. 2016 Omnibus Incentive Compensation Plan (the “2016 Plan”) provides for the granting of stock options, stock appreciation rights, restricted stock awards and performance awards to employees and non-employee directors. A committee of the Board of Directors determines the terms and conditions of awards to be granted. Vesting requirements vary by award. At September 30, 2019, there were 3,110,708 shares remaining in the 2016 Plan for future grants.

During the nine months ended September 30, 2019, we granted 345,400 stock options at a weighted average exercise price of $102.59 per share based on the grant-date fair value of our stock to employees under the 2016 Plan. The weighted average grant date fair value of options granted was $24.53 per share as determined by the Black-Scholes option valuation model using the following weighted average assumptions: a risk-free interest rate of 2.3%; expected life of 5.6 years based on prior experience; stock volatility of 22.5% based on historical data; and a dividend yield of 0.7%. Stock option expense is recognized over the vesting period, net of forfeitures.

During the nine months ended September 30, 2019, we granted 82,646 stock-settled performance share unit (“PSU”) awards at a weighted average grant-date fair value of $102.59 per share to eligible employees. These awards are earned based on the Company’s performance against pre-established targets, including annual growth rate of revenue and return on invested capital, over a specified performance period. Depending on the achievement of the targets, recipients of stock-settled PSU awards are entitled to receive a certain number of shares of common stock. Shares earned under PSU awards may vary from 0% to 200% of an employee’s targeted award. The fair value of stock-settled PSU awards is based on the market price of our stock at the grant date and is recognized as expense over the performance period, adjusted for estimated target outcomes and net of forfeitures.

During the nine months ended September 30, 2019, we granted 11,631 stock-settled restricted share unit (“RSU”) awards at a weighted average grant-date fair value of $112.49 per share to eligible employees. These awards are earned over a specified performance period. The fair value of stock-settled RSU awards is based on the market price of our stock at the grant date and is recognized as expense over the vesting period, net of forfeitures.

Total stock-based compensation expense was $5.4 million and $18.8 million for the three and nine months ended September 30, 2019, respectively. For the three and nine months ended September 30, 2018, stock-based compensation expense was $5.3 million and $14.7 million, respectively.


23

Note 14:  Benefit Plans

The components of net periodic benefit cost for the three months ended September 30 were as follows:

 
Pension benefits
 
Other retirement benefits
 
Total
($ in millions)
2019
 
2018
 
2019
 
2018
 
2019
 
2018
Service cost
$
0.4

 
$
2.6

 
$
—

 
$
—

 
$
0.4

 
$
2.6

Interest cost
1.9

 
2.3

 
0.1

 
0.1

 
2.0

 
2.4

Expected return on assets
(3.1
)
 
(3.9
)
 
—

 
—

 
(3.1
)
 
(3.9
)
Amortization of prior service credit
0.1

 
(0.3
)
 
(0.2
)
 
(0.2
)
 
(0.1
)
 
(0.5
)
Recognized actuarial losses (gains)
0.5

 
0.9

 
(0.7
)
 
(0.7
)
 
(0.2
)
 
0.2

Settlements
2.7

 
—

 
—

 
—

 
2.7

 
—

Net periodic benefit cost
$
2.5

 
$
1.6

 
$
(0.8
)
 
$
(0.8
)
 
$
1.7

 
$
0.8


 
Pension benefits
 
Other retirement benefits
 
Total
($ in millions)
2019
 
2018
 
2019
 
2018
 
2019
 
2018
U.S. plans
$
2.0

 
$
1.0

 
$
(0.8
)
 
$
(0.8
)
 
$
1.2

 
$
0.2

International plans
0.5

 
0.6

 
—

 
—

 
0.5

 
0.6

Net periodic benefit cost
$
2.5

 
$
1.6

 
$
(0.8
)
 
$
(0.8
)
 
$
1.7

 
$
0.8


The components of net periodic benefit cost for the nine months ended September 30 were as follows:

 
Pension benefits
 
Other retirement benefits
 
Total
($ in millions)
2019
 
2018
 
2019
 
2018
 
2019
 
2018
Service cost
$
1.1

 
$
8.1

 
$
—

 
$
—

 
$
1.1

 
$
8.1

Interest cost
6.8

 
7.0

 
0.2

 
0.2

 
7.0

 
7.2

Expected return on assets
(8.9
)
 
(11.7
)
 
—

 
—

 
(8.9
)
 
(11.7
)
Amortization of prior service credit
0.1

 
(1.1
)
 
(0.5
)
 
(0.5
)
 
(0.4
)
 
(1.6
)
Recognized actuarial losses (gains)
1.6

 
2.8

 
(1.8
)
 
(1.8
)
 
(0.2
)
 
1.0

Settlements
2.7

 
—

 
—

 
—

 
2.7

 
—

Net periodic benefit cost
$
3.4

 
$
5.1

 
$
(2.1
)
 
$
(2.1
)
 
$
1.3

 
$
3.0


 
Pension benefits
 
Other retirement benefits
 
Total
($ in millions)
2019
 
2018
 
2019
 
2018
 
2019
 
2018
U.S. plans
$
1.9

 
$
3.5

 
$
(2.1
)
 
$
(2.1
)
 
$
(0.2
)
 
$
1.4

International plans
1.5

 
1.6

 
—

 
—

 
1.5

 
1.6

Net periodic benefit cost
$
3.4

 
$
5.1

 
$
(2.1
)
 
$
(2.1
)
 
$
1.3

 
$
3.0



During the three and nine months ended September 30, 2019, we recorded a $2.7 million pension settlement charge within other nonoperating expense (income), as we determined that normal-course lump-sum payments for each of our U.S. qualified and non-qualified defined benefit pension plans exceeded the threshold for settlement accounting under U.S. GAAP for the year. Effective January 1, 2019, except for interest crediting, benefit accruals under these defined benefit pension plans ceased.

24


During the three and nine months ended September 30, 2019, we contributed $2.6 million to our U.S. qualified defined benefit pension plan.

Note 15:  Other Expense (Income)

Other expense (income) consists of:

 
Three Months Ended
September 30,
 
Nine Months Ended
September 30,
($ in millions)
2019
 
2018
 
2019
 
2018
Restructuring and related charges:
 
 
 
 
 
 
 
Severance and post-employment benefits
$
0.6

 
$
0.1

 
$
2.2

 
$
3.4

Asset-related charges
0.1

 
0.4

 
0.1

 
0.8

Other charges
1.1

 
0.7

 
1.5

 
2.5

Total restructuring and related charges
1.8

 
1.2

 
3.8

 
6.7

Argentina currency devaluation
1.0

 
1.1

 
1.0

 
1.1

Development and licensing income
(0.2
)
 
(0.2
)
 
(0.6
)
 
(0.6
)
Contingent consideration
0.1

 
0.2

 
0.4

 
0.8

Other items
3.7

 
(2.5
)
 
(3.0
)
 
(4.0
)
Total other expense (income)
$
6.4

 
$
(0.2
)
 
$
1.6

 
$
4.0



Restructuring and Related Charges

In February 2018, our Board of Directors approved a restructuring plan designed to realign our manufacturing capacity with demand. These changes are expected to be implemented over a period of up to twenty-four months from the date of approval. The plan will require restructuring and related charges of approximately $16.0 million. Since its approval, we have recorded $12.6 million in restructuring and related charges associated with this plan.

During the three months ended September 30, 2019, we recorded $1.8 million in restructuring and related charges associated with this plan, consisting of $0.6 million for severance charges, $0.1 million for non-cash asset write-downs associated with the discontinued use of certain equipment, and $1.1 million for other non-cash charges. During the three months ended September 30, 2018, we recorded $1.2 million in restructuring and related charges associated with this plan, consisting of $0.1 million for severance charges, $0.4 million for non-cash asset write-downs associated with the discontinued use of certain equipment, and $0.7 million for other non-cash charges.

During the nine months ended September 30, 2019, we recorded $3.8 million in restructuring and related charges associated with this plan, consisting of $2.2 million for severance charges, $0.1 million for non-cash asset write-downs associated with the discontinued use of certain equipment, and $1.5 million for other non-cash charges. During the nine months ended September 30, 2018, we recorded $6.7 million in restructuring and related charges associated with this plan, consisting of $3.4 million for severance charges, $0.8 million for non-cash asset write-downs associated with the discontinued use of certain equipment, and $2.5 million for other non-cash charges.


25

The following table presents activity related to our restructuring obligations related to our 2018 restructuring plan:

($ in millions)
Severance
and benefits
 
Asset-related charges
 
Other charges
 
Total
Balance, December 31, 2018
$
2.3

 
$
—

 
$
—

 
$
2.3

Charges
2.2

 
0.1

 
1.5

 
3.8

Cash payments
(2.0
)
 
—

 
—

 
(2.0
)
Non-cash asset write-downs
—

 
(0.1
)
 
(1.5
)
 
(1.6
)
Balance, September 30, 2019
$
2.5

 
$
—

 
$
—

 
$
2.5



On February 15, 2016, our Board of Directors approved a restructuring plan designed to repurpose several of our production facilities in support of growing high-value proprietary products and to realign operational and commercial activities to meet the needs of our new market-focused commercial organization. Our remaining restructuring obligations related to the 2016 restructuring plan as of September 30, 2019 were $0.2 million.

Other Items

During the three and nine months ended September 30, 2019, we recorded a charge of $1.0 million as a result of the continued devaluation of Argentina’s currency. During the three and nine months ended September 30, 2018, we recorded a charge of $1.1 million related to the classification of Argentina’s economy as highly inflationary under U.S. GAAP as of July 1, 2018.

During both the three and nine months ended September 30, 2019 and 2018, we recorded development income of $0.2 million and $0.6 million, respectively, related to a nonrefundable customer payment of $20.0 million received in June 2013 in return for the exclusive use of the SmartDose technology platform within a specific therapeutic area. Please refer to Note 3, Revenue, for additional information.

Contingent consideration represents changes in the fair value of the SmartDose contingent consideration. Please refer to Note 10, Fair Value Measurements, for additional details.

Other items consist of foreign exchange transaction gains and losses, gains and losses on the sale of fixed assets, and miscellaneous income and charges. Other items changed by $6.2 million for the three months ended September 30, 2019, as compared to the same period in 2018, primarily as a result of foreign exchange transaction losses of $5.1 million during the three months ended September 30, 2019, as compared to foreign exchange transaction gains of $2.7 million during the three months ended September 30, 2018. Other items decreased by $1.0 million for the nine months ended September 30, 2019, as compared to the same period in 2018, primarily due to losses on the sale of fixed assets during the nine months ended September 30, 2019.

Note 16:  Income Taxes

The tax provision for interim periods is determined using the estimated annual effective consolidated tax rate, based on the current estimate of full-year earnings before taxes, adjusted for the impact of discrete quarterly items.

The provision for income taxes was $10.9 million and $8.0 million for the three months ended September 30, 2019 and 2018, respectively, and the effective tax rate was 16.8% and 13.1%, respectively. The provision for income taxes was $42.5 million and $26.5 million for the nine months ended September 30, 2019 and 2018, respectively, and the effective tax rate was 19.8% and 15.1%, respectively.

During the three and nine months ended September 30, 2019, we recorded a tax benefit of $1.0 million due to the impact of federal law changes enacted during the quarter. During the three and nine months ended September 30, 2018, we recorded a net tax charge of $0.4 million and a net tax benefit of $4.1 million, respectively, for the

26

estimated impact of the 2017 Tax Act. Please refer to Note 16, Income Taxes, to the consolidated financial statements in our 2018 Annual Report for further discussion.

Note 17:  Commitments and Contingencies

From time to time, we are involved in product liability matters and other legal proceedings and claims generally incidental to our normal business activities. We accrue for loss contingencies when it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. While the outcome of current proceedings cannot be accurately predicted, we believe their ultimate resolution should not have a material adverse effect on our business, financial condition, results of operations or liquidity.

There have been no significant changes to the commitments and contingencies included in our 2018 Annual Report.

On January 1, 2019, we adopted ASC 842. Please refer to Note 6, Leases, for additional information.

Note 18:  Segment Information

Our business operations are organized into two reportable segments, Proprietary Products and Contract-Manufactured Products. Our Proprietary Products reportable segment offers proprietary packaging, containment and drug delivery products, along with analytical lab services, to biologic, generic and pharmaceutical drug customers. Our Contract-Manufactured Products reportable segment serves as a fully integrated business, focused on the design, manufacture, and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers.

We evaluate the performance of our segments based upon, among other things, segment net sales and operating profit. Segment operating profit excludes general corporate costs, which include executive and director compensation, stock-based compensation, adjustments to annual incentive plan expense for over- or under-attainment of targets, certain pension and other retirement benefit costs, and other corporate facilities and administrative expenses not allocated to the segments. Also excluded are items that we consider not representative of ongoing operations. Such items are referred to as other unallocated items and generally include restructuring and related charges, certain asset impairments and other specifically-identified income or expense items.


27

The following table presents information about our reportable segments, reconciled to consolidated totals:

 
Three Months Ended
September 30,
 
Nine Months Ended
September 30,
($ in millions)
2019
 
2018
 
2019
 
2018
Net sales:
 
 
 
 
 
 
 
Proprietary Products
$
345.2

 
$
325.2

 
$
1,045.9

 
$
997.4

Contract-Manufactured Products
111.1

 
106.7

 
323.6

 
297.7

Intersegment sales elimination
(0.2
)
 
(0.2
)
 
(0.2
)
 
(0.2
)
Consolidated net sales
$
456.1

 
$
431.7

 
$
1,369.3

 
$
1,294.9

Operating profit (loss):
 
 
 
 
 
 
 
Proprietary Products
$
72.9

 
$
68.2

 
$
238.7

 
$
202.7

Contract-Manufactured Products
11.6

 
11.2

 
33.5

 
29.7

Corporate
(14.4
)
 
(16.3
)
 
(48.9
)
 
(50.1
)
Other unallocated items
(2.8
)
 
(2.3
)
 
(4.8
)
 
(7.8
)
Total operating profit
$
67.3

 
$
60.8

 
$
218.5

 
$
174.5

Interest expense
2.1

 
2.0

 
6.4

 
6.1

Interest income
(1.0
)
 
(0.5
)
 
(2.5
)
 
(1.4
)
Other nonoperating expense (income)
1.3

 
(1.8
)
 
0.2

 
(5.1
)
Income before income taxes
$
64.9

 
$
61.1

 
$
214.4

 
$
174.9



The intersegment sales elimination, which is required for the presentation of consolidated net sales, represents the elimination of components sold between our segments.

Other unallocated items during the three and nine months ended September 30, 2019 consisted of $1.8 million and $3.8 million, respectively, in restructuring and related charges. In addition, during the three and nine months ended September 30, 2019, other unallocated items included a charge of $1.0 million as a result of the continued devaluation of Argentina’s currency. Other unallocated items during the three and nine months ended September 30, 2018 consisted of $1.2 million and $6.7 million, respectively, in restructuring and related charges. In addition, during the three and nine months ended September 30, 2018, other unallocated items included a charge of $1.1 million related to the classification of Argentina’s economy as highly inflationary under U.S. GAAP as of July 1, 2018. Please refer to Note 15, Other Expense (Income), for further discussion of these items.

Note 19:  Subsequent Event

On October 15, 2019, we entered into an Amendment Agreement (the “Amendment”) with Daikyo, amending certain commercial agreements between the parties in order to make each party’s rights under such agreements exclusive. The Amendment amends the Amended and Restated Technology Exchange and CrossLicense Agreement and Distributorship Agreements, each dated and effective January 18, 2017, as modified by the Letter Agreement dated and effective July 2, 2018. In addition, on October 16, 2019, we announced that we increased our ownership interest in Daikyo to 49%. We believe that the increase in ownership interest will not have a material impact on our financial statements.


28

ITEM 2.  MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

OVERVIEW

The following discussion is intended to further the reader’s understanding of the consolidated financial condition and results of operations of our Company. It should be read in conjunction with our condensed consolidated financial statements and accompanying notes elsewhere in this Quarterly Report on Form 10-Q (“Form 10-Q”) as well as Management’s Discussion and Analysis of Financial Condition and Results of Operations and the consolidated financial statements and accompanying notes included in our 2018 Annual Report. Our historical financial statements may not be indicative of our future performance. This Management’s Discussion and Analysis of Financial Condition and Results of Operations contains a number of forward-looking statements, all of which are based on our current expectations and could be affected by the uncertainties and risks discussed in Part I, Item 1A of our 2018 Annual Report and in Part II, Item 1A of this Form 10-Q.

Throughout this section, references to “Notes” refer to the notes to our condensed consolidated financial statements (unaudited) in Part I, Item 1 of this Form 10-Q, unless otherwise indicated.

Non-U.S. GAAP Financial Measures

For the purpose of aiding the comparison of our year-over-year results, we may refer to net sales and other financial results excluding the effects of changes in foreign currency exchange rates. Organic net sales exclude the impact from acquisitions and/or divestitures and translate the current-period reported sales of subsidiaries whose functional currency is other than USD at the applicable foreign exchange rates in effect during the comparable prior-year period. We may also refer to financial results excluding the effects of unallocated items. The re-measured results excluding effects from currency translation, the impact from acquisitions and/or divestitures, and the effects of unallocated items are not in conformity with U.S. GAAP and should not be used as a substitute for the comparable U.S. GAAP financial measures. The non-U.S. GAAP financial measures are incorporated into our discussion and analysis as management uses them in evaluating our results of operations and believes that this information provides users a valuable insight into our overall performance and financial position.

Our Operations

We are a leading global manufacturer in the design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. Our products include a variety of primary packaging, containment solutions, reconstitution and transfer systems, and drug delivery systems, as well as contract manufacturing and analytical lab services. Our customers include the leading biologic, generic, pharmaceutical, diagnostic, and medical device companies in the world. Our top priority is delivering quality products that meet the exact product specifications and quality standards customers require and expect. This focus on quality includes excellence in manufacturing, scientific and technical expertise and management, so we can partner with our customers to deliver safe, effective drug products to patients quickly and efficiently. The Company was incorporated under the laws of the Commonwealth of Pennsylvania on July 27, 1923.

Our business operations are organized into two reportable segments, Proprietary Products and Contract-Manufactured Products. Our Proprietary Products reportable segment offers proprietary packaging, containment and drug delivery products, along with analytical lab services, to biologic, generic and pharmaceutical drug customers. Our Contract-Manufactured Products reportable segment serves as a fully integrated business, focused on the design, manufacture, and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. We also maintain partnerships to share technologies and market products with affiliates in Japan and Mexico.


29

2019 Financial Performance Summary

Consolidated net sales increased by $24.4 million, or 5.7%, for the three months ended September 30, 2019, as compared to the same period in 2018. Excluding foreign currency translation effects, as well as incremental sales of $1.0 million from our recent acquisition, consolidated net sales for the three months ended September 30, 2019 increased by $34.0 million, or 7.9%, as compared to the same period in 2018.

Consolidated net sales increased by $74.4 million, or 5.7%, for the nine months ended September 30, 2019, as compared to the same period in 2018. Excluding foreign currency translation effects, as well as incremental sales of $2.0 million from our recent acquisition, consolidated net sales for the nine months ended September 30, 2019 increased by $117.7 million, or 9.1%, as compared to the same period in 2018.

Net income for the three months ended September 30, 2019 was $56.3 million, or $0.75 per diluted share, as compared to $55.2 million, or $0.73 per diluted share, for the same period in 2018. Net income for the three months ended September 30, 2019 included the impact of restructuring and related charges of $1.4 million (net of $0.4 million in tax), or $0.01 per diluted share, a pension settlement charge of $2.1 million (net of $0.6 million in tax), or $0.03 per diluted share, a charge of $0.7 million (net of $0.3 million in tax), or $0.01 per diluted share, related to the continued devaluation of Argentina’s currency, a tax benefit of $1.0 million, or $0.01 per diluted share, related to the impact of federal law changes enacted during the quarter, and a tax benefit of $4.0 million, or $0.05 per diluted share, associated with stock-based compensation. Net income for the three months ended September 30, 2018 included the impact of restructuring and related charges of $0.9 million (net of $0.3 million in tax), or $0.01 per diluted share, a net tax charge of $0.4 million for the estimated impact of the 2017 Tax Act, a tax benefit of $7.7 million, or $0.10 per diluted share, associated with stock-based compensation, and a charge of $1.1 million, or $0.02 per diluted share, related to the classification of Argentina’s economy as highly inflationary under U.S. GAAP as of July 1, 2018.

Net income for the nine months ended September 30, 2019 was $177.8 million, or $2.36 per diluted share, as compared to $154.9 million, or $2.05 per diluted share, for the same period in 2018. Net income for the nine months ended September 30, 2019 included the impact of restructuring and related charges of $2.9 million (net of $0.9 million in tax), or $0.03 per diluted share, a pension settlement charge of $2.1 million (net of $0.6 million in tax), or $0.03 per diluted share, a charge of $0.7 million (net of $0.3 million in tax), or $0.01 per diluted share, related to the continued devaluation of Argentina’s currency, a tax benefit of $1.0 million, or $0.01 per diluted share, related to the impact of federal law changes enacted during the quarter, and a tax benefit of $9.2 million, or $0.12 per diluted share, associated with stock-based compensation. Net income for the nine months ended September 30, 2018 included the impact of restructuring and related charges of $5.2 million (net of $1.5 million in tax), or $0.07 per diluted share, a net tax benefit of $4.1 million, or $0.06 per diluted share, for the estimated impact of the 2017 Tax Act, a tax benefit of $13.2 million, or $0.17 per diluted share, associated with stock-based compensation, and a charge of $1.1 million, or $0.02 per diluted share, related to the classification of Argentina’s economy as highly inflationary under U.S. GAAP as of July 1, 2018.

On January 24, 2019, we issued a voluntary recall of our Vial2Bag product line due to reports of potential unpredictable or variable dosing under certain conditions. Our fourth quarter 2018 results included an $11.3 million provision for product returns, recorded as a reduction of sales, partially offset by a reduction in cost of goods sold reflecting our inventory balance for these devices at December 31, 2018. During the three and nine months ended September 30, 2019, we recorded a net adjustment of $0.9 million and a net provision of $4.9 million, respectively, for potential inventory returns from our customers and related in-house inventory, partially offset by a reduction in our provision for product returns. We continue to work to get the products back on the market.

At September 30, 2019, our cash and cash equivalents balance totaled $396.0 million and our available borrowing capacity under our Credit Facility was $269.9 million.


30


RESULTS OF OPERATIONS

We evaluate the performance of our segments based upon, among other things, segment net sales and operating profit. Segment operating profit excludes general corporate costs, which include executive and director compensation, stock-based compensation, adjustments to annual incentive plan expense for over- or under-attainment of targets, certain pension and other retirement benefit costs, and other corporate facilities and administrative expenses not allocated to the segments. Also excluded are items that we consider not representative of ongoing operations. Such items are referred to as other unallocated items and generally include restructuring and related charges, certain asset impairments and other specifically-identified income or expense items.

Percentages in the following tables and throughout the Results of Operations section may reflect rounding adjustments.

Net Sales

The following table presents net sales, consolidated and by reportable segment, for the three months ended September 30, 2019 and 2018:

 
Three Months Ended
September 30,
 
% Change
($ in millions)
2019
 
2018
 
As-Reported
 
Organic
Proprietary Products
$
345.2

 
$
325.2

 
6.2
%
 
8.5
%
Contract-Manufactured Products
111.1

 
106.7

 
4.2
%
 
6.0
%
Intersegment sales elimination
(0.2
)
 
(0.2
)
 
—

 
—

Consolidated net sales
$
456.1

 
$
431.7

 
5.7
%
 
7.9
%

Consolidated net sales increased by $24.4 million, or 5.7%, for the three months ended September 30, 2019, as compared to the same period in 2018, including an unfavorable foreign currency translation impact of $10.6 million. Excluding foreign currency translation effects, as well as incremental sales of $1.0 million from our recent acquisition, consolidated net sales for the three months ended September 30, 2019 increased by $34.0 million, or 7.9%, as compared to the same period in 2018.

Proprietary Products – Proprietary Products net sales increased by $20.0 million, or 6.2%, for the three months ended September 30, 2019, as compared to the same period in 2018, including an unfavorable foreign currency translation impact of $8.6 million. Excluding foreign currency translation effects, as well as incremental sales of $1.0 million from our recent acquisition, net sales for the three months ended September 30, 2019 increased by $27.6 million, or 8.5%, as compared to the same period in 2018, primarily due to growth in our high-value product offerings, including our Daikyo® components, our Daikyo Crystal Zenith® (“CZ”) products, and our NovaPure® and FluroTec®-coated components.

Contract-Manufactured Products – Contract-Manufactured Products net sales increased by $4.4 million, or 4.2%, for the three months ended September 30, 2019, as compared to the same period in 2018, including an unfavorable foreign currency translation impact of $2.0 million. Excluding foreign currency translation effects, net sales for the three months ended September 30, 2019 increased by $6.4 million, or 6.0%, as compared to the same period in 2018, due to an increase in the sale of healthcare-related injection and diagnostic devices.

The intersegment sales elimination, which is required for the presentation of consolidated net sales, represents the elimination of components sold between our segments.

The following table presents net sales, consolidated and by reportable segment, for the nine months ended September 30, 2019 and 2018:

31


 
Nine Months Ended
September 30,
 
% Change
($ in millions)
2019
 
2018
 
As-Reported
 
Organic
Proprietary Products
$
1,045.9

 
$
997.4

 
4.9
%
 
8.4
%
Contract-Manufactured Products
323.6

 
297.7

 
8.7
%
 
11.3
%
Intersegment sales elimination
(0.2
)
 
(0.2
)
 
—

 
—

Consolidated net sales
$
1,369.3

 
$
1,294.9

 
5.7
%
 
9.1
%

Consolidated net sales increased by $74.4 million, or 5.7%, for the nine months ended September 30, 2019, as compared to the same period in 2018, including an unfavorable foreign currency translation impact of $45.3 million. Excluding foreign currency translation effects, as well as incremental sales of $2.0 million from our recent acquisition, consolidated net sales for the nine months ended September 30, 2019 increased by $117.7 million, or 9.1%, as compared to the same period in 2018.

Proprietary Products – Proprietary Products net sales increased by $48.5 million, or 4.9%, for the nine months ended September 30, 2019, as compared to the same period in 2018, including an unfavorable foreign currency translation impact of $37.6 million. Excluding foreign currency translation effects, as well as incremental sales of $2.0 million from our recent acquisition, net sales for the nine months ended September 30, 2019 increased by $84.1 million, or 8.4%, as compared to the same period in 2018, primarily due to growth in our high-value product offerings, including our NovaPure components, our ready-to-use seals, stoppers, and plungers, our Daikyo components and CZ products, and our FluroTec-coated components.

Contract-Manufactured Products – Contract-Manufactured Products net sales increased by $25.9 million, or 8.7%, for the nine months ended September 30, 2019, as compared to the same period in 2018, including an unfavorable foreign currency translation impact of $7.7 million. Excluding foreign currency translation effects, net sales for the nine months ended September 30, 2019 increased by $33.6 million, or 11.3%, as compared to the same period in 2018, due to an increase in the sale of healthcare-related injection and diagnostic devices.

The intersegment sales elimination, which is required for the presentation of consolidated net sales, represents the elimination of components sold between our segments.

Gross Profit

The following table presents gross profit and related gross profit margins, consolidated and by reportable segment:

 
Three Months Ended
September 30,
 
Nine Months Ended
September 30,
($ in millions)
2019
 
2018
 
2019
 
2018
Proprietary Products:
 
 
 
 
 
 
 
Gross Profit
$
131.8

 
$
120.4

 
$
406.3

 
$
370.4

Gross Profit Margin
38.2
%
 
37.0
%
 
38.8
%
 
37.1
%
Contract-Manufactured Products:
 

 
 

 
 
 
 

Gross Profit
$
16.0

 
$
15.2

 
$
46.2

 
$
41.8

Gross Profit Margin
14.4
%
 
14.3
%
 
14.3
%
 
14.0
%
Consolidated Gross Profit
$
147.8

 
$
135.6

 
$
452.5

 
$
412.2

Consolidated Gross Profit Margin
32.4
%
 
31.4
%
 
33.0
%
 
31.8
%


32

Consolidated gross profit increased by $12.2 million, or 9.0%, and $40.3 million, or 9.8%, for the three and nine months ended September 30, 2019, respectively, as compared to the same periods in 2018, including an unfavorable foreign currency translation impact of $2.9 million and $13.8 million for the three and nine months ended September 30, 2019, respectively. Consolidated gross profit margin increased by 1.0 margin points and 1.2 margin points for the three and nine months ended September 30, 2019, respectively, as compared to the same periods in 2018.

Proprietary Products – Proprietary Products gross profit increased by $11.4 million, or 9.5%, and $35.9 million, or 9.7%, for the three and nine months ended September 30, 2019, respectively, as compared to the same periods in 2018, including an unfavorable foreign currency translation impact of $2.6 million and $12.6 million for the three and nine months ended September 30, 2019, respectively. Proprietary Products gross profit margin increased by 1.2 margin points and 1.7 margin points for the three and nine months ended September 30, 2019, respectively, as compared to the same periods in 2018, due to a favorable mix of products sold, production efficiencies, and sales price increases, partially offset by increased overhead costs.

Contract-Manufactured Products – Contract-Manufactured Products gross profit increased by $0.8 million, or 5.3%, and $4.4 million, or 10.5%, for the three and nine months ended September 30, 2019, respectively, as compared to the same periods in 2018, including an unfavorable foreign currency translation impact of $0.3 million and $1.2 million for the three and nine months ended September 30, 2019, respectively. Contract-Manufactured Products gross profit margin increased by 0.1 margin points and 0.3 margin points for the three and nine months ended September 30, 2019, respectively, as compared to the same periods in 2018, due to a moderate improvement in the mix of products sold, partially offset by costs related to new projects.

Research and Development (“R&D”) Costs

The following table presents R&D costs, consolidated and by reportable segment:

 
Three Months Ended
September 30,
 
Nine Months Ended
September 30,
($ in millions)
2019
 
2018
 
2019
 
2018
Proprietary Products
$
9.3

 
$
10.1

 
$
28.7

 
$
30.5

Contract-Manufactured Products
—

 
—

 
—

 
—

Consolidated R&D Costs
$
9.3

 
$
10.1

 
$
28.7

 
$
30.5


Consolidated R&D costs decreased by $0.8 million, or 7.9%, and $1.8 million, or 5.9%, for the three and nine months ended September 30, 2019, respectively, as compared to the same periods in 2018. Efforts remain focused on the continued investment in self-injection systems development, elastomeric packaging components, and formulation development.

All of the R&D costs incurred during the three and nine months ended September 30, 2019 related to Proprietary Products.


33

Selling, General and Administrative (“SG&A”) Costs

The following table presents SG&A costs, consolidated and by reportable segment and corporate:

 
Three Months Ended
September 30,
 
Nine Months Ended
September 30,
($ in millions)
2019
 
2018
 
2019
 
2018
Proprietary Products
$
46.3

 
$
44.4

 
$
142.3

 
$
140.3

Contract-Manufactured Products
4.1

 
4.1

 
12.5

 
12.7

Corporate
14.4

 
16.4

 
48.9

 
50.2

Consolidated SG&A costs
$
64.8

 
$
64.9

 
$
203.7

 
$
203.2

SG&A as a % of net sales
14.2
%
 
15.0
%
 
14.9
%
 
15.7
%

Consolidated SG&A costs decreased by $0.1 million, or 0.2%, for the three months ended September 30, 2019, as compared to the same period in 2018, including the impact of foreign currency translation, which decreased SG&A costs by $0.7 million for the three months ended September 30, 2019. Consolidated SG&A costs increased by $0.5 million, or 0.2%, for the nine months ended September 30, 2019, as compared to the same period in 2018, including the impact of foreign currency translation, which decreased SG&A costs by $3.2 million for the nine months ended September 30, 2019.

Proprietary Products – Proprietary Products SG&A costs increased by $1.9 million, or 4.3%, and $2.0 million, or 1.4%, for the three and nine months ended September 30, 2019, respectively, as compared to the same periods in 2018, primarily due to an increase in compensation costs and incremental costs associated with our voluntary recall, partially offset by ongoing cost control measures. Foreign currency translation decreased Proprietary Products SG&A costs by $0.7 million and $3.2 million for the three and nine months ended September 30, 2019, respectively.

Contract-Manufactured Products – Contract-Manufactured Products SG&A costs remained constant for the three months ended September 30, 2019, as compared to the same period in 2018. Contract-Manufactured Products SG&A costs decreased by $0.2 million, or 1.6%, for the nine months ended September 30, 2019, as compared to the same period in 2018, due to ongoing cost control measures.

Corporate – Corporate SG&A costs decreased by $2.0 million, or 12.2%, for the three months ended September 30, 2019, as compared to the same period in 2018, primarily due to a decrease in U.S. pension costs due to the cessation of our U.S. qualified and non-qualified defined benefit pension plans as of January 1, 2019 (except for interest crediting). Corporate SG&A costs decreased by $1.3 million, or 2.6%, for the nine months ended September 30, 2019, as compared to the same period in 2018, primarily due to a decrease in U.S. pension costs and ongoing cost control measures, partially offset by increases in stock-based compensation costs and incentive compensation costs.


34

Other Expense (Income)

The following table presents other income and expense items, consolidated and by reportable segment and unallocated items:

Expense (Income)
Three Months Ended
September 30,
 
Nine Months Ended
September 30,
($ in millions)
2019
 
2018
 
2019
 
2018
Proprietary Products
$
3.3

 
$
(2.3
)
 
$
(3.4
)
 
$
(3.1
)
Contract-Manufactured Products
0.3

 
(0.1
)
 
0.2

 
(0.6
)
Corporate
—

 
(0.1
)
 
—

 
(0.1
)
Unallocated items
2.8

 
2.3

 
4.8

 
7.8

Consolidated other expense (income)
$
6.4

 
$
(0.2
)
 
$
1.6

 
$
4.0


Other income and expense items, consisting of foreign exchange transaction gains and losses, gains and losses on the sale of fixed assets, development and licensing income, contingent consideration, and miscellaneous income and charges, are generally recorded within segment results.

Consolidated other expense (income) changed by $6.6 million for the three months ended September 30, 2019, as compared to the same period in 2018. Consolidated other expense decreased by $2.4 million for the nine months ended September 30, 2019, as compared to the same period in 2018.

Proprietary Products – Proprietary Products other expense (income) changed by $5.6 million for the three months ended September 30, 2019, as compared to the same period in 2018, primarily due to foreign exchange transaction losses in Europe. Proprietary Products other income increased by $0.3 million for the nine months ended September 30, 2019, as compared to the same period in 2018, primarily due to foreign exchange transaction gains in Europe, offset by losses on the sale of fixed assets.

Contract-Manufactured Products – Contract-Manufactured Products other expense (income) changed by $0.4 million for the three months ended September 30, 2019, as compared to the same period in 2018, primarily due to losses on the sale of fixed assets during the three months ended September 30, 2019. Contract-Manufactured Products other expense (income) changed by $0.8 million for the nine months ended September 30, 2019, as compared to the same period in 2018, primarily due to a decrease in gains on the sale of fixed assets during the nine months ended September 30, 2019.

Corporate – Corporate other income decreased by $0.1 million for both the three and nine months ended September 30, 2019, respectively, as compared to the same periods in 2018.

Unallocated items – During the three and nine months ended September 30, 2019, we recorded $1.8 million and $3.8 million, respectively, in restructuring and related charges. During the three and nine months ended September 30, 2018, we recorded $1.2 million and $6.7 million, respectively, in restructuring and related charges. Once fully completed, we expect that our 2018 restructuring plan will provide annualized savings of approximately $14.0 million. In addition, during the three and nine months ended September 30, 2019, we recorded a charge of $1.0 million as a result of the continued devaluation of Argentina’s currency. During the three and nine months ended September 30, 2018, we recorded a charge of $1.1 million related to the classification of Argentina’s economy as highly inflationary under U.S. GAAP as of July 1, 2018. Please refer to Note 15, Other Expense (Income), for further discussion of these items.


35

Operating Profit

The following table presents adjusted operating profit, consolidated and by reportable segment, corporate and unallocated items:

 
Three Months Ended
September 30,
 
Nine Months Ended
September 30,
($ in millions)
2019
 
2018
 
2019
 
2018
Proprietary Products
$
72.9

 
$
68.2

 
$
238.7

 
$
202.7

Contract-Manufactured Products
11.6

 
11.2

 
33.5

 
29.7

Corporate
(14.4
)
 
(16.3
)
 
(48.9
)
 
(50.1
)
Adjusted consolidated operating profit
$
70.1

 
$
63.1

 
$
223.3

 
$
182.3

Adjusted consolidated operating profit margin
15.4
%
 
14.6
%
 
16.3
%
 
14.1
%
Unallocated items
(2.8
)
 
(2.3
)
 
(4.8
)
 
(7.8
)
Consolidated operating profit
$
67.3

 
$
60.8

 
$
218.5

 
$
174.5

Consolidated operating profit margin
14.8
%
 
14.1
%
 
16.0
%
 
13.5
%

Consolidated operating profit increased by $6.5 million, or 10.7%, and $44.0 million, or 25.2%, for the three and nine months ended September 30, 2019, respectively, as compared to the same periods in 2018, including an unfavorable foreign currency translation impact of $2.1 million and $10.9 million for the three and nine months ended September 30, 2019, respectively.

Proprietary Products – Proprietary Products operating profit increased by $4.7 million, or 6.9%, and $36.0 million, or 17.8%, for the three and nine months ended September 30, 2019, respectively, as compared to the same periods in 2018, including an unfavorable foreign currency translation impact of $1.8 million and $9.8 million for the three and nine months ended September 30, 2019, respectively, due to the factors described above.

Contract-Manufactured Products – Contract-Manufactured Products operating profit increased by $0.4 million, or 3.6%, and $3.8 million, or 12.8%, for the three and nine months ended September 30, 2019, respectively, as compared to the same periods in 2018, including an unfavorable foreign currency translation impact of $0.3 million and $1.1 million for the three and nine months ended September 30, 2019, respectively, due to the factors described above.

Corporate – Corporate costs decreased by $1.9 million, or 11.7%, and $1.2 million, or 2.4%, for the three and nine months ended September 30, 2019, respectively, as compared to the same periods in 2018, due to the factors described above.

Unallocated items – Please refer to the Other Expense (Income) section for details.


36

Interest Expense, Net

The following table presents interest expense, net, by significant component:

 
Three Months Ended
September 30,
 
Nine Months Ended
September 30,
($ in millions)
2019
 
2018
 
2019
 
2018
Interest expense
$
2.2

 
$
2.3

 
$
7.0

 
$
6.9

Capitalized interest
(0.1
)
 
(0.3
)
 
(0.6
)
 
(0.8
)
Interest income
(1.0
)
 
(0.5
)
 
(2.5
)
 
(1.4
)
Interest expense, net
$
1.1

 
$
1.5

 
$
3.9

 
$
4.7


Interest expense, net, decreased by $0.4 million, or 26.7%, and $0.8 million, or 17.0%, for the three and nine months ended September 30, 2019, respectively, as compared to the same periods in 2018, primarily due to an increase in interest income during the three and nine months ended September 30, 2019.

Other Nonoperating Expense (Income)

Other nonoperating expense (income) changed by $3.1 million and $5.3 million for the three and nine months ended September 30, 2019, as compared to the same periods in 2018, primarily due to a decrease in the expected return on pension plan assets and a pension settlement charge of $2.7 million recorded in the three and nine months ended September 30, 2019, as we determined that normal-course lump-sum payments for each of our U.S. qualified and non-qualified defined benefit pension plans exceeded the threshold for settlement accounting under U.S. GAAP for the year. Effective January 1, 2019, except for interest crediting, benefit accruals under these defined benefit pension plans ceased.

Income Taxes

The provision for income taxes was $10.9 million and $8.0 million for the three months ended September 30, 2019 and 2018, respectively, and the effective tax rate was 16.8% and 13.1%, respectively. The provision for income taxes was $42.5 million and $26.5 million for the nine months ended September 30, 2019 and 2018, respectively, and the effective tax rate was 19.8% and 15.1%, respectively.

During the three and nine months ended September 30, 2019, we recorded a tax benefit of $1.0 million due to the impact of federal law changes enacted during the quarter. During the three and nine months ended September 30, 2018, we recorded a net tax charge of $0.4 million and a net tax benefit of $4.1 million, respectively, for the estimated impact of the 2017 Tax Act. Please refer to Note 16, Income Taxes, to the consolidated financial statements in our 2018 Annual Report for further discussion.

Equity in Net Income of Affiliated Companies

Equity in net income of affiliated companies represents the contribution to earnings from our 25% ownership interest in Daikyo and our 49% ownership interest in four companies in Mexico. Equity in net income of affiliated companies increased by $0.2 million for the three months ended September 30, 2019, as compared to the same period in 2018, due to favorable operating results at Daikyo, partially offset by foreign exchange transaction losses in Mexico. Equity in net income of affiliated companies decreased by $0.6 million for the nine months ended September 30, 2019, as compared to the same period in 2018, due to a decrease in foreign exchange transaction gains in Mexico, partially offset by favorable operating results at Daikyo.


37

Net Income

Net income for the three months ended September 30, 2019 was $56.3 million, which included the impact of restructuring and related charges of $1.4 million (net of $0.4 million in tax), a pension settlement charge of $2.1 million (net of $0.6 million in tax), a charge of $0.7 million (net of $0.3 million in tax) related to the continued devaluation of Argentina’s currency, a tax benefit of $1.0 million related to the impact of federal law changes enacted during the quarter, and a tax benefit of $4.0 million associated with stock-based compensation. Net income for the three months ended September 30, 2018 was $55.2 million, which included the impact of restructuring and related charges of $0.9 million (net of $0.3 million in tax), a net tax charge of $0.4 million for the estimated impact of the 2017 Tax Act, a tax benefit of $7.7 million associated with stock-based compensation, and a charge of $1.1 million related to the classification of Argentina’s economy as highly inflationary under U.S. GAAP as of July 1, 2018.

Net income for the nine months ended September 30, 2019 was $177.8 million, which included the impact of restructuring and related charges of $2.9 million (net of $0.9 million in tax), a pension settlement charge of $2.1 million (net of $0.6 million in tax), a charge of $0.7 million (net of $0.3 million in tax) related to the continued devaluation of Argentina’s currency, a tax benefit of $1.0 million related to the impact of federal law changes enacted during the quarter, and a tax benefit of $9.2 million associated with stock-based compensation. Net income for the nine months ended September 30, 2018 was $154.9 million, which included the impact of restructuring and related charges of $5.2 million (net of $1.5 million in tax), a net tax benefit of $4.1 million for the estimated impact of the 2017 Tax Act, a tax benefit of $13.2 million associated with stock-based compensation, and a charge of $1.1 million related to the classification of Argentina’s economy as highly inflationary under U.S. GAAP as of July 1, 2018.

FINANCIAL CONDITION, LIQUIDITY AND CAPITAL RESOURCES

Cash Flows

The following table presents cash flow data for the nine months ended September 30:

($ in millions)
2019
 
2018
Net cash provided by operating activities
$
260.8

 
$
215.4

Net cash used in investing activities
$
(107.4
)
 
$
(72.2
)
Net cash used in financing activities
$
(87.8
)
 
$
(72.5
)

Net Cash Provided by Operating Activities – Net cash provided by operating activities increased by $45.4 million for the nine months ended September 30, 2019, as compared to the same period in 2018, primarily due to improved operating results.

Net Cash Used in Investing Activities – Net cash used in investing activities increased by $35.2 million for the nine months ended September 30, 2019, as compared to the same period in 2018, primarily due to the acquisition of our distributor in South Korea and an increase in capital expenditures.

Net Cash Used in Financing Activities – Net cash used in financing activities increased by $15.3 million for the nine months ended September 30, 2019, as compared to the same period in 2018, primarily due to increases in purchases under our share repurchases programs and dividend payments.


38

Liquidity and Capital Resources

The table below presents selected liquidity and capital measures:

($ in millions)
September 30,
2019
 
December 31,
2018
Cash and cash equivalents
$
396.0

 
$
337.4

Accounts receivable, net
$
316.1

 
$
288.2

Inventories
$
230.4

 
$
214.5

Accounts payable
$
145.3

 
$
130.4

Debt
$
195.1

 
$
196.1

Equity
$
1,487.6

 
$
1,396.3

Working capital
$
669.1

 
$
610.7


Cash and cash equivalents include all instruments that have maturities of ninety days or less when purchased. Working capital is defined as current assets less current liabilities.

Cash and cash equivalents – Our cash and cash equivalents balance at September 30, 2019 consisted of cash held in depository accounts with banks around the world and cash invested in high-quality, short-term investments. The cash and cash equivalents balance at September 30, 2019 included $167.6 million of cash held by subsidiaries within the U.S., and $228.4 million of cash held by subsidiaries outside of the U.S. During the nine months ended September 30, 2019, we purchased 800,000 shares of our common stock under our now-completed calendar-year 2019 share repurchase program at a cost of $83.1 million, or an average price of $103.89 per share.

Working capital – Working capital at September 30, 2019 increased by $58.4 million, or 9.6%, as compared to December 31, 2018, including a decrease of $2.9 million due to foreign currency translation. Excluding the impact of currency exchange rates, cash, accounts receivable, inventories and total current liabilities increased by $65.6 million, $35.4 million, $21.9 million and $70.4 million. The increase in accounts receivable was due to increased sales activity and longer customer payment terms. The increase in total current liabilities was primarily due to increases in accounts payable, other current liabilities, and income taxes payable, as well as our adoption of ASC 842, which required us to record operating lease liabilities for operating leases where we are the lessee in our condensed consolidated balance sheet as of September 30, 2019.

Debt and credit facilities – The $1.0 million decrease in total debt at September 30, 2019, as compared to December 31, 2018, primarily resulted from foreign currency rate fluctuations.

Our sources of liquidity include our Credit Facility. At September 30, 2019, we had $27.6 million in outstanding long-term borrowings under this facility, of which $4.6 million was denominated in Yen and $23.0 million was denominated in Euro. These borrowings, together with outstanding letters of credit of $2.5 million, resulted in a borrowing capacity available under our Credit Facility of $269.9 million at September 30, 2019. We do not expect any significant limitations on our ability to access this source of funds.

The Credit Agreement contains financial covenants providing that we shall not permit the ratio of our net consolidated debt to our modified EBITDA to be greater than 3.5 to 1; provided that, no more than three times during the term of the Credit Agreement, upon the occurrence of a qualified acquisition for each of our four fiscal quarters immediately following such qualified acquisition, the ratio shall be increased to 4.0 to 1. The Credit Agreement also contains customary limitations on liens securing our indebtedness, fundamental changes (mergers, consolidations, liquidations and dissolutions), asset sales, distributions and acquisitions. At September 30, 2019, we were in compliance with all of our debt covenants.


39

We believe that cash on hand and cash generated from operations, together with availability under our Credit Facility, will be adequate to address our foreseeable liquidity needs based on our current expectations of our business operations, capital expenditures and scheduled payments of debt obligations.

Commitments and Contractual Obligations

A table summarizing the amounts and estimated timing of future cash payments resulting from commitments and contractual obligations was provided in our 2018 Annual Report. During the three months ended September 30, 2019, there were no material changes outside of the ordinary course of business to our commitments and contractual obligations.

In March 2019, we entered into the Credit Agreement that replaced our prior revolving credit facility, which was scheduled to expire in October 2020. The Credit Agreement expires in March 2024. Please refer to Note 8, Debt, for additional information.

On January 1, 2019, we adopted ASC 842. Please refer to Note 6, Leases, for additional information.

OFF-BALANCE SHEET ARRANGEMENTS

At September 30, 2019, we had no off-balance sheet financing arrangements other than unconditional purchase obligations incurred in the ordinary course of business and outstanding letters of credit related to various insurance programs, as noted in our 2018 Annual Report.

CRITICAL ACCOUNTING POLICIES AND ESTIMATES

There have been no changes to the Critical Accounting Policies and Estimates disclosed in Part II, Item 7 of our 2018 Annual Report.

NEW ACCOUNTING STANDARDS

For information on new accounting standards that were adopted, and those issued but not yet adopted, during the three months ended September 30, 2019, and the impact, if any, on our financial position or results of operations, see Note 2, New Accounting Standards.

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS

Our disclosure and analysis in this Form 10-Q contains some forward-looking statements that are based on management’s beliefs and assumptions, current expectations, estimates and forecasts. We also provide forward-looking statements in other materials we release to the public, as well as oral forward-looking statements. Such statements provide our current expectations or forecasts of future events. They do not relate strictly to historical or current facts. We have attempted, wherever possible, to identify forward-looking statements by using words such as “plan,” “expect,” “believe,” “intend,” “will,” “estimate,” “continue” and other words of similar meaning in conjunction with, among other things, discussions of future operations and financial performance, as well as our strategy for growth, product development, market position and expenditures.  All statements that address operating performance or events or developments that we expect or anticipate will occur in the future - including statements relating to sales and earnings per share growth, cash flows or uses, and statements expressing views about future operating results - are forward-looking statements.

Forward-looking statements are based on current expectations of future events. The forward-looking statements are, and will be, based on management’s then-current views and assumptions regarding future events and operating performance, and speak only as of their dates. Investors should realize that, if underlying assumptions prove inaccurate or unknown risks or uncertainties materialize, actual results could vary materially from our expectations and projections. Investors are therefore cautioned not to place undue reliance on any forward-looking statements.


40

The following are some important factors that could cause our actual results to differ from our expectations in any forward-looking statements:
•
sales demand and our ability to meet that demand;
•
competition from other providers in our businesses, including customers’ in-house operations, and from lower-cost producers in emerging markets, which can impact unit volume, price and profitability;
•
customers’ changing inventory requirements and manufacturing plans that alter existing orders or ordering patterns for the products we supply to them;
•
the timing, regulatory approval and commercial success of customer products that incorporate our products and systems;
•
whether customers agree to incorporate our products and delivery systems with their new and existing drug products, the ultimate timing and successful commercialization of those products and systems, which involves substantial evaluations of the functional, operational, clinical and economic viability of our products, and the rate, timing and success of regulatory approval for the drug products that incorporate our components and systems;
•
the timely and adequate availability of filling capacity, which is essential to conducting definitive stability trials and the timing of first commercialization of customers’ products in CZ prefilled syringes;
•
average profitability, or mix, of the products sold in any reporting period, including lower-than-expected sales growth of our high-value proprietary product offerings;
•
maintaining or improving production efficiencies and overhead absorption;
•
dependence on third-party suppliers and partners, some of which are single-source suppliers of critical materials and products, including our Japanese partner and affiliate, Daikyo;
•
the loss of key personnel or highly-skilled employees;
•
the availability and cost of skilled employees required to meet increased production, managerial, research and other needs, including professional employees and persons employed under collective bargaining agreements;
•
interruptions or weaknesses in our supply chain, including from reasons beyond our control such as extreme weather, longer-term climate changes, natural disasters, pandemic, war, accidental damage, or unauthorized access to our or our customers’ information and systems, which could cause delivery delays or restrict the availability of raw materials, key purchased components and finished products;
•
the successful and timely implementation of price increases necessary to offset rising production costs, including raw material prices, particularly petroleum-based raw materials;
•
the cost and progress of development, regulatory approval and marketing of new products;
•
our ability to obtain and maintain licenses in any jurisdiction in which we do business;
•
the relative strength of USD in relation to other currencies, particularly the Euro, SGD, the Danish Krone, Yen, Colombian Peso, Brazilian Real, and the South Korean Won; and
•
the potential adverse effects of global healthcare legislation on customer demand, product pricing and profitability.

This list sets forth many, but not all, of the factors that could affect our ability to achieve results described in any forward-looking statements. Investors should understand that it is not possible to predict or identify all of the factors and should not consider this list to be a complete statement of all potential risks and uncertainties. For further

41

discussion of these and other factors, see the risk factors disclosed in Part I, Item 1A of our 2018 Annual Report. Except as required by law or regulation, we do not intend to update any forward-looking statements.

ITEM 3.  QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

There have been no material changes in our exposure to market risk or the information provided in Part II, Item 7A of our 2018 Annual Report.

In March 2019, we entered into the Credit Agreement that replaced our prior revolving credit facility, which was scheduled to expire in October 2020. The Credit Agreement expires in March 2024. Please refer to Note 8, Debt, for additional information.

ITEM 4.  CONTROLS AND PROCEDURES

Disclosure controls are controls and procedures designed to reasonably ensure that information required to be disclosed in our reports filed under the Exchange Act, such as this quarterly report, is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls include, without limitation, controls and procedures designed to ensure that information required to be disclosed in our reports filed under the Securities Exchange Act of 1934, as amended, is accumulated and communicated to our management, including our Chief Executive Officer (“CEO”) and Chief Financial Officer (“CFO”), or persons performing similar functions, as appropriate, to allow timely decisions regarding required disclosure. Our disclosure controls include some, but not all, components of our internal control over financial reporting.

Evaluation of Disclosure Controls and Procedures
An evaluation was performed under the supervision and with the participation of our management, including our CEO and CFO, of the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934), as of the end of the period covered by this quarterly report on Form 10-Q. Based on this evaluation, our CEO and CFO have concluded that, as of September 30, 2019, our disclosure controls and procedures are effective.

Changes in Internal Controls
During the quarter ended September 30, 2019, there have been no changes to our internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

On January 1, 2019, we adopted ASC 842. Although our adoption of ASC 842 resulted in no change to our internal control over financial reporting that materially affected, or is reasonably likely to materially affect, our internal control over financial reporting, we did implement changes to our internal controls relating to leases. These changes included the development of new policies, enhanced contract review requirements, and other ongoing monitoring activities. These controls were designed to provide assurance at a reasonable level of the fair presentation of our condensed consolidated financial statements and related disclosures.

PART II.  OTHER INFORMATION

ITEM 1.  LEGAL PROCEEDINGS

None.

ITEM 1A.  RISK FACTORS

There are no material changes to the risk factors disclosed in Part I, Item 1A of our 2018 Annual Report.


42

ITEM 2.  UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

During the three months ended September 30, 2019, there were no purchases of our common stock made by us or any of our “affiliated purchasers” as defined in Rule 10b-18(a)(3) under the Exchange Act.
 

In February 2019, we announced a share repurchase program for calendar-year 2019 authorizing the repurchase of up to 800,000 shares of our common stock from time to time on the open market or in privately-negotiated transactions as permitted under the Securities Exchange Act of 1934 Rule 10b-18. The number of shares repurchased and the timing of such transactions depended on a variety of factors, including market conditions. There were no shares purchased during the three months ended September 30, 2019. During the nine months ended September 30, 2019, we purchased 800,000 shares of our common stock under the now-completed program at a cost of $83.1 million, or an average price of $103.89 per share.

ITEM 6.  EXHIBITS


The list of exhibits in the Exhibit Index to this report is incorporated herein by reference.



43

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, West Pharmaceutical Services, Inc. has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

WEST PHARMACEUTICAL SERVICES, INC.
(Registrant)




By: /s/ Bernard J. Birkett
Bernard J. Birkett
Senior Vice President, Chief Financial Officer and Treasurer



October 28, 2019

44

EXHIBIT INDEX

Exhibit #
Description
3.1
3.2
4.1
4.2
4.3
4.4 (1)
Instruments defining the rights of holders of long-term debt securities of West and its subsidiaries have been omitted.
10.1
31.1
31.2
32.1*
32.2*
101.INS
The instance document does not appear in the interactive data file because its XBRL tags are embedded within the inline XBRL document.
101.SCH
XBRL Taxonomy Extension Schema Document
101.CAL
XBRL Taxonomy Extension Calculation Linkbase Document
101.LAB
XBRL Taxonomy Extension Label Linkbase Document
101.PRE
XBRL Taxonomy Extension Presentation Linkbase Document
101.DEF
XBRL Taxonomy Extension Definition Linkbase Document


(1) We agree to furnish to the SEC, upon request, a copy of each instrument with respect to issuances of long-term debt of the Company and its subsidiaries.

* Furnished, not filed.

F-1
 EX-31.1 2 ex311q32019.htm EXHIBIT 31.1 Exhibit


EXHIBIT 31.1
CERTIFICATION

I, Eric M. Green, certify that:
1.
I have reviewed this quarterly report on Form 10-Q of West Pharmaceutical Services, Inc.;
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.
The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a.
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b.
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c.
Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d.
Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5.
The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
a.
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
b.
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.


/s/ Eric M. Green
Eric M. Green
President and Chief Executive Officer

Date: October 28, 2019


EX-31.2 3 ex312q32019.htm EXHIBIT 31.2 Exhibit


EXHIBIT 31.2
CERTIFICATION

I, Bernard J. Birkett, certify that:
1.
I have reviewed this quarterly report on Form 10-Q of West Pharmaceutical Services, Inc.;
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.
The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a.
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b.
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c.
Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d.
Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5.
The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
a.
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
b.
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.


/s/ Bernard J. Birkett
Bernard J. Birkett
Senior Vice President, Chief Financial Officer and Treasurer

Date: October 28, 2019


EX-32.1 4 ex321q32019.htm EXHIBIT 32.1 Exhibit


EXHIBIT 32.1


CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO SECTION 906 OF
THE SARBANES-OXLEY ACT OF 2002


In connection with the Quarterly Report on Form 10-Q of West Pharmaceutical Services, Inc. (the “Company”) for the period ended September 30, 2019, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Eric M. Green, President and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.



/s/ Eric M. Green
Eric M. Green
President and Chief Executive Officer

Date: October 28, 2019


 EX-32.2 5 ex322q32019.htm EXHIBIT 32.2 Exhibit


EXHIBIT 32.2


CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO SECTION 906 OF
THE SARBANES-OXLEY ACT OF 2002


In connection with the Quarterly Report on Form 10-Q of West Pharmaceutical Services, Inc. (the “Company”) for the period ended September 30, 2019, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Bernard J. Birkett, Senior Vice President, Chief Financial Officer and Treasurer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.



/s/ Bernard J. Birkett
Bernard J. Birkett
Senior Vice President, Chief Financial Officer and Treasurer

Date: October 28, 2019



 EX-101.SCH 6 wst-20190930.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 2111100 - Disclosure - Accumulated Other Comprehensive Loss link:presentationLink link:calculationLink link:definitionLink 2411404 - Disclosure - Accumulated Other Comprehensive Loss Accumulated Other Comprehensive Loss (Details) link:presentationLink link:calculationLink link:definitionLink 2411402 - Disclosure - Accumulated Other Comprehensive Loss Components (Details) link:presentationLink link:calculationLink link:definitionLink 2411403 - Disclosure - Accumulated Other Comprehensive Loss Reclassifications (Details) link:presentationLink link:calculationLink link:definitionLink 2411403 - Disclosure - Accumulated Other Comprehensive Loss Reclassifications (Details) link:presentationLink link:calculationLink link:definitionLink 2311301 - Disclosure - Accumulated Other Comprehensive Loss (Tables) link:presentationLink link:calculationLink link:definitionLink 2107100 - Disclosure - Affiliated Companies link:presentationLink link:calculationLink link:definitionLink 2407401 - Disclosure - Affiliated Companies (Details) link:presentationLink link:calculationLink link:definitionLink 2114100 - Disclosure - Benefit Plans link:presentationLink link:calculationLink link:definitionLink 2414402 - Disclosure - Benefit Plans (Details) link:presentationLink link:calculationLink link:definitionLink 2314301 - Disclosure - Benefit Plans (Tables) link:presentationLink link:calculationLink link:definitionLink 2412403 - Disclosure - Change in Shareholders' Equity (Details) link:presentationLink link:calculationLink link:definitionLink 2117100 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 1003000 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) link:presentationLink link:calculationLink link:definitionLink 1003001 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 1005000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) link:presentationLink link:calculationLink link:definitionLink 1002000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED) link:presentationLink link:calculationLink link:definitionLink 1002501 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 1001000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED) link:presentationLink link:calculationLink link:definitionLink 2403403 - Disclosure - Contracts and Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 2408403 - Disclosure - Credit Facility (Details) link:presentationLink link:calculationLink link:definitionLink 2108100 - Disclosure - Debt link:presentationLink link:calculationLink link:definitionLink 2308301 - Disclosure - Debt (Tables) link:presentationLink link:calculationLink link:definitionLink 2109100 - Disclosure - Derivative Financial Instruments link:presentationLink link:calculationLink link:definitionLink 2309301 - Disclosure - Derivative Financial Instruments (Tables) link:presentationLink link:calculationLink link:definitionLink 2409402 - Disclosure - Derivative Financial Instruments (Textuals) (Details) link:presentationLink link:calculationLink link:definitionLink 0001000 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 2409403 - Disclosure - Effects of Derivative Instruments on OCI and Earnings (Details) link:presentationLink link:calculationLink link:definitionLink 2110100 - Disclosure - Fair Value Measurements link:presentationLink link:calculationLink link:definitionLink 2410402 - Disclosure - Fair Value Measurements (Details) link:presentationLink link:calculationLink link:definitionLink 2410403 - Disclosure - Fair Value Measurements Level 3 (Details) link:presentationLink link:calculationLink link:definitionLink 2410404 - Disclosure - Fair Value Measurements Other Financial Instruments (Details) link:presentationLink link:calculationLink link:definitionLink 2310301 - Disclosure - Fair Value Measurements (Tables) link:presentationLink link:calculationLink link:definitionLink 2116100 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 2416401 - Disclosure - Income Taxes (Details) link:presentationLink link:calculationLink link:definitionLink 2105100 - Disclosure - Inventories link:presentationLink link:calculationLink link:definitionLink 2405402 - Disclosure - Inventories (Details) link:presentationLink link:calculationLink link:definitionLink 2305301 - Disclosure - Inventories (Tables) link:presentationLink link:calculationLink link:definitionLink 2106100 - Disclosure - Leases link:presentationLink link:calculationLink link:definitionLink 2406402 - Disclosure - Leases Adoption of ASC 842 (Details) link:presentationLink link:calculationLink link:definitionLink 2406404 - Disclosure - Leases Lease Cash Flow and Supplemental Information (Details) link:presentationLink link:calculationLink link:definitionLink 2406403 - Disclosure - Leases Lease Cost (Details) link:presentationLink link:calculationLink link:definitionLink 2406405 - Disclosure - Leases Lease Weighted Average (Details) link:presentationLink link:calculationLink link:definitionLink 2306301 - Disclosure - Leases Leases (Tables) link:presentationLink link:calculationLink link:definitionLink 2406406 - Disclosure - Leases Maturities of Operating Lease Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 2408402 - Disclosure - Long-term Debt (Details) link:presentationLink link:calculationLink link:definitionLink 2104100 - Disclosure - Net Income Per Share link:presentationLink link:calculationLink link:definitionLink 2404402 - Disclosure - Net Income Per Share (Details) link:presentationLink link:calculationLink link:definitionLink 2304301 - Disclosure - Net Income Per Share (Tables) link:presentationLink link:calculationLink link:definitionLink 2102100 - Disclosure - New Accounting Standards link:presentationLink link:calculationLink link:definitionLink 2115100 - Disclosure - Other Expense link:presentationLink link:calculationLink link:definitionLink 2415402 - Disclosure - Other Expense (Details) link:presentationLink link:calculationLink link:definitionLink 2415403 - Disclosure - Other Expense Items (Details) link:presentationLink link:calculationLink link:definitionLink 2415405 - Disclosure - Other Expense Other (Income) Development and Licensing Income (Details) link:presentationLink link:calculationLink link:definitionLink 2415404 - Disclosure - Other Expense Restructuring and Related Charges (Details) link:presentationLink link:calculationLink link:definitionLink 2315301 - Disclosure - Other Expense (Tables) link:presentationLink link:calculationLink link:definitionLink 2103100 - Disclosure - Revenue link:presentationLink link:calculationLink link:definitionLink 2403402 - Disclosure - Revenue Recognition (Details) link:presentationLink link:calculationLink link:definitionLink 2403404 - Disclosure - Revenue Supply Chain Financing (Details) link:presentationLink link:calculationLink link:definitionLink 2303301 - Disclosure - Revenue (Tables) link:presentationLink link:calculationLink link:definitionLink 2403405 - Disclosure - Revenue Voluntary Recall (Details) link:presentationLink link:calculationLink link:definitionLink 2118100 - Disclosure - Segment Information link:presentationLink link:calculationLink link:definitionLink 2418402 - Disclosure - Segment Information (Details) link:presentationLink link:calculationLink link:definitionLink 2318301 - Disclosure - Segment Information (Tables) link:presentationLink link:calculationLink link:definitionLink 2112100 - Disclosure - Shareholders' Equity link:presentationLink link:calculationLink link:definitionLink 2312301 - Disclosure - Shareholders' Equity (Tables) link:presentationLink link:calculationLink link:definitionLink 2113100 - Disclosure - Stock-Based Compensation link:presentationLink link:calculationLink link:definitionLink 2413401 - Disclosure - Stock-Based Compensation (Details) link:presentationLink link:calculationLink link:definitionLink 2419402 - Disclosure - Subsequent Event (Details) link:presentationLink link:calculationLink link:definitionLink 2119100 - Disclosure - Subsequent Event (Notes) link:presentationLink link:calculationLink link:definitionLink 2319301 - Disclosure - Subsequent Event (Tables) link:presentationLink link:calculationLink link:definitionLink 2101100 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 2401402 - Disclosure - Summary of Significant Accounting Policies Business Combinations (Details) link:presentationLink link:calculationLink link:definitionLink 2201201 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 2412402 - Disclosure - Supplemental Equity Information (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 7 wst-20190930_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 8 wst-20190930_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 9 wst-20190930_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Other Income and Expenses [Abstract] Other Expense Other Income and Other Expense Disclosure [Text Block] Accounting Policies [Abstract] Basis of Presentation Basis of Accounting, Policy [Policy Text Block] New Accounting Standards New Accounting Pronouncements, Policy [Policy Text Block] Earnings Per Share [Abstract] Reconciliation of Basic to Diluted Net Income Per Share Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Subsequent Event [Abstract] Subsequent Event [Abstract] Subsequent Event [Table] Subsequent Event [Table] Subsequent Event Type [Axis] Subsequent Event Type [Axis] Subsequent Event Type [Domain] Subsequent Event Type [Domain] Subsequent Event [Line Items] Subsequent Event [Line Items] Equity Method Investment, Ownership Percentage Equity Method Investment, Ownership Percentage Net income Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Weighted average common shares outstanding (in shares) Weighted Average Number of Shares Outstanding, Basic Dilutive effect of equity awards, based on the treasury stock method (in shares) Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements Weighted average shares assuming dilution (in shares) Weighted Average Number of Shares Outstanding, Diluted Antidilutive options excluded from computation of diluted net income per share (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Stock repurchase program, shares authorized Stock Repurchase Program, Number of Shares Authorized to be Repurchased Stock repurchase program, shares purchased Treasury Stock, Shares, Acquired Stock purchase program, cost of shares purchased Treasury Stock, Value, Acquired, Cost Method Stock repurchase program, average price per share Treasury Stock Acquired, Average Cost Per Share Summary of Significant Accounting Policies Significant Accounting Policies [Text Block] Lease, Cost [Abstract] Operating lease cost Operating Lease, Cost Short-term lease cost Short-term Lease, Cost Variable lease cost Variable Lease, Cost Total lease cost Lease, Cost Fair Value Disclosures [Abstract] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Table] Fair Value, Recurring and Nonrecurring [Table] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Fair Value, Measurements, Fair Value Hierarchy [Domain] Fair Value Hierarchy and NAV [Domain] Level 1 [Member] Fair Value, Inputs, Level 1 [Member] Level 2 [Member] Fair Value, Inputs, Level 2 [Member] Level 3 [Member] Fair Value, Inputs, Level 3 [Member] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Assets: Assets, Fair Value Disclosure [Abstract] Deferred compensation assets Deferred Compensation Plan Assets Foreign currency contracts Foreign Currency Contract, Asset, Fair Value Disclosure Commodity call options Other Assets, Fair Value Disclosure Total assets at fair value Assets, Fair Value Disclosure Liabilities: Liabilities, Fair Value Disclosure [Abstract] Contingent consideration Business Combination, Contingent Consideration, Liability Deferred compensation liabilities Deferred Compensation Liability, Classified, Noncurrent Foreign currency contracts Foreign Currency Contracts, Liability, Fair Value Disclosure Total liabilities at fair value Financial and Nonfinancial Liabilities, Fair Value Disclosure Inventory Disclosure [Abstract] Inventories Inventory Disclosure [Text Block] Inventories Schedule of Inventory, Current [Table Text Block] Supply Chain Financing [Abstract] Supply Chain Financing [Abstract] Sales of certain accounts receivable Transfer of Financial Assets Accounted for as Sales, Cash Proceeds Received for Assets Derecognized, Amount Lease Cash Flow and Supplemental Information [Abstract] Lease Cash Flow and Supplemental Information [Abstract] Operating lease payments Operating Lease, Payments Right-of-use assets obtained in exchange for new operating lease liabilities Right-of-Use Asset Obtained in Exchange for Operating Lease Liability Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Abstract] Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table] Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table] Income Statement Location [Axis] Income Statement Location [Axis] Income Statement Location [Domain] Income Statement Location [Domain] Other Nonoperating Income (Expense) [Member] Other Nonoperating Income (Expense) [Member] Retirement Plan Type [Axis] Retirement Plan Type [Axis] Retirement Plan Type [Domain] Retirement Plan Type [Domain] Pension Benefits [Member] Pension Plan [Member] Other Retirement Benefits [Member] Other Postretirement Benefits Plan [Member] Retirement Plan Sponsor Location [Axis] Retirement Plan Sponsor Location [Axis] Retirement Plan Sponsor Location [Domain] Retirement Plan Sponsor Location [Domain] UNITED STATES UNITED STATES Foreign Plan [Member] Foreign Plan [Member] Defined Benefit Plans and Other Postretirement Benefit Plans [Line Items] Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] Service cost Defined Benefit Plan, Service Cost Interest cost Defined Benefit Plan, Interest Cost Expected return on assets Defined Benefit Plan, Expected Return (Loss) on Plan Assets Amortization of prior service credit Defined Benefit Plan, Amortization of Prior Service Cost (Credit) Recognized actuarial losses (gains) Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss) Settlements Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement Net periodic benefit cost Defined Benefit Plan, Net Periodic Benefit Cost (Credit) Contributions by employer Defined Benefit Plan, Plan Assets, Contributions by Employer Equity Method Investments and Joint Ventures [Abstract] Affiliated Companies Equity Method Investments and Joint Ventures Disclosure [Text Block] Revenue [Abstract] Revenue [Abstract] Revenue from Contract with Customer [Text Block] Revenue from Contract with Customer [Text Block] Restructuring Charges Restructuring Charges Increase (decrease) of other items Increase (Decrease) of Other Operating Income and Expense Increase (Decrease) of Other Operating Income and Expense Foreign exchange transaction (gain) loss Foreign Currency Transaction Gain (Loss), before Tax Balance Sheet Related Disclosures [Abstract] Statement [Table] Statement [Table] Scenario [Axis] Scenario [Axis] Scenario [Domain] Scenario [Domain] Class of Stock [Axis] Class of Stock [Axis] Class of Stock [Domain] Class of Stock [Domain] Statement [Line Items] Statement [Line Items] ASSETS Assets [Abstract] Current assets: Assets, Current [Abstract] Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Accounts receivable, net Accounts Receivable, after Allowance for Credit Loss, Current Inventories Inventory, Net Other current assets Other Assets, Current Total current assets Assets, Current Property, plant and equipment Property, Plant and Equipment, Gross Less: accumulated depreciation and amortization Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Property, plant and equipment, net Property, Plant and Equipment, Net Operating lease right-of-use assets Operating Lease, Right-of-Use Asset Investments in affiliated companies Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures Goodwill Goodwill Deferred income taxes Deferred Tax Assets, Net of Valuation Allowance, Noncurrent Intangible assets, net Intangible Assets, Net (Excluding Goodwill) Other noncurrent assets Other Assets, Noncurrent Total Assets Assets LIABILITIES AND EQUITY Liabilities and Equity [Abstract] Current liabilities: Liabilities, Current [Abstract] Notes payable and other current debt Debt, Current Accounts payable Accounts Payable, Current Pension and other postretirement benefits Liability, Defined Benefit Plan, Current Accrued salaries, wages and benefits Employee-related Liabilities, Current Income taxes payable Accrued Income Taxes, Current Operating lease liabilities, current Operating Lease, Liability, Current Other current liabilities Other Liabilities, Current Total current liabilities Liabilities, Current Long-term debt Long-term Debt, Excluding Current Maturities Deferred income taxes Deferred Tax Liabilities, Net, Noncurrent Pension and other postretirement benefits Liability, Defined Benefit Plan, Noncurrent Operating lease liabilities, noncurrent Operating Lease, Liability, Noncurrent Other long-term liabilities Other Liabilities, Noncurrent Total Liabilities Liabilities Commitments and contingencies (Note 15) Commitments and Contingencies Equity: Equity [Abstract] Preferred stock, 3.0 million shares authorized; 0 shares issued and outstanding Preferred Stock, Value, Issued Common stock, par value $0.25 per share; 100.0 million shares authorized; shares issued: 75.3 million and 75.3 million; shares outstanding: 74.0 million and 74.1 million Common Stock, Value, Issued Capital in excess of par value Additional Paid in Capital Retained earnings Retained Earnings (Accumulated Deficit) Accumulated other comprehensive loss Accumulated Other Comprehensive Income (Loss), Net of Tax Treasury stock, at cost (1.3 million and 1.2 million shares) Treasury Stock, Value Total Equity Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest Total Liabilities and Equity Liabilities and Equity Statement of Cash Flows [Abstract] Cash flows from operating activities: Net Cash Provided by (Used in) Operating Activities [Abstract] Net income Adjustments to reconcile net income to net cash provided by operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Depreciation Depreciation Amortization Amortization Stock-based compensation Share-based Payment Arrangement, Noncash Expense Non-cash restructuring charges Restructuring Reserve, Settled without Cash Pension settlement charge Pension settlement charge Amount of expense as a result of an irrevocable action that relieves the employer (or the plan) of primary responsibility for a benefit obligation and eliminates significant risks related to the obligation and the assets used to effect the settlement. Examples of transactions that constitute a settlement include, but are not limited to, lump-sum cash payments to plan participants in exchange for their rights to receive specified benefits and purchasing nonparticipating annuity contracts to cover vested benefits. Contingent consideration payments in excess of acquisition-date liability Payment for Contingent Consideration Liability, Operating Activities Other non-cash items, net Increase (Decrease) in Other Operating Assets and Liabilities, Net Changes in assets and liabilities Other Noncash Income (Expense) Net cash provided by operating activities Net Cash Provided by (Used in) Operating Activities Cash flows from investing activities: Net Cash Provided by (Used in) Investing Activities [Abstract] Capital expenditures Payments to Acquire Property, Plant, and Equipment Acquisition of business Payments to Acquire Businesses, Gross Other, net Payments for (Proceeds from) Other Investing Activities Net cash used in investing activities Net Cash Provided by (Used in) Investing Activities Cash flows from financing activities: Net Cash Provided by (Used in) Financing Activities [Abstract] Borrowings under revolving credit agreements Proceeds from Long-term Lines of Credit Repayments under revolving credit agreements Repayments of Long-term Lines of Credit Repayments of long-term debt Repayment of Long-term Debt, Long-term Lease Obligation, and Capital Security Debt issuance costs Payments of Debt Issuance Costs Dividend payments Payments of Ordinary Dividends, Common Stock Contingent consideration payments up to amount of acquisition-date liability Proceeds from (Payments for) Other Financing Activities Proceeds from stock-based compensation awards Proceeds from Stock Options Exercised Employee stock purchase plan contributions Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised Shares purchased under share repurchase programs Payments for Repurchase of Common Stock Shares repurchased for employee tax withholdings Payment, Tax Withholding, Share-based Payment Arrangement Net cash used in financing activities Net Cash Provided by (Used in) Financing Activities Effect of exchange rates on cash Effect of Exchange Rate on Cash and Cash Equivalents Net increase in cash and cash equivalents Cash and Cash Equivalents, Period Increase (Decrease) Cash and cash equivalents at beginning of period Cash and cash equivalents at end of period Revenue from Contract with Customer [Abstract] Provision for sales returns Revenue Recognition, Sales Returns, Reserve for Sales Returns Severance and post-employment benefits Severance Costs Asset-related charges Asset Impairment Charges Asset impairment charges, equipment Asset Impairment Charges, Patent and Equipment Amount of write-down of a patent and certain equipment, recognized in the income statement. Other charges Other Restructuring Costs Total restructuring and related charges Restructuring and Related Cost, Incurred Cost Argentina currency devaluation Foreign Currency Transaction Loss, before Tax Development and licensing income Development and licensing income The amount of consideration recognized during the period under a development, licensing and supply agreement entered into with a customer. Contingent consideration Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability Other items Other Operating Income (Expense), Net Total other expense (income) Other Income Expense The total amount of other income and expense items that are associated with the entity's normal revenue producing operation. Weighted average remaining lease term Operating Lease, Weighted Average Remaining Lease Term Weighted average discount rate Operating Lease, Weighted Average Discount Rate, Percent Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Income Tax Disclosure [Abstract] Income Taxes Income Tax Disclosure [Text Block] Accumulated Other Comprehensive Income (Loss) [Table] Reclassification out of Accumulated Other Comprehensive Income [Axis] Reclassification out of Accumulated Other Comprehensive Income [Axis] Reclassification out of Accumulated Other Comprehensive Income [Domain] Reclassification out of Accumulated Other Comprehensive Income [Domain] Reclassification out of Accumulated Other Comprehensive Loss [Member] Reclassification out of Accumulated Other Comprehensive Income [Member] Equity Components [Axis] Equity Components [Axis] Equity Component [Domain] Equity Component [Domain] Gains (Losses) on Cash Flow Hedges [Member] Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member] Unrealized Gains on Investment Securities [Member] AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Parent [Member] Defined Benefit Pension and Other Postretirement Plans [Member] Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member] Foreign Currency Translation [Member] Accumulated Foreign Currency Adjustment Attributable to Parent [Member] Accumulated Other Comprehensive Income (Loss) [Line Items] Accumulated Other Comprehensive Income (Loss) [Line Items] Changes in the Components of Accumulated Other Comprehensive Loss, Net of Tax [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Balance, beginning Other comprehensive income (loss) before reclassifications Other Comprehensive Income (Loss), before Reclassifications, Net of Tax Amounts reclassified out Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax Other comprehensive loss, net of tax Other Comprehensive Income (Loss), Net of Tax Balance, ending Preferred stock, shares authorized (in shares) Preferred Stock, Shares Authorized Preferred stock, shares issued (in shares) Preferred Stock, Shares Issued Preferred stock, shares outstanding (in shares) Preferred Stock, Shares Outstanding Common stock, par value (in dollars per share) Common Stock, Par or Stated Value Per Share Common stock, shares authorized (in shares) Common Stock, Shares Authorized Common stock, shares issued (in shares) Common Stock, Shares, Issued Common stock, shares outstanding (in shares) Common Stock, Shares, Outstanding Treasury stock, at cost (in shares) Treasury Stock, Shares Business Combinations [Abstract] Business acquisition, transaction costs Business Acquisition, Transaction Costs Business combination, recognized inventory Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory Business combination, recognized property, plant, and equipment Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment Business combination, recognized goodwill Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net Business combination, recognized intangible assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles Benefit Plans Pension and Other Postretirement Benefits Disclosure [Text Block] Fair Value Measurements Fair Value Disclosures [Text Block] Share-based Payment Arrangement [Abstract] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Award Type [Axis] Award Type [Axis] Award Type [Domain] Award Type [Domain] Performance Share Unit (PSUs) [Member] Performance Shares [Member] Restricted Stock Units (RSUs) [Member] Restricted Stock Units (RSUs) [Member] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Shares available for issuance under the 2016 Plan (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant Stock options, granted (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures Stock options, weighted average exercise price (in dollars per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Stock options, weighted average grant date fair value (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Risk-free interest rate (in hundredths) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Expected life (in years) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term Stock volatility (in hundredths) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate Dividend yield (in hundredths) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate Granted (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period Grant date fair value (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value PSU payout, minimum (in hundredths) PVS Payout Minimum Percent of an employee's targeted award to be paid out, Minimum. PSU payout, maximum (in hundredths) PVS Payout Maximum Percent of an employee's targeted award to be paid out, Maximum. Stock-based compensation expense Share-based Payment Arrangement, Expense Net Income Per Share Earnings Per Share [Text Block] Schedule of Stockholders Equity [Table Text Block] Schedule of Stockholders Equity [Table Text Block] Subsequent Events [Abstract] Subsequent Events [Text Block] Subsequent Events [Text Block] Revenue Recognition and Deferred Revenue [Abstract] Disaggregation of Revenue [Table] Disaggregation of Revenue [Table] Nature of Expense [Axis] Nature of Expense [Axis] Interim Period, Costs Not Allocable [Domain] Interim Period, Costs Not Allocable [Domain] SmartDose [Member] SmartDose [Member] SmartDose [Member] Geographical [Axis] Geographical [Axis] Geographical [Domain] Geographical [Domain] Americas [Member] Americas [Member] Europe, Middle East, Africa [Member] EMEA [Member] Asia Pacific [Member] Asia Pacific [Member] Customer [Axis] Customer [Axis] Customer [Domain] Customer [Domain] Biologics [Member] Biologics Customers [Member] Biologics Customers [Member] Generics [Member] Generics Customers [Member] Generics Customers [Member] Pharma Customers [Member] Pharma Customers [Member] Pharma Customers [Member] Contract-Manufactured Products [Member] Contract-Manufactured Customers [Member] Contract-Manufactured Customers [Member] Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] Revenue Benchmark [Member] Revenue Benchmark [Member] Concentration Risk Type [Axis] Concentration Risk Type [Axis] Concentration Risk Type [Domain] Concentration Risk Type [Domain] Geographic Concentration Risk [Member] Geographic Concentration Risk [Member] Product Concentration Risk [Member] Product Concentration Risk [Member] Customer Concentration Risk [Member] Customer Concentration Risk [Member] Product and Service [Axis] Product and Service [Axis] Product and Service [Domain] Product and Service [Domain] High-Value Components [Member] High-Value Components [Member] High-Value Components [Member] Standard Packaging [Member] Standard Packaging [Member] Standard Packaging [Member] Delivery Devices [Member] Delivery Devices [Member] Delivery Devices [Member] Contract-Manufactured Products [Member] Contract Manufactured Products [Member] Contract Manufactured Products [Member] Disaggregation of Revenue [Line Items] Disaggregation of Revenue [Line Items] Percentage of net sales Concentration Risk, Percentage Schedule of Other Expense Schedule of Other Income and Expense, by Component [Table Text Block] Schedule of Other Income and Expense, by Component [Table Text Block] Schedule of Restructuring Reserve Schedule of Restructuring Reserve by Type of Cost [Table Text Block] Other Financial Instruments [Abstract] Other Financial Instruments [Abstract] -- None. No documentation exists for this element. -- Long-term debt, fair value Long-term Debt, Fair Value Common Stock [Member] Common Stock [Member] Additional Paid-in Capital [Member] Additional Paid-in Capital [Member] Treasury Stock [Member] Treasury Stock [Member] Retained Earnings [Member] Retained Earnings [Member] AOCI Attributable to Parent [Member] AOCI Attributable to Parent [Member] Increase (Decrease) in Stockholders' Equity [Roll Forward] Balance Balance (in shares) Shares, Issued Cumulative effect of new accounting principle in period of adoption Cumulative Effect of New Accounting Principle in Period of Adoption Stock-based compensation APIC, Share-based Payment Arrangement, Increase for Cost Recognition Shares issued under stock plans (in shares) Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture Activity related to stock-based compensation Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture Share purchased under share repurchase program (in shares) Shares purchased under share repurchase program Share repurchased for employee tax withholdings (in shares) Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation Shares repurchased for employee tax withholdings Share-based Payment Arrangement, Decrease for Tax Withholding Obligation Dividends declared Dividends, Common Stock, Cash Other comprehensive income, net of tax Balance Balance (in shares) Statement of Comprehensive Income [Abstract] Other comprehensive (loss) income, net of tax: Other Comprehensive Income (Loss), Net of Tax [Abstract] Foreign currency translation adjustments Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Defined benefit pension and other postretirement plan adjustments, net of tax of $0.7, $0, $0.7 and $0.1, respectively Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax Net loss on investment securities, net of tax of $0 Other Comprehensive Income (Loss), Securities, Available-for-sale, Adjustment, after Tax Net gain (loss) on derivatives, net of tax of $1.5, $(0.1), $0.7, and $1.0, respectively Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax Comprehensive income Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest Development and licensing income [Table] Development and licensing income [Table] Development and licensing income [Table] Other [Member] Other [Member] Other [Member] Development and licensing income [Line Items] Development and licensing income [Line Items] [Line Items] for Development and licensing income [Table] Development and licensing income Deferred income Contract with Customer, Liability New Accounting Pronouncements and Changes in Accounting Principles [Abstract] New Accounting Standards New Accounting Pronouncements and Changes in Accounting Principles [Text Block] Schedule of Restructuring and Related Costs [Table] Schedule of Restructuring and Related Costs [Table] Restructuring Plan [Axis] Restructuring Plan [Axis] Restructuring Plan [Domain] Restructuring Plan [Domain] 2018 Restructuring Plan [Member] 2018 Restructuring Plan [Member] 2018 Restructuring Plan [Member] 2016 Restructuring Plan [Member] 2016 Restructuring Plan [Member] [Member] 2016 Restructuring Plan [Member] [Member] Statistical Measurement [Axis] Statistical Measurement [Axis] Statistical Measurement [Domain] Statistical Measurement [Domain] Minimum [Member] Minimum [Member] Maximum [Member] Maximum [Member] Restructuring Type [Axis] Restructuring Type [Axis] Type of Restructuring [Domain] Type of Restructuring [Domain] Severance and benefits [Member] Employee Severance [Member] Asset-related charges [Member] Asset-Related Charges [Member] Asset-Related Charges [Member] Other charges [Member] Other Restructuring [Member] Restructuring Cost and Reserve [Line Items] Restructuring Cost and Reserve [Line Items] Restructuring and related cost, expected cost Restructuring and Related Cost, Expected Cost Restructuring and related cost, cumulative cost incurred Restructuring and Related Cost, Cost Incurred to Date Payments to acquire property, plant, and equipment Severance charges Restructuring and related charges Restructuring Reserve [Roll Forward] Restructuring Reserve [Roll Forward] Balance, December 31, 2018 Restructuring Reserve Charges Cash payments Payments for Restructuring Non-cash asset-write-downs Balance, September 30, 2019 Level 3 Fair Value Measurements [Roll Forward] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Balance, beginning of period Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value Increase (decrease) in fair value recorded in earnings Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings Payments Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements Balance, end of period Stock-Based Compensation Share-based Payment Arrangement [Text Block] Derivative Instruments and Hedging Activities Disclosure [Abstract] Derivative Instruments, Gain (Loss) by Hedging Relationship, by Income Statement Location, by Derivative Instrument Risk [Table] Derivative Instruments, Gain (Loss) [Table] Derivative Instrument [Axis] Derivative Instrument [Axis] Derivative Contract Type [Domain] Derivative Contract [Domain] Foreign Currency Hedge Contracts [Member] Foreign Exchange Contract [Member] Foreign Currency Hedge Contracts [Member] Commodity Option [Member] Interest Rate Swap Contracts [Member] Interest Rate Swap [Member] Forward Treasury Locks [Member] Treasury Lock [Member] Foreign Currency - Denominated Debt [Member] Foreign Currency, Denominated Debt [Member] Foreign currency-denominated debt designated as a hedge of our net investments in foreign operations. Net sales [Member] Net Sales [Member] Net sales member Cost of goods and services sold [Member] Cost of Sales [Member] Interest expense [Member] Interest Expense [Member] Other expense [Member] Foreign Currency Gain (Loss) [Member] Hedging Relationship [Axis] Hedging Relationship [Axis] Hedging Relationship [Domain] Hedging Relationship [Domain] Fair Value Hedging [Member] Fair Value Hedging [Member] Cash Flow Hedges [Member] Cash Flow Hedging [Member] Cash Flow Hedges [Member] Not Designated as Hedging Instrument [Member] Net Investment Hedges [Member] Net Investment Hedging [Member] Derivative Instruments, Gain (Loss) [Line Items] Derivative Instruments, Gain (Loss) [Line Items] Document Period End Date Document Period End Date Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net Derivative, Gain (Loss) on Derivative, Net Derivative, Gain (Loss) on Derivative, Net Amount of (gain) loss reclassified from accumulated OCI into income Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net Debt Disclosure [Abstract] Line of Credit Facility [Table] Line of Credit Facility [Table] Long-term Debt, Type [Axis] Long-term Debt, Type [Axis] Long-term Debt, Type [Domain] Long-term Debt, Type [Domain] Revolving credit facility, Due 2024 [Member] Revolving credit facility, due 2024 [Member] Revolving credit facility, due 2024 [Member] Credit Facility [Axis] Credit Facility [Axis] Credit Facility [Domain] Credit Facility [Domain] London Interbank Offered Rate (LIBOR) [Member] London Interbank Offered Rate (LIBOR) [Member] Fed Funds Effective Rate Overnight Index Swap Rate [Member] Fed Funds Effective Rate Overnight Index Swap Rate [Member] Base Rate [Member] Base Rate [Member] Letter of Credit [Member] Letter of Credit [Member] Line of Credit [Member] Line of Credit [Member] Foreign Line of Credit [Member] Foreign Line of Credit [Member] Domestic Line of Credit [Member] Domestic Line of Credit [Member] Line of Credit Facility [Line Items] Line of Credit Facility [Line Items] Long-term Line of Credit Long-term Line of Credit Line of Credit Facility, current borrowing capacity Line of Credit Facility, Current Borrowing Capacity Line of Credit Facility, additional borrowing capacity Line of Credit Facility Additional Borrowing Capacity Additional borrowing capacity under the credit facility. Credit facility is available for swing-line loans Credit facility is available for swing-line loans This refers to credit facility is available for swing-line loans Credit available for the issuance of letters of credit Credit available for the issuance of letters of credit this refers to Credit available for the issuance of letters of credit Line of Credit Facility, noncurrent Long-term Line of Credit, Noncurrent Line of Credit Facility outstanding borrowings, Yen Line of credit facility outstanding borrowings, Yen Line of credit facility outstanding borrowings, Yen Line of Credit Facility outstanding borrowings, Euro Line of credit facility outstanding borrowings, Euro Line of credit facility outstanding borrowings, Euro Line of Credit Facility, unused commitment level Line of Credit Facility, Remaining Borrowing Capacity Debt issuance costs Deferred Finance Costs, Own-share Lending Arrangement, Issuance Costs, Adjustment Debt instrument, maturity date Line of Credit Facility, Expiration Date Debt instrument, stated interest rate Debt Instrument, Basis Spread on Variable Rate Ratio of debt to EBITDA Ratio of deb to EBITDA Ratio of deb to EBITDA Unamortized debt issuance costs Unamortized Debt Issuance Expense Stockholders' Equity Note Disclosure [Text Block] Stockholders' Equity Note Disclosure [Text Block] Schedule of Long-term Debt Instruments [Table] Schedule of Long-term Debt Instruments [Table] Notes payable, Due 2019 [Member] Notes Payable, Other Payables [Member] Revolving credit facility, Due 2020 [Member] Revolving credit facility, due 2020 [Member] Revolving credit facility, due 2020. Series A Notes, Due 2022 [Member] Senior A Notes Due 2022 [Member] Senior A Notes Due 2022 [Member] Series B Notes, Due 2024 [Member] Senior B Notes Due 2024 [Member] Senior B Notes Due 2024 [Member] Series C Notes, Due 2027 [Member] Senior C Notes Due 2027 [Member] Senior C Notes Due 2027 [Member] Debt Instrument [Line Items] Debt Instrument [Line Items] Debt instrument, stated interest rate Debt Instrument, Interest Rate, Stated Percentage Long-term debt, gross Long-term Debt, Gross Long-term debt Long-term Debt Current portion of long-term debt Long-term debt, excluding current portion Defined benefit pension and other postretirement plan adjustments, tax Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax Net loss on investment securities, tax Other Comprehensive Income (Loss), Securities, Available-for-sale, Tax Net gain (loss) on derivatives, tax Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Tax Segment Reporting [Abstract] Segment Information Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block] Disaggregation of Revenue [Table Text Block] Disaggregation of Revenue [Table Text Block] Change in Contract with Customer, Asset and Liability [Abstract] Contract with Customer, Asset and Liability [Table Text Block] Leases [Abstract] 2019 (remaining three months) Lessee, Operating Lease, Liability, Payments, Remainder of Fiscal Year 2020 Lessee, Operating Lease, Liability, Payments, Due Year Two 2021 Lessee, Operating Lease, Liability, Payments, Due Year Three 2022 Lessee, Operating Lease, Liability, Payments, Due Year Four 2023 Lessee, Operating Lease, Liability, Payments, Due Year Five Thereafter Lessee, Operating Lease, Liability, Payments, Due after Year Five Operating leases liabilities payments due Lessee, Operating Lease, Liability, Payments, Due Less: imputed lease interest Lessee, Operating Lease, Liability, Undiscounted Excess Amount Total lease liabilities Operating Lease, Liability 2019 Operating Leases, Future Minimum Payments Due, Next Twelve Months 2020 Operating Leases, Future Minimum Payments, Due in Two Years 2021 Operating Leases, Future Minimum Payments, Due in Three Years 2022 Operating Leases, Future Minimum Payments, Due in Four Years 2023 Operating Leases, Future Minimum Payments, Due in Five Years Thereafter Operating Leases, Future Minimum Payments, Due Thereafter Total Operating Leases, Future Minimum Payments Due Long-term Debt Obligations, Net of Current Maturities Schedule of Debt [Table Text Block] Document and Entity Information [Abstract] -- None. No documentation exists for this element. -- Document Type Document Type Document Quarterly Report Document Quarterly Report Document Transition Report Document Transition Report Entity File Number Entity File Number Entity Registrant Name Entity Registrant Name Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line One Entity Address, City or Town Entity Address, City or Town Entity Address, State or Province Entity Address, State or Province Entity Address, Postal Zip Code Entity Address, Postal Zip Code City Area Code City Area Code Local Phone Number Local Phone Number Entity Current Reporting Status Entity Current Reporting Status Entity Interactive Data Current Entity Interactive Data Current Entity Filer Category Entity Filer Category Entity Small Business Entity Small Business Entity Emerging Growth Company Entity Emerging Growth Company Entity Shell Company Entity Shell Company Title of each class Title of 12(b) Security Trading Symbol Trading Symbol Security Exchange Name Security Exchange Name Entity Central Index Key Entity Central Index Key Current Fiscal Year End Date Current Fiscal Year End Date Document Fiscal Year Focus Document Fiscal Year Focus Document Fiscal Period Focus Document Fiscal Period Focus Amendment Flag Amendment Flag Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Derivative Financial Instruments Derivative Instruments and Hedging Activities Disclosure [Text Block] Income Statement [Abstract] Net sales Revenues Cost of goods and services sold Cost of Goods and Services Sold Gross profit Gross Profit Research and development Research and Development Expense Selling, general and administrative expenses Selling, General and Administrative Expense Other expense (income) (Note 15) Operating profit Operating Income (Loss) Interest expense Interest Expense Interest income Investment Income, Net Other nonoperating expense (income) Other Nonoperating Income (Expense) Income before income taxes Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest Income tax expense Income Tax Expense (Benefit) Equity in net income of affiliated companies Income (Loss) from Equity Method Investments Net income Net income per share: Basic (in dollars per share) Earnings Per Share, Basic Diluted (in dollars per share) Earnings Per Share, Diluted Weighted average shares outstanding: Weighted Average Number of Shares Outstanding Reconciliation [Abstract] Basic (in shares) Diluted (in shares) Lease, Cost [Table Text Block] Lease, Cost [Table Text Block] Lessee, Lease Cash Flow and Supplemental Information [Table Text Block] Lessee, Lease Cash Flow and Supplemental Information [Table Text Block] Lessee, Lease Cash Flow and Supplemental Information [Table Text Block] Lessee, Operating Lease, Liability, Maturity [Table Text Block] Lessee, Operating Lease, Liability, Maturity [Table Text Block] Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block] Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block] Components of Accumulated Other Comprehensive Loss Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block] Reclassification out of Accumulated Other Comprehensive Loss Reclassification out of Accumulated Other Comprehensive Income [Table Text Block] Leases of Lessee Disclosure [Text Block] Leases of Lessee Disclosure [Text Block] Segment Information Segment Reporting Disclosure [Text Block] New Accounting Pronouncements or Change in Accounting Principle [Table] New Accounting Pronouncements or Change in Accounting Principle [Table] Adjustments for New Accounting Pronouncements [Axis] Adjustments for New Accounting Pronouncements [Axis] Type of Adoption [Domain] Type of Adoption [Domain] Accounting Standards Update 2016-02 [Member] Accounting Standards Update 2016-02 [Member] New Accounting Pronouncements or Change in Accounting Principle [Line Items] New Accounting Pronouncements or Change in Accounting Principle [Line Items] Operating leases, term of contracts Lessee, Operating Lease, Term of Contract Operating leases, option to extend Lessee, Operating Lease, Term of Renewal Contract Lessee, Operating Lease, Term of Renewal Contract Schedule of Assets and Liabilities Measured at Fair Value Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Summary of Changes in Level 3 Fair Value Measurements Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] Tax expense (benefit) Effective income tax rate Effective Income Tax Rate Reconciliation, Percent Other Income Tax Expense (Benefit), Continuing Operations Other Income Tax Expense (Benefit), Continuing Operations Effective Income Tax Rate Reconciliation, Repatriation of Foreign Earnings, Amount Effective Income Tax Rate Reconciliation, Repatriation of Foreign Earnings, Amount Accounting Standards Update 2016-09 [Member] Accounting Standards Update 2016-09 [Member] Deferred tax liabilities, undistributed foreign earnings Deferred Tax Liabilities, Undistributed Foreign Earnings Tax Cuts and Jobs Act of 2017, provisional income tax expense Tax Cuts and Jobs Act of 2017, Incomplete Accounting, Change in Tax Rate, Provisional Income Tax Expense Tax Cuts and Jobs Act of 2017, Incomplete Accounting, Change in Tax Rate, Provisional Income Tax Expense Accumulated Other Comprehensive Loss Comprehensive Income (Loss) Note [Text Block] Dividends declared per share Common Stock, Dividends, Per Share, Declared Contract assets, December 31, 2018 Contract with Customer, Asset, after Allowance for Credit Loss Contract assets, September 30, 2019 Change in contract assets - increase (decrease) Contract with Customer, Asset, Increase (Decrease) Contract with Customer, Asset, Increase (Decrease) Deferred income, December 31, 2018 Deferred income, September 30, 2019 Change in deferred income - decrease (increase) Contract with Customer, Liability, Change in Timeframe, Performance Obligation Satisfied, Revenue Recognized Revenue recognized that was included in the deferred income balance Contract with Customer, Liability, Revenue Recognized Contract with Customer, Liability, Cumulative Catch-up Adjustment to Revenue, Change in Measure of Progress Contract with Customer, Liability, Cumulative Catch-up Adjustment to Revenue, Change in Measure of Progress Receipt of advance cash payment Contract with Customer, Timing of Satisfaction of Performance Obligation and Payment Other adjustments Increase (Decrease) in Contract with Customer, Liability Deferred income, current Contract with Customer, Liability, Current Deferred income, noncurrent Contract with Customer, Liability, Noncurrent Customer advance cash payments Increase (Decrease) in Customer Advances Schedule of Equity Method Investments [Table] Schedule of Equity Method Investments [Table] Investment, Name [Axis] Investment, Name [Axis] Investment, Name [Domain] Investment, Name [Domain] Disposal Group Classification [Axis] Disposal Group Classification [Axis] Disposal Group Classification [Domain] Disposal Group Classification [Domain] Schedule of Equity Method Investments [Line Items] Schedule of Equity Method Investments [Line Items] Purchases and royalty payments made to affiliates Purchases and Royalty Payments from Equity Method Investees Purchases and Royalty Payments from Equity Method Investees Amount due and payable to affiliates Due to Affiliate Sales to affiliates Sales to Equity Method Investees Sales to Equity Method Investees Amount receivable from affiliates Due from Affiliates Carrying amount, equity-method investments Equity Method Investments Carrying amount, cost-method investments Cost Method Investments Debt Debt Disclosure [Text Block] Accumulated Other Comprehensive Income (Loss) [Table] Reclassification out of Accumulated Other Comprehensive Income [Table] Foreign Currency Contract [Member] Amortization of Defined Benefit Pension and Other Postretirement Plans [Member] Reclassification out of Accumulated Other Comprehensive Loss [Line Items] Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] Cost of goods and services sold Interest expense Prior service cost Actuarial losses Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement Tax expense (benefit) Raw materials Inventory, Raw Materials, Net of Reserves Work in process Inventory, Work in Process, Net of Reserves Finished goods Inventory, Finished Goods, Net of Reserves Total inventories Schedule of Components of Net Periodic Benefit Cost Schedule of Net Benefit Costs [Table Text Block] Foreign Currency Contracts Schedule of Derivative Instruments [Table Text Block] Effects of Derivative Instruments on Other Comprehensive Income ('OCI') and Earnings Derivative Instruments, Gain (Loss) [Table Text Block] Derivative [Table] Derivative [Table] Position [Axis] Position [Axis] Position [Domain] Position [Domain] Long [Member] Long [Member] Short [Member] Short [Member] Hedging Designation [Axis] Hedging Designation [Axis] Hedging Designation [Domain] Hedging Designation [Domain] Designated as Hedging Instrument [Member] Designated as Hedging Instrument [Member] Currency [Axis] Currency [Axis] All Currencies [Domain] All Currencies [Domain] Euro Member Countries, Euro Euro Member Countries, Euro Singapore, Dollars Singapore, Dollars United States of America, Dollars United States of America, Dollars Japan, Yen Japan, Yen Foreign Exchange Forward [Member] Foreign Exchange Forward [Member] Forward Contracts [Member] Forward Contracts [Member] Debt EUR Denominated [Member] Debt [Member] Debt Yen Denominated [Member] Debt Yen Denominated [Member] An obligation resulting from borrowing money. Options Held [Member] Options Held [Member] Derivative [Line Items] Derivative [Line Items] Derivative, underlying basis Derivative, Underlying Basis Notional amount, nonderivative instruments Notional Amount of Nonderivative Instruments Cumulative foreign currency translation loss Translation Adjustment For Net Investment Hedge Pre Tax Pre-tax cumulative adjustment resulting from gains and losses on foreign currency derivatives that are designated as, and are effective as, hedges of a net investment in a foreign entity, commencing as of the designation date. Adjustment reported in equity as part of accumulated other comprehensive income. Cumulative foreign currency translation loss, net of tax Derivatives used in Net Investment Hedge, Net of Tax Derivative, Nonmonetary Notional Amount Derivative, Nonmonetary Notional Amount Premium paid Derivative, Cost of Hedge Gain (Loss) related to call options Gain (Loss) on Price Risk Derivative Instruments Not Designated as Hedging Instruments Derivative, Average Price Risk Option Strike Price Derivative, Average Price Risk Option Strike Price Gain (Loss) on Foreign Currency Fair Value Hedge Derivatives Gain (Loss) on Foreign Currency Fair Value Hedge Derivatives Derivative, Notional Amount Derivative, Notional Amount Number of reportable segments Number of Reportable Segments Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table] Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table] Segments [Axis] Segments [Axis] Segment [Domain] Segments [Domain] Proprietary Products [Member] Packaging Systems [Member] A component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements. Contract-Manufactured Products [Member] Delivery Systems [Member] A component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements. Intersegment sales elimination [Member] Intersegment Eliminations [Member] Corporate [Member] Corporate and Eliminations [Member] Corporate headquarter items not allocated to segments and intersegment transactions (e.g. intersegment profits). Reconciliation of the total of reportable segments' amounts of revenues, measures of profits or loss, assets, or amounts for every other significant item of information disclosed, to the consolidated amount. Other unallocated items [Member] Segment Reconciling Items [Member] Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items] Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items] Total operating (loss) profit Other nonoperating income Income before income taxes EX-101.PRE 10 wst-20190930_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 11 R60.htm IDEA: XBRL DOCUMENT v3.19.3
Accumulated Other Comprehensive Loss Components (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2019
Jun. 30, 2019
Mar. 31, 2019
Sep. 30, 2018
Jun. 30, 2018
Mar. 31, 2018
Sep. 30, 2019
Sep. 30, 2018
Changes in the Components of Accumulated Other Comprehensive Loss, Net of Tax [Roll Forward]                
Balance, beginning     $ (154.2)       $ (154.2)  
Other comprehensive income (loss) before reclassifications             (13.5)  
Amounts reclassified out             (2.7)  
Other comprehensive loss, net of tax $ (18.2) $ 1.2 0.8 $ (10.1) $ (47.9) $ 21.5 (16.2) $ (36.5)
Balance, ending (170.4)           (170.4)  
Gains (Losses) on Cash Flow Hedges [Member]                
Changes in the Components of Accumulated Other Comprehensive Loss, Net of Tax [Roll Forward]                
Balance, beginning     (0.4)       (0.4)  
Other comprehensive income (loss) before reclassifications             6.0  
Amounts reclassified out             (4.3)  
Other comprehensive loss, net of tax             1.7  
Balance, ending 1.3           1.3  
Unrealized Gains on Investment Securities [Member]                
Changes in the Components of Accumulated Other Comprehensive Loss, Net of Tax [Roll Forward]                
Balance, beginning     0.4       0.4  
Other comprehensive income (loss) before reclassifications             0.0  
Amounts reclassified out             0.0  
Other comprehensive loss, net of tax             0.0  
Balance, ending 0.4           0.4  
Defined Benefit Pension and Other Postretirement Plans [Member]                
Changes in the Components of Accumulated Other Comprehensive Loss, Net of Tax [Roll Forward]                
Balance, beginning     (40.4)       (40.4)  
Other comprehensive income (loss) before reclassifications             0.6  
Amounts reclassified out             1.6  
Other comprehensive loss, net of tax             2.2  
Balance, ending (38.2)           (38.2)  
Foreign Currency Translation [Member]                
Changes in the Components of Accumulated Other Comprehensive Loss, Net of Tax [Roll Forward]                
Balance, beginning     $ (113.8)       (113.8)  
Other comprehensive income (loss) before reclassifications             (20.1)  
Amounts reclassified out             0.0  
Other comprehensive loss, net of tax             (20.1)  
Balance, ending $ (133.9)           $ (133.9)  
JSON 12 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "wst10q93019.htm": { "axisCustom": 0, "axisStandard": 25, "contextCount": 335, "dts": { "calculationLink": { "local": [ "wst-20190930_cal.xml" ] }, "definitionLink": { "local": [ "wst-20190930_def.xml" ], "remote": [ "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-eedm-def-2019-01-31.xml", "http://xbrl.fasb.org/srt/2019/elts/srt-eedm1-def-2019-01-31.xml" ] }, "inline": { "local": [ "wst10q93019.htm" ] }, "labelLink": { "local": [ "wst-20190930_lab.xml" ], "remote": [ "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml", "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-doc-2019-01-31.xml" ] }, "presentationLink": { "local": [ "wst-20190930_pre.xml" ] }, "referenceLink": { "remote": [ "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-ref-2019-01-31.xml", "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml" ] }, "schema": { "local": [ "wst-20190930.xsd" ], "remote": [ "http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-roles-2019-01-31.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-roles-2019-01-31.xsd", "https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd", "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd", "https://xbrl.sec.gov/exch/2019/exch-2019-01-31.xsd", "http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd", "http://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd", "http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd", "https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-parts-codification-2019-01-31.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd" ] } }, "elementCount": 556, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2019-01-31": 41, "http://xbrl.sec.gov/dei/2019-01-31": 5, "total": 46 }, "keyCustom": 21, "keyStandard": 356, "memberCustom": 23, "memberStandard": 63, "nsprefix": "wst", "nsuri": "http://www.westpharma.com/20190930", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "span", "div", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0001000 - Document - Document and Entity Information", "role": "http://www.westpharma.com/role/DocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2103100 - Disclosure - Revenue", "role": "http://www.westpharma.com/role/Revenue", "shortName": "Revenue", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2104100 - Disclosure - Net Income Per Share", "role": "http://www.westpharma.com/role/NetIncomePerShare", "shortName": "Net Income Per Share", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2105100 - Disclosure - Inventories", "role": "http://www.westpharma.com/role/Inventories", "shortName": "Inventories", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LeasesOfLesseeDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2106100 - Disclosure - Leases", "role": "http://www.westpharma.com/role/Leases", "shortName": "Leases", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LeasesOfLesseeDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EquityMethodInvestmentsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2107100 - Disclosure - Affiliated Companies", "role": "http://www.westpharma.com/role/AffiliatedCompanies", "shortName": "Affiliated Companies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EquityMethodInvestmentsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2108100 - Disclosure - Debt", "role": "http://www.westpharma.com/role/Debt", "shortName": "Debt", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2109100 - Disclosure - Derivative Financial Instruments", "role": "http://www.westpharma.com/role/DerivativeFinancialInstruments", "shortName": "Derivative Financial Instruments", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2110100 - Disclosure - Fair Value Measurements", "role": "http://www.westpharma.com/role/FairValueMeasurements", "shortName": "Fair Value Measurements", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ComprehensiveIncomeNoteTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2111100 - Disclosure - Accumulated Other Comprehensive Loss", "role": "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLoss", "shortName": "Accumulated Other Comprehensive Loss", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ComprehensiveIncomeNoteTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2112100 - Disclosure - Shareholders' Equity", "role": "http://www.westpharma.com/role/ShareholdersEquity", "shortName": "Shareholders' Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock", "ix:continuation", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FD2019Q3QTD", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1001000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)", "role": "http://www.westpharma.com/role/CondensedConsolidatedStatementsOfIncomeUnaudited", "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FD2019Q3QTD", "decimals": "-5", "lang": null, "name": "us-gaap:GrossProfit", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2113100 - Disclosure - Stock-Based Compensation", "role": "http://www.westpharma.com/role/StockBasedCompensation", "shortName": "Stock-Based Compensation", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2114100 - Disclosure - Benefit Plans", "role": "http://www.westpharma.com/role/BenefitPlans", "shortName": "Benefit Plans", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2115100 - Disclosure - Other Expense", "role": "http://www.westpharma.com/role/OtherExpense", "shortName": "Other Expense", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2116100 - Disclosure - Income Taxes", "role": "http://www.westpharma.com/role/IncomeTaxes", "shortName": "Income Taxes", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2117100 - Disclosure - Commitments and Contingencies", "role": "http://www.westpharma.com/role/CommitmentsAndContingencies", "shortName": "Commitments and Contingencies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2118100 - Disclosure - Segment Information", "role": "http://www.westpharma.com/role/SegmentInformation", "shortName": "Segment Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2119100 - Disclosure - Subsequent Event (Notes)", "role": "http://www.westpharma.com/role/SubsequentEventNotes", "shortName": "Subsequent Event (Notes)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2201201 - Disclosure - Summary of Significant Accounting Policies (Policies)", "role": "http://www.westpharma.com/role/SummaryOfSignificantAccountingPoliciesPolicies", "shortName": "Summary of Significant Accounting Policies (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2303301 - Disclosure - Revenue (Tables)", "role": "http://www.westpharma.com/role/RevenueTables", "shortName": "Revenue (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2304301 - Disclosure - Net Income Per Share (Tables)", "role": "http://www.westpharma.com/role/NetIncomePerShareTables", "shortName": "Net Income Per Share (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "us-gaap:ScheduleOfStockholdersEquityTableTextBlock", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FD2019Q3QTD", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1002000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED)", "role": "http://www.westpharma.com/role/CondensedConsolidatedStatementsOfComprehensiveIncomeUnaudited", "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FD2019Q3QTD", "decimals": "-5", "lang": null, "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2305301 - Disclosure - Inventories (Tables)", "role": "http://www.westpharma.com/role/InventoriesTables", "shortName": "Inventories (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LeaseCostTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2306301 - Disclosure - Leases Leases (Tables)", "role": "http://www.westpharma.com/role/LeasesLeasesTables", "shortName": "Leases Leases (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LeaseCostTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2308301 - Disclosure - Debt (Tables)", "role": "http://www.westpharma.com/role/DebtTables", "shortName": "Debt (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2309301 - Disclosure - Derivative Financial Instruments (Tables)", "role": "http://www.westpharma.com/role/DerivativeFinancialInstrumentsTables", "shortName": "Derivative Financial Instruments (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2310301 - Disclosure - Fair Value Measurements (Tables)", "role": "http://www.westpharma.com/role/FairValueMeasurementsTables", "shortName": "Fair Value Measurements (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2311301 - Disclosure - Accumulated Other Comprehensive Loss (Tables)", "role": "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossTables", "shortName": "Accumulated Other Comprehensive Loss (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfStockholdersEquityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2312301 - Disclosure - Shareholders' Equity (Tables)", "role": "http://www.westpharma.com/role/ShareholdersEquityTables", "shortName": "Shareholders' Equity (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfStockholdersEquityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2314301 - Disclosure - Benefit Plans (Tables)", "role": "http://www.westpharma.com/role/BenefitPlansTables", "shortName": "Benefit Plans (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "wst:ScheduleofOtherIncomeandExpensebyComponentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2315301 - Disclosure - Other Expense (Tables)", "role": "http://www.westpharma.com/role/OtherExpenseTables", "shortName": "Other Expense (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "wst:ScheduleofOtherIncomeandExpensebyComponentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2318301 - Disclosure - Segment Information (Tables)", "role": "http://www.westpharma.com/role/SegmentInformationTables", "shortName": "Segment Information (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R4": { "firstAnchor": null, "groupType": "statement", "isDefault": "false", "longName": "1002501 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED) (Parenthetical)", "role": "http://www.westpharma.com/role/CondensedConsolidatedStatementsOfComprehensiveIncomeUnauditedParenthetical", "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED) (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": null }, "R40": { "firstAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "I2019Q2", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2401402 - Disclosure - Summary of Significant Accounting Policies Business Combinations (Details)", "role": "http://www.westpharma.com/role/SummaryOfSignificantAccountingPoliciesBusinessCombinationsDetails", "shortName": "Summary of Significant Accounting Policies Business Combinations (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "I2019Q2", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:DisaggregationOfRevenueTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FD2019Q3QTD", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:ConcentrationRiskPercentage1", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2403402 - Disclosure - Revenue Recognition (Details)", "role": "http://www.westpharma.com/role/RevenueRecognitionDetails", "shortName": "Revenue Recognition (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:DisaggregationOfRevenueTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FD2019Q3QTD", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:ConcentrationRiskPercentage1", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FI2018Q4", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:ContractWithCustomerAssetNet", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2403403 - Disclosure - Contracts and Liabilities (Details)", "role": "http://www.westpharma.com/role/ContractsAndLiabilitiesDetails", "shortName": "Contracts and Liabilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FI2019Q3", "decimals": "-5", "lang": null, "name": "us-gaap:ContractWithCustomerAssetNet", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FI2019Q3", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:TransferOfFinancialAssetsAccountedForAsSalesCashProceedsReceivedForAssetsDerecognizedAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2403404 - Disclosure - Revenue Supply Chain Financing (Details)", "role": "http://www.westpharma.com/role/RevenueSupplyChainFinancingDetails", "shortName": "Revenue Supply Chain Financing (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FI2019Q3", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:TransferOfFinancialAssetsAccountedForAsSalesCashProceedsReceivedForAssetsDerecognizedAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FD2019Q3QTD", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:RevenueRecognitionSalesReturnsReserveForSalesReturns", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2403405 - Disclosure - Revenue Voluntary Recall (Details)", "role": "http://www.westpharma.com/role/RevenueVoluntaryRecallDetails", "shortName": "Revenue Voluntary Recall (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FD2019Q3QTD", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:RevenueRecognitionSalesReturnsReserveForSalesReturns", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "us-gaap:ScheduleOfStockholdersEquityTableTextBlock", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FD2019Q3QTD", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2404402 - Disclosure - Net Income Per Share (Details)", "role": "http://www.westpharma.com/role/NetIncomePerShareDetails", "shortName": "Net Income Per Share (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FD2019Q3QTD", "decimals": "-5", "lang": null, "name": "us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FI2019Q3", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:InventoryRawMaterialsNetOfReserves", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2405402 - Disclosure - Inventories (Details)", "role": "http://www.westpharma.com/role/InventoriesDetails", "shortName": "Inventories (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FI2019Q3", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:InventoryRawMaterialsNetOfReserves", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FI2019Q3", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:OperatingLeaseLiability", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2406402 - Disclosure - Leases Adoption of ASC 842 (Details)", "role": "http://www.westpharma.com/role/LeasesAdoptionOfAsc842Details", "shortName": "Leases Adoption of ASC 842 (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "I2019Q1Jan01_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_us-gaap_AccountingStandardsUpdate201602Member", "decimals": "-5", "lang": null, "name": "us-gaap:OperatingLeaseLiability", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:LeaseCostTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FD2019Q3QTD", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:OperatingLeaseCost", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2406403 - Disclosure - Leases Lease Cost (Details)", "role": "http://www.westpharma.com/role/LeasesLeaseCostDetails", "shortName": "Leases Lease Cost (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:LeaseCostTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FD2019Q3QTD", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:OperatingLeaseCost", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "wst:LesseeLeaseCashFlowandSupplementalInformationTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FD2019Q3QTD", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:OperatingLeasePayments", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2406404 - Disclosure - Leases Lease Cash Flow and Supplemental Information (Details)", "role": "http://www.westpharma.com/role/LeasesLeaseCashFlowAndSupplementalInformationDetails", "shortName": "Leases Lease Cash Flow and Supplemental Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "wst:LesseeLeaseCashFlowandSupplementalInformationTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FD2019Q3QTD", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:OperatingLeasePayments", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FI2019Q3", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1003000 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)", "role": "http://www.westpharma.com/role/CondensedConsolidatedBalanceSheetsUnaudited", "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FI2019Q3", "decimals": "-5", "lang": null, "name": "us-gaap:AccountsReceivableNetCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FI2019Q3", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2406405 - Disclosure - Leases Lease Weighted Average (Details)", "role": "http://www.westpharma.com/role/LeasesLeaseWeightedAverageDetails", "shortName": "Leases Lease Weighted Average (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FI2019Q3", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FI2019Q3", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2406406 - Disclosure - Leases Maturities of Operating Lease Liabilities (Details)", "role": "http://www.westpharma.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails", "shortName": "Leases Maturities of Operating Lease Liabilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FI2019Q3", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R52": { "firstAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FD2019Q3QTD", "decimals": "-5", "first": true, "lang": null, "name": "wst:PurchasesAndRoyaltyPaymentsFromEquityMethodInvestees", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2407401 - Disclosure - Affiliated Companies (Details)", "role": "http://www.westpharma.com/role/AffiliatedCompaniesDetails", "shortName": "Affiliated Companies (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FD2019Q3QTD", "decimals": "-5", "first": true, "lang": null, "name": "wst:PurchasesAndRoyaltyPaymentsFromEquityMethodInvestees", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfDebtTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FI2019Q3", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentCarryingAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2408402 - Disclosure - Long-term Debt (Details)", "role": "http://www.westpharma.com/role/LongTermDebtDetails", "shortName": "Long-term Debt (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfDebtTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FI2019Q3", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentCarryingAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R54": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfDebtTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FI2019Q3", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:UnamortizedDebtIssuanceExpense", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2408403 - Disclosure - Credit Facility (Details)", "role": "http://www.westpharma.com/role/CreditFacilityDetails", "shortName": "Credit Facility (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FI2019Q3_us-gaap_LongtermDebtTypeAxis_wst_Revolvingcreditfacilitydue2024Member", "decimals": "INF", "lang": null, "name": "us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R55": { "firstAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FD2019Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_DebtMember", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:NotionalAmountOfNonderivativeInstruments", "reportCount": 1, "unique": true, "unitRef": "U006", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2409402 - Disclosure - Derivative Financial Instruments (Textuals) (Details)", "role": "http://www.westpharma.com/role/DerivativeFinancialInstrumentsTextualsDetails", "shortName": "Derivative Financial Instruments (Textuals) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FD2019Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_DebtMember", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:NotionalAmountOfNonderivativeInstruments", "reportCount": 1, "unique": true, "unitRef": "U006", "xsiNil": "false" } }, "R56": { "firstAnchor": { "ancestors": [ "span", "span", "span", "div", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentPeriodEndDate", "reportCount": 1, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2409403 - Disclosure - Effects of Derivative Instruments on OCI and Earnings (Details)", "role": "http://www.westpharma.com/role/EffectsOfDerivativeInstrumentsOnOciAndEarningsDetails", "shortName": "Effects of Derivative Instruments on OCI and Earnings (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock", "ix:continuation", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FD2019Q3QTD_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_FairValueHedgingMember", "decimals": "-5", "lang": null, "name": "us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R57": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FI2019Q3", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:DeferredCompensationPlanAssets", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2410402 - Disclosure - Fair Value Measurements (Details)", "role": "http://www.westpharma.com/role/FairValueMeasurementsDetails", "shortName": "Fair Value Measurements (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FI2019Q3", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:DeferredCompensationPlanAssets", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R58": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "ix:continuation", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FI2018Q4", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2410403 - Disclosure - Fair Value Measurements Level 3 (Details)", "role": "http://www.westpharma.com/role/FairValueMeasurementsLevel3Details", "shortName": "Fair Value Measurements Level 3 (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "ix:continuation", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FI2017Q4", "decimals": "-5", "lang": null, "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R59": { "firstAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FI2019Q3", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:LongTermDebtFairValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2410404 - Disclosure - Fair Value Measurements Other Financial Instruments (Details)", "role": "http://www.westpharma.com/role/FairValueMeasurementsOtherFinancialInstrumentsDetails", "shortName": "Fair Value Measurements Other Financial Instruments (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FI2019Q3", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:LongTermDebtFairValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R6": { "firstAnchor": null, "groupType": "statement", "isDefault": "false", "longName": "1003001 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical)", "role": "http://www.westpharma.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical", "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": null }, "R60": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FI2018Q4", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2411402 - Disclosure - Accumulated Other Comprehensive Loss Components (Details)", "role": "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossComponentsDetails", "shortName": "Accumulated Other Comprehensive Loss Components (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FD2019Q3YTD", "decimals": "-5", "lang": null, "name": "us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R61": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock", "ix:continuation", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FD2019Q3QTD", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2411403 - Disclosure - Accumulated Other Comprehensive Loss Reclassifications (Details)", "role": "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossReclassificationsDetails", "shortName": "Accumulated Other Comprehensive Loss Reclassifications (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FD2019Q3QTD_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember", "decimals": "-5", "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R62": { "firstAnchor": null, "groupType": "disclosure", "isDefault": "false", "longName": "2412402 - Disclosure - Supplemental Equity Information (Details)", "role": "http://www.westpharma.com/role/SupplementalEquityInformationDetails", "shortName": "Supplemental Equity Information (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R63": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "us-gaap:ScheduleOfStockholdersEquityTableTextBlock", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FI2019Q2", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2412403 - Disclosure - Change in Shareholders' Equity (Details)", "role": "http://www.westpharma.com/role/ChangeInShareholdersEquityDetails", "shortName": "Change in Shareholders' Equity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "us-gaap:ScheduleOfStockholdersEquityTableTextBlock", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FI2018Q1", "decimals": "-5", "lang": null, "name": "us-gaap:CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R64": { "firstAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FI2019Q3", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2413401 - Disclosure - Stock-Based Compensation (Details)", "role": "http://www.westpharma.com/role/StockBasedCompensationDetails", "shortName": "Stock-Based Compensation (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FD2019Q3YTD", "decimals": "INF", "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R65": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FD2019Q3QTD", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:DefinedBenefitPlanServiceCost", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2414402 - Disclosure - Benefit Plans (Details)", "role": "http://www.westpharma.com/role/BenefitPlansDetails", "shortName": "Benefit Plans (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FD2019Q3QTD", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:DefinedBenefitPlanServiceCost", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R66": { "firstAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FD2019Q3QTD", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:RestructuringCharges", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2415402 - Disclosure - Other Expense (Details)", "role": "http://www.westpharma.com/role/OtherExpenseDetails", "shortName": "Other Expense (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "wst:ScheduleofOtherIncomeandExpensebyComponentTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FD2019Q3QTD", "decimals": "-5", "lang": null, "name": "us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R67": { "firstAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FD2019Q3QTD", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:RestructuringCharges", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2415403 - Disclosure - Other Expense Items (Details)", "role": "http://www.westpharma.com/role/OtherExpenseItemsDetails", "shortName": "Other Expense Items (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FD2019Q3QTD", "decimals": "-5", "lang": null, "name": "wst:IncreaseDecreaseofOtherOperatingIncomeandExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R68": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FI2019Q3", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:ContractWithCustomerLiability", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2415404 - Disclosure - Other Expense Restructuring and Related Charges (Details)", "role": "http://www.westpharma.com/role/OtherExpenseRestructuringAndRelatedChargesDetails", "shortName": "Other Expense Restructuring and Related Charges (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock", "ix:continuation", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FI2018Q4_us-gaap_RestructuringCostAndReserveAxis_us-gaap_EmployeeSeveranceMember", "decimals": "-5", "lang": null, "name": "us-gaap:RestructuringReserve", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R69": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "wst:ScheduleofOtherIncomeandExpensebyComponentTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FD2019Q3QTD", "decimals": "-5", "first": true, "lang": null, "name": "wst:Developmentandlicensingincome", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2415405 - Disclosure - Other Expense Other (Income) Development and Licensing Income (Details)", "role": "http://www.westpharma.com/role/OtherExpenseOtherIncomeDevelopmentAndLicensingIncomeDetails", "shortName": "Other Expense Other (Income) Development and Licensing Income (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FD2019Q3QTD_us-gaap_NatureOfExpenseAxis_wst_SmartDoseMember", "decimals": "-5", "lang": null, "name": "wst:Developmentandlicensingincome", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FD2019Q3YTD", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1005000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)", "role": "http://www.westpharma.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited", "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FD2019Q3YTD", "decimals": "-5", "lang": null, "name": "us-gaap:Depreciation", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R70": { "firstAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FD2019Q3QTD", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:IncomeTaxExpenseBenefit", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2416401 - Disclosure - Income Taxes (Details)", "role": "http://www.westpharma.com/role/IncomeTaxesDetails", "shortName": "Income Taxes (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FD2019Q3QTD", "decimals": "3", "lang": null, "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R71": { "firstAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FD2019Q3YTD", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:NumberOfReportableSegments", "reportCount": 1, "unique": true, "unitRef": "segment", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2418402 - Disclosure - Segment Information (Details)", "role": "http://www.westpharma.com/role/SegmentInformationDetails", "shortName": "Segment Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FD2019Q3YTD", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:NumberOfReportableSegments", "reportCount": 1, "unique": true, "unitRef": "segment", "xsiNil": "false" } }, "R72": { "firstAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "I2019Q4", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:EquityMethodInvestmentOwnershipPercentage", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2419402 - Disclosure - Subsequent Event (Details)", "role": "http://www.westpharma.com/role/SubsequentEventDetails", "shortName": "Subsequent Event (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "I2019Q4", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:EquityMethodInvestmentOwnershipPercentage", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2101100 - Disclosure - Summary of Significant Accounting Policies", "role": "http://www.westpharma.com/role/SummaryOfSignificantAccountingPolicies", "shortName": "Summary of Significant Accounting Policies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2102100 - Disclosure - New Accounting Standards", "role": "http://www.westpharma.com/role/NewAccountingStandards", "shortName": "New Accounting Standards", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "wst10q93019.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 87, "tag": { "country_US": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "UNITED STATES", "terseLabel": "UNITED STATES" } } }, "localname": "US", "nsuri": "http://xbrl.sec.gov/country/2017-01-31", "presentation": [ "http://www.westpharma.com/role/BenefitPlansDetails" ], "xbrltype": "domainItemType" }, "currency_AllCurrenciesDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "All Currencies [Domain]", "terseLabel": "All Currencies [Domain]" } } }, "localname": "AllCurrenciesDomain", "nsuri": "http://xbrl.sec.gov/currency/2019-01-31", "presentation": [ "http://www.westpharma.com/role/DerivativeFinancialInstrumentsTextualsDetails" ], "xbrltype": "domainItemType" }, "currency_EUR": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Euro Member Countries, Euro", "terseLabel": "Euro Member Countries, Euro" } } }, "localname": "EUR", "nsuri": "http://xbrl.sec.gov/currency/2019-01-31", "presentation": [ "http://www.westpharma.com/role/DerivativeFinancialInstrumentsTextualsDetails" ], "xbrltype": "domainItemType" }, "currency_JPY": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Japan, Yen", "terseLabel": "Japan, Yen" } } }, "localname": "JPY", "nsuri": "http://xbrl.sec.gov/currency/2019-01-31", "presentation": [ "http://www.westpharma.com/role/DerivativeFinancialInstrumentsTextualsDetails" ], "xbrltype": "domainItemType" }, "currency_SGD": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Singapore, Dollars", "terseLabel": "Singapore, Dollars" } } }, "localname": "SGD", "nsuri": "http://xbrl.sec.gov/currency/2019-01-31", "presentation": [ "http://www.westpharma.com/role/DerivativeFinancialInstrumentsTextualsDetails" ], "xbrltype": "domainItemType" }, "currency_USD": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "United States of America, Dollars", "terseLabel": "United States of America, Dollars" } } }, "localname": "USD", "nsuri": "http://xbrl.sec.gov/currency/2019-01-31", "presentation": [ "http://www.westpharma.com/role/DerivativeFinancialInstrumentsTextualsDetails" ], "xbrltype": "domainItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.westpharma.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.westpharma.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.westpharma.com/role/DocumentAndEntityInformation" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus", "terseLabel": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.westpharma.com/role/DocumentAndEntityInformation" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus", "terseLabel": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.westpharma.com/role/DocumentAndEntityInformation" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.westpharma.com/role/DocumentAndEntityInformation", "http://www.westpharma.com/role/EffectsOfDerivativeInstrumentsOnOciAndEarningsDetails" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r431" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report", "terseLabel": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.westpharma.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r432" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report", "terseLabel": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.westpharma.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.westpharma.com/role/DocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.westpharma.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.westpharma.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.westpharma.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.westpharma.com/role/DocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r433" ], "lang": { "en-US": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.westpharma.com/role/DocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding", "terseLabel": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.westpharma.com/role/DocumentAndEntityInformation" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status", "terseLabel": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.westpharma.com/role/DocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r433" ], "lang": { "en-US": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.westpharma.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.westpharma.com/role/DocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r433" ], "lang": { "en-US": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category", "terseLabel": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.westpharma.com/role/DocumentAndEntityInformation" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.westpharma.com/role/DocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r434" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current", "terseLabel": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.westpharma.com/role/DocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r433" ], "lang": { "en-US": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.westpharma.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r433" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company", "terseLabel": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.westpharma.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r433" ], "lang": { "en-US": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business", "terseLabel": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.westpharma.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r433" ], "lang": { "en-US": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.westpharma.com/role/DocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.westpharma.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r429" ], "lang": { "en-US": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of each class" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.westpharma.com/role/DocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r430" ], "lang": { "en-US": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.westpharma.com/role/DocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.westpharma.com/role/DocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "srt_AmericasMember": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Americas [Member]", "terseLabel": "Americas [Member]" } } }, "localname": "AmericasMember", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.westpharma.com/role/RevenueRecognitionDetails" ], "xbrltype": "domainItemType" }, "srt_AsiaPacificMember": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Asia Pacific [Member]", "terseLabel": "Asia Pacific [Member]" } } }, "localname": "AsiaPacificMember", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.westpharma.com/role/RevenueRecognitionDetails" ], "xbrltype": "domainItemType" }, "srt_CurrencyAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Currency [Axis]", "terseLabel": "Currency [Axis]" } } }, "localname": "CurrencyAxis", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.westpharma.com/role/DerivativeFinancialInstrumentsTextualsDetails" ], "xbrltype": "stringItemType" }, "srt_EquityMethodInvesteeNameDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Investment, Name [Domain]", "terseLabel": "Investment, Name [Domain]" } } }, "localname": "EquityMethodInvesteeNameDomain", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.westpharma.com/role/AffiliatedCompaniesDetails" ], "xbrltype": "domainItemType" }, "srt_MajorCustomersAxis": { "auth_ref": [ "r144", "r209", "r215", "r423" ], "lang": { "en-US": { "role": { "label": "Customer [Axis]", "terseLabel": "Customer [Axis]" } } }, "localname": "MajorCustomersAxis", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.westpharma.com/role/RevenueRecognitionDetails" ], "xbrltype": "stringItemType" }, "srt_MaximumMember": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Maximum [Member]", "terseLabel": "Maximum [Member]" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CreditFacilityDetails", "http://www.westpharma.com/role/LeasesAdoptionOfAsc842Details", "http://www.westpharma.com/role/OtherExpenseRestructuringAndRelatedChargesDetails" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Minimum [Member]", "terseLabel": "Minimum [Member]" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CreditFacilityDetails", "http://www.westpharma.com/role/OtherExpenseRestructuringAndRelatedChargesDetails" ], "xbrltype": "domainItemType" }, "srt_NameOfMajorCustomerDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Customer [Domain]", "terseLabel": "Customer [Domain]" } } }, "localname": "NameOfMajorCustomerDomain", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.westpharma.com/role/RevenueRecognitionDetails" ], "xbrltype": "domainItemType" }, "srt_ProductOrServiceAxis": { "auth_ref": [ "r142", "r209", "r213", "r420", "r421" ], "lang": { "en-US": { "role": { "label": "Product and Service [Axis]", "terseLabel": "Product and Service [Axis]" } } }, "localname": "ProductOrServiceAxis", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.westpharma.com/role/ContractsAndLiabilitiesDetails", "http://www.westpharma.com/role/RevenueRecognitionDetails" ], "xbrltype": "stringItemType" }, "srt_ProductsAndServicesDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Product and Service [Domain]", "terseLabel": "Product and Service [Domain]" } } }, "localname": "ProductsAndServicesDomain", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.westpharma.com/role/ContractsAndLiabilitiesDetails", "http://www.westpharma.com/role/RevenueRecognitionDetails" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Statistical Measurement [Axis]", "terseLabel": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CreditFacilityDetails", "http://www.westpharma.com/role/LeasesAdoptionOfAsc842Details", "http://www.westpharma.com/role/OtherExpenseRestructuringAndRelatedChargesDetails" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Statistical Measurement [Domain]", "terseLabel": "Statistical Measurement [Domain]" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CreditFacilityDetails", "http://www.westpharma.com/role/LeasesAdoptionOfAsc842Details", "http://www.westpharma.com/role/OtherExpenseRestructuringAndRelatedChargesDetails" ], "xbrltype": "domainItemType" }, "srt_ScenarioUnspecifiedDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Scenario [Domain]", "terseLabel": "Scenario [Domain]" } } }, "localname": "ScenarioUnspecifiedDomain", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CondensedConsolidatedBalanceSheetsUnaudited", "http://www.westpharma.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "domainItemType" }, "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": { "auth_ref": [ "r149" ], "lang": { "en-US": { "role": { "label": "Investment, Name [Axis]", "terseLabel": "Investment, Name [Axis]" } } }, "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.westpharma.com/role/AffiliatedCompaniesDetails" ], "xbrltype": "stringItemType" }, "srt_SegmentGeographicalDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Geographical [Domain]", "terseLabel": "Geographical [Domain]" } } }, "localname": "SegmentGeographicalDomain", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.westpharma.com/role/RevenueRecognitionDetails" ], "xbrltype": "domainItemType" }, "srt_StatementGeographicalAxis": { "auth_ref": [ "r143", "r209", "r214", "r422", "r426", "r427" ], "lang": { "en-US": { "role": { "label": "Geographical [Axis]", "terseLabel": "Geographical [Axis]" } } }, "localname": "StatementGeographicalAxis", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.westpharma.com/role/RevenueRecognitionDetails" ], "xbrltype": "stringItemType" }, "srt_StatementScenarioAxis": { "auth_ref": [ "r185", "r391" ], "lang": { "en-US": { "role": { "label": "Scenario [Axis]", "terseLabel": "Scenario [Axis]" } } }, "localname": "StatementScenarioAxis", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CondensedConsolidatedBalanceSheetsUnaudited", "http://www.westpharma.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_AccountingStandardsUpdate201602Member": { "auth_ref": [ "r371" ], "lang": { "en-US": { "role": { "documentation": "Accounting Standards Update 2016-02 Leases (Topic 842).", "label": "Accounting Standards Update 2016-02 [Member]", "terseLabel": "Accounting Standards Update 2016-02 [Member]" } } }, "localname": "AccountingStandardsUpdate201602Member", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/LeasesAdoptionOfAsc842Details" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingStandardsUpdate201609Member": { "auth_ref": [ "r266", "r267", "r268", "r269", "r270", "r271", "r272", "r273", "r274", "r275" ], "lang": { "en-US": { "role": { "documentation": "Accounting Standards Update 2016-09 Compensation - Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting.", "label": "Accounting Standards Update 2016-09 [Member]", "terseLabel": "Accounting Standards Update 2016-09 [Member]" } } }, "localname": "AccountingStandardsUpdate201609Member", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/IncomeTaxesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r33" ], "calculation": { "http://www.westpharma.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts Payable, Current", "terseLabel": "Accounts payable" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r4", "r18", "r146", "r147", "r210" ], "calculation": { "http://www.westpharma.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts Receivable, after Allowance for Credit Loss, Current", "terseLabel": "Accounts receivable, net" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedIncomeTaxesCurrent": { "auth_ref": [ "r12", "r399", "r410" ], "calculation": { "http://www.westpharma.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.", "label": "Accrued Income Taxes, Current", "terseLabel": "Income taxes payable" } } }, "localname": "AccruedIncomeTaxesCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember": { "auth_ref": [ "r54", "r60", "r61", "r235", "r309" ], "lang": { "en-US": { "role": { "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans attributable to the parent.", "label": "Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]", "terseLabel": "Defined Benefit Pension and Other Postretirement Plans [Member]", "verboseLabel": "Amortization of Defined Benefit Pension and Other Postretirement Plans [Member]" } } }, "localname": "AccumulatedDefinedBenefitPlansAdjustmentMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossComponentsDetails", "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossReclassificationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "auth_ref": [ "r31", "r165" ], "calculation": { "http://www.westpharma.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "order": 2.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "terseLabel": "Less: accumulated depreciation and amortization" } } }, "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember": { "auth_ref": [ "r50", "r60", "r61", "r308" ], "lang": { "en-US": { "role": { "documentation": "Accumulated other comprehensive income (loss) resulting from gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges, attributable to the parent.", "label": "Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member]", "terseLabel": "Gains (Losses) on Cash Flow Hedges [Member]" } } }, "localname": "AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossComponentsDetails", "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossReclassificationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember": { "auth_ref": [ "r51", "r52", "r53", "r60", "r61" ], "lang": { "en-US": { "role": { "documentation": "Accumulated unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), attributable to parent.", "label": "AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Parent [Member]", "terseLabel": "Unrealized Gains on Investment Securities [Member]" } } }, "localname": "AccumulatedNetUnrealizedInvestmentGainLossMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossComponentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]", "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossComponentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r57", "r59", "r60" ], "calculation": { "http://www.westpharma.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "order": 5.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.", "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax", "periodEndLabel": "Balance, ending", "periodStartLabel": "Balance, beginning", "terseLabel": "Accumulated other comprehensive loss" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossComponentsDetails", "http://www.westpharma.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).", "label": "Accumulated Other Comprehensive Income (Loss) [Table]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossComponentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [ "r56", "r60", "r61", "r309" ], "lang": { "en-US": { "role": { "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.", "label": "AOCI Attributable to Parent [Member]", "terseLabel": "AOCI Attributable to Parent [Member]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/ChangeInShareholdersEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedTranslationAdjustmentMember": { "auth_ref": [ "r49", "r60", "r61", "r309" ], "lang": { "en-US": { "role": { "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.", "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]", "terseLabel": "Foreign Currency Translation [Member]" } } }, "localname": "AccumulatedTranslationAdjustmentMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossComponentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r19" ], "calculation": { "http://www.westpharma.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.", "label": "Additional Paid in Capital", "terseLabel": "Capital in excess of par value" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]", "terseLabel": "Additional Paid-in Capital [Member]" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/ChangeInShareholdersEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentForAmortization": { "auth_ref": [ "r97", "r161" ], "calculation": { "http://www.westpharma.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.", "label": "Amortization", "terseLabel": "Amortization" } } }, "localname": "AdjustmentForAmortization", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": { "auth_ref": [ "r109" ], "lang": { "en-US": { "role": { "documentation": "Information by new accounting pronouncement.", "label": "Adjustments for New Accounting Pronouncements [Axis]", "terseLabel": "Adjustments for New Accounting Pronouncements [Axis]" } } }, "localname": "AdjustmentsForNewAccountingPronouncementsAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/IncomeTaxesDetails", "http://www.westpharma.com/role/LeasesAdoptionOfAsc842Details" ], "xbrltype": "stringItemType" }, "us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement.", "label": "Share-based Payment Arrangement, Decrease for Tax Withholding Obligation", "negatedTerseLabel": "Shares repurchased for employee tax withholdings" } } }, "localname": "AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/ChangeInShareholdersEquityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "auth_ref": [ "r250", "r252", "r278", "r279" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.", "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition", "terseLabel": "Stock-based compensation" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/ChangeInShareholdersEquityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Adjustments to reconcile net income to net cash provided by operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_AllocatedShareBasedCompensationExpense": { "auth_ref": [ "r252", "r263", "r277" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.", "label": "Share-based Payment Arrangement, Expense", "terseLabel": "Stock-based compensation expense" } } }, "localname": "AllocatedShareBasedCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/StockBasedCompensationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r120" ], "lang": { "en-US": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "terseLabel": "Antidilutive options excluded from computation of diluted net income per share (in shares)" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/NetIncomePerShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_AssetImpairmentCharges": { "auth_ref": [ "r97", "r162" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.", "label": "Asset Impairment Charges", "verboseLabel": "Asset-related charges" } } }, "localname": "AssetImpairmentCharges", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/OtherExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Assets": { "auth_ref": [ "r135", "r398", "r409" ], "calculation": { "http://www.westpharma.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "Total Assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Assets [Abstract]", "terseLabel": "ASSETS" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r5", "r6", "r47" ], "calculation": { "http://www.westpharma.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Assets, Current [Abstract]", "terseLabel": "Current assets:" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsFairValueDisclosure": { "auth_ref": [ "r346" ], "calculation": { "http://www.westpharma.com/role/FairValueMeasurementsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Fair Value Disclosure", "totalLabel": "Total assets at fair value" } } }, "localname": "AssetsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/FairValueMeasurementsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsFairValueDisclosureAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Assets, Fair Value Disclosure [Abstract]", "terseLabel": "Assets:" } } }, "localname": "AssetsFairValueDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/FairValueMeasurementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r254", "r264" ], "lang": { "en-US": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]", "terseLabel": "Award Type [Axis]" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/StockBasedCompensationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetRelatedDisclosuresAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Balance Sheet Related Disclosures [Abstract]" } } }, "localname": "BalanceSheetRelatedDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_BaseRateMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Minimum rate investor will accept.", "label": "Base Rate [Member]", "terseLabel": "Base Rate [Member]" } } }, "localname": "BaseRateMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CreditFacilityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Basis of Accounting, Policy [Policy Text Block]", "terseLabel": "Basis of Presentation" } } }, "localname": "BasisOfAccountingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of direct costs of the business combination including legal, accounting, and other costs incurred to consummate the business acquisition.", "label": "Business Acquisition, Transaction Costs", "terseLabel": "Business acquisition, transaction costs" } } }, "localname": "BusinessAcquisitionCostOfAcquiredEntityTransactionCosts", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/SummaryOfSignificantAccountingPoliciesBusinessCombinationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1": { "auth_ref": [ "r96", "r302" ], "calculation": { "http://www.westpharma.com/role/OtherExpenseDetails": { "order": 4.0, "parentTag": "wst_OtherIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.", "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability", "terseLabel": "Contingent consideration" } } }, "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/OtherExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationContingentConsiderationLiability": { "auth_ref": [ "r298", "r299", "r301" ], "calculation": { "http://www.westpharma.com/role/FairValueMeasurementsDetails": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesFairValueDisclosure", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of liability recognized arising from contingent consideration in a business combination.", "label": "Business Combination, Contingent Consideration, Liability", "terseLabel": "Contingent consideration" } } }, "localname": "BusinessCombinationContingentConsiderationLiability", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/FairValueMeasurementsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles": { "auth_ref": [ "r296", "r297" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The amount of identifiable intangible assets recognized as of the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles", "terseLabel": "Business combination, recognized intangible assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/SummaryOfSignificantAccountingPoliciesBusinessCombinationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory": { "auth_ref": [ "r296", "r297" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The amount of inventory recognized as of the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory", "terseLabel": "Business combination, recognized inventory" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/SummaryOfSignificantAccountingPoliciesBusinessCombinationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": { "auth_ref": [ "r296", "r297" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment", "terseLabel": "Business combination, recognized property, plant, and equipment" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/SummaryOfSignificantAccountingPoliciesBusinessCombinationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet": { "auth_ref": [ "r297" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.", "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net", "terseLabel": "Business combination, recognized goodwill" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/SummaryOfSignificantAccountingPoliciesBusinessCombinationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Business Combinations [Abstract]" } } }, "localname": "BusinessCombinationsAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r2", "r28", "r99" ], "calculation": { "http://www.westpharma.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and Cash Equivalents, at Carrying Value", "periodEndLabel": "Cash and cash equivalents at end of period", "periodStartLabel": "Cash and cash equivalents at beginning of period", "terseLabel": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CondensedConsolidatedBalanceSheetsUnaudited", "http://www.westpharma.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease": { "auth_ref": [], "calculation": { "http://www.westpharma.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.", "label": "Cash and Cash Equivalents, Period Increase (Decrease)", "totalLabel": "Net increase in cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsPeriodIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFlowHedgingMember": { "auth_ref": [ "r320" ], "lang": { "en-US": { "role": { "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk.", "label": "Cash Flow Hedging [Member]", "terseLabel": "Cash Flow Hedges [Member]" } } }, "localname": "CashFlowHedgingMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/DerivativeFinancialInstrumentsTextualsDetails", "http://www.westpharma.com/role/EffectsOfDerivativeInstrumentsOnOciAndEarningsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.", "label": "Class of Stock [Domain]", "terseLabel": "Class of Stock [Domain]" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "domainItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r42", "r184", "r403", "r415" ], "calculation": { "http://www.westpharma.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and Contingencies", "terseLabel": "Commitments and contingencies (Note 15)" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r183", "r186" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies Disclosure [Text Block]", "verboseLabel": "Commitments and Contingencies" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CommitmentsAndContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommodityOptionMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Option contract in which the underlying asset is a commodity.", "label": "Commodity Option [Member]", "terseLabel": "Foreign Currency Hedge Contracts [Member]" } } }, "localname": "CommodityOptionMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/EffectsOfDerivativeInstrumentsOnOciAndEarningsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockDividendsPerShareDeclared": { "auth_ref": [ "r199" ], "lang": { "en-US": { "role": { "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.", "label": "Common Stock, Dividends, Per Share, Declared", "terseLabel": "Dividends declared per share" } } }, "localname": "CommonStockDividendsPerShareDeclared", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/SupplementalEquityInformationDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]", "terseLabel": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/ChangeInShareholdersEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r17" ], "lang": { "en-US": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Common stock, par value (in dollars per share)" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r17" ], "lang": { "en-US": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized", "terseLabel": "Common stock, shares authorized (in shares)" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r17" ], "lang": { "en-US": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued", "terseLabel": "Common stock, shares issued (in shares)" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r17", "r194" ], "lang": { "en-US": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding", "terseLabel": "Common stock, shares outstanding (in shares)" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r17" ], "calculation": { "http://www.westpharma.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, Value, Issued", "terseLabel": "Common stock, par value $0.25 per share; 100.0 million shares authorized; shares issued: 75.3 million and 75.3 million; shares outstanding: 74.0 million and 74.1 million" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r64", "r66", "r305", "r312" ], "calculation": { "http://www.westpharma.com/role/CondensedConsolidatedStatementsOfComprehensiveIncomeUnaudited": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest", "totalLabel": "Comprehensive income" } } }, "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CondensedConsolidatedStatementsOfComprehensiveIncomeUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNoteTextBlock": { "auth_ref": [ "r78" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.", "label": "Comprehensive Income (Loss) Note [Text Block]", "terseLabel": "Accumulated Other Comprehensive Loss" } } }, "localname": "ComprehensiveIncomeNoteTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLoss" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "auth_ref": [ "r128", "r129", "r354", "r355" ], "lang": { "en-US": { "role": { "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.", "label": "Concentration Risk Benchmark [Domain]", "terseLabel": "Concentration Risk Benchmark [Domain]" } } }, "localname": "ConcentrationRiskBenchmarkDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/RevenueRecognitionDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "auth_ref": [ "r128", "r129", "r354", "r355", "r424" ], "lang": { "en-US": { "role": { "documentation": "Information by benchmark of concentration risk.", "label": "Concentration Risk Benchmark [Axis]", "terseLabel": "Concentration Risk Benchmark [Axis]" } } }, "localname": "ConcentrationRiskByBenchmarkAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/RevenueRecognitionDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskByTypeAxis": { "auth_ref": [ "r128", "r129", "r354", "r355", "r424" ], "lang": { "en-US": { "role": { "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.", "label": "Concentration Risk Type [Axis]", "terseLabel": "Concentration Risk Type [Axis]" } } }, "localname": "ConcentrationRiskByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/RevenueRecognitionDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskPercentage1": { "auth_ref": [ "r128", "r129", "r354", "r355" ], "lang": { "en-US": { "role": { "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.", "label": "Concentration Risk, Percentage", "terseLabel": "Percentage of net sales" } } }, "localname": "ConcentrationRiskPercentage1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/RevenueRecognitionDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ConcentrationRiskTypeDomain": { "auth_ref": [ "r128", "r129", "r354", "r355" ], "lang": { "en-US": { "role": { "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.", "label": "Concentration Risk Type [Domain]", "terseLabel": "Concentration Risk Type [Domain]" } } }, "localname": "ConcentrationRiskTypeDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/RevenueRecognitionDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock": { "auth_ref": [ "r208" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of contract balances and changes in contract balances.", "label": "Contract with Customer, Asset and Liability [Table Text Block]", "terseLabel": "Change in Contract with Customer, Asset and Liability [Abstract]" } } }, "localname": "ContractWithCustomerAssetAndLiabilityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/RevenueTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ContractWithCustomerAssetNet": { "auth_ref": [ "r203", "r205", "r210" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.", "label": "Contract with Customer, Asset, after Allowance for Credit Loss", "periodEndLabel": "Contract assets, September 30, 2019", "periodStartLabel": "Contract assets, December 31, 2018" } } }, "localname": "ContractWithCustomerAssetNet", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/ContractsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiability": { "auth_ref": [ "r203", "r204", "r210" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.", "label": "Contract with Customer, Liability", "negatedPeriodEndLabel": "Deferred income, September 30, 2019", "negatedPeriodStartLabel": "Deferred income, December 31, 2018", "terseLabel": "Deferred income" } } }, "localname": "ContractWithCustomerLiability", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/ContractsAndLiabilitiesDetails", "http://www.westpharma.com/role/OtherExpenseOtherIncomeDevelopmentAndLicensingIncomeDetails", "http://www.westpharma.com/role/OtherExpenseRestructuringAndRelatedChargesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized": { "auth_ref": [ "r207" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of revenue recognized arising from contract liability from change in timeframe for performance obligation to be satisfied.", "label": "Contract with Customer, Liability, Change in Timeframe, Performance Obligation Satisfied, Revenue Recognized", "terseLabel": "Change in deferred income - decrease (increase)" } } }, "localname": "ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/ContractsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress": { "auth_ref": [ "r206" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) in revenue recognized for cumulative catch-up adjustment from change in measure of progress which (increases) decreases obligation to transfer good or service to customer for which consideration from customer has been received or is due.", "label": "Contract with Customer, Liability, Cumulative Catch-up Adjustment to Revenue, Change in Measure of Progress", "terseLabel": "Contract with Customer, Liability, Cumulative Catch-up Adjustment to Revenue, Change in Measure of Progress" } } }, "localname": "ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/ContractsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiabilityCurrent": { "auth_ref": [ "r203", "r204", "r210" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.", "label": "Contract with Customer, Liability, Current", "verboseLabel": "Deferred income, current" } } }, "localname": "ContractWithCustomerLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/ContractsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiabilityNoncurrent": { "auth_ref": [ "r203", "r204", "r210" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.", "label": "Contract with Customer, Liability, Noncurrent", "terseLabel": "Deferred income, noncurrent" } } }, "localname": "ContractWithCustomerLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/ContractsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": { "auth_ref": [ "r211" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.", "label": "Contract with Customer, Liability, Revenue Recognized", "terseLabel": "Revenue recognized that was included in the deferred income balance" } } }, "localname": "ContractWithCustomerLiabilityRevenueRecognized", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/ContractsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerTimingOfSatisfactionOfPerformanceObligationAndPayment": { "auth_ref": [ "r212" ], "lang": { "en-US": { "role": { "documentation": "Description of effect, from relationship that timing of satisfaction of performance obligation has on timing of payment, on right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time and on obligation to transfer good or service to customer for which consideration from customer has been received or is due.", "label": "Contract with Customer, Timing of Satisfaction of Performance Obligation and Payment", "terseLabel": "Receipt of advance cash payment" } } }, "localname": "ContractWithCustomerTimingOfSatisfactionOfPerformanceObligationAndPayment", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/ContractsAndLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CostMethodInvestments": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, after adjustment, of cost-method investment. Adjustments include, but are not limited to, dividends received in excess of earnings after date of investment that are considered a return of investment and other than temporary impairments.", "label": "Cost Method Investments", "terseLabel": "Carrying amount, cost-method investments" } } }, "localname": "CostMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/AffiliatedCompaniesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfGoodsAndServicesSold": { "auth_ref": [ "r73" ], "calculation": { "http://www.westpharma.com/role/CondensedConsolidatedStatementsOfIncomeUnaudited": { "order": 2.0, "parentTag": "us-gaap_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.", "label": "Cost of Goods and Services Sold", "negatedTerseLabel": "Cost of goods and services sold", "verboseLabel": "Cost of goods and services sold" } } }, "localname": "CostOfGoodsAndServicesSold", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossReclassificationsDetails", "http://www.westpharma.com/role/CondensedConsolidatedStatementsOfIncomeUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfSalesMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Primary financial statement caption encompassing cost of sales.", "label": "Cost of Sales [Member]", "terseLabel": "Cost of goods and services sold [Member]" } } }, "localname": "CostOfSalesMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/DerivativeFinancialInstrumentsTextualsDetails", "http://www.westpharma.com/role/EffectsOfDerivativeInstrumentsOnOciAndEarningsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CreditFacilityAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Axis]", "terseLabel": "Credit Facility [Axis]" } } }, "localname": "CreditFacilityAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CreditFacilityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CreditFacilityDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Domain]", "terseLabel": "Credit Facility [Domain]" } } }, "localname": "CreditFacilityDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CreditFacilityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after tax of increase (decrease) to equity or (increase) decrease to net assets, resulting from the cumulative effect adjustment of a new accounting principle applied in the period of adoption.", "label": "Cumulative Effect of New Accounting Principle in Period of Adoption", "terseLabel": "Cumulative effect of new accounting principle in period of adoption" } } }, "localname": "CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/ChangeInShareholdersEquityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CustomerConcentrationRiskMember": { "auth_ref": [ "r125" ], "lang": { "en-US": { "role": { "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.", "label": "Customer Concentration Risk [Member]", "terseLabel": "Customer Concentration Risk [Member]" } } }, "localname": "CustomerConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/RevenueRecognitionDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtCurrent": { "auth_ref": [ "r35" ], "calculation": { "http://www.westpharma.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of short-term debt and current maturity of long-term debt and capital lease obligations due within one year or the normal operating cycle, if longer.", "label": "Debt, Current", "terseLabel": "Current portion of long-term debt", "verboseLabel": "Notes payable and other current debt" } } }, "localname": "DebtCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CondensedConsolidatedBalanceSheetsUnaudited", "http://www.westpharma.com/role/LongTermDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Debt Disclosure [Abstract]" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_DebtDisclosureTextBlock": { "auth_ref": [ "r193" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.", "label": "Debt Disclosure [Text Block]", "verboseLabel": "Debt" } } }, "localname": "DebtDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/Debt" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.", "label": "Debt Instrument, Basis Spread on Variable Rate", "terseLabel": "Debt instrument, stated interest rate" } } }, "localname": "DebtInstrumentBasisSpreadOnVariableRate1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CreditFacilityDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentCarryingAmount": { "auth_ref": [ "r13", "r191", "r400", "r408" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.", "label": "Long-term Debt, Gross", "terseLabel": "Long-term debt, gross" } } }, "localname": "DebtInstrumentCarryingAmount", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/LongTermDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "auth_ref": [ "r39" ], "lang": { "en-US": { "role": { "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.", "label": "Debt Instrument, Interest Rate, Stated Percentage", "terseLabel": "Debt instrument, stated interest rate" } } }, "localname": "DebtInstrumentInterestRateStatedPercentage", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/LongTermDebtDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt Instrument [Line Items]", "terseLabel": "Debt Instrument [Line Items]" } } }, "localname": "DebtInstrumentLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/LongTermDebtDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentTable": { "auth_ref": [ "r40", "r102", "r195", "r196", "r197", "r198", "r363", "r364", "r366", "r407" ], "lang": { "en-US": { "role": { "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Schedule of Long-term Debt Instruments [Table]", "terseLabel": "Schedule of Long-term Debt Instruments [Table]" } } }, "localname": "DebtInstrumentTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/LongTermDebtDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtMember": { "auth_ref": [ "r283" ], "lang": { "en-US": { "role": { "documentation": "Contractual obligation to pay money on demand or on fixed or determinable dates.", "label": "Debt [Member]", "terseLabel": "Debt EUR Denominated [Member]" } } }, "localname": "DebtMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/DerivativeFinancialInstrumentsTextualsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent": { "auth_ref": [], "calculation": { "http://www.westpharma.com/role/FairValueMeasurementsDetails": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesFairValueDisclosure", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable beyond one year (or the operating cycle, if longer).", "label": "Deferred Compensation Liability, Classified, Noncurrent", "terseLabel": "Deferred compensation liabilities" } } }, "localname": "DeferredCompensationLiabilityClassifiedNoncurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/FairValueMeasurementsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredCompensationPlanAssets": { "auth_ref": [ "r32" ], "calculation": { "http://www.westpharma.com/role/FairValueMeasurementsDetails": { "order": 3.0, "parentTag": "us-gaap_AssetsFairValueDisclosure", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Carrying amount as of the balance sheet date of assets held under deferred compensation agreements.", "label": "Deferred Compensation Plan Assets", "terseLabel": "Deferred compensation assets" } } }, "localname": "DeferredCompensationPlanAssets", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/FairValueMeasurementsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsAdjustment": { "auth_ref": [ "r190" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The amount of any adjustment recognized to the balance of unamortized issuance costs associated with a share-lending arrangement entered into by the entity, in contemplation of a convertible debt offering or other financing, due, for example, to default by the share borrower.", "label": "Deferred Finance Costs, Own-share Lending Arrangement, Issuance Costs, Adjustment", "terseLabel": "Debt issuance costs" } } }, "localname": "DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsAdjustment", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CreditFacilityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsNetNoncurrent": { "auth_ref": [ "r284", "r285", "r286", "r287", "r291" ], "calculation": { "http://www.westpharma.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "order": 6.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards classified as noncurrent.", "label": "Deferred Tax Assets, Net of Valuation Allowance, Noncurrent", "verboseLabel": "Deferred income taxes" } } }, "localname": "DeferredTaxAssetsNetNoncurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilitiesNoncurrent": { "auth_ref": [ "r284", "r286", "r287" ], "calculation": { "http://www.westpharma.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "order": 3.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences, with jurisdictional netting and classified as noncurrent.", "label": "Deferred Tax Liabilities, Net, Noncurrent", "terseLabel": "Deferred income taxes" } } }, "localname": "DeferredTaxLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings": { "auth_ref": [ "r292" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from undistributed earnings of subsidiary and other recognized entity not within country of domicile. Includes, but is not limited to, other basis differences.", "label": "Deferred Tax Liabilities, Undistributed Foreign Earnings", "terseLabel": "Deferred tax liabilities, undistributed foreign earnings" } } }, "localname": "DeferredTaxLiabilitiesUndistributedForeignEarnings", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/IncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanActuarialGainLoss": { "auth_ref": [ "r224" ], "calculation": { "http://www.westpharma.com/role/BenefitPlansDetails": { "order": 5.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of gain (loss) from change in actuarial assumptions which (increases) decreases benefit obligation of defined benefit plan. Assumptions include, but are not limited to, interest, mortality, employee turnover, salary, and temporary deviation from substantive plan.", "label": "Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss)", "negatedTerseLabel": "Recognized actuarial losses (gains)", "terseLabel": "Actuarial losses" } } }, "localname": "DefinedBenefitPlanActuarialGainLoss", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossReclassificationsDetails", "http://www.westpharma.com/role/BenefitPlansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit": { "auth_ref": [ "r233", "r244", "r247" ], "calculation": { "http://www.westpharma.com/role/BenefitPlansDetails": { "order": 4.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of prior service cost (credit) recognized in net periodic benefit cost (credit) of defined benefit plan.", "label": "Defined Benefit Plan, Amortization of Prior Service Cost (Credit)", "negatedTerseLabel": "Prior service cost", "terseLabel": "Amortization of prior service credit" } } }, "localname": "DefinedBenefitPlanAmortizationOfPriorServiceCostCredit", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossReclassificationsDetails", "http://www.westpharma.com/role/BenefitPlansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanContributionsByEmployer": { "auth_ref": [ "r225", "r227", "r228", "r246", "r247" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of contribution received by defined benefit plan from employer which increases plan assets.", "label": "Defined Benefit Plan, Plan Assets, Contributions by Employer", "terseLabel": "Contributions by employer" } } }, "localname": "DefinedBenefitPlanContributionsByEmployer", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/BenefitPlansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets": { "auth_ref": [ "r232", "r243", "r247" ], "calculation": { "http://www.westpharma.com/role/BenefitPlansDetails": { "order": 3.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.", "label": "Defined Benefit Plan, Expected Return (Loss) on Plan Assets", "negatedLabel": "Expected return on assets" } } }, "localname": "DefinedBenefitPlanExpectedReturnOnPlanAssets", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/BenefitPlansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanInterestCost": { "auth_ref": [ "r223", "r231", "r242", "r247" ], "calculation": { "http://www.westpharma.com/role/BenefitPlansDetails": { "order": 2.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cost recognized for passage of time related to defined benefit plan.", "label": "Defined Benefit Plan, Interest Cost", "terseLabel": "Interest cost" } } }, "localname": "DefinedBenefitPlanInterestCost", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/BenefitPlansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost": { "auth_ref": [ "r229", "r240", "r247" ], "calculation": { "http://www.westpharma.com/role/BenefitPlansDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of net periodic benefit cost (credit) for defined benefit plan.", "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit)", "totalLabel": "Net periodic benefit cost" } } }, "localname": "DefinedBenefitPlanNetPeriodicBenefitCost", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/BenefitPlansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1": { "auth_ref": [ "r234", "r245" ], "calculation": { "http://www.westpharma.com/role/BenefitPlansDetails": { "order": 6.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit from irrevocable action relieving primary responsibility for benefit obligation and eliminating risk related to obligation and assets used to effect settlement.", "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement", "negatedTerseLabel": "Settlements", "terseLabel": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement" } } }, "localname": "DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossReclassificationsDetails", "http://www.westpharma.com/role/BenefitPlansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanServiceCost": { "auth_ref": [ "r222", "r230", "r241", "r247" ], "calculation": { "http://www.westpharma.com/role/BenefitPlansDetails": { "order": 1.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.", "label": "Defined Benefit Plan, Service Cost", "terseLabel": "Service cost" } } }, "localname": "DefinedBenefitPlanServiceCost", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/BenefitPlansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Abstract]" } } }, "localname": "DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable": { "auth_ref": [ "r236", "r237", "r238", "r239", "r247" ], "lang": { "en-US": { "role": { "documentation": "Disclosures and provisions pertaining to defined benefit pension plans or other postretirement defined benefit plans. The arrangements are generally based on terms and conditions stipulated by the entity, and which contain a promise by the employer to pay certain amounts or awards at designated future dates, including a period after retirement, upon compliance with stipulated requirements. Excludes disclosures pertaining to defined contribution plans.", "label": "Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table]", "terseLabel": "Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table]" } } }, "localname": "DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/BenefitPlansDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]", "terseLabel": "Defined Benefit Plans and Other Postretirement Benefit Plans [Line Items]" } } }, "localname": "DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/BenefitPlansDetails" ], "xbrltype": "stringItemType" }, "us-gaap_Depreciation": { "auth_ref": [ "r97", "r163" ], "calculation": { "http://www.westpharma.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.", "label": "Depreciation", "terseLabel": "Depreciation" } } }, "localname": "Depreciation", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeAveragePriceRiskOptionStrikePrice": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The average strike price on the group of price risk option contracts such as put options or call options.", "label": "Derivative, Average Price Risk Option Strike Price", "terseLabel": "Derivative, Average Price Risk Option Strike Price" } } }, "localname": "DerivativeAveragePriceRiskOptionStrikePrice", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/DerivativeFinancialInstrumentsTextualsDetails" ], "xbrltype": "perUnitItemType" }, "us-gaap_DerivativeContractTypeDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.", "label": "Derivative Contract [Domain]", "terseLabel": "Derivative Contract Type [Domain]" } } }, "localname": "DerivativeContractTypeDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossReclassificationsDetails", "http://www.westpharma.com/role/DerivativeFinancialInstrumentsTextualsDetails", "http://www.westpharma.com/role/EffectsOfDerivativeInstrumentsOnOciAndEarningsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DerivativeCostOfHedge": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The premium (cost) of a hedge, expensed during the period.", "label": "Derivative, Cost of Hedge", "terseLabel": "Premium paid" } } }, "localname": "DerivativeCostOfHedge", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/DerivativeFinancialInstrumentsTextualsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeGainLossOnDerivativeNet": { "auth_ref": [ "r325" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.", "label": "Derivative, Gain (Loss) on Derivative, Net", "terseLabel": "Derivative, Gain (Loss) on Derivative, Net" } } }, "localname": "DerivativeGainLossOnDerivativeNet", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/EffectsOfDerivativeInstrumentsOnOciAndEarningsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeInstrumentRiskAxis": { "auth_ref": [ "r324", "r326", "r331", "r337" ], "lang": { "en-US": { "role": { "documentation": "Information by type of derivative contract.", "label": "Derivative Instrument [Axis]", "terseLabel": "Derivative Instrument [Axis]" } } }, "localname": "DerivativeInstrumentRiskAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossReclassificationsDetails", "http://www.westpharma.com/role/DerivativeFinancialInstrumentsTextualsDetails", "http://www.westpharma.com/role/EffectsOfDerivativeInstrumentsOnOciAndEarningsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]" } } }, "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": { "auth_ref": [ "r345" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.", "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]", "verboseLabel": "Derivative Financial Instruments" } } }, "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/DerivativeFinancialInstruments" ], "xbrltype": "textBlockItemType" }, "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": { "auth_ref": [ "r322", "r324", "r331" ], "lang": { "en-US": { "role": { "documentation": "Information by type of hedging relationship.", "label": "Hedging Relationship [Axis]", "terseLabel": "Hedging Relationship [Axis]" } } }, "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/DerivativeFinancialInstrumentsTextualsDetails", "http://www.westpharma.com/role/EffectsOfDerivativeInstrumentsOnOciAndEarningsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": { "auth_ref": [ "r322", "r324", "r331", "r337", "r338", "r341", "r343" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.", "label": "Derivative Instruments, Gain (Loss) [Table]", "terseLabel": "Derivative Instruments, Gain (Loss) by Hedging Relationship, by Income Statement Location, by Derivative Instrument Risk [Table]" } } }, "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/EffectsOfDerivativeInstrumentsOnOciAndEarningsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsGainLossLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Derivative Instruments, Gain (Loss) [Line Items]", "terseLabel": "Derivative Instruments, Gain (Loss) [Line Items]" } } }, "localname": "DerivativeInstrumentsGainLossLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/EffectsOfDerivativeInstrumentsOnOciAndEarningsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet": { "auth_ref": [ "r329", "r336" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The effective portion of net gain (loss) reclassified from accumulated other comprehensive income into income on derivative instruments designated and qualifying as hedging instruments.", "label": "Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net", "verboseLabel": "Amount of (gain) loss reclassified from accumulated OCI into income" } } }, "localname": "DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/EffectsOfDerivativeInstrumentsOnOciAndEarningsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet": { "auth_ref": [ "r330", "r332" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of realized and unrealized gain (loss) of derivative instruments not designated or qualifying as hedging instruments.", "label": "Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net", "terseLabel": "Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net" } } }, "localname": "DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/EffectsOfDerivativeInstrumentsOnOciAndEarningsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Derivative [Line Items]", "terseLabel": "Derivative [Line Items]" } } }, "localname": "DerivativeLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/DerivativeFinancialInstrumentsTextualsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeNonmonetaryNotionalAmount": { "auth_ref": [ "r316", "r318" ], "lang": { "en-US": { "role": { "documentation": "Nominal number of units used to calculate payment on derivative.", "label": "Derivative, Nonmonetary Notional Amount", "terseLabel": "Derivative, Nonmonetary Notional Amount" } } }, "localname": "DerivativeNonmonetaryNotionalAmount", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/DerivativeFinancialInstrumentsTextualsDetails" ], "xbrltype": "decimalItemType" }, "us-gaap_DerivativeNotionalAmount": { "auth_ref": [ "r316", "r318" ], "lang": { "en-US": { "role": { "documentation": "Nominal or face amount used to calculate payment on derivative.", "label": "Derivative, Notional Amount", "terseLabel": "Derivative, Notional Amount" } } }, "localname": "DerivativeNotionalAmount", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/DerivativeFinancialInstrumentsTextualsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeTable": { "auth_ref": [ "r106", "r315", "r317", "r318", "r322", "r323", "r327", "r331", "r339", "r340", "r343" ], "lang": { "en-US": { "role": { "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.", "label": "Derivative [Table]", "terseLabel": "Derivative [Table]" } } }, "localname": "DerivativeTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/DerivativeFinancialInstrumentsTextualsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeUnderlyingBasis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Reference to the index or unit of measurement for the underlying which establishes the pricing terms of the derivative instrument. For example, the basis on the underlying for a natural gas futures contract might be the NYMEX price per million British thermal units (MMBtu).", "label": "Derivative, Underlying Basis", "terseLabel": "Derivative, underlying basis" } } }, "localname": "DerivativeUnderlyingBasis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/DerivativeFinancialInstrumentsTextualsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DesignatedAsHedgingInstrumentMember": { "auth_ref": [ "r322" ], "lang": { "en-US": { "role": { "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).", "label": "Designated as Hedging Instrument [Member]", "terseLabel": "Designated as Hedging Instrument [Member]" } } }, "localname": "DesignatedAsHedgingInstrumentMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/DerivativeFinancialInstrumentsTextualsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DisaggregationOfRevenueLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Disaggregation of Revenue [Line Items]", "terseLabel": "Disaggregation of Revenue [Line Items]" } } }, "localname": "DisaggregationOfRevenueLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/RevenueRecognitionDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "Disaggregation of Revenue [Table]", "terseLabel": "Disaggregation of Revenue [Table]" } } }, "localname": "DisaggregationOfRevenueTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/RevenueRecognitionDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTableTextBlock": { "auth_ref": [ "r209" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "Disaggregation of Revenue [Table Text Block]", "terseLabel": "Disaggregation of Revenue [Table Text Block]" } } }, "localname": "DisaggregationOfRevenueTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/RevenueTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "auth_ref": [ "r280" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for share-based payment arrangement.", "label": "Share-based Payment Arrangement [Text Block]", "verboseLabel": "Stock-Based Compensation" } } }, "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/StockBasedCompensation" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Share-based Payment Arrangement [Abstract]" } } }, "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_DisposalGroupClassificationAxis": { "auth_ref": [ "r1" ], "lang": { "en-US": { "role": { "documentation": "Information by disposal group classification.", "label": "Disposal Group Classification [Axis]", "terseLabel": "Disposal Group Classification [Axis]" } } }, "localname": "DisposalGroupClassificationAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/AffiliatedCompaniesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisposalGroupClassificationDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations.", "label": "Disposal Group Classification [Domain]", "terseLabel": "Disposal Group Classification [Domain]" } } }, "localname": "DisposalGroupClassificationDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/AffiliatedCompaniesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DividendsCommonStockCash": { "auth_ref": [ "r199" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.", "label": "Dividends, Common Stock, Cash", "negatedTerseLabel": "Dividends declared" } } }, "localname": "DividendsCommonStockCash", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/ChangeInShareholdersEquityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DomesticLineOfCreditMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars, inside the reporting entity's home country.", "label": "Domestic Line of Credit [Member]", "terseLabel": "Domestic Line of Credit [Member]" } } }, "localname": "DomesticLineOfCreditMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CreditFacilityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DueFromAffiliates": { "auth_ref": [ "r105", "r386", "r387", "r388", "r417" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "For an unclassified balance sheet, amount of receivables due from an entity that is affiliated with the reporting entity by means of direct or indirect ownership.", "label": "Due from Affiliates", "terseLabel": "Amount receivable from affiliates" } } }, "localname": "DueFromAffiliates", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/AffiliatedCompaniesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DueToAffiliateCurrentAndNoncurrent": { "auth_ref": [ "r105", "r386", "r389", "r402", "r416", "r425" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of payable due to an entity that is affiliated with the reporting entity by means of direct or indirect ownership.", "label": "Due to Affiliate", "terseLabel": "Amount due and payable to affiliates" } } }, "localname": "DueToAffiliateCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/AffiliatedCompaniesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EMEAMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Regions of Europe, Middle East and Africa.", "label": "EMEA [Member]", "terseLabel": "Europe, Middle East, Africa [Member]" } } }, "localname": "EMEAMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/RevenueRecognitionDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Earnings Per Share [Abstract]", "verboseLabel": "Net income per share:" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CondensedConsolidatedStatementsOfIncomeUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r71", "r110", "r115", "r117", "r118", "r119", "r122", "r405", "r419" ], "lang": { "en-US": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Earnings Per Share, Basic", "terseLabel": "Basic (in dollars per share)" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CondensedConsolidatedStatementsOfIncomeUnaudited" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r71", "r110", "r115", "r117", "r118", "r119", "r122", "r405", "r419" ], "lang": { "en-US": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Diluted", "terseLabel": "Diluted (in dollars per share)" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CondensedConsolidatedStatementsOfIncomeUnaudited" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareTextBlock": { "auth_ref": [ "r123" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for earnings per share.", "label": "Earnings Per Share [Text Block]", "verboseLabel": "Net Income Per Share" } } }, "localname": "EarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/NetIncomePerShare" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents": { "auth_ref": [ "r359" ], "calculation": { "http://www.westpharma.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 4.0, "parentTag": "us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) from the effect of exchange rate changes on cash and cash equivalent balances held in foreign currencies.", "label": "Effect of Exchange Rate on Cash and Cash Equivalents", "terseLabel": "Effect of exchange rates on cash" } } }, "localname": "EffectOfExchangeRateOnCashAndCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_EffectiveIncomeTaxRateContinuingOperations": { "auth_ref": [ "r104", "r289", "r290" ], "lang": { "en-US": { "role": { "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Effective Income Tax Rate Reconciliation, Percent", "terseLabel": "Effective income tax rate" } } }, "localname": "EffectiveIncomeTaxRateContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/IncomeTaxesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EmployeeRelatedLiabilitiesCurrent": { "auth_ref": [ "r37" ], "calculation": { "http://www.westpharma.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Employee-related Liabilities, Current", "terseLabel": "Accrued salaries, wages and benefits" } } }, "localname": "EmployeeRelatedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeSeveranceMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Termination of an employee associated with exit from or disposal of business activities or restructurings pursuant to a plan.", "label": "Employee Severance [Member]", "terseLabel": "Severance and benefits [Member]" } } }, "localname": "EmployeeSeveranceMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/OtherExpenseRestructuringAndRelatedChargesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Equity [Abstract]", "terseLabel": "Equity:" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r194" ], "lang": { "en-US": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]", "terseLabel": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossComponentsDetails", "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossReclassificationsDetails", "http://www.westpharma.com/role/ChangeInShareholdersEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EquityMethodInvestmentOwnershipPercentage": { "auth_ref": [ "r149" ], "lang": { "en-US": { "role": { "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.", "label": "Equity Method Investment, Ownership Percentage", "terseLabel": "Equity Method Investment, Ownership Percentage" } } }, "localname": "EquityMethodInvestmentOwnershipPercentage", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/SubsequentEventDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EquityMethodInvestments": { "auth_ref": [ "r29", "r136", "r148" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.", "label": "Equity Method Investments", "terseLabel": "Carrying amount, equity-method investments" } } }, "localname": "EquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/AffiliatedCompaniesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Equity Method Investments and Joint Ventures [Abstract]" } } }, "localname": "EquityMethodInvestmentsAndJointVenturesAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_EquityMethodInvestmentsDisclosureTextBlock": { "auth_ref": [ "r151", "r313" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for equity method investments and joint ventures. Equity method investments are investments that give the investor the ability to exercise significant influence over the operating and financial policies of an investee. Joint ventures are entities owned and operated by a small group of businesses as a separate and specific business or project for the mutual benefit of the members of the group.", "label": "Equity Method Investments and Joint Ventures Disclosure [Text Block]", "terseLabel": "Affiliated Companies" } } }, "localname": "EquityMethodInvestmentsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/AffiliatedCompanies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]", "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/FairValueMeasurementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "auth_ref": [ "r346", "r347", "r348", "r353" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.", "label": "Fair Value, Recurring and Nonrecurring [Table]", "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Table]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/FairValueMeasurementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r227", "r228", "r247", "r347", "r393" ], "lang": { "en-US": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Hierarchy and NAV [Axis]", "terseLabel": "Fair Value Hierarchy and NAV [Axis]" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/FairValueMeasurementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Fair Value Disclosures [Abstract]" } } }, "localname": "FairValueDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresTextBlock": { "auth_ref": [ "r352" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.", "label": "Fair Value Disclosures [Text Block]", "verboseLabel": "Fair Value Measurements" } } }, "localname": "FairValueDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/FairValueMeasurements" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueHedgingMember": { "auth_ref": [ "r319" ], "lang": { "en-US": { "role": { "documentation": "A hedge of the exposure to changes in the fair value of a recognized asset or liability, or of an unrecognized firm commitment, that are attributable to a particular risk.", "label": "Fair Value Hedging [Member]", "terseLabel": "Fair Value Hedging [Member]" } } }, "localname": "FairValueHedgingMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/EffectsOfDerivativeInstrumentsOnOciAndEarningsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel1Member": { "auth_ref": [ "r227", "r228", "r247", "r347", "r394" ], "lang": { "en-US": { "role": { "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.", "label": "Fair Value, Inputs, Level 1 [Member]", "terseLabel": "Level 1 [Member]" } } }, "localname": "FairValueInputsLevel1Member", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/FairValueMeasurementsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel2Member": { "auth_ref": [ "r227", "r228", "r247", "r347", "r395" ], "lang": { "en-US": { "role": { "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.", "label": "Fair Value, Inputs, Level 2 [Member]", "terseLabel": "Level 2 [Member]" } } }, "localname": "FairValueInputsLevel2Member", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/FairValueMeasurementsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel3Member": { "auth_ref": [ "r227", "r228", "r247", "r347", "r396" ], "lang": { "en-US": { "role": { "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Inputs, Level 3 [Member]", "terseLabel": "Level 3 [Member]" } } }, "localname": "FairValueInputsLevel3Member", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/FairValueMeasurementsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]", "terseLabel": "Level 3 Fair Value Measurements [Roll Forward]" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/FairValueMeasurementsLevel3Details" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": { "auth_ref": [ "r349", "r353" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]", "terseLabel": "Summary of Changes in Level 3 Fair Value Measurements" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/FairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings": { "auth_ref": [ "r350" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings", "terseLabel": "Increase (decrease) in fair value recorded in earnings" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/FairValueMeasurementsLevel3Details" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements": { "auth_ref": [ "r351" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements", "negatedTerseLabel": "Payments" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/FairValueMeasurementsLevel3Details" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": { "auth_ref": [ "r349" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value", "periodEndLabel": "Balance, end of period", "periodStartLabel": "Balance, beginning of period" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/FairValueMeasurementsLevel3Details" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.", "label": "Fair Value Hierarchy and NAV [Domain]", "terseLabel": "Fair Value, Measurements, Fair Value Hierarchy [Domain]" } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/FairValueMeasurementsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FederalFundsEffectiveSwapRateMember": { "auth_ref": [ "r342" ], "lang": { "en-US": { "role": { "documentation": "Fixed rate on U.S. dollar, constant-notional interest rate swap having its variable-rate leg referenced to Federal Funds effective rate with no additional spread over Federal Funds effective rate on that variable-rate leg.", "label": "Fed Funds Effective Rate Overnight Index Swap Rate [Member]", "terseLabel": "Fed Funds Effective Rate Overnight Index Swap Rate [Member]" } } }, "localname": "FederalFundsEffectiveSwapRateMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CreditFacilityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ForeignCurrencyContractAssetFairValueDisclosure": { "auth_ref": [], "calculation": { "http://www.westpharma.com/role/FairValueMeasurementsDetails": { "order": 1.0, "parentTag": "us-gaap_AssetsFairValueDisclosure", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Fair value portion of asset contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward contracts, and swaps.", "label": "Foreign Currency Contract, Asset, Fair Value Disclosure", "terseLabel": "Foreign currency contracts" } } }, "localname": "ForeignCurrencyContractAssetFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/FairValueMeasurementsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure": { "auth_ref": [], "calculation": { "http://www.westpharma.com/role/FairValueMeasurementsDetails": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesFairValueDisclosure", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Fair value portion of liability contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward (delivery or nondelivery) contracts, and swaps entered into.", "label": "Foreign Currency Contracts, Liability, Fair Value Disclosure", "terseLabel": "Foreign currency contracts" } } }, "localname": "ForeignCurrencyContractsLiabilityFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/FairValueMeasurementsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignCurrencyGainLossMember": { "auth_ref": [ "r336" ], "lang": { "en-US": { "role": { "documentation": "Primary financial statement caption encompassing foreign currency gain (loss).", "label": "Foreign Currency Gain (Loss) [Member]", "terseLabel": "Other expense [Member]" } } }, "localname": "ForeignCurrencyGainLossMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/DerivativeFinancialInstrumentsTextualsDetails", "http://www.westpharma.com/role/EffectsOfDerivativeInstrumentsOnOciAndEarningsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ForeignCurrencyTransactionGainLossBeforeTax": { "auth_ref": [ "r356", "r357", "r358" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.", "label": "Foreign Currency Transaction Gain (Loss), before Tax", "terseLabel": "Foreign exchange transaction (gain) loss" } } }, "localname": "ForeignCurrencyTransactionGainLossBeforeTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/OtherExpenseItemsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignCurrencyTransactionLossBeforeTax": { "auth_ref": [ "r356", "r357", "r358" ], "calculation": { "http://www.westpharma.com/role/OtherExpenseDetails": { "order": 5.0, "parentTag": "wst_OtherIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount before tax of foreign currency transaction realized and unrealized loss recognized in the income statement.", "label": "Foreign Currency Transaction Loss, before Tax", "terseLabel": "Argentina currency devaluation" } } }, "localname": "ForeignCurrencyTransactionLossBeforeTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/OtherExpenseDetails", "http://www.westpharma.com/role/OtherExpenseRestructuringAndRelatedChargesDetails", "http://www.westpharma.com/role/SegmentInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignExchangeContractMember": { "auth_ref": [ "r227", "r335" ], "lang": { "en-US": { "role": { "documentation": "Derivative instrument whose primary underlying risk is tied to foreign exchange rates.", "label": "Foreign Exchange Contract [Member]", "terseLabel": "Foreign Currency Hedge Contracts [Member]", "verboseLabel": "Foreign Currency Contract [Member]" } } }, "localname": "ForeignExchangeContractMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossReclassificationsDetails", "http://www.westpharma.com/role/DerivativeFinancialInstrumentsTextualsDetails", "http://www.westpharma.com/role/EffectsOfDerivativeInstrumentsOnOciAndEarningsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ForeignExchangeForwardMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Foreign exchange forward traded on an exchange (examples include but are not limited to the International Securities Exchange, Philadelphia Stock Exchange, or the Chicago Mercantile Exchange) for options or future contracts to buy or sell a certain currency, at a specified date, at a fixed exercise exchange rate.", "label": "Foreign Exchange Forward [Member]", "terseLabel": "Foreign Exchange Forward [Member]" } } }, "localname": "ForeignExchangeForwardMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/DerivativeFinancialInstrumentsTextualsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ForeignLineOfCreditMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars, outside the reporting entity's home country.", "label": "Foreign Line of Credit [Member]", "terseLabel": "Foreign Line of Credit [Member]" } } }, "localname": "ForeignLineOfCreditMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CreditFacilityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ForeignPlanMember": { "auth_ref": [ "r237" ], "lang": { "en-US": { "role": { "documentation": "Location of employer sponsoring plan, designed to provide retirement benefits, not determined as principal place of business. Includes, but is not limited to, defined benefit and defined contribution plans.", "label": "Foreign Plan [Member]", "terseLabel": "Foreign Plan [Member]" } } }, "localname": "ForeignPlanMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/BenefitPlansDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ForwardContractsMember": { "auth_ref": [ "r333" ], "lang": { "en-US": { "role": { "documentation": "Contracts negotiated between two parties to purchase and sell a specific quantity of a financial instrument, foreign currency, or commodity at a price specified at origination of the contract, with delivery and settlement at a specified future date.", "label": "Forward Contracts [Member]", "terseLabel": "Forward Contracts [Member]" } } }, "localname": "ForwardContractsMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/DerivativeFinancialInstrumentsTextualsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_GainLossOnForeignCurrencyFairValueHedgeDerivatives": { "auth_ref": [ "r324", "r328" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of gain (loss) from the increase (decrease) in fair value of foreign currency derivatives and nonderivative instruments designated as fair value hedging instruments which were recognized in earnings, net of offsets by the gain (loss) on the hedged item to the extent that the fair value hedge was determined to be effective.", "label": "Gain (Loss) on Foreign Currency Fair Value Hedge Derivatives", "terseLabel": "Gain (Loss) on Foreign Currency Fair Value Hedge Derivatives" } } }, "localname": "GainLossOnForeignCurrencyFairValueHedgeDerivatives", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/DerivativeFinancialInstrumentsTextualsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainLossOnPriceRiskDerivativeInstrumentsNotDesignatedAsHedgingInstruments": { "auth_ref": [ "r330" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of gain (loss) recognized in earnings in the period from the increase (decrease) in fair value of price risk derivatives not designated as hedging instruments.", "label": "Gain (Loss) on Price Risk Derivative Instruments Not Designated as Hedging Instruments", "terseLabel": "Gain (Loss) related to call options" } } }, "localname": "GainLossOnPriceRiskDerivativeInstrumentsNotDesignatedAsHedgingInstruments", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/DerivativeFinancialInstrumentsTextualsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeographicConcentrationRiskMember": { "auth_ref": [ "r127" ], "lang": { "en-US": { "role": { "documentation": "Reflects the percentage that a specified dollar value on the balance sheet or income statement in the period from one or more specified geographic areas is to a corresponding consolidated, segment, or product line amount. Risk is the materially adverse effects of economic decline or antagonistic political actions resulting in loss of assets, sales volume, labor supply, or source of materials and supplies in a US state or a specified country, continent, or region such as EMEA (Europe, Middle East, Africa).", "label": "Geographic Concentration Risk [Member]", "terseLabel": "Geographic Concentration Risk [Member]" } } }, "localname": "GeographicConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/RevenueRecognitionDetails" ], "xbrltype": "domainItemType" }, "us-gaap_Goodwill": { "auth_ref": [ "r156", "r157" ], "calculation": { "http://www.westpharma.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "order": 5.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill", "terseLabel": "Goodwill" } } }, "localname": "Goodwill", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_GrossProfit": { "auth_ref": [ "r72" ], "calculation": { "http://www.westpharma.com/role/CondensedConsolidatedStatementsOfIncomeUnaudited": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.", "label": "Gross Profit", "totalLabel": "Gross profit" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CondensedConsolidatedStatementsOfIncomeUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_HedgingDesignationAxis": { "auth_ref": [ "r322", "r338" ], "lang": { "en-US": { "role": { "documentation": "Information by designation of purpose of derivative instrument.", "label": "Hedging Designation [Axis]", "terseLabel": "Hedging Designation [Axis]" } } }, "localname": "HedgingDesignationAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/DerivativeFinancialInstrumentsTextualsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_HedgingDesignationDomain": { "auth_ref": [ "r322" ], "lang": { "en-US": { "role": { "documentation": "Designation of purpose of derivative instrument.", "label": "Hedging Designation [Domain]", "terseLabel": "Hedging Designation [Domain]" } } }, "localname": "HedgingDesignationDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/DerivativeFinancialInstrumentsTextualsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_HedgingRelationshipDomain": { "auth_ref": [ "r322" ], "lang": { "en-US": { "role": { "documentation": "Nature or intent of a hedge.", "label": "Hedging Relationship [Domain]", "terseLabel": "Hedging Relationship [Domain]" } } }, "localname": "HedgingRelationshipDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/DerivativeFinancialInstrumentsTextualsDetails", "http://www.westpharma.com/role/EffectsOfDerivativeInstrumentsOnOciAndEarningsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": { "auth_ref": [ "r103" ], "calculation": { "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossReclassificationsDetails": { "order": 1.0, "parentTag": "us-gaap_ProfitLoss", "weight": 1.0 }, "http://www.westpharma.com/role/CondensedConsolidatedStatementsOfIncomeUnaudited": { "order": 1.0, "parentTag": "us-gaap_ProfitLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.", "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest", "terseLabel": "Income before income taxes", "totalLabel": "Income before income taxes" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossReclassificationsDetails", "http://www.westpharma.com/role/CondensedConsolidatedStatementsOfIncomeUnaudited", "http://www.westpharma.com/role/SegmentInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromEquityMethodInvestments": { "auth_ref": [ "r70", "r97", "r133", "r148", "r404", "r418" ], "calculation": { "http://www.westpharma.com/role/CondensedConsolidatedStatementsOfIncomeUnaudited": { "order": 3.0, "parentTag": "us-gaap_ProfitLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss).", "label": "Income (Loss) from Equity Method Investments", "negatedTerseLabel": "Equity in net income of affiliated companies" } } }, "localname": "IncomeLossFromEquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CondensedConsolidatedStatementsOfIncomeUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationAxis": { "auth_ref": [ "r167" ], "lang": { "en-US": { "role": { "documentation": "Information by location in the income statement.", "label": "Income Statement Location [Axis]", "terseLabel": "Income Statement Location [Axis]" } } }, "localname": "IncomeStatementLocationAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/BenefitPlansDetails", "http://www.westpharma.com/role/DerivativeFinancialInstrumentsTextualsDetails", "http://www.westpharma.com/role/EffectsOfDerivativeInstrumentsOnOciAndEarningsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Location in the income statement.", "label": "Income Statement Location [Domain]", "terseLabel": "Income Statement Location [Domain]" } } }, "localname": "IncomeStatementLocationDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/BenefitPlansDetails", "http://www.westpharma.com/role/DerivativeFinancialInstrumentsTextualsDetails", "http://www.westpharma.com/role/EffectsOfDerivativeInstrumentsOnOciAndEarningsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Income Tax Disclosure [Abstract]" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r295" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "Income Tax Disclosure [Text Block]", "verboseLabel": "Income Taxes" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/IncomeTaxes" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r101", "r134", "r294" ], "calculation": { "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossReclassificationsDetails": { "order": 2.0, "parentTag": "us-gaap_ProfitLoss", "weight": -1.0 }, "http://www.westpharma.com/role/CondensedConsolidatedStatementsOfIncomeUnaudited": { "order": 2.0, "parentTag": "us-gaap_ProfitLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense (Benefit)", "negatedTerseLabel": "Tax expense (benefit)", "terseLabel": "Tax expense (benefit)", "verboseLabel": "Income tax expense" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossReclassificationsDetails", "http://www.westpharma.com/role/CondensedConsolidatedStatementsOfIncomeUnaudited", "http://www.westpharma.com/role/IncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationRepatriationOfForeignEarnings": { "auth_ref": [ "r289", "r290" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to repatriation of foreign earnings.", "label": "Effective Income Tax Rate Reconciliation, Repatriation of Foreign Earnings, Amount", "terseLabel": "Effective Income Tax Rate Reconciliation, Repatriation of Foreign Earnings, Amount" } } }, "localname": "IncomeTaxReconciliationRepatriationOfForeignEarnings", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/IncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": { "auth_ref": [ "r96" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.", "label": "Increase (Decrease) in Contract with Customer, Liability", "terseLabel": "Other adjustments" } } }, "localname": "IncreaseDecreaseInContractWithCustomerLiability", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/ContractsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInCustomerAdvances": { "auth_ref": [ "r96" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The increase (decrease) during the reporting period in the amount of prepayments by customers for goods or services to be provided at a later date.", "label": "Increase (Decrease) in Customer Advances", "terseLabel": "Customer advance cash payments" } } }, "localname": "IncreaseDecreaseInCustomerAdvances", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/ContractsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet": { "auth_ref": [ "r96" ], "calculation": { "http://www.westpharma.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.", "label": "Increase (Decrease) in Other Operating Assets and Liabilities, Net", "negatedLabel": "Other non-cash items, net" } } }, "localname": "IncreaseDecreaseInOtherOperatingCapitalNet", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "verboseLabel": "Changes in the Components of Accumulated Other Comprehensive Loss, Net of Tax [Roll Forward]" } } }, "localname": "IncreaseDecreaseInStockholdersEquityRollForward", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossComponentsDetails", "http://www.westpharma.com/role/ChangeInShareholdersEquityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": { "auth_ref": [ "r116", "r121" ], "calculation": { "http://www.westpharma.com/role/NetIncomePerShareDetails": { "order": 2.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-US": { "role": { "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.", "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements", "terseLabel": "Dilutive effect of equity awards, based on the treasury stock method (in shares)" } } }, "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/NetIncomePerShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "auth_ref": [ "r159", "r160" ], "calculation": { "http://www.westpharma.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "order": 7.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.", "label": "Intangible Assets, Net (Excluding Goodwill)", "terseLabel": "Intangible assets, net" } } }, "localname": "IntangibleAssetsNetExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpense": { "auth_ref": [ "r68", "r132", "r362", "r365", "r406" ], "calculation": { "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossReclassificationsDetails": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": -1.0 }, "http://www.westpharma.com/role/CondensedConsolidatedStatementsOfIncomeUnaudited": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.", "label": "Interest Expense", "negatedTerseLabel": "Interest expense", "terseLabel": "Interest expense" } } }, "localname": "InterestExpense", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossReclassificationsDetails", "http://www.westpharma.com/role/CondensedConsolidatedStatementsOfIncomeUnaudited", "http://www.westpharma.com/role/SegmentInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpenseMember": { "auth_ref": [ "r336" ], "lang": { "en-US": { "role": { "documentation": "Primary financial statement caption encompassing interest expense.", "label": "Interest Expense [Member]", "terseLabel": "Interest expense [Member]" } } }, "localname": "InterestExpenseMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/DerivativeFinancialInstrumentsTextualsDetails", "http://www.westpharma.com/role/EffectsOfDerivativeInstrumentsOnOciAndEarningsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_InterestRateSwapMember": { "auth_ref": [ "r334" ], "lang": { "en-US": { "role": { "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.", "label": "Interest Rate Swap [Member]", "terseLabel": "Interest Rate Swap Contracts [Member]" } } }, "localname": "InterestRateSwapMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossReclassificationsDetails", "http://www.westpharma.com/role/DerivativeFinancialInstrumentsTextualsDetails", "http://www.westpharma.com/role/EffectsOfDerivativeInstrumentsOnOciAndEarningsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_InterimPeriodCostsNotAllocableDomain": { "auth_ref": [ "r124" ], "lang": { "en-US": { "role": { "documentation": "This element represents the type of costs and expenses incurred during an interim period that cannot be readily identified with the activities or benefits of other interim periods and are charged to the interim period in which incurred.", "label": "Interim Period, Costs Not Allocable [Domain]", "terseLabel": "Interim Period, Costs Not Allocable [Domain]" } } }, "localname": "InterimPeriodCostsNotAllocableDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/ContractsAndLiabilitiesDetails", "http://www.westpharma.com/role/OtherExpenseOtherIncomeDevelopmentAndLicensingIncomeDetails", "http://www.westpharma.com/role/RevenueRecognitionDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IntersegmentEliminationMember": { "auth_ref": [ "r138" ], "lang": { "en-US": { "role": { "documentation": "Eliminating entries used in operating segment consolidation.", "label": "Intersegment Eliminations [Member]", "terseLabel": "Intersegment sales elimination [Member]" } } }, "localname": "IntersegmentEliminationMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/SegmentInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_InventoryDisclosureAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Inventory Disclosure [Abstract]" } } }, "localname": "InventoryDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_InventoryDisclosureTextBlock": { "auth_ref": [ "r155" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.", "label": "Inventory Disclosure [Text Block]", "verboseLabel": "Inventories" } } }, "localname": "InventoryDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/Inventories" ], "xbrltype": "textBlockItemType" }, "us-gaap_InventoryFinishedGoodsNetOfReserves": { "auth_ref": [ "r22", "r154" ], "calculation": { "http://www.westpharma.com/role/InventoriesDetails": { "order": 1.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.", "label": "Inventory, Finished Goods, Net of Reserves", "terseLabel": "Finished goods" } } }, "localname": "InventoryFinishedGoodsNetOfReserves", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/InventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r3", "r45", "r153" ], "calculation": { "http://www.westpharma.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 }, "http://www.westpharma.com/role/InventoriesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventory, Net", "totalLabel": "Total inventories", "verboseLabel": "Inventories" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CondensedConsolidatedBalanceSheetsUnaudited", "http://www.westpharma.com/role/InventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryRawMaterialsNetOfReserves": { "auth_ref": [ "r24", "r154" ], "calculation": { "http://www.westpharma.com/role/InventoriesDetails": { "order": 3.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.", "label": "Inventory, Raw Materials, Net of Reserves", "terseLabel": "Raw materials" } } }, "localname": "InventoryRawMaterialsNetOfReserves", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/InventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryWorkInProcessNetOfReserves": { "auth_ref": [ "r23", "r154" ], "calculation": { "http://www.westpharma.com/role/InventoriesDetails": { "order": 2.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.", "label": "Inventory, Work in Process, Net of Reserves", "terseLabel": "Work in process" } } }, "localname": "InventoryWorkInProcessNetOfReserves", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/InventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentIncomeNet": { "auth_ref": [ "r75", "r76", "r77" ], "calculation": { "http://www.westpharma.com/role/CondensedConsolidatedStatementsOfIncomeUnaudited": { "order": 3.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities.", "label": "Investment Income, Net", "negatedTerseLabel": "Interest income" } } }, "localname": "InvestmentIncomeNet", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CondensedConsolidatedStatementsOfIncomeUnaudited", "http://www.westpharma.com/role/SegmentInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures": { "auth_ref": [ "r29" ], "calculation": { "http://www.westpharma.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "order": 4.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of investment in equity method investee and investment in and advance to affiliate.", "label": "Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures", "terseLabel": "Investments in affiliated companies" } } }, "localname": "InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeaseCost": { "auth_ref": [ "r383", "r385" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of lease cost recognized by lessee for lease contract.", "label": "Lease, Cost", "terseLabel": "Total lease cost" } } }, "localname": "LeaseCost", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/LeasesLeaseCostDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeaseCostAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Lease, Cost [Abstract]" } } }, "localname": "LeaseCostAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_LeaseCostTableTextBlock": { "auth_ref": [ "r383" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.", "label": "Lease, Cost [Table Text Block]", "terseLabel": "Lease, Cost [Table Text Block]" } } }, "localname": "LeaseCostTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/LeasesLeasesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LeasesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Leases [Abstract]" } } }, "localname": "LeasesAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_LeasesOfLesseeDisclosureTextBlock": { "auth_ref": [ "r370" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for lessee entity's leasing arrangements including, but not limited to, all of the following: (a.) The basis on which contingent rental payments are determined, (b.) The existence and terms of renewal or purchase options and escalation clauses, (c.) Restrictions imposed by lease agreements, such as those concerning dividends, additional debt, and further leasing.", "label": "Leases of Lessee Disclosure [Text Block]", "terseLabel": "Leases of Lessee Disclosure [Text Block]" } } }, "localname": "LeasesOfLesseeDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/Leases" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": { "auth_ref": [ "r384" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.", "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]", "terseLabel": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]" } } }, "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/LeasesLeasesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "auth_ref": [ "r384" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease.", "label": "Lessee, Operating Lease, Liability, Payments, Due", "terseLabel": "Operating leases liabilities payments due" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": { "auth_ref": [ "r384" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease, due after fifth fiscal year following latest fiscal year.", "label": "Lessee, Operating Lease, Liability, Payments, Due after Year Five", "terseLabel": "Thereafter" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": { "auth_ref": [ "r384" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease, due in fifth fiscal year following latest fiscal year.", "label": "Lessee, Operating Lease, Liability, Payments, Due Year Five", "terseLabel": "2023" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": { "auth_ref": [ "r384" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease, due in fourth fiscal year following latest fiscal year.", "label": "Lessee, Operating Lease, Liability, Payments, Due Year Four", "terseLabel": "2022" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": { "auth_ref": [ "r384" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease, due in third fiscal year following latest fiscal year.", "label": "Lessee, Operating Lease, Liability, Payments, Due Year Three", "terseLabel": "2021" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": { "auth_ref": [ "r384" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease, due in second fiscal year following latest fiscal year.", "label": "Lessee, Operating Lease, Liability, Payments, Due Year Two", "terseLabel": "2020" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": { "auth_ref": [ "r384" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease having an initial or remaining lease term in excess of one year due in remainder of fiscal year following latest fiscal year.", "label": "Lessee, Operating Lease, Liability, Payments, Remainder of Fiscal Year", "terseLabel": "2019 (remaining three months)" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": { "auth_ref": [ "r384" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.", "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount", "terseLabel": "Less: imputed lease interest" } } }, "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseTermOfContract": { "auth_ref": [ "r375" ], "lang": { "en-US": { "role": { "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Lessee, Operating Lease, Term of Contract", "terseLabel": "Operating leases, term of contracts" } } }, "localname": "LesseeOperatingLeaseTermOfContract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/LeasesAdoptionOfAsc842Details" ], "xbrltype": "durationItemType" }, "us-gaap_LetterOfCreditMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "A document typically issued by a financial institution which acts as a guarantee of payment to a beneficiary, or as the source of payment for a specific transaction (for example, wiring funds to a foreign exporter if and when specified merchandise is accepted pursuant to the terms of the letter of credit).", "label": "Letter of Credit [Member]", "terseLabel": "Letter of Credit [Member]" } } }, "localname": "LetterOfCreditMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CreditFacilityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r36" ], "calculation": { "http://www.westpharma.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total Liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r21", "r401", "r413" ], "calculation": { "http://www.westpharma.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total Liabilities and Equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Liabilities and Equity [Abstract]", "terseLabel": "LIABILITIES AND EQUITY" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r38" ], "calculation": { "http://www.westpharma.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Liabilities, Current [Abstract]", "terseLabel": "Current liabilities:" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesFairValueDisclosure": { "auth_ref": [ "r346" ], "calculation": { "http://www.westpharma.com/role/FairValueMeasurementsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Fair value of financial and nonfinancial obligations.", "label": "Financial and Nonfinancial Liabilities, Fair Value Disclosure", "totalLabel": "Total liabilities at fair value" } } }, "localname": "LiabilitiesFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/FairValueMeasurementsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesFairValueDisclosureAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Liabilities, Fair Value Disclosure [Abstract]", "terseLabel": "Liabilities:" } } }, "localname": "LiabilitiesFairValueDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/FairValueMeasurementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCredit": { "auth_ref": [ "r13", "r400", "r408" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.", "label": "Long-term Line of Credit", "terseLabel": "Long-term Line of Credit" } } }, "localname": "LineOfCredit", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CreditFacilityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity": { "auth_ref": [ "r34" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of current borrowing capacity under the credit facility considering any current restrictions on the amount that could be borrowed (for example, borrowings may be limited by the amount of current assets), but without considering any amounts currently outstanding under the facility.", "label": "Line of Credit Facility, Current Borrowing Capacity", "terseLabel": "Line of Credit Facility, current borrowing capacity" } } }, "localname": "LineOfCreditFacilityCurrentBorrowingCapacity", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CreditFacilityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityExpirationDate1": { "auth_ref": [ "r34" ], "lang": { "en-US": { "role": { "documentation": "Date the credit facility terminates, in CCYY-MM-DD format.", "label": "Line of Credit Facility, Expiration Date", "terseLabel": "Debt instrument, maturity date" } } }, "localname": "LineOfCreditFacilityExpirationDate1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CreditFacilityDetails" ], "xbrltype": "dateItemType" }, "us-gaap_LineOfCreditFacilityLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Line of Credit Facility [Line Items]", "terseLabel": "Line of Credit Facility [Line Items]" } } }, "localname": "LineOfCreditFacilityLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CreditFacilityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity": { "auth_ref": [ "r34" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).", "label": "Line of Credit Facility, Remaining Borrowing Capacity", "terseLabel": "Line of Credit Facility, unused commitment level" } } }, "localname": "LineOfCreditFacilityRemainingBorrowingCapacity", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CreditFacilityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityTable": { "auth_ref": [ "r34", "r102" ], "lang": { "en-US": { "role": { "documentation": "A table or schedule providing information pertaining to short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.", "label": "Line of Credit Facility [Table]", "terseLabel": "Line of Credit Facility [Table]" } } }, "localname": "LineOfCreditFacilityTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CreditFacilityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCreditMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.", "label": "Line of Credit [Member]", "terseLabel": "Line of Credit [Member]" } } }, "localname": "LineOfCreditMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CreditFacilityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LondonInterbankOfferedRateLIBORMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Interest rate at which a bank borrows funds from other banks in the London interbank market.", "label": "London Interbank Offered Rate (LIBOR) [Member]", "terseLabel": "London Interbank Offered Rate (LIBOR) [Member]" } } }, "localname": "LondonInterbankOfferedRateLIBORMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CreditFacilityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LongMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Indicates an ownership position in, or purchase of, a security.", "label": "Long [Member]", "terseLabel": "Long [Member]" } } }, "localname": "LongMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/DerivativeFinancialInstrumentsTextualsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LongTermDebt": { "auth_ref": [ "r13", "r192", "r400", "r411" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.", "label": "Long-term Debt", "terseLabel": "Long-term debt" } } }, "localname": "LongTermDebt", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/LongTermDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtFairValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.", "label": "Long-term Debt, Fair Value", "verboseLabel": "Long-term debt, fair value" } } }, "localname": "LongTermDebtFairValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/FairValueMeasurementsOtherFinancialInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtNoncurrent": { "auth_ref": [ "r40" ], "calculation": { "http://www.westpharma.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.", "label": "Long-term Debt, Excluding Current Maturities", "terseLabel": "Long-term debt", "verboseLabel": "Long-term debt, excluding current portion" } } }, "localname": "LongTermDebtNoncurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CondensedConsolidatedBalanceSheetsUnaudited", "http://www.westpharma.com/role/FairValueMeasurementsOtherFinancialInstrumentsDetails", "http://www.westpharma.com/role/LongTermDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermLineOfCredit": { "auth_ref": [ "r40", "r187", "r188" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The carrying value as of the balance sheet date of the noncurrent portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.", "label": "Long-term Line of Credit, Noncurrent", "terseLabel": "Line of Credit Facility, noncurrent" } } }, "localname": "LongTermLineOfCredit", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CreditFacilityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongtermDebtTypeAxis": { "auth_ref": [ "r40" ], "lang": { "en-US": { "role": { "documentation": "Information by type of long-term debt.", "label": "Long-term Debt, Type [Axis]", "terseLabel": "Long-term Debt, Type [Axis]" } } }, "localname": "LongtermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CreditFacilityDetails", "http://www.westpharma.com/role/LongTermDebtDetails", "http://www.westpharma.com/role/SegmentInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LongtermDebtTypeDomain": { "auth_ref": [ "r40", "r189" ], "lang": { "en-US": { "role": { "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Long-term Debt, Type [Domain]", "terseLabel": "Long-term Debt, Type [Domain]" } } }, "localname": "LongtermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CreditFacilityDetails", "http://www.westpharma.com/role/LongTermDebtDetails", "http://www.westpharma.com/role/SegmentInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MaterialReconcilingItemsMember": { "auth_ref": [ "r138", "r139" ], "lang": { "en-US": { "role": { "documentation": "Items used in reconciling reportable segments' amounts to consolidated amount. Excludes corporate-level activity.", "label": "Segment Reconciling Items [Member]", "terseLabel": "Other unallocated items [Member]" } } }, "localname": "MaterialReconcilingItemsMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/SegmentInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NatureOfExpenseAxis": { "auth_ref": [ "r124" ], "lang": { "en-US": { "role": { "documentation": "Information by type of cost or expense.", "label": "Nature of Expense [Axis]", "terseLabel": "Nature of Expense [Axis]" } } }, "localname": "NatureOfExpenseAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/ContractsAndLiabilitiesDetails", "http://www.westpharma.com/role/OtherExpenseOtherIncomeDevelopmentAndLicensingIncomeDetails", "http://www.westpharma.com/role/RevenueRecognitionDetails" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r94" ], "calculation": { "http://www.westpharma.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 3.0, "parentTag": "us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash used in financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]", "terseLabel": "Cash flows from financing activities:" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r94" ], "calculation": { "http://www.westpharma.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 2.0, "parentTag": "us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash used in investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]", "terseLabel": "Cash flows from investing activities:" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r94", "r95", "r98" ], "calculation": { "http://www.westpharma.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 1.0, "parentTag": "us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease", "weight": 1.0 } }, "lang": { "en-US": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash provided by operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Cash flows from operating activities:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_NetInvestmentHedgingMember": { "auth_ref": [ "r321" ], "lang": { "en-US": { "role": { "documentation": "Hedges of a net investment in a foreign operation.", "label": "Net Investment Hedging [Member]", "terseLabel": "Net Investment Hedges [Member]" } } }, "localname": "NetInvestmentHedgingMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/DerivativeFinancialInstrumentsTextualsDetails", "http://www.westpharma.com/role/EffectsOfDerivativeInstrumentsOnOciAndEarningsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "New Accounting Pronouncements and Changes in Accounting Principles [Abstract]" } } }, "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock": { "auth_ref": [ "r112" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure of changes in accounting principles, including adoption of new accounting pronouncements, that describes the new methods, amount and effects on financial statement line items.", "label": "New Accounting Pronouncements and Changes in Accounting Principles [Text Block]", "verboseLabel": "New Accounting Standards" } } }, "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/NewAccountingStandards" ], "xbrltype": "textBlockItemType" }, "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]", "terseLabel": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]" } } }, "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/IncomeTaxesDetails", "http://www.westpharma.com/role/LeasesAdoptionOfAsc842Details" ], "xbrltype": "stringItemType" }, "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable": { "auth_ref": [ "r109", "r111" ], "lang": { "en-US": { "role": { "documentation": "Summarization of the changes in an accounting principle or a new accounting pronouncement, including the line items affected by the change and the financial effects of the change on those particular line items.", "label": "New Accounting Pronouncements or Change in Accounting Principle [Table]", "terseLabel": "New Accounting Pronouncements or Change in Accounting Principle [Table]" } } }, "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/IncomeTaxesDetails", "http://www.westpharma.com/role/LeasesAdoptionOfAsc842Details" ], "xbrltype": "stringItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "terseLabel": "New Accounting Standards" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NondesignatedMember": { "auth_ref": [ "r322" ], "lang": { "en-US": { "role": { "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).", "label": "Not Designated as Hedging Instrument [Member]", "terseLabel": "Cash Flow Hedges [Member]" } } }, "localname": "NondesignatedMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/EffectsOfDerivativeInstrumentsOnOciAndEarningsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NotesPayableOtherPayablesMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "A written promise to pay a note to a third party.", "label": "Notes Payable, Other Payables [Member]", "terseLabel": "Notes payable, Due 2019 [Member]" } } }, "localname": "NotesPayableOtherPayablesMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/LongTermDebtDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NotionalAmountOfNonderivativeInstruments": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Nominal or face amount used to calculate payments on a nonderivative instrument.", "label": "Notional Amount of Nonderivative Instruments", "terseLabel": "Notional amount, nonderivative instruments" } } }, "localname": "NotionalAmountOfNonderivativeInstruments", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/DerivativeFinancialInstrumentsTextualsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NumberOfReportableSegments": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.", "label": "Number of Reportable Segments", "terseLabel": "Number of reportable segments" } } }, "localname": "NumberOfReportableSegments", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/SegmentInformationDetails" ], "xbrltype": "integerItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [], "calculation": { "http://www.westpharma.com/role/CondensedConsolidatedStatementsOfIncomeUnaudited": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "terseLabel": "Total operating (loss) profit", "totalLabel": "Operating profit" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CondensedConsolidatedStatementsOfIncomeUnaudited", "http://www.westpharma.com/role/SegmentInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseCost": { "auth_ref": [ "r376", "r385" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.", "label": "Operating Lease, Cost", "terseLabel": "Operating lease cost" } } }, "localname": "OperatingLeaseCost", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/LeasesLeaseCostDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiability": { "auth_ref": [ "r373" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.", "label": "Operating Lease, Liability", "terseLabel": "Total lease liabilities" } } }, "localname": "OperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/LeasesAdoptionOfAsc842Details", "http://www.westpharma.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [ "r373" ], "calculation": { "http://www.westpharma.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "order": 6.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.", "label": "Operating Lease, Liability, Current", "terseLabel": "Operating lease liabilities, current" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "auth_ref": [ "r373" ], "calculation": { "http://www.westpharma.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "order": 5.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.", "label": "Operating Lease, Liability, Noncurrent", "terseLabel": "Operating lease liabilities, noncurrent" } } }, "localname": "OperatingLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasePayments": { "auth_ref": [ "r374", "r379" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.", "label": "Operating Lease, Payments", "terseLabel": "Operating lease payments" } } }, "localname": "OperatingLeasePayments", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/LeasesLeaseCashFlowAndSupplementalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r372" ], "calculation": { "http://www.westpharma.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Operating Lease, Right-of-Use Asset", "terseLabel": "Operating lease right-of-use assets" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CondensedConsolidatedBalanceSheetsUnaudited", "http://www.westpharma.com/role/LeasesAdoptionOfAsc842Details" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "auth_ref": [ "r382", "r385" ], "lang": { "en-US": { "role": { "documentation": "Weighted average discount rate for operating lease calculated at point in time.", "label": "Operating Lease, Weighted Average Discount Rate, Percent", "terseLabel": "Weighted average discount rate" } } }, "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/LeasesLeaseWeightedAverageDetails" ], "xbrltype": "percentItemType" }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "auth_ref": [ "r381", "r385" ], "lang": { "en-US": { "role": { "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Operating Lease, Weighted Average Remaining Lease Term", "terseLabel": "Weighted average remaining lease term" } } }, "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/LeasesLeaseWeightedAverageDetails" ], "xbrltype": "durationItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDue": { "auth_ref": [ "r367", "r368" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of required minimum rental payments for leases having an initial or remaining non-cancelable letter-terms in excess of one year.", "label": "Operating Leases, Future Minimum Payments Due", "terseLabel": "Total" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent": { "auth_ref": [ "r367", "r368" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Operating Leases, Future Minimum Payments Due, Next Twelve Months", "terseLabel": "2019" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears": { "auth_ref": [ "r367", "r368" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Operating Leases, Future Minimum Payments, Due in Five Years", "terseLabel": "2023" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueInFiveYears", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears": { "auth_ref": [ "r367", "r368" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Operating Leases, Future Minimum Payments, Due in Four Years", "terseLabel": "2022" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueInFourYears", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears": { "auth_ref": [ "r367", "r368" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Operating Leases, Future Minimum Payments, Due in Three Years", "terseLabel": "2021" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueInThreeYears", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears": { "auth_ref": [ "r367", "r368" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Operating Leases, Future Minimum Payments, Due in Two Years", "terseLabel": "2020" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueInTwoYears", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter": { "auth_ref": [ "r367", "r368" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due after the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Operating Leases, Future Minimum Payments, Due Thereafter", "terseLabel": "Thereafter" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueThereafter", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OptionMember": { "auth_ref": [ "r314" ], "lang": { "en-US": { "role": { "documentation": "Contracts conveying rights, but not obligations, to buy or sell a specific commodity, or financial or equity instrument, at a specified price during a specified period (an American option) or at a specified date (a European option) which were purchased or otherwise acquired, excluding options written (for which a premium was received).", "label": "Options Held [Member]", "terseLabel": "Options Held [Member]" } } }, "localname": "OptionMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/DerivativeFinancialInstrumentsTextualsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherAssetsCurrent": { "auth_ref": [ "r46" ], "calculation": { "http://www.westpharma.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of current assets classified as other.", "label": "Other Assets, Current", "terseLabel": "Other current assets" } } }, "localname": "OtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsFairValueDisclosure": { "auth_ref": [], "calculation": { "http://www.westpharma.com/role/FairValueMeasurementsDetails": { "order": 2.0, "parentTag": "us-gaap_AssetsFairValueDisclosure", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Fair value portion of other assets.", "label": "Other Assets, Fair Value Disclosure", "terseLabel": "Commodity call options" } } }, "localname": "OtherAssetsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/FairValueMeasurementsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsNoncurrent": { "auth_ref": [ "r32" ], "calculation": { "http://www.westpharma.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "order": 8.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of noncurrent assets classified as other.", "label": "Other Assets, Noncurrent", "terseLabel": "Other noncurrent assets" } } }, "localname": "OtherAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax": { "auth_ref": [ "r51", "r52", "r57" ], "calculation": { "http://www.westpharma.com/role/CondensedConsolidatedStatementsOfComprehensiveIncomeUnaudited": { "order": 4.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after tax and reclassification adjustments, of appreciation (loss) in value of unsold available-for-sale securities. Excludes amounts related to other than temporary impairment (OTTI) loss.", "label": "Other Comprehensive Income (Loss), Securities, Available-for-sale, Adjustment, after Tax", "terseLabel": "Net loss on investment securities, net of tax of $0" } } }, "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CondensedConsolidatedStatementsOfComprehensiveIncomeUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax": { "auth_ref": [ "r51", "r52", "r58" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of tax expense (benefit), after reclassification adjustments, of appreciation (loss) in value of unsold available-for-sale securities. Excludes amounts related to other than temporary impairment (OTTI) loss.", "label": "Other Comprehensive Income (Loss), Securities, Available-for-sale, Tax", "terseLabel": "Net loss on investment securities, tax" } } }, "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CondensedConsolidatedStatementsOfComprehensiveIncomeUnauditedParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax": { "auth_ref": [ "r60", "r67" ], "calculation": { "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossComponentsDetails": { "order": 1.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after tax, before reclassification adjustments of other comprehensive income (loss).", "label": "Other Comprehensive Income (Loss), before Reclassifications, Net of Tax", "terseLabel": "Other comprehensive income (loss) before reclassifications" } } }, "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossComponentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax": { "auth_ref": [ "r50" ], "calculation": { "http://www.westpharma.com/role/CondensedConsolidatedStatementsOfComprehensiveIncomeUnaudited": { "order": 3.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after tax and reclassification adjustments, of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).", "label": "Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax", "terseLabel": "Net gain (loss) on derivatives, net of tax of $1.5, $(0.1), $0.7, and $1.0, respectively" } } }, "localname": "OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CondensedConsolidatedStatementsOfComprehensiveIncomeUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax": { "auth_ref": [ "r50", "r58" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of tax expense (benefit), after reclassification adjustments, of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).", "label": "Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Tax", "terseLabel": "Net gain (loss) on derivatives, tax" } } }, "localname": "OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CondensedConsolidatedStatementsOfComprehensiveIncomeUnauditedParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": { "auth_ref": [ "r48", "r361" ], "calculation": { "http://www.westpharma.com/role/CondensedConsolidatedStatementsOfComprehensiveIncomeUnaudited": { "order": 1.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax", "terseLabel": "Foreign currency translation adjustments" } } }, "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CondensedConsolidatedStatementsOfComprehensiveIncomeUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r63", "r66", "r67", "r194" ], "calculation": { "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossComponentsDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.westpharma.com/role/CondensedConsolidatedStatementsOfComprehensiveIncomeUnaudited": { "order": 2.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).", "label": "Other Comprehensive Income (Loss), Net of Tax", "terseLabel": "Other comprehensive income, net of tax", "totalLabel": "Other comprehensive loss, net of tax" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossComponentsDetails", "http://www.westpharma.com/role/ChangeInShareholdersEquityDetails", "http://www.westpharma.com/role/CondensedConsolidatedStatementsOfComprehensiveIncomeUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]", "terseLabel": "Other comprehensive (loss) income, net of tax:" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CondensedConsolidatedStatementsOfComprehensiveIncomeUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax": { "auth_ref": [ "r55", "r57" ], "calculation": { "http://www.westpharma.com/role/CondensedConsolidatedStatementsOfComprehensiveIncomeUnaudited": { "order": 2.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.", "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax", "negatedLabel": "Defined benefit pension and other postretirement plan adjustments, net of tax of $0.7, $0, $0.7 and $0.1, respectively" } } }, "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CondensedConsolidatedStatementsOfComprehensiveIncomeUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax": { "auth_ref": [ "r55", "r58", "r305" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount, after reclassification adjustment, of tax (expense) benefit for (increase) decrease in accumulated other comprehensive income of defined benefit plan.", "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax", "terseLabel": "Defined benefit pension and other postretirement plan adjustments, tax" } } }, "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CondensedConsolidatedStatementsOfComprehensiveIncomeUnauditedParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax": { "auth_ref": [ "r50", "r57", "r344" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount before tax of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).", "label": "Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax", "terseLabel": "Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax" } } }, "localname": "OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/EffectsOfDerivativeInstrumentsOnOciAndEarningsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherIncomeAndExpensesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Other Income and Expenses [Abstract]" } } }, "localname": "OtherIncomeAndExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock": { "auth_ref": [ "r217", "r281" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for other income or other expense items (both operating and nonoperating). Sources of nonoperating income or nonoperating expense that may be disclosed, include amounts earned from dividends, interest on securities, profits (losses) on securities, net and miscellaneous other income or income deductions.", "label": "Other Income and Other Expense Disclosure [Text Block]", "verboseLabel": "Other Expense" } } }, "localname": "OtherIncomeAndOtherExpenseDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/OtherExpense" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherIncomeTaxExpenseBenefitContinuingOperations": { "auth_ref": [ "r288", "r293" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of other current and other deferred income tax expense (benefit) attributable to continuing operations.", "label": "Other Income Tax Expense (Benefit), Continuing Operations", "negatedTerseLabel": "Other Income Tax Expense (Benefit), Continuing Operations" } } }, "localname": "OtherIncomeTaxExpenseBenefitContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/IncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLiabilitiesCurrent": { "auth_ref": [ "r7", "r8", "r37" ], "calculation": { "http://www.westpharma.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "order": 7.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.", "label": "Other Liabilities, Current", "terseLabel": "Other current liabilities" } } }, "localname": "OtherLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLiabilitiesNoncurrent": { "auth_ref": [ "r41" ], "calculation": { "http://www.westpharma.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "order": 6.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.", "label": "Other Liabilities, Noncurrent", "terseLabel": "Other long-term liabilities" } } }, "localname": "OtherLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNoncashIncomeExpense": { "auth_ref": [ "r98" ], "calculation": { "http://www.westpharma.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.", "label": "Other Noncash Income (Expense)", "negatedTerseLabel": "Changes in assets and liabilities" } } }, "localname": "OtherNoncashIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNonoperatingIncomeExpense": { "auth_ref": [ "r77" ], "calculation": { "http://www.westpharma.com/role/CondensedConsolidatedStatementsOfIncomeUnaudited": { "order": 4.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.", "label": "Other Nonoperating Income (Expense)", "negatedLabel": "Other nonoperating income", "verboseLabel": "Other nonoperating expense (income)" } } }, "localname": "OtherNonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CondensedConsolidatedStatementsOfIncomeUnaudited", "http://www.westpharma.com/role/SegmentInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNonoperatingIncomeExpenseMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Primary financial statement caption encompassing other nonoperating income (expense).", "label": "Other Nonoperating Income (Expense) [Member]", "terseLabel": "Other Nonoperating Income (Expense) [Member]" } } }, "localname": "OtherNonoperatingIncomeExpenseMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/BenefitPlansDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherOperatingIncomeExpenseNet": { "auth_ref": [], "calculation": { "http://www.westpharma.com/role/OtherExpenseDetails": { "order": 2.0, "parentTag": "wst_OtherIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations.", "label": "Other Operating Income (Expense), Net", "negatedTerseLabel": "Other items" } } }, "localname": "OtherOperatingIncomeExpenseNet", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/OtherExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember": { "auth_ref": [ "r219", "r236", "r237", "r248" ], "lang": { "en-US": { "role": { "documentation": "Plan designed to provide other postretirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes pension benefits.", "label": "Other Postretirement Benefits Plan [Member]", "terseLabel": "Other Retirement Benefits [Member]" } } }, "localname": "OtherPostretirementBenefitPlansDefinedBenefitMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/BenefitPlansDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherRestructuringCosts": { "auth_ref": [ "r97", "r169", "r175", "r181" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of other expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses associated with a discontinued operation or an asset retirement obligation.", "label": "Other Restructuring Costs", "terseLabel": "Other charges" } } }, "localname": "OtherRestructuringCosts", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/OtherExpenseDetails", "http://www.westpharma.com/role/OtherExpenseRestructuringAndRelatedChargesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherRestructuringMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Restructuring and related activities classified as other.", "label": "Other Restructuring [Member]", "terseLabel": "Other charges [Member]" } } }, "localname": "OtherRestructuringMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/OtherExpenseRestructuringAndRelatedChargesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities": { "auth_ref": [ "r91" ], "calculation": { "http://www.westpharma.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability exceeding amount recognized at acquisition date. Includes, but is not limited to, measurement period adjustment and less amount paid soon after acquisition date.", "label": "Payment for Contingent Consideration Liability, Operating Activities", "negatedTerseLabel": "Contingent consideration payments in excess of acquisition-date liability" } } }, "localname": "PaymentForContingentConsiderationLiabilityOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": { "auth_ref": [ "r79", "r82", "r107" ], "calculation": { "http://www.westpharma.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.", "label": "Payments for (Proceeds from) Other Investing Activities", "negatedLabel": "Other, net" } } }, "localname": "PaymentsForProceedsFromOtherInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForRepurchaseOfCommonStock": { "auth_ref": [ "r86" ], "calculation": { "http://www.westpharma.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cash outflow to reacquire common stock during the period.", "label": "Payments for Repurchase of Common Stock", "negatedTerseLabel": "Shares purchased under share repurchase programs" } } }, "localname": "PaymentsForRepurchaseOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForRestructuring": { "auth_ref": [ "r92", "r171" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.", "label": "Payments for Restructuring", "negatedTerseLabel": "Cash payments" } } }, "localname": "PaymentsForRestructuring", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/OtherExpenseRestructuringAndRelatedChargesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfDebtIssuanceCosts": { "auth_ref": [ "r89" ], "calculation": { "http://www.westpharma.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.", "label": "Payments of Debt Issuance Costs", "negatedTerseLabel": "Debt issuance costs" } } }, "localname": "PaymentsOfDebtIssuanceCosts", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfDividendsCommonStock": { "auth_ref": [ "r86" ], "calculation": { "http://www.westpharma.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.", "label": "Payments of Ordinary Dividends, Common Stock", "negatedLabel": "Dividend payments" } } }, "localname": "PaymentsOfDividendsCommonStock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": { "auth_ref": [ "r86" ], "calculation": { "http://www.westpharma.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.", "label": "Payment, Tax Withholding, Share-based Payment Arrangement", "negatedLabel": "Shares repurchased for employee tax withholdings" } } }, "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireBusinessesGross": { "auth_ref": [ "r80", "r300" ], "calculation": { "http://www.westpharma.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.", "label": "Payments to Acquire Businesses, Gross", "negatedTerseLabel": "Acquisition of business" } } }, "localname": "PaymentsToAcquireBusinessesGross", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r81" ], "calculation": { "http://www.westpharma.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments to Acquire Property, Plant, and Equipment", "negatedLabel": "Capital expenditures", "verboseLabel": "Payments to acquire property, plant, and equipment" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited", "http://www.westpharma.com/role/OtherExpenseRestructuringAndRelatedChargesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": { "auth_ref": [ "r249" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for pension and other postretirement benefits.", "label": "Pension and Other Postretirement Benefits Disclosure [Text Block]", "verboseLabel": "Benefit Plans" } } }, "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/BenefitPlans" ], "xbrltype": "textBlockItemType" }, "us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities": { "auth_ref": [ "r12", "r220", "r221", "r226" ], "calculation": { "http://www.westpharma.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as current.", "label": "Liability, Defined Benefit Plan, Current", "verboseLabel": "Pension and other postretirement benefits" } } }, "localname": "PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent": { "auth_ref": [ "r14", "r220", "r221", "r226" ], "calculation": { "http://www.westpharma.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "order": 4.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as noncurrent.", "label": "Liability, Defined Benefit Plan, Noncurrent", "terseLabel": "Pension and other postretirement benefits" } } }, "localname": "PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_PensionPlansDefinedBenefitMember": { "auth_ref": [ "r218", "r236", "r237", "r248" ], "lang": { "en-US": { "role": { "documentation": "Plan designed to provide participant with pension benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes other postretirement benefits.", "label": "Pension Plan [Member]", "terseLabel": "Pension Benefits [Member]" } } }, "localname": "PensionPlansDefinedBenefitMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/BenefitPlansDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PerformanceSharesMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Share-based payment arrangement awarded for meeting performance target.", "label": "Performance Shares [Member]", "terseLabel": "Performance Share Unit (PSUs) [Member]" } } }, "localname": "PerformanceSharesMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/StockBasedCompensationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PositionAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information by position taken for a security.", "label": "Position [Axis]", "terseLabel": "Position [Axis]" } } }, "localname": "PositionAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/DerivativeFinancialInstrumentsTextualsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PositionDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Indicates position taken for a security.", "label": "Position [Domain]", "terseLabel": "Position [Domain]" } } }, "localname": "PositionDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/DerivativeFinancialInstrumentsTextualsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r16" ], "lang": { "en-US": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred Stock, Shares Authorized", "terseLabel": "Preferred stock, shares authorized (in shares)" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r16" ], "lang": { "en-US": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred Stock, Shares Issued", "terseLabel": "Preferred stock, shares issued (in shares)" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r16" ], "lang": { "en-US": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred Stock, Shares Outstanding", "terseLabel": "Preferred stock, shares outstanding (in shares)" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r16" ], "calculation": { "http://www.westpharma.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred Stock, Value, Issued", "terseLabel": "Preferred stock, 3.0 million shares authorized; 0 shares issued and outstanding" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans": { "auth_ref": [ "r83", "r265" ], "calculation": { "http://www.westpharma.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash inflow from issuance of shares under share-based payment arrangement. Excludes option exercised.", "label": "Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised", "terseLabel": "Employee stock purchase plan contributions" } } }, "localname": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromLongTermLinesOfCredit": { "auth_ref": [ "r84" ], "calculation": { "http://www.westpharma.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The cash inflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.", "label": "Proceeds from Long-term Lines of Credit", "terseLabel": "Borrowings under revolving credit agreements" } } }, "localname": "ProceedsFromLongTermLinesOfCredit", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": { "auth_ref": [ "r85", "r90", "r107" ], "calculation": { "http://www.westpharma.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.", "label": "Proceeds from (Payments for) Other Financing Activities", "terseLabel": "Contingent consideration payments up to amount of acquisition-date liability" } } }, "localname": "ProceedsFromPaymentsForOtherFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromStockOptionsExercised": { "auth_ref": [ "r83", "r265" ], "calculation": { "http://www.westpharma.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.", "label": "Proceeds from Stock Options Exercised", "terseLabel": "Proceeds from stock-based compensation awards" } } }, "localname": "ProceedsFromStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductConcentrationRiskMember": { "auth_ref": [ "r126" ], "lang": { "en-US": { "role": { "documentation": "Reflects the percentage that revenues during the period from a specified product are to a specified benchmark, such as total net revenues, segment revenues or product line revenues. May also reflect the percentage contribution the product made to operating results. Risk is materially adverse effects of a loss of sales of a significant product or line of products, which could occur upon loss of rights to sell, distribute or license others; loss of patent or copyright protection; or technological obsolescence.", "label": "Product Concentration Risk [Member]", "terseLabel": "Product Concentration Risk [Member]" } } }, "localname": "ProductConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/RevenueRecognitionDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ProfitLoss": { "auth_ref": [ "r62", "r65", "r93", "r135", "r141", "r305", "r306", "r307", "r311", "r312" ], "calculation": { "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossReclassificationsDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.westpharma.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.westpharma.com/role/CondensedConsolidatedStatementsOfComprehensiveIncomeUnaudited": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 }, "http://www.westpharma.com/role/CondensedConsolidatedStatementsOfIncomeUnaudited": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "terseLabel": "Net income", "totalLabel": "Net income", "verboseLabel": "Net income" } } }, "localname": "ProfitLoss", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossReclassificationsDetails", "http://www.westpharma.com/role/ChangeInShareholdersEquityDetails", "http://www.westpharma.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited", "http://www.westpharma.com/role/CondensedConsolidatedStatementsOfComprehensiveIncomeUnaudited", "http://www.westpharma.com/role/CondensedConsolidatedStatementsOfIncomeUnaudited", "http://www.westpharma.com/role/NetIncomePerShareDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentGross": { "auth_ref": [ "r30", "r164" ], "calculation": { "http://www.westpharma.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "order": 1.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Gross", "terseLabel": "Property, plant and equipment" } } }, "localname": "PropertyPlantAndEquipmentGross", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r10", "r11", "r166", "r414" ], "calculation": { "http://www.westpharma.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Net", "totalLabel": "Property, plant and equipment, net" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]", "terseLabel": "Reclassification out of Accumulated Other Comprehensive Loss [Line Items]" } } }, "localname": "ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossReclassificationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax": { "auth_ref": [ "r60", "r61", "r67" ], "calculation": { "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossComponentsDetails": { "order": 2.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss).", "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax", "negatedTerseLabel": "Amounts reclassified out" } } }, "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossComponentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information by item reclassified out of accumulated other comprehensive income (loss).", "label": "Reclassification out of Accumulated Other Comprehensive Income [Axis]", "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Axis]" } } }, "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossComponentsDetails", "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossReclassificationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Item reclassified out of accumulated other comprehensive income (loss).", "label": "Reclassification out of Accumulated Other Comprehensive Income [Domain]", "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Domain]" } } }, "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossComponentsDetails", "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossReclassificationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Identifies item reclassified out of accumulated other comprehensive income (loss).", "label": "Reclassification out of Accumulated Other Comprehensive Income [Member]", "terseLabel": "Reclassification out of Accumulated Other Comprehensive Loss [Member]" } } }, "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossComponentsDetails", "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossReclassificationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about items reclassified out of accumulated other comprehensive income (loss).", "label": "Reclassification out of Accumulated Other Comprehensive Income [Table]", "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]" } } }, "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossReclassificationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of information about items reclassified out of accumulated other comprehensive income (loss).", "label": "Reclassification out of Accumulated Other Comprehensive Income [Table Text Block]", "terseLabel": "Reclassification out of Accumulated Other Comprehensive Loss" } } }, "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable": { "auth_ref": [ "r137", "r139" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.", "label": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table]", "terseLabel": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table]" } } }, "localname": "ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/SegmentInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock": { "auth_ref": [ "r137", "r139" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.", "label": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]", "terseLabel": "Segment Information" } } }, "localname": "ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/SegmentInformationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities": { "auth_ref": [ "r87" ], "calculation": { "http://www.westpharma.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of cash outflow for debt, mandatory redeemable security, and principal payment for finance lease obligation.", "label": "Repayment of Long-term Debt, Long-term Lease Obligation, and Capital Security", "negatedTerseLabel": "Repayments of long-term debt" } } }, "localname": "RepaymentsOfLongTermDebtAndCapitalSecurities", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_RepaymentsOfLongTermLinesOfCredit": { "auth_ref": [ "r88" ], "calculation": { "http://www.westpharma.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cash outflow for the settlement of obligation drawn from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.", "label": "Repayments of Long-term Lines of Credit", "negatedTerseLabel": "Repayments under revolving credit agreements" } } }, "localname": "RepaymentsOfLongTermLinesOfCredit", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpense": { "auth_ref": [ "r282", "r428" ], "calculation": { "http://www.westpharma.com/role/CondensedConsolidatedStatementsOfIncomeUnaudited": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.", "label": "Research and Development Expense", "terseLabel": "Research and development" } } }, "localname": "ResearchAndDevelopmentExpense", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CondensedConsolidatedStatementsOfIncomeUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedStockUnitsRSUMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.", "label": "Restricted Stock Units (RSUs) [Member]", "terseLabel": "Restricted Stock Units (RSUs) [Member]" } } }, "localname": "RestrictedStockUnitsRSUMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/StockBasedCompensationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RestructuringAndRelatedCostCostIncurredToDate1": { "auth_ref": [ "r170", "r172", "r179", "r182" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of costs incurred to date for the specified restructuring cost.", "label": "Restructuring and Related Cost, Cost Incurred to Date", "terseLabel": "Restructuring and related cost, cumulative cost incurred" } } }, "localname": "RestructuringAndRelatedCostCostIncurredToDate1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/OtherExpenseRestructuringAndRelatedChargesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestructuringAndRelatedCostExpectedCost1": { "auth_ref": [ "r170", "r172", "r179", "r182" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount expected to be recognized in earnings for the specified restructuring cost.", "label": "Restructuring and Related Cost, Expected Cost", "terseLabel": "Restructuring and related cost, expected cost" } } }, "localname": "RestructuringAndRelatedCostExpectedCost1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/OtherExpenseRestructuringAndRelatedChargesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestructuringAndRelatedCostIncurredCost": { "auth_ref": [ "r170", "r172", "r179", "r182" ], "calculation": { "http://www.westpharma.com/role/OtherExpenseDetails": { "order": 1.0, "parentTag": "wst_OtherIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Discloses the amount charged against the accrued restructuring reserves, or earnings if not previously accrued, during the period for the specified type of restructuring cost.", "label": "Restructuring and Related Cost, Incurred Cost", "terseLabel": "Charges", "totalLabel": "Total restructuring and related charges" } } }, "localname": "RestructuringAndRelatedCostIncurredCost", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/OtherExpenseDetails", "http://www.westpharma.com/role/OtherExpenseRestructuringAndRelatedChargesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestructuringCharges": { "auth_ref": [ "r97", "r169", "r175", "r181" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.", "label": "Restructuring Charges", "terseLabel": "Restructuring Charges", "verboseLabel": "Restructuring and related charges" } } }, "localname": "RestructuringCharges", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/OtherExpenseDetails", "http://www.westpharma.com/role/OtherExpenseItemsDetails", "http://www.westpharma.com/role/OtherExpenseRestructuringAndRelatedChargesDetails", "http://www.westpharma.com/role/SegmentInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestructuringCostAndReserveAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information by type of restructuring cost.", "label": "Restructuring Type [Axis]", "terseLabel": "Restructuring Type [Axis]" } } }, "localname": "RestructuringCostAndReserveAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/OtherExpenseRestructuringAndRelatedChargesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RestructuringCostAndReserveLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Restructuring Cost and Reserve [Line Items]", "terseLabel": "Restructuring Cost and Reserve [Line Items]" } } }, "localname": "RestructuringCostAndReserveLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/OtherExpenseRestructuringAndRelatedChargesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RestructuringPlanAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information by individual restructuring plan.", "label": "Restructuring Plan [Axis]", "terseLabel": "Restructuring Plan [Axis]" } } }, "localname": "RestructuringPlanAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/OtherExpenseRestructuringAndRelatedChargesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RestructuringPlanDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Identification of the individual restructuring plans.", "label": "Restructuring Plan [Domain]", "terseLabel": "Restructuring Plan [Domain]" } } }, "localname": "RestructuringPlanDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/OtherExpenseRestructuringAndRelatedChargesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RestructuringReserve": { "auth_ref": [ "r171", "r177" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.", "label": "Restructuring Reserve", "periodEndLabel": "Balance, September 30, 2019", "periodStartLabel": "Balance, December 31, 2018" } } }, "localname": "RestructuringReserve", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/OtherExpenseRestructuringAndRelatedChargesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestructuringReserveRollForward": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Restructuring Reserve [Roll Forward]", "terseLabel": "Restructuring Reserve [Roll Forward]" } } }, "localname": "RestructuringReserveRollForward", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/OtherExpenseRestructuringAndRelatedChargesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RestructuringReserveSettledWithoutCash2": { "auth_ref": [ "r169", "r176" ], "calculation": { "http://www.westpharma.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of decrease in the reserve for full or partial settlement through consideration other than cash.", "label": "Restructuring Reserve, Settled without Cash", "negatedTerseLabel": "Non-cash asset-write-downs", "terseLabel": "Non-cash restructuring charges" } } }, "localname": "RestructuringReserveSettledWithoutCash2", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited", "http://www.westpharma.com/role/OtherExpenseRestructuringAndRelatedChargesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r20", "r199", "r412" ], "calculation": { "http://www.westpharma.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings (Accumulated Deficit)", "verboseLabel": "Retained earnings" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]", "terseLabel": "Retained Earnings [Member]" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/ChangeInShareholdersEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RetirementPlanSponsorLocationAxis": { "auth_ref": [ "r237", "r239" ], "lang": { "en-US": { "role": { "documentation": "Information by location of employer sponsoring plan designed to provide retirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans.", "label": "Retirement Plan Sponsor Location [Axis]", "terseLabel": "Retirement Plan Sponsor Location [Axis]" } } }, "localname": "RetirementPlanSponsorLocationAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/BenefitPlansDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RetirementPlanSponsorLocationDomain": { "auth_ref": [ "r237", "r239" ], "lang": { "en-US": { "role": { "documentation": "Location of employer sponsoring plan designed to provide retirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans.", "label": "Retirement Plan Sponsor Location [Domain]", "terseLabel": "Retirement Plan Sponsor Location [Domain]" } } }, "localname": "RetirementPlanSponsorLocationDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/BenefitPlansDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RetirementPlanTypeAxis": { "auth_ref": [ "r218", "r219", "r236", "r237", "r248" ], "lang": { "en-US": { "role": { "documentation": "Information by type of retirement benefit plan. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.", "label": "Retirement Plan Type [Axis]", "terseLabel": "Retirement Plan Type [Axis]" } } }, "localname": "RetirementPlanTypeAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/BenefitPlansDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RetirementPlanTypeDomain": { "auth_ref": [ "r218", "r219", "r236", "r237", "r248" ], "lang": { "en-US": { "role": { "documentation": "Type of plan designed to provide participants with retirement benefits. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.", "label": "Retirement Plan Type [Domain]", "terseLabel": "Retirement Plan Type [Domain]" } } }, "localname": "RetirementPlanTypeDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/BenefitPlansDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Revenue from Contract with Customer [Abstract]" } } }, "localname": "RevenueFromContractWithCustomerAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_RevenueFromContractWithCustomerTextBlock": { "auth_ref": [ "r216" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.", "label": "Revenue from Contract with Customer [Text Block]", "terseLabel": "Revenue from Contract with Customer [Text Block]" } } }, "localname": "RevenueFromContractWithCustomerTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/Revenue" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueRecognitionAndDeferredRevenueAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Revenue Recognition and Deferred Revenue [Abstract]" } } }, "localname": "RevenueRecognitionAndDeferredRevenueAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_RevenueRecognitionSalesReturnsReserveForSalesReturns": { "auth_ref": [ "r100" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of estimated sales returns.", "label": "Revenue Recognition, Sales Returns, Reserve for Sales Returns", "negatedTerseLabel": "Provision for sales returns" } } }, "localname": "RevenueRecognitionSalesReturnsReserveForSalesReturns", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/RevenueVoluntaryRecallDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Revenues": { "auth_ref": [ "r69", "r130", "r131", "r140" ], "calculation": { "http://www.westpharma.com/role/CondensedConsolidatedStatementsOfIncomeUnaudited": { "order": 1.0, "parentTag": "us-gaap_GrossProfit", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).", "label": "Revenues", "terseLabel": "Net sales" } } }, "localname": "Revenues", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossReclassificationsDetails", "http://www.westpharma.com/role/CondensedConsolidatedStatementsOfIncomeUnaudited", "http://www.westpharma.com/role/SegmentInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": { "auth_ref": [ "r380", "r385" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.", "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability", "terseLabel": "Right-of-use assets obtained in exchange for new operating lease liabilities" } } }, "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/LeasesLeaseCashFlowAndSupplementalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SalesRevenueNetMember": { "auth_ref": [ "r128" ], "lang": { "en-US": { "role": { "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.", "label": "Revenue Benchmark [Member]", "terseLabel": "Revenue Benchmark [Member]" } } }, "localname": "SalesRevenueNetMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/RevenueRecognitionDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": { "auth_ref": [ "r60" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).", "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]", "terseLabel": "Components of Accumulated Other Comprehensive Loss" } } }, "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDebtTableTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.", "label": "Schedule of Debt [Table Text Block]", "terseLabel": "Long-term Debt Obligations, Net of Current Maturities" } } }, "localname": "ScheduleOfDebtTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/DebtTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock": { "auth_ref": [ "r324", "r331", "r338" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.", "label": "Derivative Instruments, Gain (Loss) [Table Text Block]", "terseLabel": "Effects of Derivative Instruments on Other Comprehensive Income ('OCI') and Earnings" } } }, "localname": "ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/DerivativeFinancialInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDerivativeInstrumentsTextBlock": { "auth_ref": [ "r106", "r315", "r317", "r318", "r322", "r323", "r327", "r331", "r339", "r340" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of pertinent information about a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.", "label": "Schedule of Derivative Instruments [Table Text Block]", "terseLabel": "Foreign Currency Contracts" } } }, "localname": "ScheduleOfDerivativeInstrumentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/DerivativeFinancialInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r121" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "terseLabel": "Reconciliation of Basic to Diluted Net Income Per Share" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/NetIncomePerShareTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEquityMethodInvestmentsLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Schedule of Equity Method Investments [Line Items]", "terseLabel": "Schedule of Equity Method Investments [Line Items]" } } }, "localname": "ScheduleOfEquityMethodInvestmentsLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/AffiliatedCompaniesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfEquityMethodInvestmentsTable": { "auth_ref": [ "r150" ], "lang": { "en-US": { "role": { "documentation": "Summarization of information required and determined to be disclosed concerning equity method investments in common stock. The summarized information includes: (a) the name of each investee or group of investees for which combined disclosure is appropriate, (2) the percentage ownership of common stock, (3) the difference, if any, between the carrying amount of an investment and the value of the underlying equity in the net assets and the accounting treatment of difference, if any, and (4) the aggregate value of each identified investment based on its quoted market price, if available.", "label": "Schedule of Equity Method Investments [Table]", "terseLabel": "Schedule of Equity Method Investments [Table]" } } }, "localname": "ScheduleOfEquityMethodInvestmentsTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/AffiliatedCompaniesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": { "auth_ref": [ "r346", "r347" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).", "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]", "terseLabel": "Schedule of Assets and Liabilities Measured at Fair Value" } } }, "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/FairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock": { "auth_ref": [ "r369" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of future minimum payments required in the aggregate and for each of the five succeeding fiscal years for operating leases having initial or remaining noncancelable lease terms in excess of one year and the total minimum rentals to be received in the future under noncancelable subleases as of the balance sheet date.", "label": "Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]", "terseLabel": "Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]" } } }, "localname": "ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/LeasesLeasesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": { "auth_ref": [ "r9", "r25", "r26", "r27" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.", "label": "Schedule of Inventory, Current [Table Text Block]", "terseLabel": "Inventories" } } }, "localname": "ScheduleOfInventoryCurrentTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/InventoriesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfNetBenefitCostsTableTextBlock": { "auth_ref": [ "r229" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments.", "label": "Schedule of Net Benefit Costs [Table Text Block]", "terseLabel": "Schedule of Components of Net Periodic Benefit Cost" } } }, "localname": "ScheduleOfNetBenefitCostsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/BenefitPlansTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": { "auth_ref": [ "r173", "r174", "r178" ], "lang": { "en-US": { "role": { "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.", "label": "Schedule of Restructuring and Related Costs [Table]", "terseLabel": "Schedule of Restructuring and Related Costs [Table]" } } }, "localname": "ScheduleOfRestructuringAndRelatedCostsTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/OtherExpenseRestructuringAndRelatedChargesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock": { "auth_ref": [ "r171", "r180" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.", "label": "Schedule of Restructuring Reserve by Type of Cost [Table Text Block]", "terseLabel": "Schedule of Restructuring Reserve" } } }, "localname": "ScheduleOfRestructuringReserveByTypeOfCostTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/OtherExpenseTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "auth_ref": [ "r254", "r264" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about share-based payment arrangement.", "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]", "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/StockBasedCompensationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfStockholdersEquityTableTextBlock": { "auth_ref": [ "r194" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of changes in the separate accounts comprising stockholders' equity (in addition to retained earnings) and of the changes in the number of shares of equity securities during at least the most recent annual fiscal period and any subsequent interim period presented is required to make the financial statements sufficiently informative if both financial position and results of operations are presented.", "label": "Schedule of Stockholders Equity [Table Text Block]", "terseLabel": "Schedule of Stockholders Equity [Table Text Block]" } } }, "localname": "ScheduleOfStockholdersEquityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/ShareholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.", "label": "Segments [Domain]", "terseLabel": "Segment [Domain]" } } }, "localname": "SegmentDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/SegmentInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SegmentReportingAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Segment Reporting [Abstract]" } } }, "localname": "SegmentReportingAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingDisclosureTextBlock": { "auth_ref": [ "r145" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.", "label": "Segment Reporting Disclosure [Text Block]", "verboseLabel": "Segment Information" } } }, "localname": "SegmentReportingDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/SegmentInformation" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]", "terseLabel": "Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]" } } }, "localname": "SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/SegmentInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "auth_ref": [ "r74", "r152" ], "calculation": { "http://www.westpharma.com/role/CondensedConsolidatedStatementsOfIncomeUnaudited": { "order": 3.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.", "label": "Selling, General and Administrative Expense", "terseLabel": "Selling, general and administrative expenses" } } }, "localname": "SellingGeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CondensedConsolidatedStatementsOfIncomeUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_SeveranceCosts1": { "auth_ref": [ "r97", "r169", "r175", "r181" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.", "label": "Severance Costs", "terseLabel": "Severance charges", "verboseLabel": "Severance and post-employment benefits" } } }, "localname": "SeveranceCosts1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/OtherExpenseDetails", "http://www.westpharma.com/role/OtherExpenseRestructuringAndRelatedChargesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r96" ], "calculation": { "http://www.westpharma.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Share-based Payment Arrangement, Noncash Expense", "terseLabel": "Stock-based compensation" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "auth_ref": [ "r257" ], "lang": { "en-US": { "role": { "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period", "terseLabel": "Granted (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/StockBasedCompensationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r257" ], "lang": { "en-US": { "role": { "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Grant date fair value (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/StockBasedCompensationDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": { "auth_ref": [ "r261" ], "lang": { "en-US": { "role": { "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate", "terseLabel": "Dividend yield (in hundredths)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/StockBasedCompensationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": { "auth_ref": [ "r260" ], "lang": { "en-US": { "role": { "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate", "terseLabel": "Stock volatility (in hundredths)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/StockBasedCompensationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "auth_ref": [ "r262" ], "lang": { "en-US": { "role": { "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate", "terseLabel": "Risk-free interest rate (in hundredths)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/StockBasedCompensationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/StockBasedCompensationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": { "auth_ref": [ "r264" ], "lang": { "en-US": { "role": { "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant", "terseLabel": "Shares available for issuance under the 2016 Plan (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/StockBasedCompensationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod": { "auth_ref": [ "r256" ], "lang": { "en-US": { "role": { "documentation": "Net number of share options (or share units) granted during the period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures", "terseLabel": "Stock options, granted (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/StockBasedCompensationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r258" ], "lang": { "en-US": { "role": { "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Stock options, weighted average grant date fair value (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/StockBasedCompensationDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r251", "r255" ], "lang": { "en-US": { "role": { "documentation": "Award under share-based payment arrangement.", "label": "Award Type [Domain]", "terseLabel": "Award Type [Domain]" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/StockBasedCompensationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.", "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price", "terseLabel": "Stock options, weighted average exercise price (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/StockBasedCompensationDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "auth_ref": [ "r259", "r276" ], "lang": { "en-US": { "role": { "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term", "terseLabel": "Expected life (in years)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/StockBasedCompensationDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharesIssued": { "auth_ref": [ "r194" ], "lang": { "en-US": { "role": { "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.", "label": "Shares, Issued", "periodEndLabel": "Balance (in shares)", "periodStartLabel": "Balance (in shares)" } } }, "localname": "SharesIssued", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/ChangeInShareholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement.", "label": "Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation", "terseLabel": "Share repurchased for employee tax withholdings (in shares)" } } }, "localname": "SharesPaidForTaxWithholdingForShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/ChangeInShareholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShortMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Indicates the sale of a borrowed security or written option.", "label": "Short [Member]", "terseLabel": "Short [Member]" } } }, "localname": "ShortMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/DerivativeFinancialInstrumentsTextualsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShortTermLeaseCost": { "auth_ref": [ "r377", "r385" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of short-term lease cost, excluding expense for lease with term of one month or less.", "label": "Short-term Lease, Cost", "terseLabel": "Short-term lease cost" } } }, "localname": "ShortTermLeaseCost", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/LeasesLeaseCostDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r108" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "Significant Accounting Policies [Text Block]", "verboseLabel": "Summary of Significant Accounting Policies" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/SummaryOfSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_StatementBusinessSegmentsAxis": { "auth_ref": [ "r0", "r135", "r158", "r168", "r172", "r182", "r420" ], "lang": { "en-US": { "role": { "documentation": "Information by business segments.", "label": "Segments [Axis]", "terseLabel": "Segments [Axis]" } } }, "localname": "StatementBusinessSegmentsAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/SegmentInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r15", "r16", "r17", "r194" ], "lang": { "en-US": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Class of Stock [Axis]", "terseLabel": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r44", "r194" ], "lang": { "en-US": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]", "terseLabel": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossComponentsDetails", "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossReclassificationsDetails", "http://www.westpharma.com/role/ChangeInShareholdersEquityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]", "terseLabel": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/ChangeInShareholdersEquityDetails", "http://www.westpharma.com/role/CondensedConsolidatedBalanceSheetsUnaudited", "http://www.westpharma.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited", "http://www.westpharma.com/role/ContractsAndLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Statement of Comprehensive Income [Abstract]" } } }, "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]", "terseLabel": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/ChangeInShareholdersEquityDetails", "http://www.westpharma.com/role/CondensedConsolidatedBalanceSheetsUnaudited", "http://www.westpharma.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited", "http://www.westpharma.com/role/ContractsAndLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": { "auth_ref": [ "r16", "r17", "r194", "r199" ], "lang": { "en-US": { "role": { "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).", "label": "Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture", "terseLabel": "Shares issued under stock plans (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/ChangeInShareholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": { "auth_ref": [ "r16", "r17", "r199", "r253", "r258" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).", "label": "Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture", "terseLabel": "Activity related to stock-based compensation" } } }, "localname": "StockIssuedDuringPeriodValueShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/ChangeInShareholdersEquityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The number of shares authorized to be repurchased by an entity's Board of Directors under a stock repurchase plan.", "label": "Stock Repurchase Program, Number of Shares Authorized to be Repurchased", "terseLabel": "Stock repurchase program, shares authorized" } } }, "localname": "StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/NetIncomePerShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r303", "r304", "r310" ], "calculation": { "http://www.westpharma.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.", "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest", "periodEndLabel": "Balance", "periodStartLabel": "Balance", "totalLabel": "Total Equity" } } }, "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/ChangeInShareholdersEquityDetails", "http://www.westpharma.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r202" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "Stockholders' Equity Note Disclosure [Text Block]", "terseLabel": "Stockholders' Equity Note Disclosure [Text Block]" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/ShareholdersEquity" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsequentEventLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.", "label": "Subsequent Event [Line Items]", "terseLabel": "Subsequent Event [Line Items]" } } }, "localname": "SubsequentEventLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/SubsequentEventDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTable": { "auth_ref": [ "r390" ], "lang": { "en-US": { "role": { "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.", "label": "Subsequent Event [Table]", "terseLabel": "Subsequent Event [Table]" } } }, "localname": "SubsequentEventTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/SubsequentEventDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r390" ], "lang": { "en-US": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Axis]", "terseLabel": "Subsequent Event Type [Axis]" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/SubsequentEventDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [ "r390" ], "lang": { "en-US": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Domain]", "terseLabel": "Subsequent Event Type [Domain]" } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/SubsequentEventDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r392" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "Subsequent Events [Text Block]", "terseLabel": "Subsequent Events [Text Block]" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/SubsequentEventNotes" ], "xbrltype": "textBlockItemType" }, "us-gaap_TransferOfFinancialAssetsAccountedForAsSalesCashProceedsReceivedForAssetsDerecognizedAmount": { "auth_ref": [ "r397" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, before counterparty netting, of cash proceeds received in transfers of derecognized financial assets from transactions which comprise an initial transfer and an agreement entered into in contemplation of the initial transfer resulting in retention of substantially all of the exposure to the economic return throughout the term of the transaction.", "label": "Transfer of Financial Assets Accounted for as Sales, Cash Proceeds Received for Assets Derecognized, Amount", "terseLabel": "Sales of certain accounts receivable" } } }, "localname": "TransferOfFinancialAssetsAccountedForAsSalesCashProceedsReceivedForAssetsDerecognizedAmount", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/RevenueSupplyChainFinancingDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_TranslationAdjustmentForNetInvestmentHedgeNetOfTax": { "auth_ref": [ "r360" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount, after tax, of cumulative translation adjustment attributable to gain (loss) on foreign currency derivatives that are designated as, and are effective as, economic hedges of a net investment in a foreign entity.", "label": "Derivatives used in Net Investment Hedge, Net of Tax", "negatedTerseLabel": "Cumulative foreign currency translation loss, net of tax" } } }, "localname": "TranslationAdjustmentForNetInvestmentHedgeNetOfTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/DerivativeFinancialInstrumentsTextualsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_TreasuryLockMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Customized agreement that fixes the yield or price on a specified treasury security for a specific period.", "label": "Treasury Lock [Member]", "terseLabel": "Forward Treasury Locks [Member]" } } }, "localname": "TreasuryLockMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossReclassificationsDetails", "http://www.westpharma.com/role/DerivativeFinancialInstrumentsTextualsDetails", "http://www.westpharma.com/role/EffectsOfDerivativeInstrumentsOnOciAndEarningsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TreasuryStockAcquiredAverageCostPerShare": { "auth_ref": [ "r200" ], "lang": { "en-US": { "role": { "documentation": "Total cost of shares repurchased divided by the total number of shares repurchased.", "label": "Treasury Stock Acquired, Average Cost Per Share", "terseLabel": "Stock repurchase program, average price per share" } } }, "localname": "TreasuryStockAcquiredAverageCostPerShare", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/NetIncomePerShareDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_TreasuryStockMember": { "auth_ref": [ "r43", "r200" ], "lang": { "en-US": { "role": { "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.", "label": "Treasury Stock [Member]", "terseLabel": "Treasury Stock [Member]" } } }, "localname": "TreasuryStockMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/ChangeInShareholdersEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TreasuryStockShares": { "auth_ref": [ "r43", "r200" ], "lang": { "en-US": { "role": { "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.", "label": "Treasury Stock, Shares", "terseLabel": "Treasury stock, at cost (in shares)" } } }, "localname": "TreasuryStockShares", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_TreasuryStockSharesAcquired": { "auth_ref": [ "r17", "r194", "r199" ], "lang": { "en-US": { "role": { "documentation": "Number of shares that have been repurchased during the period and are being held in treasury.", "label": "Treasury Stock, Shares, Acquired", "terseLabel": "Share purchased under share repurchase program (in shares)", "verboseLabel": "Stock repurchase program, shares purchased" } } }, "localname": "TreasuryStockSharesAcquired", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/ChangeInShareholdersEquityDetails", "http://www.westpharma.com/role/NetIncomePerShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_TreasuryStockValue": { "auth_ref": [ "r43", "r200", "r201" ], "calculation": { "http://www.westpharma.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "order": 6.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.", "label": "Treasury Stock, Value", "negatedTerseLabel": "Treasury stock, at cost (1.3 million and 1.2 million shares)" } } }, "localname": "TreasuryStockValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_TreasuryStockValueAcquiredCostMethod": { "auth_ref": [ "r194", "r199", "r200" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.", "label": "Treasury Stock, Value, Acquired, Cost Method", "negatedTerseLabel": "Shares purchased under share repurchase program", "terseLabel": "Stock purchase program, cost of shares purchased" } } }, "localname": "TreasuryStockValueAcquiredCostMethod", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/ChangeInShareholdersEquityDetails", "http://www.westpharma.com/role/NetIncomePerShareDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_TypeOfAdoptionMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Adoption and early adoption of sources of change to generally accepted accounting principles (GAAP) in the United States. The FASB released the FASB Accounting Standards Codification as the authoritative source of literature effective for interim and annual periods ending after September 15, 2009. As part of the Codification process, the FASB issues Accounting Standards Updates to amend the Codification but otherwise the Accounting Standards Updates are not authoritative in their own right. All previous accounting standards (such as FASB Statements of Financial Accounting Standards, FASB Interpretations, FASB Staff Positions, Emerging Issues Task Force Consensuses, other pronouncements of the FASB or other designated bodies, or other forms of GAAP are considered accounting pronouncements) were superseded upon the adoption of the Codification. For an interim period, references to the superseded standards are included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.", "label": "Type of Adoption [Domain]", "terseLabel": "Type of Adoption [Domain]" } } }, "localname": "TypeOfAdoptionMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/IncomeTaxesDetails", "http://www.westpharma.com/role/LeasesAdoptionOfAsc842Details" ], "xbrltype": "domainItemType" }, "us-gaap_TypeOfRestructuringDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Identification of the types of restructuring costs.", "label": "Type of Restructuring [Domain]", "terseLabel": "Type of Restructuring [Domain]" } } }, "localname": "TypeOfRestructuringDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/OtherExpenseRestructuringAndRelatedChargesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_UnamortizedDebtIssuanceExpense": { "auth_ref": [ "r32" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The remaining balance of debt issuance expenses that were capitalized and are being amortized against income over the lives of the respective bond issues. This does not include the amounts capitalized as part of the cost of the utility plant or asset.", "label": "Unamortized Debt Issuance Expense", "terseLabel": "Unamortized debt issuance costs" } } }, "localname": "UnamortizedDebtIssuanceExpense", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CreditFacilityDetails", "http://www.westpharma.com/role/LongTermDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_VariableLeaseCost": { "auth_ref": [ "r378", "r385" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.", "label": "Variable Lease, Cost", "terseLabel": "Variable lease cost" } } }, "localname": "VariableLeaseCost", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/LeasesLeaseCostDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r114", "r119" ], "calculation": { "http://www.westpharma.com/role/NetIncomePerShareDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-US": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted Average Number of Shares Outstanding, Diluted", "terseLabel": "Diluted (in shares)", "totalLabel": "Weighted average shares assuming dilution (in shares)" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CondensedConsolidatedStatementsOfIncomeUnaudited", "http://www.westpharma.com/role/NetIncomePerShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r113", "r119" ], "calculation": { "http://www.westpharma.com/role/NetIncomePerShareDetails": { "order": 1.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-US": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted Average Number of Shares Outstanding, Basic", "terseLabel": "Weighted average common shares outstanding (in shares)", "verboseLabel": "Basic (in shares)" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CondensedConsolidatedStatementsOfIncomeUnaudited", "http://www.westpharma.com/role/NetIncomePerShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Weighted Average Number of Shares Outstanding Reconciliation [Abstract]", "verboseLabel": "Weighted average shares outstanding:" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.westpharma.com/role/CondensedConsolidatedStatementsOfIncomeUnaudited" ], "xbrltype": "stringItemType" }, "wst_A2016RestructuringPlanMemberMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "2016 Restructuring Plan [Member] [Member]", "label": "2016 Restructuring Plan [Member] [Member]", "terseLabel": "2016 Restructuring Plan [Member]" } } }, "localname": "A2016RestructuringPlanMemberMember", "nsuri": "http://www.westpharma.com/20190930", "presentation": [ "http://www.westpharma.com/role/OtherExpenseRestructuringAndRelatedChargesDetails" ], "xbrltype": "domainItemType" }, "wst_A2018RestructuringPlanMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "2018 Restructuring Plan [Member]", "label": "2018 Restructuring Plan [Member]", "terseLabel": "2018 Restructuring Plan [Member]" } } }, "localname": "A2018RestructuringPlanMember", "nsuri": "http://www.westpharma.com/20190930", "presentation": [ "http://www.westpharma.com/role/OtherExpenseRestructuringAndRelatedChargesDetails" ], "xbrltype": "domainItemType" }, "wst_AssetImpairmentChargesPatentandEquipment": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of write-down of a patent and certain equipment, recognized in the income statement.", "label": "Asset Impairment Charges, Patent and Equipment", "terseLabel": "Asset impairment charges, equipment" } } }, "localname": "AssetImpairmentChargesPatentandEquipment", "nsuri": "http://www.westpharma.com/20190930", "presentation": [ "http://www.westpharma.com/role/OtherExpenseDetails", "http://www.westpharma.com/role/OtherExpenseRestructuringAndRelatedChargesDetails" ], "xbrltype": "monetaryItemType" }, "wst_AssetRelatedChargesMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Asset-Related Charges [Member]", "label": "Asset-Related Charges [Member]", "terseLabel": "Asset-related charges [Member]" } } }, "localname": "AssetRelatedChargesMember", "nsuri": "http://www.westpharma.com/20190930", "presentation": [ "http://www.westpharma.com/role/OtherExpenseRestructuringAndRelatedChargesDetails" ], "xbrltype": "domainItemType" }, "wst_BiologicsCustomersMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Biologics Customers [Member]", "label": "Biologics Customers [Member]", "terseLabel": "Biologics [Member]" } } }, "localname": "BiologicsCustomersMember", "nsuri": "http://www.westpharma.com/20190930", "presentation": [ "http://www.westpharma.com/role/RevenueRecognitionDetails" ], "xbrltype": "domainItemType" }, "wst_ContractManufacturedCustomersMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Contract-Manufactured Customers [Member]", "label": "Contract-Manufactured Customers [Member]", "terseLabel": "Contract-Manufactured Products [Member]" } } }, "localname": "ContractManufacturedCustomersMember", "nsuri": "http://www.westpharma.com/20190930", "presentation": [ "http://www.westpharma.com/role/RevenueRecognitionDetails" ], "xbrltype": "domainItemType" }, "wst_ContractManufacturedProductsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Contract Manufactured Products [Member]", "label": "Contract Manufactured Products [Member]", "terseLabel": "Contract-Manufactured Products [Member]" } } }, "localname": "ContractManufacturedProductsMember", "nsuri": "http://www.westpharma.com/20190930", "presentation": [ "http://www.westpharma.com/role/RevenueRecognitionDetails" ], "xbrltype": "domainItemType" }, "wst_ContractwithCustomerAssetIncreaseDecrease": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Contract with Customer, Asset, Increase (Decrease)", "label": "Contract with Customer, Asset, Increase (Decrease)", "terseLabel": "Change in contract assets - increase (decrease)" } } }, "localname": "ContractwithCustomerAssetIncreaseDecrease", "nsuri": "http://www.westpharma.com/20190930", "presentation": [ "http://www.westpharma.com/role/ContractsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "wst_CorporateAndEliminationsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Corporate headquarter items not allocated to segments and intersegment transactions (e.g. intersegment profits). Reconciliation of the total of reportable segments' amounts of revenues, measures of profits or loss, assets, or amounts for every other significant item of information disclosed, to the consolidated amount.", "label": "Corporate and Eliminations [Member]", "terseLabel": "Corporate [Member]" } } }, "localname": "CorporateAndEliminationsMember", "nsuri": "http://www.westpharma.com/20190930", "presentation": [ "http://www.westpharma.com/role/SegmentInformationDetails" ], "xbrltype": "domainItemType" }, "wst_CreditAvailableForIssuanceOfLettersOfCredit": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "this refers to Credit available for the issuance of letters of credit", "label": "Credit available for the issuance of letters of credit", "terseLabel": "Credit available for the issuance of letters of credit" } } }, "localname": "CreditAvailableForIssuanceOfLettersOfCredit", "nsuri": "http://www.westpharma.com/20190930", "presentation": [ "http://www.westpharma.com/role/CreditFacilityDetails" ], "xbrltype": "monetaryItemType" }, "wst_CreditFacilityIsAvailableForSwingLineLoans": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "This refers to credit facility is available for swing-line loans", "label": "Credit facility is available for swing-line loans", "terseLabel": "Credit facility is available for swing-line loans" } } }, "localname": "CreditFacilityIsAvailableForSwingLineLoans", "nsuri": "http://www.westpharma.com/20190930", "presentation": [ "http://www.westpharma.com/role/CreditFacilityDetails" ], "xbrltype": "monetaryItemType" }, "wst_DebtYenDenominatedMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "An obligation resulting from borrowing money.", "label": "Debt Yen Denominated [Member]", "terseLabel": "Debt Yen Denominated [Member]" } } }, "localname": "DebtYenDenominatedMember", "nsuri": "http://www.westpharma.com/20190930", "presentation": [ "http://www.westpharma.com/role/DerivativeFinancialInstrumentsTextualsDetails" ], "xbrltype": "domainItemType" }, "wst_DeliveryDevicesMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Delivery Devices [Member]", "label": "Delivery Devices [Member]", "terseLabel": "Delivery Devices [Member]" } } }, "localname": "DeliveryDevicesMember", "nsuri": "http://www.westpharma.com/20190930", "presentation": [ "http://www.westpharma.com/role/RevenueRecognitionDetails" ], "xbrltype": "domainItemType" }, "wst_DeliverySystemsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "A component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.", "label": "Delivery Systems [Member]", "terseLabel": "Contract-Manufactured Products [Member]" } } }, "localname": "DeliverySystemsMember", "nsuri": "http://www.westpharma.com/20190930", "presentation": [ "http://www.westpharma.com/role/SegmentInformationDetails" ], "xbrltype": "domainItemType" }, "wst_Developmentandlicensingincome": { "auth_ref": [], "calculation": { "http://www.westpharma.com/role/OtherExpenseDetails": { "order": 3.0, "parentTag": "wst_OtherIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The amount of consideration recognized during the period under a development, licensing and supply agreement entered into with a customer.", "label": "Development and licensing income", "negatedLabel": "Development and licensing income", "terseLabel": "Development and licensing income" } } }, "localname": "Developmentandlicensingincome", "nsuri": "http://www.westpharma.com/20190930", "presentation": [ "http://www.westpharma.com/role/OtherExpenseDetails", "http://www.westpharma.com/role/OtherExpenseOtherIncomeDevelopmentAndLicensingIncomeDetails" ], "xbrltype": "monetaryItemType" }, "wst_DevelopmentandlicensingincomeLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "[Line Items] for Development and licensing income [Table]", "label": "Development and licensing income [Line Items]", "terseLabel": "Development and licensing income [Line Items]" } } }, "localname": "DevelopmentandlicensingincomeLineItems", "nsuri": "http://www.westpharma.com/20190930", "presentation": [ "http://www.westpharma.com/role/OtherExpenseOtherIncomeDevelopmentAndLicensingIncomeDetails" ], "xbrltype": "stringItemType" }, "wst_DevelopmentandlicensingincomeTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Development and licensing income [Table]", "label": "Development and licensing income [Table]", "terseLabel": "Development and licensing income [Table]" } } }, "localname": "DevelopmentandlicensingincomeTable", "nsuri": "http://www.westpharma.com/20190930", "presentation": [ "http://www.westpharma.com/role/OtherExpenseOtherIncomeDevelopmentAndLicensingIncomeDetails" ], "xbrltype": "stringItemType" }, "wst_DocumentAndEntityInformationAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "-- None. No documentation exists for this element. --", "label": "Document and Entity Information [Abstract]" } } }, "localname": "DocumentAndEntityInformationAbstract", "nsuri": "http://www.westpharma.com/20190930", "xbrltype": "stringItemType" }, "wst_ForeignCurrencyDenominatedDebtMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Foreign currency-denominated debt designated as a hedge of our net investments in foreign operations.", "label": "Foreign Currency, Denominated Debt [Member]", "terseLabel": "Foreign Currency - Denominated Debt [Member]" } } }, "localname": "ForeignCurrencyDenominatedDebtMember", "nsuri": "http://www.westpharma.com/20190930", "presentation": [ "http://www.westpharma.com/role/DerivativeFinancialInstrumentsTextualsDetails", "http://www.westpharma.com/role/EffectsOfDerivativeInstrumentsOnOciAndEarningsDetails" ], "xbrltype": "domainItemType" }, "wst_GenericsCustomersMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Generics Customers [Member]", "label": "Generics Customers [Member]", "terseLabel": "Generics [Member]" } } }, "localname": "GenericsCustomersMember", "nsuri": "http://www.westpharma.com/20190930", "presentation": [ "http://www.westpharma.com/role/RevenueRecognitionDetails" ], "xbrltype": "domainItemType" }, "wst_HighValueComponentsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "High-Value Components [Member]", "label": "High-Value Components [Member]", "terseLabel": "High-Value Components [Member]" } } }, "localname": "HighValueComponentsMember", "nsuri": "http://www.westpharma.com/20190930", "presentation": [ "http://www.westpharma.com/role/RevenueRecognitionDetails" ], "xbrltype": "domainItemType" }, "wst_IncreaseDecreaseofOtherOperatingIncomeandExpense": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Increase (Decrease) of Other Operating Income and Expense", "label": "Increase (Decrease) of Other Operating Income and Expense", "negatedTerseLabel": "Increase (decrease) of other items" } } }, "localname": "IncreaseDecreaseofOtherOperatingIncomeandExpense", "nsuri": "http://www.westpharma.com/20190930", "presentation": [ "http://www.westpharma.com/role/OtherExpenseItemsDetails" ], "xbrltype": "monetaryItemType" }, "wst_LeaseCashFlowandSupplementalInformationAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Lease Cash Flow and Supplemental Information [Abstract]", "label": "Lease Cash Flow and Supplemental Information [Abstract]" } } }, "localname": "LeaseCashFlowandSupplementalInformationAbstract", "nsuri": "http://www.westpharma.com/20190930", "xbrltype": "stringItemType" }, "wst_LesseeLeaseCashFlowandSupplementalInformationTableTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Lessee, Lease Cash Flow and Supplemental Information [Table Text Block]", "label": "Lessee, Lease Cash Flow and Supplemental Information [Table Text Block]", "terseLabel": "Lessee, Lease Cash Flow and Supplemental Information [Table Text Block]" } } }, "localname": "LesseeLeaseCashFlowandSupplementalInformationTableTextBlock", "nsuri": "http://www.westpharma.com/20190930", "presentation": [ "http://www.westpharma.com/role/LeasesLeasesTables" ], "xbrltype": "textBlockItemType" }, "wst_LesseeOperatingLeaseTermofRenewalContract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Lessee, Operating Lease, Term of Renewal Contract", "label": "Lessee, Operating Lease, Term of Renewal Contract", "terseLabel": "Operating leases, option to extend" } } }, "localname": "LesseeOperatingLeaseTermofRenewalContract", "nsuri": "http://www.westpharma.com/20190930", "presentation": [ "http://www.westpharma.com/role/LeasesAdoptionOfAsc842Details" ], "xbrltype": "durationItemType" }, "wst_LineOfCreditFacilityOutstandingBorrowingsEuro": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Line of credit facility outstanding borrowings, Euro", "label": "Line of credit facility outstanding borrowings, Euro", "terseLabel": "Line of Credit Facility outstanding borrowings, Euro" } } }, "localname": "LineOfCreditFacilityOutstandingBorrowingsEuro", "nsuri": "http://www.westpharma.com/20190930", "presentation": [ "http://www.westpharma.com/role/CreditFacilityDetails" ], "xbrltype": "monetaryItemType" }, "wst_LineOfCreditFacilityOutstandingBorrowingsYen": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Line of credit facility outstanding borrowings, Yen", "label": "Line of credit facility outstanding borrowings, Yen", "terseLabel": "Line of Credit Facility outstanding borrowings, Yen" } } }, "localname": "LineOfCreditFacilityOutstandingBorrowingsYen", "nsuri": "http://www.westpharma.com/20190930", "presentation": [ "http://www.westpharma.com/role/CreditFacilityDetails" ], "xbrltype": "monetaryItemType" }, "wst_LineofCreditFacilityAdditionalBorrowingCapacity": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Additional borrowing capacity under the credit facility.", "label": "Line of Credit Facility Additional Borrowing Capacity", "terseLabel": "Line of Credit Facility, additional borrowing capacity" } } }, "localname": "LineofCreditFacilityAdditionalBorrowingCapacity", "nsuri": "http://www.westpharma.com/20190930", "presentation": [ "http://www.westpharma.com/role/CreditFacilityDetails" ], "xbrltype": "monetaryItemType" }, "wst_NetSalesMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Net sales member", "label": "Net Sales [Member]", "terseLabel": "Net sales [Member]" } } }, "localname": "NetSalesMember", "nsuri": "http://www.westpharma.com/20190930", "presentation": [ "http://www.westpharma.com/role/DerivativeFinancialInstrumentsTextualsDetails", "http://www.westpharma.com/role/EffectsOfDerivativeInstrumentsOnOciAndEarningsDetails" ], "xbrltype": "domainItemType" }, "wst_OtherFinancialInstrumentsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "-- None. No documentation exists for this element. --", "label": "Other Financial Instruments [Abstract]", "terseLabel": "Other Financial Instruments [Abstract]" } } }, "localname": "OtherFinancialInstrumentsAbstract", "nsuri": "http://www.westpharma.com/20190930", "presentation": [ "http://www.westpharma.com/role/FairValueMeasurementsOtherFinancialInstrumentsDetails" ], "xbrltype": "stringItemType" }, "wst_OtherIncomeExpense": { "auth_ref": [], "calculation": { "http://www.westpharma.com/role/CondensedConsolidatedStatementsOfIncomeUnaudited": { "order": 4.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 }, "http://www.westpharma.com/role/OtherExpenseDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The total amount of other income and expense items that are associated with the entity's normal revenue producing operation.", "label": "Other Income Expense", "negatedLabel": "Other expense (income) (Note 15)", "negatedTotalLabel": "Total other expense (income)" } } }, "localname": "OtherIncomeExpense", "nsuri": "http://www.westpharma.com/20190930", "presentation": [ "http://www.westpharma.com/role/CondensedConsolidatedStatementsOfIncomeUnaudited", "http://www.westpharma.com/role/OtherExpenseDetails" ], "xbrltype": "monetaryItemType" }, "wst_OtherMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Other [Member]", "label": "Other [Member]", "terseLabel": "Other [Member]" } } }, "localname": "OtherMember", "nsuri": "http://www.westpharma.com/20190930", "presentation": [ "http://www.westpharma.com/role/OtherExpenseOtherIncomeDevelopmentAndLicensingIncomeDetails" ], "xbrltype": "domainItemType" }, "wst_PackagingSystemsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "A component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.", "label": "Packaging Systems [Member]", "terseLabel": "Proprietary Products [Member]" } } }, "localname": "PackagingSystemsMember", "nsuri": "http://www.westpharma.com/20190930", "presentation": [ "http://www.westpharma.com/role/SegmentInformationDetails" ], "xbrltype": "domainItemType" }, "wst_Pensionsettlementcharge": { "auth_ref": [], "calculation": { "http://www.westpharma.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of expense as a result of an irrevocable action that relieves the employer (or the plan) of primary responsibility for a benefit obligation and eliminates significant risks related to the obligation and the assets used to effect the settlement. Examples of transactions that constitute a settlement include, but are not limited to, lump-sum cash payments to plan participants in exchange for their rights to receive specified benefits and purchasing nonparticipating annuity contracts to cover vested benefits.", "label": "Pension settlement charge", "terseLabel": "Pension settlement charge" } } }, "localname": "Pensionsettlementcharge", "nsuri": "http://www.westpharma.com/20190930", "presentation": [ "http://www.westpharma.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "wst_PharmaCustomersMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Pharma Customers [Member]", "label": "Pharma Customers [Member]", "terseLabel": "Pharma Customers [Member]" } } }, "localname": "PharmaCustomersMember", "nsuri": "http://www.westpharma.com/20190930", "presentation": [ "http://www.westpharma.com/role/RevenueRecognitionDetails" ], "xbrltype": "domainItemType" }, "wst_PurchasesAndRoyaltyPaymentsFromEquityMethodInvestees": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Purchases and Royalty Payments from Equity Method Investees", "label": "Purchases and Royalty Payments from Equity Method Investees", "terseLabel": "Purchases and royalty payments made to affiliates" } } }, "localname": "PurchasesAndRoyaltyPaymentsFromEquityMethodInvestees", "nsuri": "http://www.westpharma.com/20190930", "presentation": [ "http://www.westpharma.com/role/AffiliatedCompaniesDetails" ], "xbrltype": "monetaryItemType" }, "wst_PvsPayoutMaximum": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Percent of an employee's targeted award to be paid out, Maximum.", "label": "PVS Payout Maximum", "verboseLabel": "PSU payout, maximum (in hundredths)" } } }, "localname": "PvsPayoutMaximum", "nsuri": "http://www.westpharma.com/20190930", "presentation": [ "http://www.westpharma.com/role/StockBasedCompensationDetails" ], "xbrltype": "percentItemType" }, "wst_PvsPayoutMinimum": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Percent of an employee's targeted award to be paid out, Minimum.", "label": "PVS Payout Minimum", "verboseLabel": "PSU payout, minimum (in hundredths)" } } }, "localname": "PvsPayoutMinimum", "nsuri": "http://www.westpharma.com/20190930", "presentation": [ "http://www.westpharma.com/role/StockBasedCompensationDetails" ], "xbrltype": "percentItemType" }, "wst_RatioofdebtoEBITDA": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Ratio of deb to EBITDA", "label": "Ratio of deb to EBITDA", "terseLabel": "Ratio of debt to EBITDA" } } }, "localname": "RatioofdebtoEBITDA", "nsuri": "http://www.westpharma.com/20190930", "presentation": [ "http://www.westpharma.com/role/CreditFacilityDetails" ], "xbrltype": "pureItemType" }, "wst_RevenueAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Revenue [Abstract]", "label": "Revenue [Abstract]" } } }, "localname": "RevenueAbstract", "nsuri": "http://www.westpharma.com/20190930", "xbrltype": "stringItemType" }, "wst_Revolvingcreditfacilitydue2020Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Revolving credit facility, due 2020.", "label": "Revolving credit facility, due 2020 [Member]", "terseLabel": "Revolving credit facility, Due 2020 [Member]" } } }, "localname": "Revolvingcreditfacilitydue2020Member", "nsuri": "http://www.westpharma.com/20190930", "presentation": [ "http://www.westpharma.com/role/LongTermDebtDetails" ], "xbrltype": "domainItemType" }, "wst_Revolvingcreditfacilitydue2024Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Revolving credit facility, due 2024 [Member]", "label": "Revolving credit facility, due 2024 [Member]", "terseLabel": "Revolving credit facility, Due 2024 [Member]" } } }, "localname": "Revolvingcreditfacilitydue2024Member", "nsuri": "http://www.westpharma.com/20190930", "presentation": [ "http://www.westpharma.com/role/CreditFacilityDetails", "http://www.westpharma.com/role/LongTermDebtDetails" ], "xbrltype": "domainItemType" }, "wst_SalesToEquityMethodInvestees": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Sales to Equity Method Investees", "label": "Sales to Equity Method Investees", "terseLabel": "Sales to affiliates" } } }, "localname": "SalesToEquityMethodInvestees", "nsuri": "http://www.westpharma.com/20190930", "presentation": [ "http://www.westpharma.com/role/AffiliatedCompaniesDetails" ], "xbrltype": "monetaryItemType" }, "wst_ScheduleofOtherIncomeandExpensebyComponentTableTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Schedule of Other Income and Expense, by Component [Table Text Block]", "label": "Schedule of Other Income and Expense, by Component [Table Text Block]", "terseLabel": "Schedule of Other Expense" } } }, "localname": "ScheduleofOtherIncomeandExpensebyComponentTableTextBlock", "nsuri": "http://www.westpharma.com/20190930", "presentation": [ "http://www.westpharma.com/role/OtherExpenseTables" ], "xbrltype": "textBlockItemType" }, "wst_SeniorBNotesDue2024Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Senior B Notes Due 2024 [Member]", "label": "Senior B Notes Due 2024 [Member]", "terseLabel": "Series B Notes, Due 2024 [Member]" } } }, "localname": "SeniorBNotesDue2024Member", "nsuri": "http://www.westpharma.com/20190930", "presentation": [ "http://www.westpharma.com/role/LongTermDebtDetails" ], "xbrltype": "domainItemType" }, "wst_SeniorCNotesDue2027Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Senior C Notes Due 2027 [Member]", "label": "Senior C Notes Due 2027 [Member]", "terseLabel": "Series C Notes, Due 2027 [Member]" } } }, "localname": "SeniorCNotesDue2027Member", "nsuri": "http://www.westpharma.com/20190930", "presentation": [ "http://www.westpharma.com/role/LongTermDebtDetails" ], "xbrltype": "domainItemType" }, "wst_SeniorNotesDue2022Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Senior A Notes Due 2022 [Member]", "label": "Senior A Notes Due 2022 [Member]", "terseLabel": "Series A Notes, Due 2022 [Member]" } } }, "localname": "SeniorNotesDue2022Member", "nsuri": "http://www.westpharma.com/20190930", "presentation": [ "http://www.westpharma.com/role/LongTermDebtDetails" ], "xbrltype": "domainItemType" }, "wst_SmartDoseMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "SmartDose [Member]", "label": "SmartDose [Member]", "terseLabel": "SmartDose [Member]" } } }, "localname": "SmartDoseMember", "nsuri": "http://www.westpharma.com/20190930", "presentation": [ "http://www.westpharma.com/role/ContractsAndLiabilitiesDetails", "http://www.westpharma.com/role/OtherExpenseOtherIncomeDevelopmentAndLicensingIncomeDetails", "http://www.westpharma.com/role/RevenueRecognitionDetails" ], "xbrltype": "domainItemType" }, "wst_StandardPackagingMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Standard Packaging [Member]", "label": "Standard Packaging [Member]", "terseLabel": "Standard Packaging [Member]" } } }, "localname": "StandardPackagingMember", "nsuri": "http://www.westpharma.com/20190930", "presentation": [ "http://www.westpharma.com/role/RevenueRecognitionDetails" ], "xbrltype": "domainItemType" }, "wst_SubsequentEventAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Subsequent Event [Abstract]", "label": "Subsequent Event [Abstract]" } } }, "localname": "SubsequentEventAbstract", "nsuri": "http://www.westpharma.com/20190930", "xbrltype": "stringItemType" }, "wst_SupplyChainFinancingAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Supply Chain Financing [Abstract]", "label": "Supply Chain Financing [Abstract]" } } }, "localname": "SupplyChainFinancingAbstract", "nsuri": "http://www.westpharma.com/20190930", "xbrltype": "stringItemType" }, "wst_TaxCutsandJobsActof2017IncompleteAccountingChangeinTaxRateProvisionalIncomeTaxExpense": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Tax Cuts and Jobs Act of 2017, Incomplete Accounting, Change in Tax Rate, Provisional Income Tax Expense", "label": "Tax Cuts and Jobs Act of 2017, Incomplete Accounting, Change in Tax Rate, Provisional Income Tax Expense", "negatedTerseLabel": "Tax Cuts and Jobs Act of 2017, provisional income tax expense" } } }, "localname": "TaxCutsandJobsActof2017IncompleteAccountingChangeinTaxRateProvisionalIncomeTaxExpense", "nsuri": "http://www.westpharma.com/20190930", "presentation": [ "http://www.westpharma.com/role/IncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "wst_TranslationAdjustmentForNetInvestmentHedgePreTax": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Pre-tax cumulative adjustment resulting from gains and losses on foreign currency derivatives that are designated as, and are effective as, hedges of a net investment in a foreign entity, commencing as of the designation date. Adjustment reported in equity as part of accumulated other comprehensive income.", "label": "Translation Adjustment For Net Investment Hedge Pre Tax", "negatedLabel": "Cumulative foreign currency translation loss" } } }, "localname": "TranslationAdjustmentForNetInvestmentHedgePreTax", "nsuri": "http://www.westpharma.com/20190930", "presentation": [ "http://www.westpharma.com/role/DerivativeFinancialInstrumentsTextualsDetails" ], "xbrltype": "monetaryItemType" } }, "unitCount": 10 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "5C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(2)", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(e),(f))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(h)(1)(i))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(h)(2))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(k)(1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(n)(2))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e24072-122690" }, "r108": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "http://asc.fasb.org/topic&trid=2122369" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794" }, "r112": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "250", "URI": "http://asc.fasb.org/topic&trid=2122394" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1448-109256" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1505-109256" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1252-109256" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "28A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1500-109256" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=SL5780133-109256" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1337-109256" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=117327953&loc=d3e4984-109258" }, "r123": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "260", "URI": "http://asc.fasb.org/topic&trid=2144383" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "270", "URI": "http://asc.fasb.org/extlink&oid=116846552&loc=d3e639-108305" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8813-108599" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8906-108599" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8906-108599" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8924-108599" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(24))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8933-108599" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8933-108599" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e9031-108599" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e9038-108599" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e9054-108599" }, "r145": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "280", "URI": "http://asc.fasb.org/topic&trid=2134510" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=118952595&loc=d3e4428-111522" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=118952595&loc=d3e4531-111522" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(b)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r151": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "323", "URI": "http://asc.fasb.org/topic&trid=2196965" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "30", "SubTopic": "10", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=68048583&loc=d3e3636-108311" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=116846819&loc=d3e3927-108312" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.BB)", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729" }, "r155": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "330", "URI": "http://asc.fasb.org/topic&trid=2126998" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=77989000&loc=SL49117168-202975" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=108376223&loc=d3e13816-109267" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "((a)(1),(b))", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(2)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226348&loc=d3e2420-110228" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 5.P.3)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.3)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 5.P.4(b)(2))", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 5.P.4(b))", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 5.P.4)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(b)(1))", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(b)(2))", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(b))", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(d))", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r183": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "http://asc.fasb.org/topic&trid=2144648" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14326-108349" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14615-108349" }, "r186": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "http://asc.fasb.org/topic&trid=2127136" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=99376301&loc=d3e1314-112600" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=99376301&loc=d3e1336-112600" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=SL6230698-112601" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "2C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=7656903&loc=SL6757497-112611" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=109500613&loc=SL6031897-161870" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=109500613&loc=SL6031897-161870" }, "r193": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "http://asc.fasb.org/topic&trid=2208564" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656" }, "r202": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "http://asc.fasb.org/topic&trid=2208762" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=118944033&loc=SL49130531-203044" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=118944033&loc=SL49130532-203044" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=118944033&loc=SL49130533-203044" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130551-203045" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130551-203045" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130551-203045" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130545-203045" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130549-203045" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130549-203045" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130550-203045" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=118944142&loc=SL49130690-203046-203046" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=118944142&loc=SL49130690-203046-203046" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=118944142&loc=SL49130690-203046-203046" }, "r216": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "606", "URI": "http://asc.fasb.org/topic&trid=49130388" }, "r217": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "610", "URI": "http://asc.fasb.org/topic&trid=49130413" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "15", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "712", "URI": "http://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "15", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "712", "URI": "http://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=109237824&loc=d3e1703-114919" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=109237824&loc=d3e1731-114919" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(1)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(2)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(4)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(1)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(2)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(5)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(7)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(j)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2410-114920" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2417-114920" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2439-114920" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(4))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(1)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(2)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(5)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(7)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4179-114921" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "70", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942" }, "r249": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "715", "URI": "http://asc.fasb.org/topic&trid=2235017" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116855982&loc=d3e4534-113899" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5047-113901" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5047-113901" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5047-113901" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5047-113901" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a),(g)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "2A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=SL79508275-113901" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116863282&loc=SL79507997-165333" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116863282&loc=SL79507997-165333" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116863282&loc=SL79508013-165333" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116863282&loc=SL79508013-165333" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(c))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116863282&loc=SL79508029-165333" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116863282&loc=SL79508029-165333" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116863282&loc=SL79508043-165333" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116863282&loc=SL79508043-165333" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116863282&loc=SL79508057-165333" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116863282&loc=SL79508057-165333" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.D.2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.F)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=118258462&loc=d3e11149-113907" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=118258462&loc=d3e11178-113907" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.1)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r280": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "http://asc.fasb.org/topic&trid=2228938" }, "r281": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "720", "URI": "http://asc.fasb.org/topic&trid=2122503" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "730", "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=117330534&loc=d3e28446-109314" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116821951&loc=d3e31917-109318" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116821951&loc=d3e31928-109318" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116821951&loc=d3e31931-109318" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116821951&loc=d3e31958-109318" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32672-109319" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.12)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32698-109319" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32621-109319" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)-(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=109238882&loc=d3e38679-109324" }, "r295": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "http://asc.fasb.org/topic&trid=2144680" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "37", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116868840&loc=d3e2207-128464" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116869197&loc=d3e4845-128472" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "25", "SubTopic": "30", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "35", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.13)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(1)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)(1)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=35744584&loc=d3e7008-128479" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568447-111683" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568740-111683" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(3)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c),(3)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.14)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "4I", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116874947&loc=SL4590271-111686" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116874947&loc=SL4591551-111686" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116874947&loc=SL4591552-111686" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3A-04)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116822174&loc=d3e355119-122828" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "83", "Publisher": "FASB", "Section": "15", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=117415099&loc=d3e34841-113949" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5579240-113959" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5579245-113959" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5579245-113959" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5580258-113959" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)(i)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41620-113959" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.17)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)(ii)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41620-113959" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)(iii)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41620-113959" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41620-113959" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41638-113959" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5618551-113959" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5618551-113959" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624163-113959" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624163-113959" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624171-113959" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624171-113959" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624171-113959" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624171-113959" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "4CC", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL109998890-113959" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624177-113959" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624177-113959" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624177-113959" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624177-113959" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624177-113959" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "4E", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624181-113959" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41641-113959" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41678-113959" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "182", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=116861445&loc=SL5629052-113961" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=118875152&loc=SL5864739-113975" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "25", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109977999&loc=d3e76258-113986" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109978405&loc=d3e80720-113993" }, "r345": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "815", "URI": "http://asc.fasb.org/topic&trid=2229140" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19279-110258" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=118260190&loc=d3e13531-108611" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=118260190&loc=d3e13537-108611" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=109240200&loc=d3e30690-110894" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=109240200&loc=d3e30700-110894" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450222&loc=d3e30840-110895" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b,c)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=114775744&loc=d3e28541-108399" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=114775744&loc=d3e28551-108399" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=114775744&loc=d3e28555-108399" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(Note 3)", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=82846649&loc=d3e38371-112697" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=77902758&loc=d3e41502-112717" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=77902758&loc=d3e41502-112717" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r370": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "840", "URI": "http://asc.fasb.org/topic&trid=2208923" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=119364159&loc=SL77916155-209984" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=77888419&loc=SL77918627-209977" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=77888419&loc=SL77918627-209977" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=77888419&loc=SL77918643-209977" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(3)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918673-209980" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(1)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(2)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(3)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(4)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918701-209980" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "53", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=77888399&loc=SL77918982-209971" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39622-107864" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=6918054&loc=d3e56071-112765" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662" }, "r392": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "http://asc.fasb.org/topic&trid=2122774" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=118948506&loc=d3e107207-111719" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=118948506&loc=d3e107207-111719" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=118948506&loc=d3e107207-111719" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=118948506&loc=d3e107207-111719" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=118948506&loc=SL51823488-111719" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(15)(1))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.15(3))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(13)(f))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.9)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.24)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(15)(b)(1))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.17)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.3)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(10))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=116637232&loc=SL114874131-224263" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(19))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=116637232&loc=SL114874131-224263" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=117419784&loc=SL117783719-158441" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=117419784&loc=SL117783719-158441" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(c)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=117419784&loc=SL117783719-158441" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=99380617&loc=SL75241803-196195" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04.12(3))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=6488278&loc=d3e603758-122996" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "310", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Topic": "948", "URI": "http://asc.fasb.org/extlink&oid=6589523&loc=d3e617274-123014" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=6590653&loc=d3e638233-123024" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "985", "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756" }, "r429": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29,30)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r430": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r431": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-13" }, "r432": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1-" }, "r433": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r434": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.8)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.9)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a),(b),(c)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(i),(j),(k)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(i-k)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=d3e637-108580" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=d3e640-108580" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=d3e681-108580" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6801-107765" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669686-108580" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "17B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL34724394-108580" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669619-108580" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669619-108580" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669619-108580" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669625-108580" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669625-108580" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118951672&loc=d3e1436-108581" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(210.5-03(11))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(1))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6904-107765" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(12))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(21))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1,2)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2(a),(d))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7(a),(b))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.8)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.9)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r78": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "220", "URI": "http://asc.fasb.org/topic&trid=2134417" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3179-108585" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6911-107765" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3213-108585" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3213-108585" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3213-108585" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3255-108585" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3255-108585" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3255-108585" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3291-108585" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a),(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3291-108585" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3291-108585" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3291-108585" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3291-108585" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(ee)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3367-108585" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3367-108585" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3000-108585" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3521-108585" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3536-108585" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3044-108585" } }, "version": "2.1" } XML 13 R64.htm IDEA: XBRL DOCUMENT v3.19.3
Stock-Based Compensation (Details) - USD ($)
$ / shares in Units, $ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Shares available for issuance under the 2016 Plan (in shares) 3,110,708   3,110,708  
Stock options, granted (in shares)     345,400  
Stock options, weighted average exercise price (in dollars per share)     $ 102.59  
Stock options, weighted average grant date fair value (in dollars per share)     $ 24.53  
Risk-free interest rate (in hundredths)     2.30%  
Expected life (in years)     5 years 7 months 6 days  
Stock volatility (in hundredths)     22.50%  
Dividend yield (in hundredths)     0.70%  
Stock-based compensation expense $ 5.4 $ 5.3 $ 18.8 $ 14.7
Performance Share Unit (PSUs) [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Granted (in shares)     82,646  
Grant date fair value (in dollars per share)     $ 102.59  
PSU payout, minimum (in hundredths) 0.00%   0.00%  
PSU payout, maximum (in hundredths) 200.00%   200.00%  
Restricted Stock Units (RSUs) [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Granted (in shares)     11,631  
Grant date fair value (in dollars per share)     $ 112.49  
XML 14 R6.htm IDEA: XBRL DOCUMENT v3.19.3
CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical) - $ / shares
shares in Millions
Sep. 30, 2019
Dec. 31, 2018
Balance Sheet Related Disclosures [Abstract]    
Preferred stock, shares authorized (in shares) 3.0 3.0
Preferred stock, shares issued (in shares) 0.0 0.0
Preferred stock, shares outstanding (in shares) 0.0 0.0
Common stock, par value (in dollars per share) $ 0.25 $ 0.25
Common stock, shares authorized (in shares) 100.0 100.0
Common stock, shares issued (in shares) 75.3 75.3
Common stock, shares outstanding (in shares) 74.0 74.1
Treasury stock, at cost (in shares) 1.3 1.2
XML 15 R2.htm IDEA: XBRL DOCUMENT v3.19.3
CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED) - USD ($)
shares in Millions, $ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Income Statement [Abstract]        
Net sales $ 456.1 $ 431.7 $ 1,369.3 $ 1,294.9
Cost of goods and services sold 308.3 296.1 916.8 882.7
Gross profit 147.8 135.6 452.5 412.2
Research and development 9.3 10.1 28.7 30.5
Selling, general and administrative expenses 64.8 64.9 203.7 203.2
Other expense (income) (Note 15) 6.4 (0.2) 1.6 4.0
Operating profit 67.3 60.8 218.5 174.5
Interest expense 2.1 2.0 6.4 6.1
Interest income (1.0) (0.5) (2.5) (1.4)
Other nonoperating expense (income) (1.3) 1.8 (0.2) 5.1
Income before income taxes 64.9 61.1 214.4 174.9
Income tax expense 10.9 8.0 42.5 26.5
Equity in net income of affiliated companies (2.3) (2.1) (5.9) (6.5)
Net income $ 56.3 $ 55.2 $ 177.8 $ 154.9
Net income per share:        
Basic (in dollars per share) $ 0.76 $ 0.75 $ 2.40 $ 2.10
Diluted (in dollars per share) $ 0.75 $ 0.73 $ 2.36 $ 2.05
Weighted average shares outstanding:        
Basic (in shares) 74.0 73.9 73.9 73.9
Diluted (in shares) 75.5 75.7 75.3 75.4
XML 16 R68.htm IDEA: XBRL DOCUMENT v3.19.3
Other Expense Restructuring and Related Charges (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Dec. 31, 2019
Dec. 31, 2018
Restructuring Cost and Reserve [Line Items]            
Deferred income $ 30.9   $ 30.9     $ 33.4
Argentina currency devaluation 1.0 $ 1.1 1.0 $ 1.1    
Payments to acquire property, plant, and equipment     88.8 74.7    
Restructuring and related charges 1.8 1.2 3.8 6.7    
Restructuring Reserve [Roll Forward]            
Non-cash asset-write-downs     (1.6) (0.8)    
Severance and benefits [Member]            
Restructuring Reserve [Roll Forward]            
Balance, December 31, 2018     2.3      
Charges     2.2      
Cash payments     (2.0)      
Non-cash asset-write-downs     0.0      
Balance, September 30, 2019 2.5   2.5      
Asset-related charges [Member]            
Restructuring Reserve [Roll Forward]            
Cash payments     0.0      
Other charges [Member]            
Restructuring Reserve [Roll Forward]            
Cash payments     0.0      
2018 Restructuring Plan [Member]            
Restructuring Cost and Reserve [Line Items]            
Restructuring and related cost, cumulative cost incurred 12.6   12.6      
Severance charges 0.6 0.1 2.2 3.4    
Asset impairment charges, equipment 0.1 0.4 0.1 0.8    
Other charges 1.1 0.7 1.5 2.5    
Restructuring and related charges 1.8   3.8      
Restructuring Reserve [Roll Forward]            
Balance, December 31, 2018     2.3      
Charges   $ 1.2 3.8 $ 6.7    
Cash payments     (2.0)      
Non-cash asset-write-downs     (1.6)      
Balance, September 30, 2019 2.5   2.5      
2018 Restructuring Plan [Member] | Asset-related charges [Member]            
Restructuring Reserve [Roll Forward]            
Balance, December 31, 2018     0.0      
Charges     0.1      
Non-cash asset-write-downs     (0.1)      
Balance, September 30, 2019 0.0   0.0      
2018 Restructuring Plan [Member] | Other charges [Member]            
Restructuring Reserve [Roll Forward]            
Balance, December 31, 2018     0.0      
Charges     1.5      
Non-cash asset-write-downs     (1.5)      
Balance, September 30, 2019 0.0   0.0      
2018 Restructuring Plan [Member] | Maximum [Member]            
Restructuring Cost and Reserve [Line Items]            
Restructuring and related cost, expected cost         $ 16.0  
2016 Restructuring Plan [Member]            
Restructuring Reserve [Roll Forward]            
Balance, September 30, 2019 $ 0.2   $ 0.2      
XML 17 R47.htm IDEA: XBRL DOCUMENT v3.19.3
Leases Adoption of ASC 842 (Details) - USD ($)
$ in Millions
 9 Months Ended
Sep. 30, 2019
Jan. 01, 2019
Dec. 31, 2018
New Accounting Pronouncements or Change in Accounting Principle [Line Items]      
Total lease liabilities $ 73.3    
Operating lease right-of-use assets $ 71.3   $ 0.0
Accounting Standards Update 2016-02 [Member]      
New Accounting Pronouncements or Change in Accounting Principle [Line Items]      
Total lease liabilities   $ 73.1  
Operating lease right-of-use assets   $ 71.0  
Maximum [Member]      
New Accounting Pronouncements or Change in Accounting Principle [Line Items]      
Operating leases, term of contracts 12 months    
Operating leases, option to extend 5 years    
XML 18 R43.htm IDEA: XBRL DOCUMENT v3.19.3
Revenue Supply Chain Financing (Details)
$ in Millions
Sep. 30, 2019
USD ($)
Supply Chain Financing [Abstract]  
Sales of certain accounts receivable $ 7.9
XML 19 R22.htm IDEA: XBRL DOCUMENT v3.19.3
Other Expense
 9 Months Ended
Sep. 30, 2019
Other Income and Expenses [Abstract]  
Other Expense Other Expense (Income)

Other expense (income) consists of:

 
Three Months Ended
September 30,
 
Nine Months Ended
September 30,
($ in millions)
2019
 
2018
 
2019
 
2018
Restructuring and related charges:
 
 
 
 
 
 
 
Severance and post-employment benefits
$
0.6

 
$
0.1

 
$
2.2

 
$
3.4

Asset-related charges
0.1

 
0.4

 
0.1

 
0.8

Other charges
1.1

 
0.7

 
1.5

 
2.5

Total restructuring and related charges
1.8

 
1.2

 
3.8

 
6.7

Argentina currency devaluation
1.0

 
1.1

 
1.0

 
1.1

Development and licensing income
(0.2
)
 
(0.2
)
 
(0.6
)
 
(0.6
)
Contingent consideration
0.1

 
0.2

 
0.4

 
0.8

Other items
3.7

 
(2.5
)
 
(3.0
)
 
(4.0
)
Total other expense (income)
$
6.4

 
$
(0.2
)
 
$
1.6

 
$
4.0



Restructuring and Related Charges

In February 2018, our Board of Directors approved a restructuring plan designed to realign our manufacturing capacity with demand. These changes are expected to be implemented over a period of up to twenty-four months from the date of approval. The plan will require restructuring and related charges of approximately $16.0 million. Since its approval, we have recorded $12.6 million in restructuring and related charges associated with this plan.

During the three months ended September 30, 2019, we recorded $1.8 million in restructuring and related charges associated with this plan, consisting of $0.6 million for severance charges, $0.1 million for non-cash asset write-downs associated with the discontinued use of certain equipment, and $1.1 million for other non-cash charges. During the three months ended September 30, 2018, we recorded $1.2 million in restructuring and related charges associated with this plan, consisting of $0.1 million for severance charges, $0.4 million for non-cash asset write-downs associated with the discontinued use of certain equipment, and $0.7 million for other non-cash charges.

During the nine months ended September 30, 2019, we recorded $3.8 million in restructuring and related charges associated with this plan, consisting of $2.2 million for severance charges, $0.1 million for non-cash asset write-downs associated with the discontinued use of certain equipment, and $1.5 million for other non-cash charges. During the nine months ended September 30, 2018, we recorded $6.7 million in restructuring and related charges associated with this plan, consisting of $3.4 million for severance charges, $0.8 million for non-cash asset write-downs associated with the discontinued use of certain equipment, and $2.5 million for other non-cash charges.

The following table presents activity related to our restructuring obligations related to our 2018 restructuring plan:

($ in millions)
Severance
and benefits
 
Asset-related charges
 
Other charges
 
Total
Balance, December 31, 2018
$
2.3

 
$
—

 
$
—

 
$
2.3

Charges
2.2

 
0.1

 
1.5

 
3.8

Cash payments
(2.0
)
 
—

 
—

 
(2.0
)
Non-cash asset write-downs
—

 
(0.1
)
 
(1.5
)
 
(1.6
)
Balance, September 30, 2019
$
2.5

 
$
—

 
$
—

 
$
2.5



On February 15, 2016, our Board of Directors approved a restructuring plan designed to repurpose several of our production facilities in support of growing high-value proprietary products and to realign operational and commercial activities to meet the needs of our new market-focused commercial organization. Our remaining restructuring obligations related to the 2016 restructuring plan as of September 30, 2019 were $0.2 million.

Other Items

During the three and nine months ended September 30, 2019, we recorded a charge of $1.0 million as a result of the continued devaluation of Argentina’s currency. During the three and nine months ended September 30, 2018, we recorded a charge of $1.1 million related to the classification of Argentina’s economy as highly inflationary under U.S. GAAP as of July 1, 2018.

During both the three and nine months ended September 30, 2019 and 2018, we recorded development income of $0.2 million and $0.6 million, respectively, related to a nonrefundable customer payment of $20.0 million received in June 2013 in return for the exclusive use of the SmartDose technology platform within a specific therapeutic area. Please refer to Note 3, Revenue, for additional information.

Contingent consideration represents changes in the fair value of the SmartDose contingent consideration. Please refer to Note 10, Fair Value Measurements, for additional details.

Other items consist of foreign exchange transaction gains and losses, gains and losses on the sale of fixed assets, and miscellaneous income and charges. Other items changed by $6.2 million for the three months ended September 30, 2019, as compared to the same period in 2018, primarily as a result of foreign exchange transaction losses of $5.1 million during the three months ended September 30, 2019, as compared to foreign exchange transaction gains of $2.7 million during the three months ended September 30, 2018. Other items decreased by $1.0 million for the nine months ended September 30, 2019, as compared to the same period in 2018, primarily due to losses on the sale of fixed assets during the nine months ended September 30, 2019.
XML 20 R26.htm IDEA: XBRL DOCUMENT v3.19.3
Subsequent Event (Notes)
 9 Months Ended
Sep. 30, 2019
Subsequent Events [Abstract]  
Subsequent Events [Text Block] Subsequent Event

On October 15, 2019, we entered into an Amendment Agreement (the “Amendment”) with Daikyo, amending certain commercial agreements between the parties in order to make each party’s rights under such agreements exclusive. The Amendment amends the Amended and Restated Technology Exchange and CrossLicense Agreement and Distributorship Agreements, each dated and effective January 18, 2017, as modified by the Letter Agreement dated and effective July 2, 2018. In addition, on October 16, 2019, we announced that we increased our ownership interest in Daikyo to 49%. We believe that the increase in ownership interest will not have a material impact on our financial statements.
XML 21 R37.htm IDEA: XBRL DOCUMENT v3.19.3
Benefit Plans (Tables)
 9 Months Ended
Sep. 30, 2019
Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Abstract]  
Schedule of Components of Net Periodic Benefit Cost

The components of net periodic benefit cost for the three months ended September 30 were as follows:

 
Pension benefits
 
Other retirement benefits
 
Total
($ in millions)
2019
 
2018
 
2019
 
2018
 
2019
 
2018
Service cost
$
0.4

 
$
2.6

 
$
—

 
$
—

 
$
0.4

 
$
2.6

Interest cost
1.9

 
2.3

 
0.1

 
0.1

 
2.0

 
2.4

Expected return on assets
(3.1
)
 
(3.9
)
 
—

 
—

 
(3.1
)
 
(3.9
)
Amortization of prior service credit
0.1

 
(0.3
)
 
(0.2
)
 
(0.2
)
 
(0.1
)
 
(0.5
)
Recognized actuarial losses (gains)
0.5

 
0.9

 
(0.7
)
 
(0.7
)
 
(0.2
)
 
0.2

Settlements
2.7

 
—

 
—

 
—

 
2.7

 
—

Net periodic benefit cost
$
2.5

 
$
1.6

 
$
(0.8
)
 
$
(0.8
)
 
$
1.7

 
$
0.8


 
Pension benefits
 
Other retirement benefits
 
Total
($ in millions)
2019
 
2018
 
2019
 
2018
 
2019
 
2018
U.S. plans
$
2.0

 
$
1.0

 
$
(0.8
)
 
$
(0.8
)
 
$
1.2

 
$
0.2

International plans
0.5

 
0.6

 
—

 
—

 
0.5

 
0.6

Net periodic benefit cost
$
2.5

 
$
1.6

 
$
(0.8
)
 
$
(0.8
)
 
$
1.7

 
$
0.8


The components of net periodic benefit cost for the nine months ended September 30 were as follows:

 
Pension benefits
 
Other retirement benefits
 
Total
($ in millions)
2019
 
2018
 
2019
 
2018
 
2019
 
2018
Service cost
$
1.1

 
$
8.1

 
$
—

 
$
—

 
$
1.1

 
$
8.1

Interest cost
6.8

 
7.0

 
0.2

 
0.2

 
7.0

 
7.2

Expected return on assets
(8.9
)
 
(11.7
)
 
—

 
—

 
(8.9
)
 
(11.7
)
Amortization of prior service credit
0.1

 
(1.1
)
 
(0.5
)
 
(0.5
)
 
(0.4
)
 
(1.6
)
Recognized actuarial losses (gains)
1.6

 
2.8

 
(1.8
)
 
(1.8
)
 
(0.2
)
 
1.0

Settlements
2.7

 
—

 
—

 
—

 
2.7

 
—

Net periodic benefit cost
$
3.4

 
$
5.1

 
$
(2.1
)
 
$
(2.1
)
 
$
1.3

 
$
3.0


 
Pension benefits
 
Other retirement benefits
 
Total
($ in millions)
2019
 
2018
 
2019
 
2018
 
2019
 
2018
U.S. plans
$
1.9

 
$
3.5

 
$
(2.1
)
 
$
(2.1
)
 
$
(0.2
)
 
$
1.4

International plans
1.5

 
1.6

 
—

 
—

 
1.5

 
1.6

Net periodic benefit cost
$
3.4

 
$
5.1

 
$
(2.1
)
 
$
(2.1
)
 
$
1.3

 
$
3.0
XML 22 R33.htm IDEA: XBRL DOCUMENT v3.19.3
Derivative Financial Instruments (Tables)
 9 Months Ended
Sep. 30, 2019
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Foreign Currency Contracts As of September 30, 2019, we had outstanding foreign currency contracts to purchase and sell certain pairs of currencies, as follows:
(in millions)
 
 
Sell
Currency
Purchase
 
USD
Euro
USD
39.3

 
—

34.2

Yen
5,921.1

 
31.8

20.2

SGD
31.9

 
18.7

4.3
Effects of Derivative Instruments on Other Comprehensive Income ('OCI') and Earnings
The following table summarizes the effects of derivative instruments designated as fair value hedges on the condensed consolidated statements of income:
 
Amount of Loss (Gain) Recognized in Income for the
 
Amount of Gain Recognized in Income for the
 
 
 
Three Months Ended
September 30,
 
Nine Months Ended
September 30,
 
Location on Statement of Income
($ in millions)
2019
 
2018
 
2019
 
2018
 
 
Fair Value Hedges:
 
 
 
 
 
 
 
 
 
Foreign currency hedge contracts
$
4.3

 
$
(2.0
)
 
$
(5.0
)
 
$
(3.4
)
 
Other expense (income)
Total
$
4.3

 
$
(2.0
)
 
$
(5.0
)
 
$
(3.4
)
 
 

We recognize in earnings the initial value of forward point components on a straight-line basis over the life of the fair value hedge.

The following tables summarize the effects of derivative instruments designated as fair value, cash flow, and net investment hedges on other comprehensive income (“OCI”) and earnings, net of tax:
 
Amount of (Loss) Gain Recognized in OCI for the
 
Amount of Loss (Gain) Reclassified from Accumulated OCI into Income for the
 
Location of Loss (Gain) Reclassified from Accumulated OCI into Income
 
Three Months Ended
September 30,
 
Three Months Ended
September 30,
 
($ in millions)
2019
 
2018
 
2019
 
2018
 
 
Fair Value Hedges
 
 
 
 
 
 
 
 
 
Foreign currency hedge contracts
$
(0.6
)
 
$
—

 
$
2.9

 
$
—

 
Other expense (income)
Total
$
(0.6
)
 
$
—

 
$
2.9

 
$
—

 
 
Cash Flow Hedges:
 
 
 
 
 
 
 
 
 
Foreign currency hedge contracts
$
0.7

 
$
0.1

 
$
(0.3
)
 
$
—

 
Net sales
Foreign currency hedge contracts
0.6

 
(0.5
)
 
(0.2
)
 
(0.1
)
 
Cost of goods and services sold
Forward treasury locks
—

 
—

 
0.1

 
0.1

 
Interest expense
Total
$
1.3

 
$
(0.4
)
 
$
(0.4
)
 
$
—

 
 
Net Investment Hedges:
 

 
 

 
 

 
 

 
 
Foreign currency-denominated debt
$
0.7

 
$
0.2

 
$
—

 
$
—

 
Other expense (income)
Total
$
0.7

 
$
0.2

 
$
—

 
$
—

 
 

 
Amount of Gain (Loss) Recognized in OCI for the
 
Amount of (Gain) Loss Reclassified from Accumulated OCI into Income for the
 
Location of (Gain) Loss Reclassified from Accumulated OCI into Income
 
Nine Months Ended
September 30,
 
Nine Months Ended
September 30,
 
($ in millions)
2019
 
2018
 
2019
 
2018
 
 
Fair Value Hedges
 
 
 
 
 
 
 
 
 
Foreign currency hedge contracts
$
3.9

 
$
—

 
$
(3.3
)
 
$
—

 
Other expense (income)
Total
$
3.9

 
$
—

 
$
(3.3
)
 
$
—

 
 
Cash Flow Hedges:
 
 
 
 
 
 
 
 
 
Foreign currency hedge contracts
$
1.0

 
$
0.2

 
$
(0.7
)
 
$
0.8

 
Net sales
Foreign currency hedge contracts
1.1

 
0.9

 
(0.5
)
 
0.4

 
Cost of goods and services sold
Forward treasury locks
—

 
—

 
0.2

 
0.2

 
Interest expense
Total
$
2.1

 
$
1.1

 
$
(1.0
)
 
$
1.4

 
 
Net Investment Hedges:
 

 
 

 
 

 
 

 
 
Foreign currency-denominated debt
$
0.5

 
$
0.7

 
$
—

 
$
—

 
Other expense (income)
Total
$
0.5

 
$
0.7

 
$
—

 
$
—

 
 


The following table summarizes the effects of derivative instruments not designated as hedges on the condensed consolidated statements of income:
 
Amount of Loss Recognized in Income for the
 
Amount of Loss (Gain) Recognized in Income for the
 
 
 
Three Months Ended
September 30,
 
Nine Months Ended
September 30,
 
Location on Statement of Income
($ in millions)
2019
 
2018
 
2019
 
2018
 
 
Commodity call options
$
0.1

 
$
—

 
$
0.3

 
$
(0.5
)
 
Cost of goods and services sold
Total
$
0.1

 
$
—

 
$
0.3

 
$
(0.5
)
 
 
EXCEL 23 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0 ( /V67$\?(\\#P !," + 7W)E;',O+G)E;'.MDD^+ MPD ,Q;]*F?L:5\'#8CUYZ6U9_ )Q)OU#.Y,A$[%^>X>];+=44/ 87O+>CT?V M/S2@=AQ2V\54C'X(J32M:OP"2+8ECVG%D4)6:A:/FD=I(*+ML2'8K-<[D*F' M.>RGGD7E2B.5^S3%":4A+,*P).B0\5?UX^8 TBTH_0(:+L A#&^NQT:E8(C M-R."?S]PN -02P,$% @ _99<3R?HAPZ" L0 ! !D;V-0&UL38Y-"\(P$$3_2NG=;BGH06) L$?!D_>0;FP@R8;-"OGYIH(? MMWF\81AU8\K(XK%T-8943OTJDH\ Q:X831F:3LTXXFBD(3^ G/,6+V2?$9/ M-(X'P"J8%EQV^3O8:W7..7AKQ%/25V^9"CGIYFHQ*/B76_..7+8\#?NW_+"" MWTG] E!+ P04 " #]EEQ/4A6$L.\ K @ $0 &1O8U!R;W!S+V-O M&ULS9+!3L,P#(9?!>7>NFEA&E&7"X@32$A, G&+$F^+:-HH,6KW]J1A MZX3@ 3C&_O/YL^16>Z&'@,]A\!C(8KR:7-='H?V&'8B\ (CZ@$[%,B7ZU-P- MP2E*S[ 'K_2'VB/45;4"AZ2,(@4SL/ +D?HZ(]3U\(%,,,(@XO?!30+,5?_Q.8.L%-RBG9)C>-8CDW.I1TX MO#T]ON1U"]M'4KW&]"M:04>/&W:>_-KB6;W/ MKC_\+L)N,'9G_['Q65"V\.LNY!=02P,$% @ _99<3YE&UL[5I;<]HX%'[OK]!X9_9M"\8V@;:T M$W-I=MNTF83M3A^%$5B-;'EDD81_OTV23;J;/ 0LZ?O.14?GZ#AY M\^XN8NB&B)3R> +]O6N[!3+UES@6QHO(];JM-O=5H1I;*$81V1@?5XL:$#05%%:;U\@M.4? M,_@5RU2-9:,!$U=!)KF(M/+Y;,7\VMX^9<_I.ATR@6XP&U@@?\YOI^1.6HCA M5,+$P&IG/U9KQ]'22(""R7V4!;I)]J/3%0@R#3LZG5C.=GSVQ.V?C,K:=#1M M&N#C\7@XMLO2BW A(5M>5 TR 6'!VULS2 Y9>*?IUE!K9';O=05SP6.XYB1'^QL4$UFG2&98T M1G*=D 4. #?$T4Q0?*]!MHK@PI+27)#6SRFU4!H(FLB!]4>"(<7K;YH]5Z%82=J$^!!&&N*<<^9ST6S[!Z5&T?95O-RCEU@5 9<8WS2J M-2S%UGB5P/&MG#P=$Q+-E L&08:7)"82J3E^34@3_BNEVOZKR2. MFJW"$2M"/F(9-AIRM1:!MG&IA&!:$L;1>$[2M!'\6:PUDSY@R.S-D77.UI$. M$9)>-T(^8LZ+D!&_'H8X2IKMHG%8!/V>7L-)P>B"RV;]N'Z&U3-L+([W1]07 M2N0/)J<_Z3(T!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL! M_]':-\*K^(+ .7\N?<^E[[GT/:'2MSAD M6R4)RU3393>*$IY"&V[I4_5*E=?EK[DHN#Q;Y.FOH70^+,_Y/%_GM,T+,T.W MF)&Y"M-2D&_#^>G%>!KB.=D$N7V85VWGV-'1^^?!4;"C[SR6'<>( M\J(A[J&&F,_#0X=Y>U^89Y7&4#04;6RL)"Q&MV"XU_$L%.!D8"V@!X.O40+R M4E5@,5O& RN0HGQ,C$7H<.>77%_CT9+CVZ9EM6ZO*7<9;2)2.<)IF!-GJ\K> M9;'!51W/55ORL+YJ/;053L_^6:W(GPP13A8+$DACE!>F2J+S&5.^YRM)Q%4X MOT4SMA*7&+SCYL=Q3E.X$G:V#P(RN;LYJ7IE,6>F\M\M# DL6XA9$N)-7>W5 MYYN MTB42%(JP# 4A%W+C[^^3:G>,U_HL@6V$5#)DU1?*0XG!/3-R0]A4)?.NVB8+ MA=OB5,V[&KXF8$O#>FZ=+2?_VU[4/;07/4;SHYG@'K.'YA,L0Z1^P7V*BH 1JV*^NJ]/^26<.[1[\8$@F_S6VZ3VW> , M?-2K6J5D*Q$_2P=\'Y(&8XQ;]#1?CQ1BK::QK<;:,0QY@%CS#*%F.-^'19H: M,]6+K#F-"F]!U4#E/]O4#6CV#30,9FV-J/D3@H\W/[O#;#"Q([A[8N_ M 5!+ P04 " #]EEQ/PK R2@# #F#@ & 'AL+W=O9)DZ""C@# M)^G>?L;0-/(]_E+ G'N/S?7/S5U<=/O6'90RT7M=-=TR/AASO$^2;G-0=='= MZ:-J[)N=;NO"V,=VGW3'5A5;%U17":7I)*F+LHE7"S?VU*X6^F2JLE%/;=2= MZKIH_ZU5I2_+6,0? \_E_F#Z@62U.!9[]4N9W\>GUCXEURS;LE9-5^HF:M5N M&3^(^[6D/L I7DIUZ6[NHWXIKUJ_]0_?M\LX[6>D*K4Q?8K"7L[J4555G\G. MX^^8-+YZ]H&W]Q_9O[K%V\6\%IUZU-6?=:7;VI<4!Y' MX^I_J+.JK+R?B?78Z*IS?Z/-J3.Z'K/8J=3%^W M&W>]#&^R; S# 30&T&> M\TD&(S?S+X4I5HM67Z)V^/C'HJ^QN"?[;3;]H/L4[IV=?&='SZMTD9S[-*-B M/2CH1B&NBL3FOAH0,E@3"R<<+N'\I N7-^$2AV

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end XML 24 R10.htm IDEA: XBRL DOCUMENT v3.19.3
Revenue
 9 Months Ended
Sep. 30, 2019
Revenue [Abstract]  
Revenue from Contract with Customer [Text Block] Revenue

The following table presents the approximate percentage of our net sales by market group:
 
Three Months Ended
September 30,
 
Nine Months Ended
September 30,
 
2019
 
2018
 
2019
 
2018
Biologics
26
%
 
21
%
 
25
%
 
21
%
Generics
20
%
 
21
%
 
20
%
 
21
%
Pharma
30
%
 
34
%
 
31
%
 
35
%
Contract-Manufactured Products
24
%
 
24
%
 
24
%
 
23
%
 
100
%
 
100
%
 
100
%
 
100
%
The following table presents the approximate percentage of our net sales by product category:
 
Three Months Ended
September 30,
 
Nine Months Ended
September 30,
 
2019
 
2018
 
2019
 
2018
High-Value Components
42
%
 
41
%
 
43
%
 
42
%
Standard Packaging
28
%
 
31
%
 
29
%
 
32
%
Delivery Devices
6
%
 
4
%
 
4
%
 
3
%
Contract-Manufactured Products
24
%
 
24
%
 
24
%
 
23
%
 
100
%
 
100
%
 
100
%
 
100
%
The following table presents the approximate percentage of our net sales by geographic location:
 
Three Months Ended
September 30,
 
Nine Months Ended
September 30,
 
2019
 
2018
 
2019
 
2018
Americas
48
%
 
51
%
 
48
%
 
48
%
Europe, Middle East, Africa
44
%
 
41
%
 
44
%
 
44
%
Asia Pacific
8
%
 
8
%
 
8
%
 
8
%
 
100
%
 
100
%
 
100
%
 
100
%

Contract Assets and Liabilities
The following table summarizes our contract assets and liabilities, excluding contract assets included in accounts receivable, net:
 
($ in millions)
Contract assets, December 31, 2018
$
9.1

Contract assets, September 30, 2019
9.4

Change in contract assets - increase (decrease)
$
0.3

 
 
Deferred income, December 31, 2018
$
(33.4
)
Deferred income, September 30, 2019
(30.9
)
Change in deferred income - decrease (increase)
$
2.5


The decrease in deferred income during the nine months ended September 30, 2019 was primarily due to the recognition of revenue of $79.3 million, including $18.0 million of revenue that was included in deferred income at the beginning of the year, and $2.7 million in other adjustments, partially offset by additional cash payments of $79.5 million received in advance of satisfying future performance obligations.
The majority of the performance obligations within our contracts are satisfied within one year or less. Performance obligations satisfied beyond one year include those relating to a nonrefundable customer payment of $20.0 million received in June 2013 in return for the exclusive use of the SmartDose® technology platform within a specific therapeutic area. As of September 30, 2019, there was $5.9 million of unearned income related to this payment, of which $0.9 million was included in other current liabilities and $5.0 million was included in other long-term liabilities. The unearned income is being recognized as income on a straight-line basis over the remaining term of the agreement. The agreement does not include a future minimum purchase commitment from the customer.
Supply Chain Financing
We have entered into supply chain financing agreements with certain banks, pursuant to which we offer for sale certain accounts receivable to such banks from time to time, subject to the terms of the applicable agreements. These transactions result in a reduction in accounts receivable, as the agreements transfer effective control over, and credit risk related to, the receivables to the banks. These agreements do not allow for recourse in the event of uncollectibility, and we do not retain any interest in the underlying accounts receivable once sold. As of September 30, 2019, we derecognized $7.9 million of accounts receivable under these agreements. Discount fees related to the sale of such accounts receivable on our condensed consolidated income statements for the nine months ended September 30, 2019 were not material.

Voluntary Recall
On January 24, 2019, we issued a voluntary recall of our Vial2Bag® product line due to reports of potential unpredictable or variable dosing under certain conditions. Our fourth quarter 2018 results included an $11.3 million provision for product returns, recorded as a reduction of sales, partially offset by a reduction in cost of goods sold reflecting our inventory balance for these devices at December 31, 2018. During the three and nine months ended September 30, 2019, we recorded a net adjustment of $0.9 million and a net provision of $4.9 million, respectively, for potential inventory returns from our customers and related in-house inventory, partially offset by a reduction in our provision for product returns. We continue to work to get the products back on the market.

XML 25 R14.htm IDEA: XBRL DOCUMENT v3.19.3
Affiliated Companies
 9 Months Ended
Sep. 30, 2019
Equity Method Investments and Joint Ventures [Abstract]  
Affiliated Companies Affiliated Companies

At September 30, 2019 and December 31, 2018, the aggregate carrying amount of our investment in affiliated companies that are accounted for under the equity method was $84.0 million and $77.8 million, respectively, and the aggregate carrying amount of our investment in affiliated companies that are not accounted for under the equity method was $13.4 million at both period-ends. We have elected to record these investments, for which fair value was not readily determinable, at cost, less impairment, adjusted for subsequent observable price changes. We test these investments for impairment whenever circumstances indicate that the carrying value of the investments may not be recoverable.

Our purchases from, and royalty payments made to, affiliates totaled $33.0 million and $85.2 million, respectively, for the three and nine months ended September 30, 2019, as compared to $16.3 million and $64.0 million, respectively, for the same periods in 2018. As of September 30, 2019 and December 31, 2018, the payable balance due to affiliates was $24.3 million and $12.9 million, respectively. The majority of these transactions related to a distributorship agreement with Daikyo Seiko, Ltd. (“Daikyo”) that allows us to purchase and re-sell Daikyo products.

Sales to affiliates were $2.2 million and $6.9 million, respectively, for the three and nine months ended September 30, 2019, as compared to $3.0 million and $8.0 million, respectively, for the same periods in 2018. As of September 30, 2019 and December 31, 2018, the receivable balance due from affiliates was $1.4 million and $1.6 million, respectively.

Please refer to Note 6, Affiliated Companies, to the consolidated financial statements in our 2018 Annual Report for additional details.
XML 26 R18.htm IDEA: XBRL DOCUMENT v3.19.3
Accumulated Other Comprehensive Loss
 9 Months Ended
Sep. 30, 2019
Equity [Abstract]  
Accumulated Other Comprehensive Loss Accumulated Other Comprehensive Loss
 
The following table presents the changes in the components of accumulated other comprehensive loss, net of tax, for the nine months ended September 30, 2019:

($ in millions)
(Losses) gains on
derivatives
 
Unrealized gains
on investment
securities
 
Defined benefit
pension and other
postretirement plans
 
Foreign
currency
translation
 
Total
Balance, December 31, 2018
$
(0.4
)
 
$
0.4

 
$
(40.4
)
 
$
(113.8
)
 
$
(154.2
)
Other comprehensive income (loss) before reclassifications
6.0

 
—

 
0.6

 
(20.1
)
 
(13.5
)
Amounts reclassified out
(4.3
)
 
—

 
1.6

 
—

 
(2.7
)
Other comprehensive income (loss), net of tax
1.7

 
—

 
2.2

 
(20.1
)
 
(16.2
)
Balance, September 30, 2019
$
1.3

 
$
0.4

 
$
(38.2
)
 
$
(133.9
)
 
$
(170.4
)


A summary of the reclassifications out of accumulated other comprehensive loss is presented in the following table:

($ in millions)
 
Three Months Ended
September 30,
 
Nine Months Ended
September 30,
 
Location on Statement of Income
Detail of components
 
2019
 
2018
 
2019
 
2018

 
Gains (losses) on derivatives:
 
 
 
 
 
 
 
 
 
 
Foreign currency contracts
 
$
0.3

 
$
0.1

 
$
0.8

 
$
(0.8
)
 
Net sales
Foreign currency contracts
 
0.3

 
—

 
0.8

 
(0.7
)
 
Cost of goods and services sold
Foreign currency contracts
 
(4.3
)
 
—

 
5.0

 
—

 
Other expense (income)
Forward treasury locks
 
(0.1
)
 
(0.1
)
 
(0.3
)
 
(0.3
)
 
Interest expense
Total before tax
 
(3.8
)
 
—

 
6.3

 
(1.8
)
 
 
Tax expense
 
1.3

 
—

 
(2.0
)
 
0.4

 
 
Net of tax
 
$
(2.5
)
 
$
—

 
$
4.3

 
$
(1.4
)
 
 
Amortization of defined benefit pension and other postretirement plans:
 
 
 
 
 
 
 
 
 
 
Prior service credit
 
$
0.1

 
$
0.5

 
$
0.4

 
$
1.6

 
(a)
Actuarial gains (losses)
 
0.2

 
(0.2
)
 
0.2

 
(1.0
)
 
(a)
Settlements
 
(2.7
)
 
—

 
(2.7
)
 
—

 
(a)
Total before tax
 
(2.4
)
 
0.3

 
(2.1
)
 
0.6

 
 
Tax expense
 
0.6

 
—

 
0.5

 
(0.1
)
 
 
Net of tax
 
$
(1.8
)
 
$
0.3

 
$
(1.6
)
 
$
0.5

 
 
Total reclassifications for the period, net of tax
 
$
(4.3
)
 
$
0.3

 
$
2.7

 
$
(0.9
)
 
 

(a) These components are included in the computation of net periodic benefit cost. Please refer to Note 14, Benefit Plans, for additional details.
XML 27 FilingSummary.xml IDEA: XBRL DOCUMENT 3.19.3 html 335 377 1 true 87 0 false 10 false false R1.htm 0001000 - Document - Document and Entity Information Sheet http://www.westpharma.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 1001000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED) Sheet http://www.westpharma.com/role/CondensedConsolidatedStatementsOfIncomeUnaudited CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED) Statements 2 false false R3.htm 1002000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED) Sheet http://www.westpharma.com/role/CondensedConsolidatedStatementsOfComprehensiveIncomeUnaudited CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED) Statements 3 false false R4.htm 1002501 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED) (Parenthetical) Sheet http://www.westpharma.com/role/CondensedConsolidatedStatementsOfComprehensiveIncomeUnauditedParenthetical CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED) (Parenthetical) Statements 4 false false R5.htm 1003000 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) Sheet http://www.westpharma.com/role/CondensedConsolidatedBalanceSheetsUnaudited CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) Statements 5 false false R6.htm 1003001 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical) Sheet http://www.westpharma.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical) Statements 6 false false R7.htm 1005000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) Sheet http://www.westpharma.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) Statements 7 false false R8.htm 2101100 - Disclosure - Summary of Significant Accounting Policies Sheet http://www.westpharma.com/role/SummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 8 false false R9.htm 2102100 - Disclosure - New Accounting Standards Sheet http://www.westpharma.com/role/NewAccountingStandards New Accounting Standards Notes 9 false false R10.htm 2103100 - Disclosure - Revenue Sheet http://www.westpharma.com/role/Revenue Revenue Notes 10 false false R11.htm 2104100 - Disclosure - Net Income Per Share Sheet http://www.westpharma.com/role/NetIncomePerShare Net Income Per Share Notes 11 false false R12.htm 2105100 - Disclosure - Inventories Sheet http://www.westpharma.com/role/Inventories Inventories Notes 12 false false R13.htm 2106100 - Disclosure - Leases Sheet http://www.westpharma.com/role/Leases Leases Notes 13 false false R14.htm 2107100 - Disclosure - Affiliated Companies Sheet http://www.westpharma.com/role/AffiliatedCompanies Affiliated Companies Notes 14 false false R15.htm 2108100 - Disclosure - Debt Sheet http://www.westpharma.com/role/Debt Debt Notes 15 false false R16.htm 2109100 - Disclosure - Derivative Financial Instruments Sheet http://www.westpharma.com/role/DerivativeFinancialInstruments Derivative Financial Instruments Notes 16 false false R17.htm 2110100 - Disclosure - Fair Value Measurements Sheet http://www.westpharma.com/role/FairValueMeasurements Fair Value Measurements Notes 17 false false R18.htm 2111100 - Disclosure - Accumulated Other Comprehensive Loss Sheet http://www.westpharma.com/role/AccumulatedOtherComprehensiveLoss Accumulated Other Comprehensive Loss Notes 18 false false R19.htm 2112100 - Disclosure - Shareholders' Equity Sheet http://www.westpharma.com/role/ShareholdersEquity Shareholders' Equity Notes 19 false false R20.htm 2113100 - Disclosure - Stock-Based Compensation Sheet http://www.westpharma.com/role/StockBasedCompensation Stock-Based Compensation Notes 20 false false R21.htm 2114100 - Disclosure - Benefit Plans Sheet http://www.westpharma.com/role/BenefitPlans Benefit Plans Notes 21 false false R22.htm 2115100 - Disclosure - Other Expense Sheet http://www.westpharma.com/role/OtherExpense Other Expense Notes 22 false false R23.htm 2116100 - Disclosure - Income Taxes Sheet http://www.westpharma.com/role/IncomeTaxes Income Taxes Notes 23 false false R24.htm 2117100 - Disclosure - Commitments and Contingencies Sheet http://www.westpharma.com/role/CommitmentsAndContingencies Commitments and Contingencies Notes 24 false false R25.htm 2118100 - Disclosure - Segment Information Sheet http://www.westpharma.com/role/SegmentInformation Segment Information Notes 25 false false R26.htm 2119100 - Disclosure - Subsequent Event (Notes) Notes http://www.westpharma.com/role/SubsequentEventNotes Subsequent Event (Notes) Notes 26 false false R27.htm 2201201 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://www.westpharma.com/role/SummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://www.westpharma.com/role/SummaryOfSignificantAccountingPolicies 27 false false R28.htm 2303301 - Disclosure - Revenue (Tables) Sheet http://www.westpharma.com/role/RevenueTables Revenue (Tables) Tables http://www.westpharma.com/role/Revenue 28 false false R29.htm 2304301 - Disclosure - Net Income Per Share (Tables) Sheet http://www.westpharma.com/role/NetIncomePerShareTables Net Income Per Share (Tables) Tables http://www.westpharma.com/role/NetIncomePerShare 29 false false R30.htm 2305301 - Disclosure - Inventories (Tables) Sheet http://www.westpharma.com/role/InventoriesTables Inventories (Tables) Tables http://www.westpharma.com/role/Inventories 30 false false R31.htm 2306301 - Disclosure - Leases Leases (Tables) Sheet http://www.westpharma.com/role/LeasesLeasesTables Leases Leases (Tables) Tables 31 false false R32.htm 2308301 - Disclosure - Debt (Tables) Sheet http://www.westpharma.com/role/DebtTables Debt (Tables) Tables http://www.westpharma.com/role/Debt 32 false false R33.htm 2309301 - Disclosure - Derivative Financial Instruments (Tables) Sheet http://www.westpharma.com/role/DerivativeFinancialInstrumentsTables Derivative Financial Instruments (Tables) Tables http://www.westpharma.com/role/DerivativeFinancialInstruments 33 false false R34.htm 2310301 - Disclosure - Fair Value Measurements (Tables) Sheet http://www.westpharma.com/role/FairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://www.westpharma.com/role/FairValueMeasurements 34 false false R35.htm 2311301 - Disclosure - Accumulated Other Comprehensive Loss (Tables) Sheet http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossTables Accumulated Other Comprehensive Loss (Tables) Tables http://www.westpharma.com/role/AccumulatedOtherComprehensiveLoss 35 false false R36.htm 2312301 - Disclosure - Shareholders' Equity (Tables) Sheet http://www.westpharma.com/role/ShareholdersEquityTables Shareholders' Equity (Tables) Tables http://www.westpharma.com/role/ShareholdersEquity 36 false false R37.htm 2314301 - Disclosure - Benefit Plans (Tables) Sheet http://www.westpharma.com/role/BenefitPlansTables Benefit Plans (Tables) Tables http://www.westpharma.com/role/BenefitPlans 37 false false R38.htm 2315301 - Disclosure - Other Expense (Tables) Sheet http://www.westpharma.com/role/OtherExpenseTables Other Expense (Tables) Tables http://www.westpharma.com/role/OtherExpense 38 false false R39.htm 2318301 - Disclosure - Segment Information (Tables) Sheet http://www.westpharma.com/role/SegmentInformationTables Segment Information (Tables) Tables http://www.westpharma.com/role/SegmentInformation 39 false false R40.htm 2401402 - Disclosure - Summary of Significant Accounting Policies Business Combinations (Details) Sheet http://www.westpharma.com/role/SummaryOfSignificantAccountingPoliciesBusinessCombinationsDetails Summary of Significant Accounting Policies Business Combinations (Details) Details 40 false false R41.htm 2403402 - Disclosure - Revenue Recognition (Details) Sheet http://www.westpharma.com/role/RevenueRecognitionDetails Revenue Recognition (Details) Details 41 false false R42.htm 2403403 - Disclosure - Contracts and Liabilities (Details) Sheet http://www.westpharma.com/role/ContractsAndLiabilitiesDetails Contracts and Liabilities (Details) Details 42 false false R43.htm 2403404 - Disclosure - Revenue Supply Chain Financing (Details) Sheet http://www.westpharma.com/role/RevenueSupplyChainFinancingDetails Revenue Supply Chain Financing (Details) Details 43 false false R44.htm 2403405 - Disclosure - Revenue Voluntary Recall (Details) Sheet http://www.westpharma.com/role/RevenueVoluntaryRecallDetails Revenue Voluntary Recall (Details) Details 44 false false R45.htm 2404402 - Disclosure - Net Income Per Share (Details) Sheet http://www.westpharma.com/role/NetIncomePerShareDetails Net Income Per Share (Details) Details http://www.westpharma.com/role/NetIncomePerShareTables 45 false false R46.htm 2405402 - Disclosure - Inventories (Details) Sheet http://www.westpharma.com/role/InventoriesDetails Inventories (Details) Details http://www.westpharma.com/role/InventoriesTables 46 false false R47.htm 2406402 - Disclosure - Leases Adoption of ASC 842 (Details) Sheet http://www.westpharma.com/role/LeasesAdoptionOfAsc842Details Leases Adoption of ASC 842 (Details) Details 47 false false R48.htm 2406403 - Disclosure - Leases Lease Cost (Details) Sheet http://www.westpharma.com/role/LeasesLeaseCostDetails Leases Lease Cost (Details) Details 48 false false R49.htm 2406404 - Disclosure - Leases Lease Cash Flow and Supplemental Information (Details) Sheet http://www.westpharma.com/role/LeasesLeaseCashFlowAndSupplementalInformationDetails Leases Lease Cash Flow and Supplemental Information (Details) Details 49 false false R50.htm 2406405 - Disclosure - Leases Lease Weighted Average (Details) Sheet http://www.westpharma.com/role/LeasesLeaseWeightedAverageDetails Leases Lease Weighted Average (Details) Details 50 false false R51.htm 2406406 - Disclosure - Leases Maturities of Operating Lease Liabilities (Details) Sheet http://www.westpharma.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails Leases Maturities of Operating Lease Liabilities (Details) Details 51 false false R52.htm 2407401 - Disclosure - Affiliated Companies (Details) Sheet http://www.westpharma.com/role/AffiliatedCompaniesDetails Affiliated Companies (Details) Details http://www.westpharma.com/role/AffiliatedCompanies 52 false false R53.htm 2408402 - Disclosure - Long-term Debt (Details) Sheet http://www.westpharma.com/role/LongTermDebtDetails Long-term Debt (Details) Details 53 false false R54.htm 2408403 - Disclosure - Credit Facility (Details) Sheet http://www.westpharma.com/role/CreditFacilityDetails Credit Facility (Details) Details 54 false false R55.htm 2409402 - Disclosure - Derivative Financial Instruments (Textuals) (Details) Sheet http://www.westpharma.com/role/DerivativeFinancialInstrumentsTextualsDetails Derivative Financial Instruments (Textuals) (Details) Details http://www.westpharma.com/role/DerivativeFinancialInstrumentsTables 55 false false R56.htm 2409403 - Disclosure - Effects of Derivative Instruments on OCI and Earnings (Details) Sheet http://www.westpharma.com/role/EffectsOfDerivativeInstrumentsOnOciAndEarningsDetails Effects of Derivative Instruments on OCI and Earnings (Details) Details 56 false false R57.htm 2410402 - Disclosure - Fair Value Measurements (Details) Sheet http://www.westpharma.com/role/FairValueMeasurementsDetails Fair Value Measurements (Details) Details http://www.westpharma.com/role/FairValueMeasurementsTables 57 false false R58.htm 2410403 - Disclosure - Fair Value Measurements Level 3 (Details) Sheet http://www.westpharma.com/role/FairValueMeasurementsLevel3Details Fair Value Measurements Level 3 (Details) Details 58 false false R59.htm 2410404 - Disclosure - Fair Value Measurements Other Financial Instruments (Details) Sheet http://www.westpharma.com/role/FairValueMeasurementsOtherFinancialInstrumentsDetails Fair Value Measurements Other Financial Instruments (Details) Details 59 false false R60.htm 2411402 - Disclosure - Accumulated Other Comprehensive Loss Components (Details) Sheet http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossComponentsDetails Accumulated Other Comprehensive Loss Components (Details) Details 60 false false R61.htm 2411403 - Disclosure - Accumulated Other Comprehensive Loss Reclassifications (Details) Sheet http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossReclassificationsDetails Accumulated Other Comprehensive Loss Reclassifications (Details) Details 61 false false R62.htm 2412402 - Disclosure - Supplemental Equity Information (Details) Sheet http://www.westpharma.com/role/SupplementalEquityInformationDetails Supplemental Equity Information (Details) Details 62 false false R63.htm 2412403 - Disclosure - Change in Shareholders' Equity (Details) Sheet http://www.westpharma.com/role/ChangeInShareholdersEquityDetails Change in Shareholders' Equity (Details) Details 63 false false R64.htm 2413401 - Disclosure - Stock-Based Compensation (Details) Sheet http://www.westpharma.com/role/StockBasedCompensationDetails Stock-Based Compensation (Details) Details http://www.westpharma.com/role/StockBasedCompensation 64 false false R65.htm 2414402 - Disclosure - Benefit Plans (Details) Sheet http://www.westpharma.com/role/BenefitPlansDetails Benefit Plans (Details) Details http://www.westpharma.com/role/BenefitPlansTables 65 false false R66.htm 2415402 - Disclosure - Other Expense (Details) Sheet http://www.westpharma.com/role/OtherExpenseDetails Other Expense (Details) Details http://www.westpharma.com/role/OtherExpenseTables 66 false false R67.htm 2415403 - Disclosure - Other Expense Items (Details) Sheet http://www.westpharma.com/role/OtherExpenseItemsDetails Other Expense Items (Details) Details 67 false false R68.htm 2415404 - Disclosure - Other Expense Restructuring and Related Charges (Details) Sheet http://www.westpharma.com/role/OtherExpenseRestructuringAndRelatedChargesDetails Other Expense Restructuring and Related Charges (Details) Details 68 false false R69.htm 2415405 - Disclosure - Other Expense Other (Income) Development and Licensing Income (Details) Sheet http://www.westpharma.com/role/OtherExpenseOtherIncomeDevelopmentAndLicensingIncomeDetails Other Expense Other (Income) Development and Licensing Income (Details) Details 69 false false R70.htm 2416401 - Disclosure - Income Taxes (Details) Sheet http://www.westpharma.com/role/IncomeTaxesDetails Income Taxes (Details) Details http://www.westpharma.com/role/IncomeTaxes 70 false false R71.htm 2418402 - Disclosure - Segment Information (Details) Sheet http://www.westpharma.com/role/SegmentInformationDetails Segment Information (Details) Details http://www.westpharma.com/role/SegmentInformationTables 71 false false R72.htm 2419402 - Disclosure - Subsequent Event (Details) Sheet http://www.westpharma.com/role/SubsequentEventDetails Subsequent Event (Details) Details http://www.westpharma.com/role/SubsequentEventNotes 72 false false All Reports Book All Reports wst10q93019.htm ex311q32019.htm ex312q32019.htm ex321q32019.htm ex322q32019.htm wst-20190930.xsd wst-20190930_cal.xml wst-20190930_def.xml wst-20190930_lab.xml wst-20190930_pre.xml http://fasb.org/us-gaap/2019-01-31 http://xbrl.sec.gov/currency/2019-01-31 http://xbrl.sec.gov/country/2017-01-31 http://fasb.org/srt/2019-01-31 http://xbrl.sec.gov/dei/2019-01-31 true true XML 28 R71.htm IDEA: XBRL DOCUMENT v3.19.3
Segment Information (Details)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2019
USD ($)
Sep. 30, 2018
USD ($)
Sep. 30, 2019
USD ($)
segment
Sep. 30, 2018
USD ($)
Segment Reporting [Abstract]        
Number of reportable segments | segment     2  
Restructuring and related charges $ 1.8 $ 1.2 $ 3.8 $ 6.7
Argentina currency devaluation 1.0 1.1 1.0 1.1
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]        
Net sales 456.1 431.7 1,369.3 1,294.9
Total operating (loss) profit 67.3 60.8 218.5 174.5
Interest expense 2.1 2.0 6.4 6.1
Interest income (1.0) (0.5) (2.5) (1.4)
Other nonoperating income 1.3 (1.8) 0.2 (5.1)
Income before income taxes 64.9 61.1 214.4 174.9
Proprietary Products [Member]        
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]        
Net sales 345.2 325.2 1,045.9 997.4
Total operating (loss) profit 72.9 68.2 238.7 202.7
Contract-Manufactured Products [Member]        
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]        
Net sales 111.1 106.7 323.6 297.7
Total operating (loss) profit 11.6 11.2 33.5 29.7
Intersegment sales elimination [Member]        
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]        
Net sales (0.2) (0.2) (0.2) (0.2)
Corporate [Member]        
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]        
Total operating (loss) profit (14.4) (16.3) (48.9) (50.1)
Other unallocated items [Member]        
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]        
Total operating (loss) profit $ (2.8) $ (2.3) $ (4.8) $ (7.8)
XML 29 R52.htm IDEA: XBRL DOCUMENT v3.19.3
Affiliated Companies (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Dec. 31, 2018
Schedule of Equity Method Investments [Line Items]          
Purchases and royalty payments made to affiliates $ 33.0 $ 16.3 $ 85.2 $ 64.0  
Amount due and payable to affiliates 24.3   24.3   $ 12.9
Sales to affiliates 2.2 $ 3.0 6.9 $ 8.0  
Amount receivable from affiliates 1.4   1.4   1.6
Carrying amount, equity-method investments 84.0   84.0   77.8
Carrying amount, cost-method investments $ 13.4   $ 13.4   $ 13.4
XML 30 R56.htm IDEA: XBRL DOCUMENT v3.19.3
Effects of Derivative Instruments on OCI and Earnings (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Derivative Instruments, Gain (Loss) [Line Items]        
Document Period End Date     Sep. 30, 2019  
Fair Value Hedging [Member]        
Derivative Instruments, Gain (Loss) [Line Items]        
Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax $ (0.6)   $ 3.9  
Derivative, Gain (Loss) on Derivative, Net 4.3 $ (2.0) (5.0) $ (3.4)
Amount of (gain) loss reclassified from accumulated OCI into income 2.9   (3.3)  
Cash Flow Hedges [Member]        
Derivative Instruments, Gain (Loss) [Line Items]        
Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax 1.3 (0.4) 2.1 1.1
Amount of (gain) loss reclassified from accumulated OCI into income (0.4) 0.0 (1.0) 1.4
Cash Flow Hedges [Member]        
Derivative Instruments, Gain (Loss) [Line Items]        
Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net 0.1 0.0 0.3 (0.5)
Net Investment Hedges [Member]        
Derivative Instruments, Gain (Loss) [Line Items]        
Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax 0.7 0.2 0.5 0.7
Amount of (gain) loss reclassified from accumulated OCI into income 0.0 0.0 0.0 0.0
Foreign Currency Hedge Contracts [Member] | Net sales [Member] | Cash Flow Hedges [Member]        
Derivative Instruments, Gain (Loss) [Line Items]        
Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax 0.7 0.1 1.0 0.2
Amount of (gain) loss reclassified from accumulated OCI into income (0.3) 0.0 (0.7) 0.8
Foreign Currency Hedge Contracts [Member] | Cost of goods and services sold [Member] | Cash Flow Hedges [Member]        
Derivative Instruments, Gain (Loss) [Line Items]        
Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax 0.6 (0.5) 1.1 0.9
Amount of (gain) loss reclassified from accumulated OCI into income (0.2) (0.1) (0.5) 0.4
Foreign Currency Hedge Contracts [Member] | Other expense [Member] | Fair Value Hedging [Member]        
Derivative Instruments, Gain (Loss) [Line Items]        
Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax (0.6)   3.9  
Derivative, Gain (Loss) on Derivative, Net 4.3 (2.0) (5.0) (3.4)
Amount of (gain) loss reclassified from accumulated OCI into income 2.9   (3.3)  
Foreign Currency Hedge Contracts [Member] | Cost of goods and services sold [Member] | Cash Flow Hedges [Member]        
Derivative Instruments, Gain (Loss) [Line Items]        
Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net 0.1 0.0 0.3 (0.5)
Forward Treasury Locks [Member] | Interest expense [Member] | Cash Flow Hedges [Member]        
Derivative Instruments, Gain (Loss) [Line Items]        
Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax 0.0 0.0 0.0 0.0
Amount of (gain) loss reclassified from accumulated OCI into income 0.1 0.1 0.2 0.2
Foreign Currency - Denominated Debt [Member] | Other expense [Member] | Net Investment Hedges [Member]        
Derivative Instruments, Gain (Loss) [Line Items]        
Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax 0.7 0.2 0.5 0.7
Amount of (gain) loss reclassified from accumulated OCI into income $ 0.0 $ 0.0 $ 0.0 $ 0.0
XML 31 R36.htm IDEA: XBRL DOCUMENT v3.19.3
Shareholders' Equity (Tables)
 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Equity [Abstract]    
Schedule of Stockholders Equity [Table Text Block]

The following table presents the changes in shareholders’ equity for the nine months ended September 30, 2019:

 
Common Shares Issued
 
Common Stock
 
Capital in Excess of Par Value
 
Number of Treasury Shares
 
Treasury Stock
 
Retained earnings
 
Accumulated other comprehensive loss
 
Total
($ in millions)
 
 
 
 
 
 
 
Balance, December 31, 2018
75.3

 
$
18.8

 
$
282.0

 
1.2

 
$
(103.7
)
 
$
1,353.4

 
$
(154.2
)
 
$
1,396.3

Net income
—

 
—

 
—

 
—

 
—

 
55.4

 
—

 
55.4

Activity related to stock-based compensation
—

 
—

 
(3.5
)
 
(0.2
)
 
14.2

 
—

 
—

 
10.7

Shares purchased under share repurchase program
—

 
—

 
—

 
0.8

 
(83.1
)
 
—

 
—

 
(83.1
)
Dividends declared ($0.15 per share)
—

 
—

 
—

 
—

 
—

 
(10.6
)
 
—

 
(10.6
)
Other comprehensive income, net of tax
—

 
—

 
—

 
—

 
—

 
—

 
0.8

 
0.8

Balance, March 31, 2019
75.3

 
$
18.8

 
$
278.5

 
1.8

 
$
(172.6
)
 
$
1,398.2

 
$
(153.4
)
 
$
1,369.5

Net income
—

 
—

 
—

 
—

 
—

 
66.1

 
—

 
66.1

Activity related to stock-based compensation
—

 
—

 
(5.1
)
 
(0.2
)
 
24.8

 
—

 
—

 
19.7

Dividends declared ($0.15 per share)
—

 
—

 
—

 
—

 
—

 
(11.4
)
 
—

 
(11.4
)
Other comprehensive income, net of tax
—

 
—

 
—

 
—

 
—

 
—

 
1.2

 
1.2

Balance, June 30, 2019
75.3

 
$
18.8

 
$
273.4

 
1.6

 
$
(147.8
)
 
$
1,452.9

 
$
(152.2
)
 
$
1,445.1

Net income
—

 
—

 
—

 
—

 
—

 
56.3

 
—

 
56.3

Activity related to stock-based compensation
—

 
—

 
(4.9
)
 
(0.3
)
 
21.2

 
—

 
—

 
16.3

Dividends declared ($0.16 per share)
—

 
—

 
—

 
—

 
—

 
(11.9
)
 
—

 
(11.9
)
Other comprehensive loss, net of tax
—

 
—

 
—

 
—

 
—

 
—

 
(18.2
)
 
(18.2
)
Balance, September 30, 2019
75.3

 
$
18.8

 
$
268.5

 
1.3

 
$
(126.6
)
 
$
1,497.3

 
$
(170.4
)
 
$
1,487.6
The following table presents the changes in shareholders’ equity for the nine months ended September 30, 2018:

 
Common Shares Issued
 
Common Stock
 
Capital in Excess of Par Value
 
Number of Treasury Shares
 
Treasury Stock
 
Retained earnings
 
Accumulated other comprehensive loss
 
Total
($ in millions)
 
 
 
 
 
 
 
Balance, December 31, 2017
75.2

 
$
18.8

 
$
309.3

 
1.3

 
$
(109.1
)
 
$
1,178.2

 
$
(117.3
)
 
$
1,279.9

Effect of modified retrospective application of a new accounting standard
—

 
—

 
—

 
—

 
—

 
11.4

 
—

 
11.4

Net income
—

 
—

 
—

 
—

 
—

 
43.6

 
—

 
43.6

Activity related to stock-based compensation
0.1

 
—

 
(0.8
)
 
(0.1
)
 
8.0

 
—

 
—

 
7.2

Shares purchased under share repurchase program
—

 
—

 
—

 
0.5

 
(47.9
)
 
—

 
—

 
(47.9
)
Dividends declared ($0.14 per share)
—

 
—

 
—

 
—

 
—

 
(10.4
)
 
—

 
(10.4
)
Other comprehensive income, net of tax
—

 
—

 
—

 
—

 
—

 
—

 
21.5

 
21.5

Balance, March 31, 2018
75.3

 
$
18.8

 
$
308.5

 
1.7

 
$
(149.0
)
 
$
1,222.8

 
$
(95.8
)
 
$
1,305.3

Net income
—

 
—

 
—

 
—

 
—

 
56.1

 
—

 
56.1

Activity related to stock-based compensation
—

 
—

 
(3.8
)
 
(0.2
)
 
16.0

 
—

 
—

 
12.2

Shares purchased under share repurchase program
—

 
—

 
—

 
0.3

 
(22.9
)
 
—

 
—

 
(22.9
)
Dividends declared ($0.14 per share)
—

 
—

 
—

 
—

 
—

 
(20.9
)
 
—

 
(20.9
)
Other comprehensive loss, net of tax
—

 
—

 
—

 
—

 
—

 
—

 
(47.9
)
 
(47.9
)
Balance, June 30, 2018
75.3

 
$
18.8

 
$
304.7

 
1.8

 
$
(155.9
)
 
$
1,258.0

 
$
(143.7
)
 
$
1,281.9

Net income
—

 
—

 
—

 
—

 
—

 
55.2

 
—

 
55.2

Activity related to stock-based compensation
—

 
—

 
(21.9
)
 
(0.6
)
 
47.2

 
—

 
—

 
25.3

Dividends declared ($0.15 per share)
—

 
—

 
—

 
—

 
—

 
(0.5
)
 
—

 
(0.5
)
Other comprehensive loss, net of tax
—

 
—

 
—

 
—

 
—

 
—

 
(10.1
)
 
(10.1
)
Balance, September 30, 2018
75.3

 
$
18.8

 
$
282.8

 
1.2

 
$
(108.7
)
 
$
1,312.7

 
$
(153.8
)
 
$
1,351.8
XML 32 R32.htm IDEA: XBRL DOCUMENT v3.19.3
Debt (Tables)
 9 Months Ended
Sep. 30, 2019
Debt Disclosure [Abstract]  
Long-term Debt Obligations, Net of Current Maturities

The following table summarizes our long-term debt obligations, net of unamortized debt issuance costs and current maturities. The interest rates shown in parentheses are as of September 30, 2019.

($ in millions)
September 30,
2019
 
December 31,
2018
Note payable, due December 31, 2019
$
—

 
$
0.1

Credit Facility, due October 15, 2020
—

 
28.6

Credit Facility, due March 28, 2024 (0.875%)
27.6

 
—

Series A notes, due July 5, 2022 (3.67%)
42.0

 
42.0

Series B notes, due July 5, 2024 (3.82%)
53.0

 
53.0

Series C notes, due July 5, 2027 (4.02%)
73.0

 
73.0

 
195.6

 
196.7

Less: unamortized debt issuance costs
0.5

 
0.6

Total debt
195.1

 
196.1

Less: current portion of long-term debt
—

 
0.1

Long-term debt, net
$
195.1

 
$
196.0
XML 33 R19.htm IDEA: XBRL DOCUMENT v3.19.3
Shareholders' Equity
 9 Months Ended
Sep. 30, 2019
Equity [Abstract]  
Stockholders' Equity Note Disclosure [Text Block] Shareholders’ Equity

The following table presents the changes in shareholders’ equity for the nine months ended September 30, 2019:

 
Common Shares Issued
 
Common Stock
 
Capital in Excess of Par Value
 
Number of Treasury Shares
 
Treasury Stock
 
Retained earnings
 
Accumulated other comprehensive loss
 
Total
($ in millions)
 
 
 
 
 
 
 
Balance, December 31, 2018
75.3

 
$
18.8

 
$
282.0

 
1.2

 
$
(103.7
)
 
$
1,353.4

 
$
(154.2
)
 
$
1,396.3

Net income
—

 
—

 
—

 
—

 
—

 
55.4

 
—

 
55.4

Activity related to stock-based compensation
—

 
—

 
(3.5
)
 
(0.2
)
 
14.2

 
—

 
—

 
10.7

Shares purchased under share repurchase program
—

 
—

 
—

 
0.8

 
(83.1
)
 
—

 
—

 
(83.1
)
Dividends declared ($0.15 per share)
—

 
—

 
—

 
—

 
—

 
(10.6
)
 
—

 
(10.6
)
Other comprehensive income, net of tax
—

 
—

 
—

 
—

 
—

 
—

 
0.8

 
0.8

Balance, March 31, 2019
75.3

 
$
18.8

 
$
278.5

 
1.8

 
$
(172.6
)
 
$
1,398.2

 
$
(153.4
)
 
$
1,369.5

Net income
—

 
—

 
—

 
—

 
—

 
66.1

 
—

 
66.1

Activity related to stock-based compensation
—

 
—

 
(5.1
)
 
(0.2
)
 
24.8

 
—

 
—

 
19.7

Dividends declared ($0.15 per share)
—

 
—

 
—

 
—

 
—

 
(11.4
)
 
—

 
(11.4
)
Other comprehensive income, net of tax
—

 
—

 
—

 
—

 
—

 
—

 
1.2

 
1.2

Balance, June 30, 2019
75.3

 
$
18.8

 
$
273.4

 
1.6

 
$
(147.8
)
 
$
1,452.9

 
$
(152.2
)
 
$
1,445.1

Net income
—

 
—

 
—

 
—

 
—

 
56.3

 
—

 
56.3

Activity related to stock-based compensation
—

 
—

 
(4.9
)
 
(0.3
)
 
21.2

 
—

 
—

 
16.3

Dividends declared ($0.16 per share)
—

 
—

 
—

 
—

 
—

 
(11.9
)
 
—

 
(11.9
)
Other comprehensive loss, net of tax
—

 
—

 
—

 
—

 
—

 
—

 
(18.2
)
 
(18.2
)
Balance, September 30, 2019
75.3

 
$
18.8

 
$
268.5

 
1.3

 
$
(126.6
)
 
$
1,497.3

 
$
(170.4
)
 
$
1,487.6



The following table presents the changes in shareholders’ equity for the nine months ended September 30, 2018:

 
Common Shares Issued
 
Common Stock
 
Capital in Excess of Par Value
 
Number of Treasury Shares
 
Treasury Stock
 
Retained earnings
 
Accumulated other comprehensive loss
 
Total
($ in millions)
 
 
 
 
 
 
 
Balance, December 31, 2017
75.2

 
$
18.8

 
$
309.3

 
1.3

 
$
(109.1
)
 
$
1,178.2

 
$
(117.3
)
 
$
1,279.9

Effect of modified retrospective application of a new accounting standard
—

 
—

 
—

 
—

 
—

 
11.4

 
—

 
11.4

Net income
—

 
—

 
—

 
—

 
—

 
43.6

 
—

 
43.6

Activity related to stock-based compensation
0.1

 
—

 
(0.8
)
 
(0.1
)
 
8.0

 
—

 
—

 
7.2

Shares purchased under share repurchase program
—

 
—

 
—

 
0.5

 
(47.9
)
 
—

 
—

 
(47.9
)
Dividends declared ($0.14 per share)
—

 
—

 
—

 
—

 
—

 
(10.4
)
 
—

 
(10.4
)
Other comprehensive income, net of tax
—

 
—

 
—

 
—

 
—

 
—

 
21.5

 
21.5

Balance, March 31, 2018
75.3

 
$
18.8

 
$
308.5

 
1.7

 
$
(149.0
)
 
$
1,222.8

 
$
(95.8
)
 
$
1,305.3

Net income
—

 
—

 
—

 
—

 
—

 
56.1

 
—

 
56.1

Activity related to stock-based compensation
—

 
—

 
(3.8
)
 
(0.2
)
 
16.0

 
—

 
—

 
12.2

Shares purchased under share repurchase program
—

 
—

 
—

 
0.3

 
(22.9
)
 
—

 
—

 
(22.9
)
Dividends declared ($0.14 per share)
—

 
—

 
—

 
—

 
—

 
(20.9
)
 
—

 
(20.9
)
Other comprehensive loss, net of tax
—

 
—

 
—

 
—

 
—

 
—

 
(47.9
)
 
(47.9
)
Balance, June 30, 2018
75.3

 
$
18.8

 
$
304.7

 
1.8

 
$
(155.9
)
 
$
1,258.0

 
$
(143.7
)
 
$
1,281.9

Net income
—

 
—

 
—

 
—

 
—

 
55.2

 
—

 
55.2

Activity related to stock-based compensation
—

 
—

 
(21.9
)
 
(0.6
)
 
47.2

 
—

 
—

 
25.3

Dividends declared ($0.15 per share)
—

 
—

 
—

 
—

 
—

 
(0.5
)
 
—

 
(0.5
)
Other comprehensive loss, net of tax
—

 
—

 
—

 
—

 
—

 
—

 
(10.1
)
 
(10.1
)
Balance, September 30, 2018
75.3

 
$
18.8

 
$
282.8

 
1.2

 
$
(108.7
)
 
$
1,312.7

 
$
(153.8
)
 
$
1,351.8
XML 34 R11.htm IDEA: XBRL DOCUMENT v3.19.3
Net Income Per Share
 9 Months Ended
Sep. 30, 2019
Earnings Per Share [Abstract]  
Net Income Per Share Net Income Per Share

The following table reconciles the shares used in the calculation of basic net income per share to those used for diluted net income per share:

 
Three Months Ended
September 30,
 
Nine Months Ended
September 30,
(in millions)
2019
 
2018
 
2019
 
2018
Net income
$
56.3

 
$
55.2

 
$
177.8

 
$
154.9

Weighted average common shares outstanding
74.0

 
73.9

 
73.9

 
73.9

Dilutive effect of equity awards, based on the treasury stock method
1.5

 
1.8

 
1.4

 
1.5

Weighted average shares assuming dilution
75.5

 
75.7

 
75.3

 
75.4



During the three months ended September 30, 2019 and 2018, there were 0.1 million and 0.1 million shares, respectively, from stock-based compensation plans not included in the computation of diluted net income per share because their impact was antidilutive. There were 0.3 million and 0.4 million antidilutive shares outstanding during the nine months ended September 30, 2019 and 2018, respectively.

In February 2019, we announced a share repurchase program for calendar-year 2019 authorizing the repurchase of up to 800,000 shares of our common stock from time to time on the open market or in privately-negotiated transactions as permitted under the Securities Exchange Act of 1934 Rule 10b-18. The number of shares repurchased and the timing of such transactions depended on a variety of factors, including market conditions. There were no shares purchased during the three months ended September 30, 2019. During the nine months ended September 30, 2019, we purchased 800,000 shares of our common stock under the now-completed program at a cost of $83.1 million, or an average price of $103.89 per share.
XML 35 R15.htm IDEA: XBRL DOCUMENT v3.19.3
Debt
 9 Months Ended
Sep. 30, 2019
Debt Disclosure [Abstract]  
Debt Debt

The following table summarizes our long-term debt obligations, net of unamortized debt issuance costs and current maturities. The interest rates shown in parentheses are as of September 30, 2019.

($ in millions)
September 30,
2019
 
December 31,
2018
Note payable, due December 31, 2019
$
—

 
$
0.1

Credit Facility, due October 15, 2020
—

 
28.6

Credit Facility, due March 28, 2024 (0.875%)
27.6

 
—

Series A notes, due July 5, 2022 (3.67%)
42.0

 
42.0

Series B notes, due July 5, 2024 (3.82%)
53.0

 
53.0

Series C notes, due July 5, 2027 (4.02%)
73.0

 
73.0

 
195.6

 
196.7

Less: unamortized debt issuance costs
0.5

 
0.6

Total debt
195.1

 
196.1

Less: current portion of long-term debt
—

 
0.1

Long-term debt, net
$
195.1

 
$
196.0



In March 2019, we entered into a new senior unsecured, multi-currency revolving credit facility agreement (the “Credit Agreement”) that replaced our prior revolving credit facility, which was scheduled to expire in October 2020. The Credit Agreement, which expires in March 2024, contains a senior unsecured, multi-currency revolving credit facility (the “Credit Facility”) of $300.0 million, with sublimits of up to $30.0 million for swing line loans for domestic borrowers in U.S. Dollars (“USD”) and a $20.0 million swing line loan for our German Holding Company and up to $30.0 million for the issuance of standby letters of credit, which Credit Facility may be increased from time-to-time by the greater of $350.0 million and earnings before interest, taxes, depreciation and amortization (“EBITDA”) for the preceding twelve month period in the aggregate through an increase in the Credit Facility, subject to the satisfaction of certain conditions. Borrowings under the Credit Facility bear interest at either the base rate (the per annum interest rate of the highest of the Prime Rate, the Federal Funds Rate plus 50 basis points or the daily London Interbank Offered Rate (“LIBOR”), plus 1.00%) or at the applicable LIBOR rate, plus a tiered margin based on the ratio of our net consolidated debt to our modified EBITDA, ranging from 0 to 37.5 basis points for base rate loans and 87.5 to 137.5 basis points for LIBOR rate loans. The Credit Agreement contains financial covenants providing that we shall not permit the ratio of our net consolidated debt to our modified EBITDA to be greater than 3.5 to 1; provided that, no more than three times during the term of the Credit Agreement, upon the occurrence of a qualified acquisition for each of our four fiscal quarters immediately following such qualified acquisition, the ratio shall be increased to 4.0 to 1. The Credit Agreement also contains customary limitations on liens securing our indebtedness, fundamental changes (mergers, consolidations, liquidations and dissolutions), asset sales, distributions and acquisitions. As of September 30, 2019 and December 31, 2018, total unamortized debt issuance costs of $1.1 million and $0.6 million, respectively, were recorded in other noncurrent assets and are being amortized as additional interest expense over the term of the Credit Facility. A portion of these costs relate to our prior revolving credit facility.

At September 30, 2019, we had $27.6 million in outstanding long-term borrowings under the Credit Facility, of which $4.6 million was denominated in Japanese Yen (“Yen”) and $23.0 million was denominated in Euro. These borrowings, together with outstanding letters of credit of $2.5 million, resulted in a borrowing capacity available under the Credit Facility of $269.9 million at September 30, 2019. Please refer to Note 9, Derivative Financial Instruments, for a discussion of the foreign currency hedges associated with the Credit Facility.

Please refer to Note 9, Debt, to the consolidated financial statements in our 2018 Annual Report for additional details regarding our debt agreements.
XML 36 R70.htm IDEA: XBRL DOCUMENT v3.19.3
Income Taxes (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Income Tax Disclosure [Abstract]        
Tax expense (benefit) $ 10.9 $ 8.0 $ 42.5 $ 26.5
Effective income tax rate 16.80% 13.10% 19.80% 15.10%
Other Income Tax Expense (Benefit), Continuing Operations $ 1.0   $ 1.0  
New Accounting Pronouncements or Change in Accounting Principle [Line Items]        
Tax Cuts and Jobs Act of 2017, provisional income tax expense   $ (0.4)   $ 4.1
XML 37 R53.htm IDEA: XBRL DOCUMENT v3.19.3
Long-term Debt (Details) - USD ($)
$ in Millions
Sep. 30, 2019
Dec. 31, 2018
Debt Instrument [Line Items]    
Long-term debt, gross $ 195.6 $ 196.7
Long-term debt 195.1 196.1
Unamortized debt issuance costs 0.5 0.6
Current portion of long-term debt 0.0 0.1
Long-term debt, excluding current portion 195.1 196.0
Notes payable, Due 2019 [Member]    
Debt Instrument [Line Items]    
Long-term debt, gross 0.0 0.1
Revolving credit facility, Due 2020 [Member]    
Debt Instrument [Line Items]    
Long-term debt, gross $ 0.0 $ 28.6
Revolving credit facility, Due 2024 [Member]    
Debt Instrument [Line Items]    
Debt instrument, stated interest rate 0.875%  
Long-term debt, gross $ 27.6  
Series A Notes, Due 2022 [Member]    
Debt Instrument [Line Items]    
Debt instrument, stated interest rate 3.67% 3.67%
Long-term debt, gross $ 42.0 $ 42.0
Series B Notes, Due 2024 [Member]    
Debt Instrument [Line Items]    
Debt instrument, stated interest rate 3.82% 3.82%
Long-term debt, gross $ 53.0 $ 53.0
Series C Notes, Due 2027 [Member]    
Debt Instrument [Line Items]    
Debt instrument, stated interest rate 4.02% 4.02%
Long-term debt, gross $ 73.0 $ 73.0
XML 38 R57.htm IDEA: XBRL DOCUMENT v3.19.3
Fair Value Measurements (Details) - USD ($)
$ in Millions
Sep. 30, 2019
Dec. 31, 2018
Assets:    
Deferred compensation assets $ 9.9 $ 8.7
Foreign currency contracts 13.2 6.5
Commodity call options 0.1  
Total assets at fair value 23.2 15.2
Liabilities:    
Contingent consideration 1.8 1.7
Deferred compensation liabilities 11.4 9.8
Foreign currency contracts 0.2 0.2
Total liabilities at fair value 13.4 11.7
Level 1 [Member]    
Assets:    
Deferred compensation assets 9.9 8.7
Total assets at fair value 9.9 8.7
Liabilities:    
Deferred compensation liabilities 11.4 9.8
Total liabilities at fair value 11.4 9.8
Level 2 [Member]    
Assets:    
Foreign currency contracts 13.2 6.5
Commodity call options 0.1  
Total assets at fair value 13.3 6.5
Liabilities:    
Foreign currency contracts 0.2 0.2
Total liabilities at fair value 0.2 0.2
Level 3 [Member]    
Liabilities:    
Contingent consideration 1.8 1.7
Total liabilities at fair value $ 1.8 $ 1.7
XML 39 R7.htm IDEA: XBRL DOCUMENT v3.19.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
$ in Millions
 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Cash flows from operating activities:    
Net income $ 177.8 $ 154.9
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation 74.6 76.1
Amortization 2.5 2.0
Stock-based compensation 18.8 14.7
Non-cash restructuring charges 1.6 0.8
Pension settlement charge 2.7 0.0
Contingent consideration payments in excess of acquisition-date liability (0.3) (0.5)
Other non-cash items, net (0.6) (4.0)
Changes in assets and liabilities (16.3) (28.6)
Net cash provided by operating activities 260.8 215.4
Cash flows from investing activities:    
Capital expenditures (88.8) (74.7)
Acquisition of business (18.9) 0.0
Other, net 0.3 2.5
Net cash used in investing activities (107.4) (72.2)
Cash flows from financing activities:    
Borrowings under revolving credit agreements 28.0 0.0
Repayments under revolving credit agreements (28.0) 0.0
Debt issuance costs (0.9) 0.0
Dividend payments (33.3) (31.0)
Proceeds from stock-based compensation awards 25.5 25.7
Employee stock purchase plan contributions 4.0 3.6
Shares purchased under share repurchase programs (83.1) (70.8)
Net cash used in financing activities (87.8) (72.5)
Effect of exchange rates on cash (7.0) (9.3)
Net increase in cash and cash equivalents 58.6 61.4
Cash and cash equivalents at beginning of period 337.4 235.9
Cash and cash equivalents at end of period $ 396.0 $ 297.3
XML 40 R69.htm IDEA: XBRL DOCUMENT v3.19.3
Other Expense Other (Income) Development and Licensing Income (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Dec. 31, 2018
Jun. 30, 2013
Development and licensing income [Line Items]            
Development and licensing income $ 0.2 $ 0.2 $ 0.6 $ 0.6    
Deferred income 30.9   30.9   $ 33.4  
SmartDose [Member]            
Development and licensing income [Line Items]            
Development and licensing income $ 0.2   $ 0.6      
Deferred income           $ 20.0
XML 41 R3.htm IDEA: XBRL DOCUMENT v3.19.3
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Statement of Comprehensive Income [Abstract]        
Net income $ 56.3 $ 55.2 $ 177.8 $ 154.9
Other comprehensive (loss) income, net of tax:        
Foreign currency translation adjustments (23.8) (9.5) (20.1) (39.1)
Defined benefit pension and other postretirement plan adjustments, net of tax of $0.7, $0, $0.7 and $0.1, respectively 2.4 (0.2) 2.2 0.1
Net gain (loss) on derivatives, net of tax of $1.5, $(0.1), $0.7, and $1.0, respectively 3.2 (0.4) 1.7 2.5
Other comprehensive loss, net of tax (18.2) (10.1) (16.2) (36.5)
Comprehensive income $ 38.1 $ 45.1 $ 161.6 $ 118.4
XML 42 R61.htm IDEA: XBRL DOCUMENT v3.19.3
Accumulated Other Comprehensive Loss Reclassifications (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2019
Jun. 30, 2019
Mar. 31, 2019
Sep. 30, 2018
Jun. 30, 2018
Mar. 31, 2018
Sep. 30, 2019
Sep. 30, 2018
Reclassification out of Accumulated Other Comprehensive Loss [Line Items]                
Net sales $ 456.1     $ 431.7     $ 1,369.3 $ 1,294.9
Cost of goods and services sold (308.3)     (296.1)     (916.8) (882.7)
Interest expense (2.1)     (2.0)     (6.4) (6.1)
Prior service cost 0.1     0.5     0.4 1.6
Actuarial losses 0.2     (0.2)     0.2 (1.0)
Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement (2.7)     0.0     (2.7) 0.0
Income before income taxes 64.9     61.1     214.4 174.9
Tax expense (benefit) (10.9)     (8.0)     (42.5) (26.5)
Net income 56.3 $ 66.1 $ 55.4 55.2 $ 56.1 $ 43.6 177.8 154.9
Reclassification out of Accumulated Other Comprehensive Loss [Member]                
Reclassification out of Accumulated Other Comprehensive Loss [Line Items]                
Net income (4.3)     0.3     2.7 (0.9)
Reclassification out of Accumulated Other Comprehensive Loss [Member] | Gains (Losses) on Cash Flow Hedges [Member]                
Reclassification out of Accumulated Other Comprehensive Loss [Line Items]                
Income before income taxes (3.8)     0.0     6.3 (1.8)
Tax expense (benefit) 1.3     0.0     (2.0) 0.4
Net income (2.5)     0.0     4.3 (1.4)
Reclassification out of Accumulated Other Comprehensive Loss [Member] | Amortization of Defined Benefit Pension and Other Postretirement Plans [Member]                
Reclassification out of Accumulated Other Comprehensive Loss [Line Items]                
Prior service cost [1] 0.1     0.5     0.4 1.6
Actuarial losses [1] 0.2     (0.2)     0.2 (1.0)
Income before income taxes (2.4)     0.3     (2.1) 0.6
Tax expense (benefit) 0.6     0.0     0.5 (0.1)
Net income (1.8)     0.3     (1.6) 0.5
Foreign Currency Contract [Member] | Reclassification out of Accumulated Other Comprehensive Loss [Member] | Gains (Losses) on Cash Flow Hedges [Member]                
Reclassification out of Accumulated Other Comprehensive Loss [Line Items]                
Net sales 0.3     0.1     0.8 (0.8)
Cost of goods and services sold 0.3     0.0     0.8 (0.7)
Interest Rate Swap Contracts [Member] | Reclassification out of Accumulated Other Comprehensive Loss [Member] | Gains (Losses) on Cash Flow Hedges [Member]                
Reclassification out of Accumulated Other Comprehensive Loss [Line Items]                
Interest expense (4.3)     0.0     5.0 0.0
Forward Treasury Locks [Member] | Reclassification out of Accumulated Other Comprehensive Loss [Member] | Gains (Losses) on Cash Flow Hedges [Member]                
Reclassification out of Accumulated Other Comprehensive Loss [Line Items]                
Interest expense $ (0.1)     $ (0.1)     $ (0.3) $ (0.3)
[1] These components are included in the computation of net periodic benefit cost. Please refer to Note 14, Benefit Plans, for additional details.
XML 43 R65.htm IDEA: XBRL DOCUMENT v3.19.3
Benefit Plans (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Defined Benefit Plans and Other Postretirement Benefit Plans [Line Items]        
Service cost $ 0.4 $ 2.6 $ 1.1 $ 8.1
Interest cost 2.0 2.4 7.0 7.2
Expected return on assets (3.1) (3.9) (8.9) (11.7)
Amortization of prior service credit (0.1) (0.5) (0.4) (1.6)
Recognized actuarial losses (gains) (0.2) 0.2 (0.2) 1.0
Settlements 2.7 0.0 2.7 0.0
Net periodic benefit cost 1.7 0.8 1.3 3.0
Contributions by employer 2.6   2.6  
UNITED STATES        
Defined Benefit Plans and Other Postretirement Benefit Plans [Line Items]        
Net periodic benefit cost 1.2 0.2 (0.2) 1.4
Foreign Plan [Member]        
Defined Benefit Plans and Other Postretirement Benefit Plans [Line Items]        
Net periodic benefit cost 0.5 0.6 1.5 1.6
Pension Benefits [Member]        
Defined Benefit Plans and Other Postretirement Benefit Plans [Line Items]        
Service cost 0.4 2.6 1.1 8.1
Interest cost 1.9 2.3 6.8 7.0
Expected return on assets (3.1) (3.9) (8.9) (11.7)
Amortization of prior service credit 0.1 (0.3) 0.1 (1.1)
Recognized actuarial losses (gains) 0.5 0.9 1.6 2.8
Settlements 2.7 0.0 2.7  
Net periodic benefit cost 2.5 1.6 3.4 5.1
Pension Benefits [Member] | UNITED STATES        
Defined Benefit Plans and Other Postretirement Benefit Plans [Line Items]        
Net periodic benefit cost 2.0 1.0 1.9 3.5
Pension Benefits [Member] | Foreign Plan [Member]        
Defined Benefit Plans and Other Postretirement Benefit Plans [Line Items]        
Net periodic benefit cost 0.5 0.6 1.5 1.6
Other Retirement Benefits [Member]        
Defined Benefit Plans and Other Postretirement Benefit Plans [Line Items]        
Service cost 0.0 0.0 0.0 0.0
Interest cost 0.1 0.1 0.2 0.2
Amortization of prior service credit (0.2) (0.2) (0.5) (0.5)
Recognized actuarial losses (gains) (0.7) (0.7) (1.8) (1.8)
Net periodic benefit cost (0.8) (0.8) (2.1) (2.1)
Other Retirement Benefits [Member] | UNITED STATES        
Defined Benefit Plans and Other Postretirement Benefit Plans [Line Items]        
Net periodic benefit cost (0.8) $ (0.8) (2.1) $ (2.1)
Other Nonoperating Income (Expense) [Member]        
Defined Benefit Plans and Other Postretirement Benefit Plans [Line Items]        
Settlements $ 2.7   $ 2.7  
XML 44 R46.htm IDEA: XBRL DOCUMENT v3.19.3
Inventories (Details) - USD ($)
$ in Millions
Sep. 30, 2019
Dec. 31, 2018
Inventory Disclosure [Abstract]    
Raw materials $ 99.2 $ 90.4
Work in process 38.3 42.2
Finished goods 92.9 81.9
Total inventories $ 230.4 $ 214.5
XML 45 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 46 R42.htm IDEA: XBRL DOCUMENT v3.19.3
Contracts and Liabilities (Details) - USD ($)
$ in Millions
 9 Months Ended
Jan. 01, 2019
Sep. 30, 2019
Contract assets, December 31, 2018 $ 9.1 $ 9.1
Contract assets, September 30, 2019   9.4
Change in contract assets - increase (decrease)   0.3
Deferred income, December 31, 2018 (33.4) (33.4)
Deferred income, September 30, 2019   (30.9)
Change in deferred income - decrease (increase)   2.5
Revenue recognized that was included in the deferred income balance $ 18.0 79.3
Other adjustments   2.7
Customer advance cash payments   79.5
SmartDose [Member]    
Deferred income, September 30, 2019   (5.9)
Deferred income, current   0.9
Deferred income, noncurrent   $ 5.0
XML 47 R23.htm IDEA: XBRL DOCUMENT v3.19.3
Income Taxes
 9 Months Ended
Sep. 30, 2019
Income Tax Disclosure [Abstract]  
Income Taxes Income Taxes

The tax provision for interim periods is determined using the estimated annual effective consolidated tax rate, based on the current estimate of full-year earnings before taxes, adjusted for the impact of discrete quarterly items.

The provision for income taxes was $10.9 million and $8.0 million for the three months ended September 30, 2019 and 2018, respectively, and the effective tax rate was 16.8% and 13.1%, respectively. The provision for income taxes was $42.5 million and $26.5 million for the nine months ended September 30, 2019 and 2018, respectively, and the effective tax rate was 19.8% and 15.1%, respectively.

During the three and nine months ended September 30, 2019, we recorded a tax benefit of $1.0 million due to the impact of federal law changes enacted during the quarter. During the three and nine months ended September 30, 2018, we recorded a net tax charge of $0.4 million and a net tax benefit of $4.1 million, respectively, for the
estimated impact of the 2017 Tax Act. Please refer to Note 16, Income Taxes, to the consolidated financial statements in our 2018 Annual Report for further discussion.
XML 48 R27.htm IDEA: XBRL DOCUMENT v3.19.3
Summary of Significant Accounting Policies (Policies)
 9 Months Ended
Sep. 30, 2019
Accounting Policies [Abstract]  
Basis of Presentation

Basis of Presentation: The condensed consolidated financial statements included in this report are unaudited and have been prepared in accordance with United States (“U.S.”) generally accepted accounting principles (“U.S. GAAP”) for interim financial reporting and U.S. Securities and Exchange Commission (“SEC”) regulations. The year-end condensed consolidated balance sheet data was derived from audited financial statements, but does not include all disclosures required by U.S. GAAP. Certain information and footnote disclosures normally included in annual financial statements prepared in accordance with U.S. GAAP have been condensed or omitted. In the opinion of management, these financial statements include all adjustments, which are of a normal recurring nature, necessary for a fair statement of the financial position, results of operations, cash flows and the change in equity for the periods presented. The condensed consolidated financial statements for the three and nine months ended September 30, 2019 should be read in conjunction with the consolidated financial statements and notes thereto of West Pharmaceutical Services, Inc. and its majority-owned subsidiaries (which may be referred to as “West”, the “Company”, “we”, “us” or “our”) appearing in our Annual Report on Form 10-K for the year ended December 31, 2018 (the “2018 Annual Report”). The results of operations for any interim period are not necessarily indicative of results for the full year.

In April 2019, we acquired the business of our distributor in South Korea for $18.9 million. As a result of the acquisition, we recorded inventories, property, plant and equipment, goodwill and a customer relationships intangible asset of $4.5 million, $0.6 million, $2.6 million and $11.2 million, respectively. The goodwill was recorded within our Proprietary Products reportable segment. The results of this acquisition have been included in our condensed consolidated financial statements since the acquisition date.

As of April 1, 2017, our consolidated financial statements exclude the results of our Venezuelan subsidiary. Please refer to Note 15, Other Expense, to the consolidated financial statements in our 2018 Annual Report for further discussion.
New Accounting Standards

Recently Adopted Standards

In August 2018, the SEC adopted a final release which would eliminate or modify certain disclosure requirements that are redundant, outdated, or duplicative of U.S. GAAP or other regulatory requirements. Among other changes, the amendments provide that disclosure requirements related to the analysis of shareholders’ equity are expanded for interim purposes. An analysis of the changes in each caption of shareholders’ equity presented in the balance sheet must be provided in a note or separate statement, as well as the amount of dividends per share for each class of shares. We provided this disclosure beginning in the first quarter of 2019. Please refer to Note 12, Shareholders’ Equity.

In June 2018, the Financial Accounting Standards Board (“FASB”) issued guidance which expands the scope of accounting for share-based payment arrangements to include share-based payment transactions for acquiring goods and services from nonemployees. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2018. Early adoption was permitted. We adopted this guidance as of January 1, 2019, on a prospective basis. The adoption did not have a material impact on our financial statements.

In February 2018, the FASB issued guidance to address a specific consequence of the Tax Cuts and Jobs Acts (the “2017 Tax Act”) by allowing a reclassification from accumulated other comprehensive income (loss) to retained earnings for stranded tax effects resulting from the 2017 Tax Act’s reduction of the U.S. federal corporate income tax rate. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2018. Early adoption was permitted. We adopted this guidance as of January 1, 2019, on a prospective basis, but elected to not reclassify from accumulated other comprehensive income (loss) to retained earnings the stranded tax effects resulting from the 2017 Tax Act’s reduction of the U.S. federal corporate income tax rate.

In August 2017, the FASB issued guidance which expands and refines hedge accounting for both nonfinancial and financial risk components and aligns the recognition and presentation of the effects of the hedging instrument and the hedged item in the financial statements. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2018. Early adoption was permitted. We adopted this guidance as of January 1, 2019, on a prospective basis. The adoption did not have a material impact on our financial statements.

In February 2016, the FASB issued guidance on the accounting for leases, Accounting Standards Codification (“ASC”) Topic 842 (“ASC 842”). This guidance requires lessees to recognize lease assets and lease liabilities on the balance sheet and to expand disclosures about leasing arrangements, both qualitative and quantitative. In terms of transition, the guidance requires adoption based upon a modified retrospective approach. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2018. Early adoption was permitted. We adopted this guidance as of January 1, 2019, using the modified retrospective approach that allows companies to apply ASC 842 as of the effective date and on a prospective basis. Please refer to Note 6, Leases, for additional information.

Standards Issued Not Yet Adopted

In April 2019, the FASB issued guidance which clarifies and improves areas of guidance related to the new credit losses, hedging, and recognition and measurement standards. This guidance is effective for the same fiscal years in which the original standards are effective or, if already implemented, annual periods beginning after the issuance of this guidance. Early adoption is permitted. We believe that the adoption of this guidance will not have a material impact on our financial statements.

In August 2018, the FASB issued guidance to align the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software (and hosting arrangements that include an internal-use software license). The accounting for the service element of a hosting arrangement that is a service contract is not affected by this update. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2019. Early adoption is permitted, including adoption in any interim period. We believe that the adoption of this guidance will not have a material impact on our financial statements.

In August 2018, the FASB issued guidance which modifies the disclosure requirements for defined benefit pension plans and other postretirement plans. The guidance removes disclosures that no longer are considered cost beneficial, clarifies the specific requirements of disclosures, and adds disclosure requirements identified as relevant. This guidance is effective for fiscal years ending after December 15, 2020. Early adoption is permitted. We believe that the adoption of this guidance will not have a material impact on our financial statements.

In August 2018, the FASB issued guidance which modifies the disclosure requirements on fair value measurements by removing, modifying, or adding certain disclosures. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2019. Early adoption is permitted. We believe that the adoption of this guidance will not have a material impact on our financial statements.

In June 2016, the FASB issued guidance which provides financial statement users with more decision-useful information about the expected credit losses on financial instruments and other commitments held by a reporting entity at each reporting date. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2019. Early adoption is permitted. We believe that the adoption of this guidance will not have a material impact on our financial statements.
XML 49 R13.htm IDEA: XBRL DOCUMENT v3.19.3
Leases
 9 Months Ended
Sep. 30, 2019
Leases [Abstract]  
Leases of Lessee Disclosure [Text Block] Leases

Adoption of ASC 842

On January 1, 2019, we adopted ASC 842, using the modified retrospective approach that allows companies to apply ASC 842 as of the effective date and on a prospective basis. As a result, we were not required to adjust our comparative period financial information for effects of ASC 842 or present the new required lease disclosures for periods prior to the date of adoption. As of September 30, 2019, we had operating leases primarily related to land, buildings, and machinery and equipment, with lease terms through 2047. Certain of our operating leases include options to extend the lease term for up to five years, and certain of our operating leases include options to terminate the leases within one year. We had no finance leases as of September 30, 2019.

As a result of our adoption of ASC 842, we recorded operating lease right-of-use assets of $71.0 million and operating lease liabilities of $73.1 million for operating leases where we are the lessee in our condensed consolidated balance sheet as of January 1, 2019. The operating lease right-of-use assets are initially measured at cost, which comprises the initial amount of the lease liability adjusted for lease payments made at or before the lease commencement date, plus any initial direct costs incurred less any lease incentives received. The operating lease right-of-use assets are subsequently measured throughout the lease term at the carrying amount of the lease liability, plus initial direct costs, plus (minus) any prepaid (accrued) lease payments, less the unamortized balance of lease incentives received. Lease expense for lease payments is recognized on a straight-line basis over the lease term. The operating lease liabilities are initially measured at the present value of the unpaid lease payments at the lease commencement date.

Judgments used in applying ASC 842 include determining: i) whether a contract is, or contains, a lease; ii) the discount rate to be used to discount the unpaid lease payments to present value; iii) the lease term; and iv) the lease payments. We determine if a contract is, or contains, a lease at contract inception. A lease exists when a contract conveys to the customer the right to control the use of identified property, plant, or equipment for a period of time in exchange for consideration. The definition of a lease embodies two conditions: 1) there is an identified asset in the contract that is land or a depreciable asset (i.e., property, plant, and equipment); and 2) the customer has the right to control the use of the identified asset. ASC 842 requires a lessee to discount its unpaid lease payments using the interest rate implicit in the lease or, if that rate cannot be readily determined, its incremental borrowing rate. As all of our operating leases do not provide an implicit rate, we use our incremental borrowing rate based on the
information available at commencement date in determining the present value of lease payments. Our incremental borrowing rate for a lease is the rate of interest we would have to pay on a collateralized basis to borrow an amount equal to the lease payments under similar terms. The lease term for all of our operating leases includes the noncancellable period of the lease plus any additional periods covered by either a lessee option to extend (or not to terminate) the lease that the lessee is reasonably certain to exercise, or an option to extend (or not to terminate) the lease controlled by the lessor. Lease payments included in the measurement of the operating lease right-of-use assets and lease liabilities are comprised of fixed payments (including in-substance fixed payments), variable payments that depend on an index or rate, and the exercise price of a lessee option to purchase the underlying asset if the lessee is reasonably certain to exercise.

The components of lease expense were as follows:
($ in millions)
Three Months Ended
September 30, 2019
 
Nine Months Ended
September 30, 2019
Operating lease cost
$
3.4

 
$
9.7

Short-term lease cost
0.1

 
0.5

Variable lease cost
0.8

 
2.3

Total lease cost
$
4.3

 
$
12.5



Lease expense for the three and nine months ended September 30, 2018 was $3.3 million and $10.4 million, respectively.

Supplemental information related to leases was as follows:
($ in millions)
Three Months Ended
September 30, 2019
 
Nine Months Ended
September 30, 2019
Cash paid for amounts included in the measurement of lease liabilities:
 
 
 
Operating cash flows from operating leases
$
3.2

 
$
9.4

 
 
 
 
Right-of-use assets obtained in exchange for new operating lease liabilities
$
0.3

 
$
8.4



As of September 30, 2019, the weighted average remaining lease term for operating leases was 11.8 years, and the weighted average discount rate was 3.76%.

Maturities of lease liabilities as of September 30, 2019 were as follows:
($ in millions)
Operating
Year
Leases
2019 (remaining three months)
$
3.4

2020
12.0

2021
10.2

2022
8.3

2023
7.7

Thereafter
48.1

 
89.7

Less: imputed lease interest
(16.4
)
Total lease liabilities
$
73.3



Maturities of future minimum rental payments under non-cancelable operating leases as of December 31, 2018 were as follows:
($ in millions)
Operating
Year
Leases
2019
$
13.0

2020
10.5

2021
7.8

2022
6.9

2023
5.5

Thereafter
37.8

Total
$
81.5



Practical Expedients and Exemptions

We have elected to adopt the leasing package of practical expedients, which allows us to not retroactively reassess: i) any expired or existing contracts containing leases under the new definition of a lease; ii) the lease classification for any expired or existing leases; and iii) initial direct costs for any expired or existing leases. We have also elected to adopt practical expedients around land easements, the combination of lease and non-lease components, and the portfolio approach relating to discount rates. These practical expedients were applied consistently to all leases.

We have elected not to recognize operating lease right-of-use assets and operating lease liabilities for all short-term leases (leases with an initial lease term of 12 months or less). We recognize the lease payments associated with our short-term leases as an expense over the lease term.
XML 50 R17.htm IDEA: XBRL DOCUMENT v3.19.3
Fair Value Measurements
 9 Months Ended
Sep. 30, 2019
Fair Value Disclosures [Abstract]  
Fair Value Measurements Fair Value Measurements

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The following fair value hierarchy classifies the inputs to valuation techniques used to measure fair value into one of three levels:

•
Level 1: Unadjusted quoted prices in active markets for identical assets or liabilities.
•
Level 2: Inputs other than quoted prices that are observable for the asset or liability, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active.
•
Level 3: Unobservable inputs that reflect the reporting entity’s own assumptions.

The following tables present the assets and liabilities recorded at fair value on a recurring basis:
 
Balance at
 
Basis of Fair Value Measurements
($ in millions)
September 30,
2019
 
Level 1
 
Level 2
 
Level 3
Assets:
 
 
 
 
 
 
 
Deferred compensation assets
$
9.9

 
$
9.9

 
$
—

 
$
—

Foreign currency contracts
13.2

 
—

 
13.2

 
—

Commodity call options
0.1

 
—

 
0.1

 
—

 
$
23.2

 
$
9.9

 
$
13.3

 
$
—

Liabilities:
 

 
 

 
 

 
 

Contingent consideration
$
1.8

 
$
—

 
$
—

 
$
1.8

Deferred compensation liabilities
11.4

 
11.4

 
—

 
—

Foreign currency contracts
0.2

 
—

 
0.2

 
—

 
$
13.4

 
$
11.4

 
$
0.2

 
$
1.8


 
Balance at
 
Basis of Fair Value Measurements
($ in millions)
December 31,
2018
 
Level 1
 
Level 2
 
Level 3
Assets:
 
 
 
 
 
 
 
Deferred compensation assets
$
8.7

 
$
8.7

 
$
—

 
$
—

Foreign currency contracts
6.5

 
—

 
6.5

 
—

 
$
15.2

 
$
8.7

 
$
6.5

 
$
—

Liabilities:
 

 
 

 
 

 
 

Contingent consideration
$
1.7

 
$
—

 
$
—

 
$
1.7

Deferred compensation liabilities
9.8

 
9.8

 
—

 
—

Foreign currency contracts
0.2

 
—

 
0.2

 
—

 
$
11.7

 
$
9.8

 
$
0.2

 
$
1.7



Deferred compensation assets are included within other noncurrent assets and are valued using a market approach based on quoted market prices in an active market. The fair value of our foreign currency contracts, included within other current and other noncurrent assets, as well as other current and other long-term liabilities, is valued using an income approach based on quoted forward foreign exchange rates and spot rates at the reporting date. The fair value of our commodity call options, included within other current and other noncurrent assets, is valued using a market
approach. The fair value of our contingent consideration, included within other current and other long-term liabilities, is discussed further in the section related to Level 3 fair value measurements. The fair value of deferred compensation liabilities is based on quoted prices of the underlying employees’ investment selections and is included within other long-term liabilities. Please refer to Note 9, Derivative Financial Instruments, for further discussion of our derivatives.

Level 3 Fair Value Measurements

The fair value of the contingent consideration liability related to the SmartDose technology platform (the “SmartDose contingent consideration”) was initially determined using a probability-weighted income approach, and is revalued at each reporting date or more frequently if circumstances dictate. Changes in the fair value of this obligation are recorded as income or expense within other expense (income) in our condensed consolidated statements of income. The significant unobservable inputs used in the fair value measurement of the SmartDose contingent consideration are the sales projections, the probability of success factors, and the discount rate. Significant increases or decreases in any of those inputs in isolation would result in a significantly lower or higher fair value measurement. As development and commercialization of the SmartDose technology platform progresses, we may need to update the sales projections, the probability of success factors, and the discount rate used. This could result in a material increase or decrease to the SmartDose contingent consideration.

The following table provides a summary of changes in our Level 3 fair value measurements:
 
($ in millions)
Balance, December 31, 2017
$
4.9

Decrease in fair value recorded in earnings
(2.6
)
Payments
(0.6
)
Balance, December 31, 2018
1.7

Increase in fair value recorded in earnings
0.4

Payments
(0.3
)
Balance, September 30, 2019
$
1.8


Other Financial Instruments

We believe that the carrying amounts of our cash and cash equivalents and accounts receivable approximate their fair values due to their near-term maturities.

The estimated fair value of long-term debt is based on quoted market prices for debt issuances with similar terms and maturities and is classified as Level 2 within the fair value hierarchy. At September 30, 2019, the estimated fair value of long-term debt was $204.4 million compared to a carrying amount of $195.1 million. At December 31, 2018, the estimated fair value of long-term debt was $192.6 million and the carrying amount was $196.0 million.
XML 51 R38.htm IDEA: XBRL DOCUMENT v3.19.3
Other Expense (Tables)
 9 Months Ended
Sep. 30, 2019
Other Income and Expenses [Abstract]  
Schedule of Other Expense

Other expense (income) consists of:

 
Three Months Ended
September 30,
 
Nine Months Ended
September 30,
($ in millions)
2019
 
2018
 
2019
 
2018
Restructuring and related charges:
 
 
 
 
 
 
 
Severance and post-employment benefits
$
0.6

 
$
0.1

 
$
2.2

 
$
3.4

Asset-related charges
0.1

 
0.4

 
0.1

 
0.8

Other charges
1.1

 
0.7

 
1.5

 
2.5

Total restructuring and related charges
1.8

 
1.2

 
3.8

 
6.7

Argentina currency devaluation
1.0

 
1.1

 
1.0

 
1.1

Development and licensing income
(0.2
)
 
(0.2
)
 
(0.6
)
 
(0.6
)
Contingent consideration
0.1

 
0.2

 
0.4

 
0.8

Other items
3.7

 
(2.5
)
 
(3.0
)
 
(4.0
)
Total other expense (income)
$
6.4

 
$
(0.2
)
 
$
1.6

 
$
4.0
Schedule of Restructuring Reserve
The following table presents activity related to our restructuring obligations related to our 2018 restructuring plan:

($ in millions)
Severance
and benefits
 
Asset-related charges
 
Other charges
 
Total
Balance, December 31, 2018
$
2.3

 
$
—

 
$
—

 
$
2.3

Charges
2.2

 
0.1

 
1.5

 
3.8

Cash payments
(2.0
)
 
—

 
—

 
(2.0
)
Non-cash asset write-downs
—

 
(0.1
)
 
(1.5
)
 
(1.6
)
Balance, September 30, 2019
$
2.5

 
$
—

 
$
—

 
$
2.5
XML 52 R34.htm IDEA: XBRL DOCUMENT v3.19.3
Fair Value Measurements (Tables)
 9 Months Ended
Sep. 30, 2019
Fair Value Disclosures [Abstract]  
Schedule of Assets and Liabilities Measured at Fair Value
The following tables present the assets and liabilities recorded at fair value on a recurring basis:
 
Balance at
 
Basis of Fair Value Measurements
($ in millions)
September 30,
2019
 
Level 1
 
Level 2
 
Level 3
Assets:
 
 
 
 
 
 
 
Deferred compensation assets
$
9.9

 
$
9.9

 
$
—

 
$
—

Foreign currency contracts
13.2

 
—

 
13.2

 
—

Commodity call options
0.1

 
—

 
0.1

 
—

 
$
23.2

 
$
9.9

 
$
13.3

 
$
—

Liabilities:
 

 
 

 
 

 
 

Contingent consideration
$
1.8

 
$
—

 
$
—

 
$
1.8

Deferred compensation liabilities
11.4

 
11.4

 
—

 
—

Foreign currency contracts
0.2

 
—

 
0.2

 
—

 
$
13.4

 
$
11.4

 
$
0.2

 
$
1.8


 
Balance at
 
Basis of Fair Value Measurements
($ in millions)
December 31,
2018
 
Level 1
 
Level 2
 
Level 3
Assets:
 
 
 
 
 
 
 
Deferred compensation assets
$
8.7

 
$
8.7

 
$
—

 
$
—

Foreign currency contracts
6.5

 
—

 
6.5

 
—

 
$
15.2

 
$
8.7

 
$
6.5

 
$
—

Liabilities:
 

 
 

 
 

 
 

Contingent consideration
$
1.7

 
$
—

 
$
—

 
$
1.7

Deferred compensation liabilities
9.8

 
9.8

 
—

 
—

Foreign currency contracts
0.2

 
—

 
0.2

 
—

 
$
11.7

 
$
9.8

 
$
0.2

 
$
1.7
Summary of Changes in Level 3 Fair Value Measurements
The following table provides a summary of changes in our Level 3 fair value measurements:
 
($ in millions)
Balance, December 31, 2017
$
4.9

Decrease in fair value recorded in earnings
(2.6
)
Payments
(0.6
)
Balance, December 31, 2018
1.7

Increase in fair value recorded in earnings
0.4

Payments
(0.3
)
Balance, September 30, 2019
$
1.8
XML 53 R30.htm IDEA: XBRL DOCUMENT v3.19.3
Inventories (Tables)
 9 Months Ended
Sep. 30, 2019
Inventory Disclosure [Abstract]  
Inventories

Inventories are valued at the lower of cost (on a first-in, first-out basis) and net realizable value. Inventory balances were as follows:

($ in millions)
September 30,
2019
 
December 31,
2018
Raw materials
$
99.2

 
$
90.4

Work in process
38.3

 
42.2

Finished goods
92.9

 
81.9

 
$
230.4

 
$
214.5
XML 54 R51.htm IDEA: XBRL DOCUMENT v3.19.3
Leases Maturities of Operating Lease Liabilities (Details) - USD ($)
$ in Millions
Sep. 30, 2019
Dec. 31, 2018
Leases [Abstract]    
2019 (remaining three months) $ 3.4  
2020 12.0  
2021 10.2  
2022 8.3  
2023 7.7  
Thereafter 48.1  
Operating leases liabilities payments due 89.7  
Less: imputed lease interest 16.4  
Total lease liabilities $ 73.3  
2019   $ 13.0
2020   10.5
2021   7.8
2022   6.9
2023   5.5
Thereafter   37.8
Total   $ 81.5
XML 55 R55.htm IDEA: XBRL DOCUMENT v3.19.3
Derivative Financial Instruments (Textuals) (Details)
€ in Millions, ¥ in Millions, $ in Millions, $ in Millions
 9 Months Ended
Sep. 30, 2019
EUR (€)
MBbls
$ / bbl
Sep. 30, 2019
JPY (¥)
Sep. 30, 2019
USD ($)
Sep. 30, 2019
SGD ($)
MBbls
$ / bbl
Sep. 30, 2019
JPY (¥)
MBbls
$ / bbl
Sep. 30, 2019
USD ($)
MBbls
$ / bbl
Dec. 31, 2018
EUR (€)
Dec. 31, 2018
SGD ($)
Dec. 31, 2018
USD ($)
Nov. 22, 2017
MBbls
Debt EUR Denominated [Member]                    
Derivative [Line Items]                    
Notional amount, nonderivative instruments € 21.0   $ 23.0              
Cumulative foreign currency translation loss           $ 0.6        
Cumulative foreign currency translation loss, net of tax           0.5        
Debt Yen Denominated [Member]                    
Derivative [Line Items]                    
Notional amount, nonderivative instruments   ¥ 500.0 $ 4.6              
Cumulative foreign currency translation loss           0.5        
Cumulative foreign currency translation loss, net of tax           $ 0.4        
Options Held [Member]                    
Derivative [Line Items]                    
Derivative, Nonmonetary Notional Amount | MBbls 107,909     107,909 107,909 107,909       301,326
Derivative, Average Price Risk Option Strike Price | $ / bbl 71.15     71.15 71.15 71.15        
Euro Member Countries, Euro | Forward Contracts [Member]                    
Derivative [Line Items]                    
Derivative, Notional Amount | €             € 10.0      
Singapore, Dollars | Forward Contracts [Member]                    
Derivative [Line Items]                    
Derivative, Notional Amount       $ 601.5       $ 601.5    
United States of America, Dollars | Forward Contracts [Member]                    
Derivative [Line Items]                    
Derivative, Notional Amount           $ 13.4     $ 13.4  
Long [Member] | Designated as Hedging Instrument [Member] | Singapore, Dollars | Foreign Exchange Forward [Member]                    
Derivative [Line Items]                    
Derivative, Notional Amount       $ 31.9            
Long [Member] | Designated as Hedging Instrument [Member] | United States of America, Dollars | Foreign Exchange Forward [Member]                    
Derivative [Line Items]                    
Derivative, Notional Amount           39.3        
Long [Member] | Designated as Hedging Instrument [Member] | Japan, Yen | Foreign Exchange Forward [Member]                    
Derivative [Line Items]                    
Derivative, Notional Amount | ¥         ¥ 5,921.1          
Short [Member] | Designated as Hedging Instrument [Member] | Singapore, Dollars | Foreign Exchange Forward [Member]                    
Derivative [Line Items]                    
Derivative, Notional Amount € 4.3         18.7        
Short [Member] | Designated as Hedging Instrument [Member] | United States of America, Dollars | Foreign Exchange Forward [Member]                    
Derivative [Line Items]                    
Derivative, Notional Amount 34.2         0.0        
Short [Member] | Designated as Hedging Instrument [Member] | Japan, Yen | Foreign Exchange Forward [Member]                    
Derivative [Line Items]                    
Derivative, Notional Amount € 20.2         $ 31.8        
XML 56 R59.htm IDEA: XBRL DOCUMENT v3.19.3
Fair Value Measurements Other Financial Instruments (Details) - USD ($)
$ in Millions
Sep. 30, 2019
Dec. 31, 2018
Other Financial Instruments [Abstract]    
Long-term debt, fair value $ 204.4 $ 192.6
Long-term debt $ 195.1 $ 196.0
XML 57 R72.htm IDEA: XBRL DOCUMENT v3.19.3
Subsequent Event (Details)
Oct. 15, 2019
Subsequent Event [Line Items]  
Equity Method Investment, Ownership Percentage 49.00%
XML 58 R48.htm IDEA: XBRL DOCUMENT v3.19.3
Leases Lease Cost (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Lease, Cost [Abstract]        
Operating lease cost $ 3.4   $ 9.7  
Short-term lease cost 0.1   0.5  
Variable lease cost 0.8   2.3  
Total lease cost $ 4.3 $ 3.3 $ 12.5 $ 10.4
XML 59 R44.htm IDEA: XBRL DOCUMENT v3.19.3
Revenue Voluntary Recall (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2019
Sep. 30, 2019
Dec. 31, 2018
Revenue from Contract with Customer [Abstract]      
Provision for sales returns $ (0.9) $ (4.9) $ (11.3)
XML 60 R40.htm IDEA: XBRL DOCUMENT v3.19.3
Summary of Significant Accounting Policies Business Combinations (Details)
$ in Millions
Apr. 01, 2019
USD ($)
Business Combinations [Abstract]  
Business acquisition, transaction costs $ 18.9
Business combination, recognized inventory 4.5
Business combination, recognized property, plant, and equipment 0.6
Business combination, recognized goodwill 2.6
Business combination, recognized intangible assets $ 11.2
XML 61 R5.htm IDEA: XBRL DOCUMENT v3.19.3
CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($)
$ in Millions
Sep. 30, 2019
Dec. 31, 2018
Current assets:    
Cash and cash equivalents $ 396.0 $ 337.4
Accounts receivable, net 316.1 288.2
Inventories 230.4 214.5
Other current assets 61.6 54.3
Total current assets 1,004.1 894.4
Property, plant and equipment 1,779.8 1,752.7
Less: accumulated depreciation and amortization 967.7 930.7
Property, plant and equipment, net 812.1 822.0
Operating lease right-of-use assets 71.3 0.0
Investments in affiliated companies 97.4 91.2
Goodwill 106.6 105.8
Deferred income taxes 33.8 24.7
Intangible assets, net 28.7 20.3
Other noncurrent assets 20.0 20.5
Total Assets 2,174.0 1,978.9
Current liabilities:    
Notes payable and other current debt 0.0 0.1
Accounts payable 145.3 130.4
Pension and other postretirement benefits 2.2 2.3
Accrued salaries, wages and benefits 72.6 64.5
Income taxes payable 19.1 9.8
Operating lease liabilities, current 9.8 0.0
Other current liabilities 86.0 76.6
Total current liabilities 335.0 283.7
Long-term debt 195.1 196.0
Deferred income taxes 10.3 13.1
Pension and other postretirement benefits 46.8 56.2
Operating lease liabilities, noncurrent 63.5 0.0
Other long-term liabilities 35.7 33.6
Total Liabilities 686.4 582.6
Commitments and contingencies (Note 15)
Equity:    
Preferred stock, 3.0 million shares authorized; 0 shares issued and outstanding 0.0 0.0
Common stock, par value $0.25 per share; 100.0 million shares authorized; shares issued: 75.3 million and 75.3 million; shares outstanding: 74.0 million and 74.1 million 18.8 18.8
Capital in excess of par value 268.5 282.0
Retained earnings 1,497.3 1,353.4
Accumulated other comprehensive loss (170.4) (154.2)
Treasury stock, at cost (1.3 million and 1.2 million shares) (126.6) (103.7)
Total Equity 1,487.6 1,396.3
Total Liabilities and Equity $ 2,174.0 $ 1,978.9
XML 62 R1.htm IDEA: XBRL DOCUMENT v3.19.3
Document and Entity Information
 9 Months Ended
Sep. 30, 2019
shares
Document and Entity Information [Abstract]  
Document Type 10-Q
Document Quarterly Report true
Document Period End Date Sep. 30, 2019
Document Transition Report false
Entity File Number 1-8036
Entity Registrant Name WEST PHARMACEUTICAL SERVICES, INC.
Entity Incorporation, State or Country Code PA
Entity Tax Identification Number 23-1210010
Entity Address, Address Line One 530 Herman O. West Drive,
Entity Address, City or Town Exton,
Entity Address, State or Province PA
Entity Address, Postal Zip Code 19341-0645
City Area Code 610
Local Phone Number 594-2900
Entity Current Reporting Status Yes
Entity Interactive Data Current Yes
Entity Filer Category Large Accelerated Filer
Entity Small Business false
Entity Emerging Growth Company false
Entity Shell Company false
Title of each class Common Stock, par value $0.25 per share
Trading Symbol WST
Security Exchange Name NYSE
Entity Central Index Key 0000105770
Current Fiscal Year End Date --12-31
Document Fiscal Year Focus 2019
Document Fiscal Period Focus Q3
Amendment Flag false
Entity Common Stock, Shares Outstanding 73,990,675
XML 63 R63.htm IDEA: XBRL DOCUMENT v3.19.3
Change in Shareholders' Equity (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2019
Jun. 30, 2019
Mar. 31, 2019
Sep. 30, 2018
Jun. 30, 2018
Mar. 31, 2018
Sep. 30, 2019
Sep. 30, 2018
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Balance $ 1,445.1 $ 1,369.5 $ 1,396.3 $ 1,281.9 $ 1,305.3 $ 1,279.9 $ 1,396.3 $ 1,279.9
Cumulative effect of new accounting principle in period of adoption           11.4    
Net income 56.3 66.1 55.4 55.2 56.1 43.6 $ 177.8 154.9
Activity related to stock-based compensation 16.3 19.7 10.7 25.3 12.2 7.2    
Share purchased under share repurchase program (in shares)             800,000  
Shares purchased under share repurchase program     (83.1)   (22.9) (47.9) $ (83.1)  
Dividends declared (11.9) (11.4) (10.6) (0.5) (20.9) (10.4)    
Other comprehensive income, net of tax (18.2) 1.2 0.8 (10.1) (47.9) 21.5 (16.2) (36.5)
Balance 1,487.6 1,445.1 1,369.5 1,351.8 1,281.9 1,305.3 1,487.6 1,351.8
Common Stock [Member]                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Balance $ 18.8 $ 18.8 $ 18.8 $ 18.8 $ 18.8 $ 18.8 $ 18.8 $ 18.8
Balance (in shares) 75,300,000 75,300,000 75,300,000 75,300,000 75,300,000 75,200,000 75,300,000 75,200,000
Shares issued under stock plans (in shares) 0 0 0   0 100,000    
Activity related to stock-based compensation $ 0.0 $ 0.0 $ 0.0   $ 0.0 $ 0.0    
Balance $ 18.8 $ 18.8 $ 18.8 $ 18.8 $ 18.8 $ 18.8 $ 18.8 $ 18.8
Balance (in shares) 75,300,000 75,300,000 75,300,000 75,300,000 75,300,000 75,300,000 75,300,000 75,300,000
Additional Paid-in Capital [Member]                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Balance $ 273.4 $ 278.5 $ 282.0 $ 304.7 $ 308.5 $ 309.3 $ 282.0 $ 309.3
Activity related to stock-based compensation (4.9) (5.1) (3.5) (21.9) (3.8) (0.8)    
Balance 268.5 273.4 278.5 282.8 304.7 308.5 268.5 282.8
Treasury Stock [Member]                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Balance $ (147.8) $ (172.6) $ (103.7) $ (155.9) $ (149.0) $ (109.1) $ (103.7) $ (109.1)
Balance (in shares) 1,600,000 1,800,000 1,200,000 1,800,000 1,700,000 1,300,000 1,200,000 1,300,000
Shares issued under stock plans (in shares) (300,000) (200,000) (200,000) (600,000) (200,000) (100,000)    
Activity related to stock-based compensation $ 21.2 $ 24.8 $ 14.2 $ 47.2 $ 16.0 $ 8.0    
Share purchased under share repurchase program (in shares)     800,000   300,000 500,000    
Shares purchased under share repurchase program     $ (83.1)   $ (22.9) $ (47.9)    
Balance $ (126.6) $ (147.8) $ (172.6) $ (108.7) $ (155.9) $ (149.0) $ (126.6) $ (108.7)
Balance (in shares) 1,300,000 1,600,000 1,800,000 1,200,000 1,800,000 1,700,000 1,300,000 1,200,000
Retained Earnings [Member]                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Balance $ 1,452.9 $ 1,398.2 $ 1,353.4 $ 1,258.0 $ 1,222.8 $ 1,178.2 $ 1,353.4 $ 1,178.2
Cumulative effect of new accounting principle in period of adoption           11.4    
Net income 56.3 66.1 55.4 55.2 56.1 43.6    
Dividends declared 11.9 11.4 10.6 (0.5) (20.9) (10.4)    
Balance 1,497.3 1,452.9 1,398.2 1,312.7 1,258.0 1,222.8 1,497.3 1,312.7
AOCI Attributable to Parent [Member]                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Balance (152.2) (153.4) (154.2) (143.7) (95.8) (117.3) (154.2) (117.3)
Other comprehensive income, net of tax (18.2) 1.2 0.8 (10.1) (47.9) 21.5    
Balance $ (170.4) $ (152.2) $ (153.4) $ (153.8) $ (143.7) $ (95.8) $ (170.4) $ (153.8)
XML 64 R9.htm IDEA: XBRL DOCUMENT v3.19.3
New Accounting Standards
 9 Months Ended
Sep. 30, 2019
New Accounting Pronouncements and Changes in Accounting Principles [Abstract]  
New Accounting Standards New Accounting Standards

Recently Adopted Standards

In August 2018, the SEC adopted a final release which would eliminate or modify certain disclosure requirements that are redundant, outdated, or duplicative of U.S. GAAP or other regulatory requirements. Among other changes, the amendments provide that disclosure requirements related to the analysis of shareholders’ equity are expanded for interim purposes. An analysis of the changes in each caption of shareholders’ equity presented in the balance sheet must be provided in a note or separate statement, as well as the amount of dividends per share for each class of shares. We provided this disclosure beginning in the first quarter of 2019. Please refer to Note 12, Shareholders’ Equity.

In June 2018, the Financial Accounting Standards Board (“FASB”) issued guidance which expands the scope of accounting for share-based payment arrangements to include share-based payment transactions for acquiring goods and services from nonemployees. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2018. Early adoption was permitted. We adopted this guidance as of January 1, 2019, on a prospective basis. The adoption did not have a material impact on our financial statements.

In February 2018, the FASB issued guidance to address a specific consequence of the Tax Cuts and Jobs Acts (the “2017 Tax Act”) by allowing a reclassification from accumulated other comprehensive income (loss) to retained earnings for stranded tax effects resulting from the 2017 Tax Act’s reduction of the U.S. federal corporate income tax rate. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2018. Early adoption was permitted. We adopted this guidance as of January 1, 2019, on a prospective basis, but elected to not reclassify from accumulated other comprehensive income (loss) to retained earnings the stranded tax effects resulting from the 2017 Tax Act’s reduction of the U.S. federal corporate income tax rate.

In August 2017, the FASB issued guidance which expands and refines hedge accounting for both nonfinancial and financial risk components and aligns the recognition and presentation of the effects of the hedging instrument and the hedged item in the financial statements. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2018. Early adoption was permitted. We adopted this guidance as of January 1, 2019, on a prospective basis. The adoption did not have a material impact on our financial statements.

In February 2016, the FASB issued guidance on the accounting for leases, Accounting Standards Codification (“ASC”) Topic 842 (“ASC 842”). This guidance requires lessees to recognize lease assets and lease liabilities on the balance sheet and to expand disclosures about leasing arrangements, both qualitative and quantitative. In terms of transition, the guidance requires adoption based upon a modified retrospective approach. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2018. Early adoption was permitted. We adopted this guidance as of January 1, 2019, using the modified retrospective approach that allows companies to apply ASC 842 as of the effective date and on a prospective basis. Please refer to Note 6, Leases, for additional information.

Standards Issued Not Yet Adopted

In April 2019, the FASB issued guidance which clarifies and improves areas of guidance related to the new credit losses, hedging, and recognition and measurement standards. This guidance is effective for the same fiscal years in which the original standards are effective or, if already implemented, annual periods beginning after the issuance of this guidance. Early adoption is permitted. We believe that the adoption of this guidance will not have a material impact on our financial statements.

In August 2018, the FASB issued guidance to align the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software (and hosting arrangements that include an internal-use software license). The accounting for the service element of a hosting arrangement that is a service contract is not affected by this update. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2019. Early adoption is permitted, including adoption in any interim period. We believe that the adoption of this guidance will not have a material impact on our financial statements.

In August 2018, the FASB issued guidance which modifies the disclosure requirements for defined benefit pension plans and other postretirement plans. The guidance removes disclosures that no longer are considered cost beneficial, clarifies the specific requirements of disclosures, and adds disclosure requirements identified as relevant. This guidance is effective for fiscal years ending after December 15, 2020. Early adoption is permitted. We believe that the adoption of this guidance will not have a material impact on our financial statements.

In August 2018, the FASB issued guidance which modifies the disclosure requirements on fair value measurements by removing, modifying, or adding certain disclosures. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2019. Early adoption is permitted. We believe that the adoption of this guidance will not have a material impact on our financial statements.

In June 2016, the FASB issued guidance which provides financial statement users with more decision-useful information about the expected credit losses on financial instruments and other commitments held by a reporting entity at each reporting date. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2019. Early adoption is permitted. We believe that the adoption of this guidance will not have a material impact on our financial statements.
XML 65 R67.htm IDEA: XBRL DOCUMENT v3.19.3
Other Expense Items (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Other Income and Expenses [Abstract]        
Restructuring Charges $ 1.8 $ 1.2 $ 3.8 $ 6.7
Increase (decrease) of other items 6.2   $ 1.0  
Foreign exchange transaction (gain) loss $ 5.1 $ (2.7)    
XML 66 R21.htm IDEA: XBRL DOCUMENT v3.19.3
Benefit Plans
 9 Months Ended
Sep. 30, 2019
Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Abstract]  
Benefit Plans Benefit Plans

The components of net periodic benefit cost for the three months ended September 30 were as follows:

 
Pension benefits
 
Other retirement benefits
 
Total
($ in millions)
2019
 
2018
 
2019
 
2018
 
2019
 
2018
Service cost
$
0.4

 
$
2.6

 
$
—

 
$
—

 
$
0.4

 
$
2.6

Interest cost
1.9

 
2.3

 
0.1

 
0.1

 
2.0

 
2.4

Expected return on assets
(3.1
)
 
(3.9
)
 
—

 
—

 
(3.1
)
 
(3.9
)
Amortization of prior service credit
0.1

 
(0.3
)
 
(0.2
)
 
(0.2
)
 
(0.1
)
 
(0.5
)
Recognized actuarial losses (gains)
0.5

 
0.9

 
(0.7
)
 
(0.7
)
 
(0.2
)
 
0.2

Settlements
2.7

 
—

 
—

 
—

 
2.7

 
—

Net periodic benefit cost
$
2.5

 
$
1.6

 
$
(0.8
)
 
$
(0.8
)
 
$
1.7

 
$
0.8


 
Pension benefits
 
Other retirement benefits
 
Total
($ in millions)
2019
 
2018
 
2019
 
2018
 
2019
 
2018
U.S. plans
$
2.0

 
$
1.0

 
$
(0.8
)
 
$
(0.8
)
 
$
1.2

 
$
0.2

International plans
0.5

 
0.6

 
—

 
—

 
0.5

 
0.6

Net periodic benefit cost
$
2.5

 
$
1.6

 
$
(0.8
)
 
$
(0.8
)
 
$
1.7

 
$
0.8


The components of net periodic benefit cost for the nine months ended September 30 were as follows:

 
Pension benefits
 
Other retirement benefits
 
Total
($ in millions)
2019
 
2018
 
2019
 
2018
 
2019
 
2018
Service cost
$
1.1

 
$
8.1

 
$
—

 
$
—

 
$
1.1

 
$
8.1

Interest cost
6.8

 
7.0

 
0.2

 
0.2

 
7.0

 
7.2

Expected return on assets
(8.9
)
 
(11.7
)
 
—

 
—

 
(8.9
)
 
(11.7
)
Amortization of prior service credit
0.1

 
(1.1
)
 
(0.5
)
 
(0.5
)
 
(0.4
)
 
(1.6
)
Recognized actuarial losses (gains)
1.6

 
2.8

 
(1.8
)
 
(1.8
)
 
(0.2
)
 
1.0

Settlements
2.7

 
—

 
—

 
—

 
2.7

 
—

Net periodic benefit cost
$
3.4

 
$
5.1

 
$
(2.1
)
 
$
(2.1
)
 
$
1.3

 
$
3.0


 
Pension benefits
 
Other retirement benefits
 
Total
($ in millions)
2019
 
2018
 
2019
 
2018
 
2019
 
2018
U.S. plans
$
1.9

 
$
3.5

 
$
(2.1
)
 
$
(2.1
)
 
$
(0.2
)
 
$
1.4

International plans
1.5

 
1.6

 
—

 
—

 
1.5

 
1.6

Net periodic benefit cost
$
3.4

 
$
5.1

 
$
(2.1
)
 
$
(2.1
)
 
$
1.3

 
$
3.0



During the three and nine months ended September 30, 2019, we recorded a $2.7 million pension settlement charge within other nonoperating expense (income), as we determined that normal-course lump-sum payments for each of our U.S. qualified and non-qualified defined benefit pension plans exceeded the threshold for settlement accounting under U.S. GAAP for the year. Effective January 1, 2019, except for interest crediting, benefit accruals under these defined benefit pension plans ceased.

During the three and nine months ended September 30, 2019, we contributed $2.6 million to our U.S. qualified defined benefit pension plan.
XML 67 R25.htm IDEA: XBRL DOCUMENT v3.19.3
Segment Information
 9 Months Ended
Sep. 30, 2019
Segment Reporting [Abstract]  
Segment Information Segment Information

Our business operations are organized into two reportable segments, Proprietary Products and Contract-Manufactured Products. Our Proprietary Products reportable segment offers proprietary packaging, containment and drug delivery products, along with analytical lab services, to biologic, generic and pharmaceutical drug customers. Our Contract-Manufactured Products reportable segment serves as a fully integrated business, focused on the design, manufacture, and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers.

We evaluate the performance of our segments based upon, among other things, segment net sales and operating profit. Segment operating profit excludes general corporate costs, which include executive and director compensation, stock-based compensation, adjustments to annual incentive plan expense for over- or under-attainment of targets, certain pension and other retirement benefit costs, and other corporate facilities and administrative expenses not allocated to the segments. Also excluded are items that we consider not representative of ongoing operations. Such items are referred to as other unallocated items and generally include restructuring and related charges, certain asset impairments and other specifically-identified income or expense items.

The following table presents information about our reportable segments, reconciled to consolidated totals:

 
Three Months Ended
September 30,
 
Nine Months Ended
September 30,
($ in millions)
2019
 
2018
 
2019
 
2018
Net sales:
 
 
 
 
 
 
 
Proprietary Products
$
345.2

 
$
325.2

 
$
1,045.9

 
$
997.4

Contract-Manufactured Products
111.1

 
106.7

 
323.6

 
297.7

Intersegment sales elimination
(0.2
)
 
(0.2
)
 
(0.2
)
 
(0.2
)
Consolidated net sales
$
456.1

 
$
431.7

 
$
1,369.3

 
$
1,294.9

Operating profit (loss):
 
 
 
 
 
 
 
Proprietary Products
$
72.9

 
$
68.2

 
$
238.7

 
$
202.7

Contract-Manufactured Products
11.6

 
11.2

 
33.5

 
29.7

Corporate
(14.4
)
 
(16.3
)
 
(48.9
)
 
(50.1
)
Other unallocated items
(2.8
)
 
(2.3
)
 
(4.8
)
 
(7.8
)
Total operating profit
$
67.3

 
$
60.8

 
$
218.5

 
$
174.5

Interest expense
2.1

 
2.0

 
6.4

 
6.1

Interest income
(1.0
)
 
(0.5
)
 
(2.5
)
 
(1.4
)
Other nonoperating expense (income)
1.3

 
(1.8
)
 
0.2

 
(5.1
)
Income before income taxes
$
64.9

 
$
61.1

 
$
214.4

 
$
174.9



The intersegment sales elimination, which is required for the presentation of consolidated net sales, represents the elimination of components sold between our segments.

Other unallocated items during the three and nine months ended September 30, 2019 consisted of $1.8 million and $3.8 million, respectively, in restructuring and related charges. In addition, during the three and nine months ended September 30, 2019, other unallocated items included a charge of $1.0 million as a result of the continued devaluation of Argentina’s currency. Other unallocated items during the three and nine months ended September 30, 2018 consisted of $1.2 million and $6.7 million, respectively, in restructuring and related charges. In addition, during the three and nine months ended September 30, 2018, other unallocated items included a charge of $1.1 million related to the classification of Argentina’s economy as highly inflationary under U.S. GAAP as of July 1, 2018. Please refer to Note 15, Other Expense (Income), for further discussion of these items.
XML 68 R29.htm IDEA: XBRL DOCUMENT v3.19.3
Net Income Per Share (Tables)
 9 Months Ended
Sep. 30, 2019
Earnings Per Share [Abstract]  
Reconciliation of Basic to Diluted Net Income Per Share

The following table reconciles the shares used in the calculation of basic net income per share to those used for diluted net income per share:

 
Three Months Ended
September 30,
 
Nine Months Ended
September 30,
(in millions)
2019
 
2018
 
2019
 
2018
Net income
$
56.3

 
$
55.2

 
$
177.8

 
$
154.9

Weighted average common shares outstanding
74.0

 
73.9

 
73.9

 
73.9

Dilutive effect of equity awards, based on the treasury stock method
1.5

 
1.8

 
1.4

 
1.5

Weighted average shares assuming dilution
75.5

 
75.7

 
75.3

 
75.4
XML 69 R45.htm IDEA: XBRL DOCUMENT v3.19.3
Net Income Per Share (Details) - USD ($)
$ / shares in Units, $ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2019
Jun. 30, 2019
Mar. 31, 2019
Sep. 30, 2018
Jun. 30, 2018
Mar. 31, 2018
Sep. 30, 2019
Sep. 30, 2018
Dec. 31, 2018
Earnings Per Share [Abstract]                  
Net income $ 56.3 $ 66.1 $ 55.4 $ 55.2 $ 56.1 $ 43.6 $ 177.8 $ 154.9  
Weighted average common shares outstanding (in shares) 74,000,000.0     73,900,000     73,900,000 73,900,000  
Dilutive effect of equity awards, based on the treasury stock method (in shares) 1,500,000     1,800,000     1,400,000 1,500,000  
Weighted average shares assuming dilution (in shares) 75,500,000     75,700,000     75,300,000 75,400,000  
Antidilutive options excluded from computation of diluted net income per share (in shares) 100,000     100,000     300,000 400,000  
Stock repurchase program, shares authorized                 800,000
Stock repurchase program, shares purchased             800,000    
Stock purchase program, cost of shares purchased     $ 83.1   $ 22.9 $ 47.9 $ 83.1    
Stock repurchase program, average price per share             $ 103.89    
XML 70 R41.htm IDEA: XBRL DOCUMENT v3.19.3
Revenue Recognition (Details)
 3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Disaggregation of Revenue [Line Items]        
Percentage of net sales 100.00% 100.00% 100.00% 100.00%
Revenue Benchmark [Member] | Product Concentration Risk [Member] | High-Value Components [Member]        
Disaggregation of Revenue [Line Items]        
Percentage of net sales 42.00% 41.00% 43.00% 42.00%
Revenue Benchmark [Member] | Product Concentration Risk [Member] | Standard Packaging [Member]        
Disaggregation of Revenue [Line Items]        
Percentage of net sales 28.00% 31.00% 29.00% 32.00%
Revenue Benchmark [Member] | Product Concentration Risk [Member] | Delivery Devices [Member]        
Disaggregation of Revenue [Line Items]        
Percentage of net sales 6.00% 4.00% 4.00% 3.00%
Revenue Benchmark [Member] | Product Concentration Risk [Member] | Contract-Manufactured Products [Member]        
Disaggregation of Revenue [Line Items]        
Percentage of net sales 24.00% 24.00% 24.00% 23.00%
Biologics [Member] | Revenue Benchmark [Member] | Customer Concentration Risk [Member]        
Disaggregation of Revenue [Line Items]        
Percentage of net sales 26.00% 21.00% 25.00% 21.00%
Generics [Member] | Revenue Benchmark [Member] | Customer Concentration Risk [Member]        
Disaggregation of Revenue [Line Items]        
Percentage of net sales 20.00% 21.00% 20.00% 21.00%
Pharma Customers [Member] | Revenue Benchmark [Member] | Customer Concentration Risk [Member]        
Disaggregation of Revenue [Line Items]        
Percentage of net sales 30.00% 34.00% 31.00% 35.00%
Contract-Manufactured Products [Member] | Revenue Benchmark [Member] | Customer Concentration Risk [Member]        
Disaggregation of Revenue [Line Items]        
Percentage of net sales 24.00% 24.00% 24.00% 23.00%
Americas [Member] | Revenue Benchmark [Member] | Geographic Concentration Risk [Member]        
Disaggregation of Revenue [Line Items]        
Percentage of net sales 48.00% 51.00% 48.00% 48.00%
Europe, Middle East, Africa [Member] | Revenue Benchmark [Member] | Geographic Concentration Risk [Member]        
Disaggregation of Revenue [Line Items]        
Percentage of net sales 44.00% 41.00% 44.00% 44.00%
Asia Pacific [Member] | Revenue Benchmark [Member] | Geographic Concentration Risk [Member]        
Disaggregation of Revenue [Line Items]        
Percentage of net sales 8.00% 8.00% 8.00% 8.00%
XML 71 R49.htm IDEA: XBRL DOCUMENT v3.19.3
Leases Lease Cash Flow and Supplemental Information (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2019
Lease Cash Flow and Supplemental Information [Abstract]    
Operating lease payments $ 3.2 $ 9.4
Right-of-use assets obtained in exchange for new operating lease liabilities $ 0.3 $ 8.4
XML 72 R8.htm IDEA: XBRL DOCUMENT v3.19.3
Summary of Significant Accounting Policies
 9 Months Ended
Sep. 30, 2019
Accounting Policies [Abstract]  
Summary of Significant Accounting Policies Summary of Significant Accounting Policies

Basis of Presentation: The condensed consolidated financial statements included in this report are unaudited and have been prepared in accordance with United States (“U.S.”) generally accepted accounting principles (“U.S. GAAP”) for interim financial reporting and U.S. Securities and Exchange Commission (“SEC”) regulations. The year-end condensed consolidated balance sheet data was derived from audited financial statements, but does not include all disclosures required by U.S. GAAP. Certain information and footnote disclosures normally included in annual financial statements prepared in accordance with U.S. GAAP have been condensed or omitted. In the opinion of management, these financial statements include all adjustments, which are of a normal recurring nature, necessary for a fair statement of the financial position, results of operations, cash flows and the change in equity for the periods presented. The condensed consolidated financial statements for the three and nine months ended September 30, 2019 should be read in conjunction with the consolidated financial statements and notes thereto of West Pharmaceutical Services, Inc. and its majority-owned subsidiaries (which may be referred to as “West”, the “Company”, “we”, “us” or “our”) appearing in our Annual Report on Form 10-K for the year ended December 31, 2018 (the “2018 Annual Report”). The results of operations for any interim period are not necessarily indicative of results for the full year.

In April 2019, we acquired the business of our distributor in South Korea for $18.9 million. As a result of the acquisition, we recorded inventories, property, plant and equipment, goodwill and a customer relationships intangible asset of $4.5 million, $0.6 million, $2.6 million and $11.2 million, respectively. The goodwill was recorded within our Proprietary Products reportable segment. The results of this acquisition have been included in our condensed consolidated financial statements since the acquisition date.

As of April 1, 2017, our consolidated financial statements exclude the results of our Venezuelan subsidiary. Please refer to Note 15, Other Expense, to the consolidated financial statements in our 2018 Annual Report for further discussion.
XML 73 R62.htm IDEA: XBRL DOCUMENT v3.19.3
Supplemental Equity Information (Details) - $ / shares
 3 Months Ended
Sep. 30, 2019
Jun. 30, 2019
Mar. 31, 2019
Sep. 30, 2018
Jun. 30, 2018
Mar. 31, 2018
Equity [Abstract]            
Dividends declared per share $ 0.16 $ 0.15 $ 0.15 $ 0.15 $ 0.14 $ 0.14
XML 74 R66.htm IDEA: XBRL DOCUMENT v3.19.3
Other Expense (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Other Income and Expenses [Abstract]        
Restructuring Charges $ 1.8 $ 1.2 $ 3.8 $ 6.7
Argentina currency devaluation 1.0 1.1 1.0 1.1
Development and licensing income (0.2) (0.2) (0.6) (0.6)
Contingent consideration 0.1 0.2 0.4 0.8
Other items 3.7 (2.5) (3.0) (4.0)
Total other expense (income) $ 6.4 $ (0.2) $ 1.6 $ 4.0
XML 75 R4.htm IDEA: XBRL DOCUMENT v3.19.3
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED) (Parenthetical) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Statement of Comprehensive Income [Abstract]        
Defined benefit pension and other postretirement plan adjustments, tax $ 0.7 $ 0.0 $ 0.7 $ 0.1
Net gain (loss) on derivatives, tax $ 1.5 $ (0.1) $ 0.7 $ 1.0
XML 77 R28.htm IDEA: XBRL DOCUMENT v3.19.3
Revenue (Tables)
 9 Months Ended
Sep. 30, 2019
Revenue [Abstract]  
Disaggregation of Revenue [Table Text Block]

The following table presents the approximate percentage of our net sales by market group:
 
Three Months Ended
September 30,
 
Nine Months Ended
September 30,
 
2019
 
2018
 
2019
 
2018
Biologics
26
%
 
21
%
 
25
%
 
21
%
Generics
20
%
 
21
%
 
20
%
 
21
%
Pharma
30
%
 
34
%
 
31
%
 
35
%
Contract-Manufactured Products
24
%
 
24
%
 
24
%
 
23
%
 
100
%
 
100
%
 
100
%
 
100
%
The following table presents the approximate percentage of our net sales by product category:
 
Three Months Ended
September 30,
 
Nine Months Ended
September 30,
 
2019
 
2018
 
2019
 
2018
High-Value Components
42
%
 
41
%
 
43
%
 
42
%
Standard Packaging
28
%
 
31
%
 
29
%
 
32
%
Delivery Devices
6
%
 
4
%
 
4
%
 
3
%
Contract-Manufactured Products
24
%
 
24
%
 
24
%
 
23
%
 
100
%
 
100
%
 
100
%
 
100
%
The following table presents the approximate percentage of our net sales by geographic location:
 
Three Months Ended
September 30,
 
Nine Months Ended
September 30,
 
2019
 
2018
 
2019
 
2018
Americas
48
%
 
51
%
 
48
%
 
48
%
Europe, Middle East, Africa
44
%
 
41
%
 
44
%
 
44
%
Asia Pacific
8
%
 
8
%
 
8
%
 
8
%
 
100
%
 
100
%
 
100
%
 
100
%
Change in Contract with Customer, Asset and Liability [Abstract]
The following table summarizes our contract assets and liabilities, excluding contract assets included in accounts receivable, net:
 
($ in millions)
Contract assets, December 31, 2018
$
9.1

Contract assets, September 30, 2019
9.4

Change in contract assets - increase (decrease)
$
0.3

 
 
Deferred income, December 31, 2018
$
(33.4
)
Deferred income, September 30, 2019
(30.9
)
Change in deferred income - decrease (increase)
$
2.5
XML 78 R20.htm IDEA: XBRL DOCUMENT v3.19.3
Stock-Based Compensation
 9 Months Ended
Sep. 30, 2019
Share-based Payment Arrangement [Abstract]  
Stock-Based Compensation  Stock-Based Compensation

The West Pharmaceutical Services, Inc. 2016 Omnibus Incentive Compensation Plan (the “2016 Plan”) provides for the granting of stock options, stock appreciation rights, restricted stock awards and performance awards to employees and non-employee directors. A committee of the Board of Directors determines the terms and conditions of awards to be granted. Vesting requirements vary by award. At September 30, 2019, there were 3,110,708 shares remaining in the 2016 Plan for future grants.

During the nine months ended September 30, 2019, we granted 345,400 stock options at a weighted average exercise price of $102.59 per share based on the grant-date fair value of our stock to employees under the 2016 Plan. The weighted average grant date fair value of options granted was $24.53 per share as determined by the Black-Scholes option valuation model using the following weighted average assumptions: a risk-free interest rate of 2.3%; expected life of 5.6 years based on prior experience; stock volatility of 22.5% based on historical data; and a dividend yield of 0.7%. Stock option expense is recognized over the vesting period, net of forfeitures.

During the nine months ended September 30, 2019, we granted 82,646 stock-settled performance share unit (“PSU”) awards at a weighted average grant-date fair value of $102.59 per share to eligible employees. These awards are earned based on the Company’s performance against pre-established targets, including annual growth rate of revenue and return on invested capital, over a specified performance period. Depending on the achievement of the targets, recipients of stock-settled PSU awards are entitled to receive a certain number of shares of common stock. Shares earned under PSU awards may vary from 0% to 200% of an employee’s targeted award. The fair value of stock-settled PSU awards is based on the market price of our stock at the grant date and is recognized as expense over the performance period, adjusted for estimated target outcomes and net of forfeitures.

During the nine months ended September 30, 2019, we granted 11,631 stock-settled restricted share unit (“RSU”) awards at a weighted average grant-date fair value of $112.49 per share to eligible employees. These awards are earned over a specified performance period. The fair value of stock-settled RSU awards is based on the market price of our stock at the grant date and is recognized as expense over the vesting period, net of forfeitures.

Total stock-based compensation expense was $5.4 million and $18.8 million for the three and nine months ended September 30, 2019, respectively. For the three and nine months ended September 30, 2018, stock-based compensation expense was $5.3 million and $14.7 million, respectively.
XML 79 R24.htm IDEA: XBRL DOCUMENT v3.19.3
Commitments and Contingencies
 9 Months Ended
Sep. 30, 2019
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies Commitments and Contingencies

From time to time, we are involved in product liability matters and other legal proceedings and claims generally incidental to our normal business activities. We accrue for loss contingencies when it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. While the outcome of current proceedings cannot be accurately predicted, we believe their ultimate resolution should not have a material adverse effect on our business, financial condition, results of operations or liquidity.

There have been no significant changes to the commitments and contingencies included in our 2018 Annual Report.

On January 1, 2019, we adopted ASC 842. Please refer to Note 6, Leases, for additional information.
XML 80 R12.htm IDEA: XBRL DOCUMENT v3.19.3
Inventories
 9 Months Ended
Sep. 30, 2019
Inventory Disclosure [Abstract]  
Inventories Inventories

Inventories are valued at the lower of cost (on a first-in, first-out basis) and net realizable value. Inventory balances were as follows:

($ in millions)
September 30,
2019
 
December 31,
2018
Raw materials
$
99.2

 
$
90.4

Work in process
38.3

 
42.2

Finished goods
92.9

 
81.9

 
$
230.4

 
$
214.5
XML 81 R16.htm IDEA: XBRL DOCUMENT v3.19.3
Derivative Financial Instruments
 9 Months Ended
Sep. 30, 2019
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Derivative Financial Instruments Derivative Financial Instruments

Our ongoing business operations expose us to various risks, such as fluctuating interest rates, foreign currency exchange rates and increasing commodity prices. To manage these market risks, we periodically enter into derivative financial instruments, such as interest rate swaps, options and foreign exchange contracts for periods consistent with, and for notional amounts equal to or less than, the related underlying exposures. We do not purchase or hold any derivative financial instruments for investment or trading purposes. All derivatives are recorded in our condensed consolidated balance sheet at fair value.

Foreign Exchange Rate Risk

We have entered into forward exchange contracts, designated as fair value hedges, to manage our exposure to fluctuating foreign exchange rates on cross-currency intercompany loans. As of September 30, 2019, the total amount of these forward exchange contracts was Singapore Dollar (“SGD”) 601.5 million and $13.4 million. As of December 31, 2018, the total amount of these forward exchange contracts was €10.0 million, SGD 601.5 million and $13.4 million.

In addition, we have entered into several foreign currency contracts, designated as cash flow hedges, for periods of up to eighteen months, intended to hedge the currency risk associated with a portion of our forecasted transactions denominated in foreign currencies. As of September 30, 2019, we had outstanding foreign currency contracts to purchase and sell certain pairs of currencies, as follows:
(in millions)
 
 
Sell
Currency
Purchase
 
USD
Euro
USD
39.3

 
—

34.2

Yen
5,921.1

 
31.8

20.2

SGD
31.9

 
18.7

4.3



At September 30, 2019, a portion of our debt consisted of borrowings denominated in currencies other than USD. We have designated our €21.0 million ($23.0 million) Euro-denominated borrowings under our Credit Facility as a hedge of our net investment in certain European subsidiaries. A cumulative foreign currency translation gain of $0.6 million pre-tax ($0.5 million after tax) on this debt was recorded within accumulated other comprehensive loss as of September 30, 2019. We have also designated our ¥500.0 million ($4.6 million) Yen-denominated borrowings under our Credit Facility as a hedge of our net investment in Daikyo. At September 30, 2019, there was a cumulative foreign currency translation loss of $0.5 million pre-tax ($0.4 million after tax) on this Yen-denominated debt, which was also included within accumulated other comprehensive loss.

Commodity Price Risk

Many of our proprietary products are made from synthetic elastomers, which are derived from the petroleum refining process. We purchase the majority of our elastomers via long-term supply contracts, some of which contain clauses that provide for surcharges related to fluctuations in crude oil prices. The following economic hedges did not qualify for hedge accounting treatment since they did not meet the highly effective requirement at inception.

From November 2017 through July 2019, we purchased several series of call options for a total of 301,326 barrels of crude oil to mitigate our exposure to such oil-based surcharges and protect operating cash flows with regards to a portion of our forecasted elastomer purchases.

As of September 30, 2019, we had outstanding contracts to purchase 107,909 barrels of crude oil from October 2019 to December 2020, at a weighted-average strike price of $71.15 per barrel.

Effects of Derivative Instruments on Financial Position and Results of Operations

Please refer to Note 10, Fair Value Measurements, for the balance sheet location and fair values of our derivative instruments as of September 30, 2019 and December 31, 2018.

The following table summarizes the effects of derivative instruments designated as fair value hedges on the condensed consolidated statements of income:
 
Amount of Loss (Gain) Recognized in Income for the
 
Amount of Gain Recognized in Income for the
 
 
 
Three Months Ended
September 30,
 
Nine Months Ended
September 30,
 
Location on Statement of Income
($ in millions)
2019
 
2018
 
2019
 
2018
 
 
Fair Value Hedges:
 
 
 
 
 
 
 
 
 
Foreign currency hedge contracts
$
4.3

 
$
(2.0
)
 
$
(5.0
)
 
$
(3.4
)
 
Other expense (income)
Total
$
4.3

 
$
(2.0
)
 
$
(5.0
)
 
$
(3.4
)
 
 

We recognize in earnings the initial value of forward point components on a straight-line basis over the life of the fair value hedge.

The following tables summarize the effects of derivative instruments designated as fair value, cash flow, and net investment hedges on other comprehensive income (“OCI”) and earnings, net of tax:
 
Amount of (Loss) Gain Recognized in OCI for the
 
Amount of Loss (Gain) Reclassified from Accumulated OCI into Income for the
 
Location of Loss (Gain) Reclassified from Accumulated OCI into Income
 
Three Months Ended
September 30,
 
Three Months Ended
September 30,
 
($ in millions)
2019
 
2018
 
2019
 
2018
 
 
Fair Value Hedges
 
 
 
 
 
 
 
 
 
Foreign currency hedge contracts
$
(0.6
)
 
$
—

 
$
2.9

 
$
—

 
Other expense (income)
Total
$
(0.6
)
 
$
—

 
$
2.9

 
$
—

 
 
Cash Flow Hedges:
 
 
 
 
 
 
 
 
 
Foreign currency hedge contracts
$
0.7

 
$
0.1

 
$
(0.3
)
 
$
—

 
Net sales
Foreign currency hedge contracts
0.6

 
(0.5
)
 
(0.2
)
 
(0.1
)
 
Cost of goods and services sold
Forward treasury locks
—

 
—

 
0.1

 
0.1

 
Interest expense
Total
$
1.3

 
$
(0.4
)
 
$
(0.4
)
 
$
—

 
 
Net Investment Hedges:
 

 
 

 
 

 
 

 
 
Foreign currency-denominated debt
$
0.7

 
$
0.2

 
$
—

 
$
—

 
Other expense (income)
Total
$
0.7

 
$
0.2

 
$
—

 
$
—

 
 

 
Amount of Gain (Loss) Recognized in OCI for the
 
Amount of (Gain) Loss Reclassified from Accumulated OCI into Income for the
 
Location of (Gain) Loss Reclassified from Accumulated OCI into Income
 
Nine Months Ended
September 30,
 
Nine Months Ended
September 30,
 
($ in millions)
2019
 
2018
 
2019
 
2018
 
 
Fair Value Hedges
 
 
 
 
 
 
 
 
 
Foreign currency hedge contracts
$
3.9

 
$
—

 
$
(3.3
)
 
$
—

 
Other expense (income)
Total
$
3.9

 
$
—

 
$
(3.3
)
 
$
—

 
 
Cash Flow Hedges:
 
 
 
 
 
 
 
 
 
Foreign currency hedge contracts
$
1.0

 
$
0.2

 
$
(0.7
)
 
$
0.8

 
Net sales
Foreign currency hedge contracts
1.1

 
0.9

 
(0.5
)
 
0.4

 
Cost of goods and services sold
Forward treasury locks
—

 
—

 
0.2

 
0.2

 
Interest expense
Total
$
2.1

 
$
1.1

 
$
(1.0
)
 
$
1.4

 
 
Net Investment Hedges:
 

 
 

 
 

 
 

 
 
Foreign currency-denominated debt
$
0.5

 
$
0.7

 
$
—

 
$
—

 
Other expense (income)
Total
$
0.5

 
$
0.7

 
$
—

 
$
—

 
 


The following table summarizes the effects of derivative instruments not designated as hedges on the condensed consolidated statements of income:
 
Amount of Loss Recognized in Income for the
 
Amount of Loss (Gain) Recognized in Income for the
 
 
 
Three Months Ended
September 30,
 
Nine Months Ended
September 30,
 
Location on Statement of Income
($ in millions)
2019
 
2018
 
2019
 
2018
 
 
Commodity call options
$
0.1

 
$
—

 
$
0.3

 
$
(0.5
)
 
Cost of goods and services sold
Total
$
0.1

 
$
—

 
$
0.3

 
$
(0.5
)
 
 


For the three and nine months ended September 30, 2019 and 2018, there was no material ineffectiveness related to our hedges.
XML 82 R35.htm IDEA: XBRL DOCUMENT v3.19.3
Accumulated Other Comprehensive Loss (Tables)
 9 Months Ended
Sep. 30, 2019
Equity [Abstract]  
Components of Accumulated Other Comprehensive Loss
The following table presents the changes in the components of accumulated other comprehensive loss, net of tax, for the nine months ended September 30, 2019:

($ in millions)
(Losses) gains on
derivatives
 
Unrealized gains
on investment
securities
 
Defined benefit
pension and other
postretirement plans
 
Foreign
currency
translation
 
Total
Balance, December 31, 2018
$
(0.4
)
 
$
0.4

 
$
(40.4
)
 
$
(113.8
)
 
$
(154.2
)
Other comprehensive income (loss) before reclassifications
6.0

 
—

 
0.6

 
(20.1
)
 
(13.5
)
Amounts reclassified out
(4.3
)
 
—

 
1.6

 
—

 
(2.7
)
Other comprehensive income (loss), net of tax
1.7

 
—

 
2.2

 
(20.1
)
 
(16.2
)
Balance, September 30, 2019
$
1.3

 
$
0.4

 
$
(38.2
)
 
$
(133.9
)
 
$
(170.4
)
Reclassification out of Accumulated Other Comprehensive Loss
A summary of the reclassifications out of accumulated other comprehensive loss is presented in the following table:

($ in millions)
 
Three Months Ended
September 30,
 
Nine Months Ended
September 30,
 
Location on Statement of Income
Detail of components
 
2019
 
2018
 
2019
 
2018

 
Gains (losses) on derivatives:
 
 
 
 
 
 
 
 
 
 
Foreign currency contracts
 
$
0.3

 
$
0.1

 
$
0.8

 
$
(0.8
)
 
Net sales
Foreign currency contracts
 
0.3

 
—

 
0.8

 
(0.7
)
 
Cost of goods and services sold
Foreign currency contracts
 
(4.3
)
 
—

 
5.0

 
—

 
Other expense (income)
Forward treasury locks
 
(0.1
)
 
(0.1
)
 
(0.3
)
 
(0.3
)
 
Interest expense
Total before tax
 
(3.8
)
 
—

 
6.3

 
(1.8
)
 
 
Tax expense
 
1.3

 
—

 
(2.0
)
 
0.4

 
 
Net of tax
 
$
(2.5
)
 
$
—

 
$
4.3

 
$
(1.4
)
 
 
Amortization of defined benefit pension and other postretirement plans:
 
 
 
 
 
 
 
 
 
 
Prior service credit
 
$
0.1

 
$
0.5

 
$
0.4

 
$
1.6

 
(a)
Actuarial gains (losses)
 
0.2

 
(0.2
)
 
0.2

 
(1.0
)
 
(a)
Settlements
 
(2.7
)
 
—

 
(2.7
)
 
—

 
(a)
Total before tax
 
(2.4
)
 
0.3

 
(2.1
)
 
0.6

 
 
Tax expense
 
0.6

 
—

 
0.5

 
(0.1
)
 
 
Net of tax
 
$
(1.8
)
 
$
0.3

 
$
(1.6
)
 
$
0.5

 
 
Total reclassifications for the period, net of tax
 
$
(4.3
)
 
$
0.3

 
$
2.7

 
$
(0.9
)
 
 

(a) These components are included in the computation of net periodic benefit cost. Please refer to Note 14, Benefit Plans, for additional details.
XML 83 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 84 R31.htm IDEA: XBRL DOCUMENT v3.19.3
Leases Leases (Tables)
 9 Months Ended
Sep. 30, 2019
Leases [Abstract]  
Lease, Cost [Table Text Block]
The components of lease expense were as follows:
($ in millions)
Three Months Ended
September 30, 2019
 
Nine Months Ended
September 30, 2019
Operating lease cost
$
3.4

 
$
9.7

Short-term lease cost
0.1

 
0.5

Variable lease cost
0.8

 
2.3

Total lease cost
$
4.3

 
$
12.5
Lessee, Lease Cash Flow and Supplemental Information [Table Text Block]
Supplemental information related to leases was as follows:
($ in millions)
Three Months Ended
September 30, 2019
 
Nine Months Ended
September 30, 2019
Cash paid for amounts included in the measurement of lease liabilities:
 
 
 
Operating cash flows from operating leases
$
3.2

 
$
9.4

 
 
 
 
Right-of-use assets obtained in exchange for new operating lease liabilities
$
0.3

 
$
8.4
Lessee, Operating Lease, Liability, Maturity [Table Text Block]
Maturities of lease liabilities as of September 30, 2019 were as follows:
($ in millions)
Operating
Year
Leases
2019 (remaining three months)
$
3.4

2020
12.0

2021
10.2

2022
8.3

2023
7.7

Thereafter
48.1

 
89.7

Less: imputed lease interest
(16.4
)
Total lease liabilities
$
73.3
Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block] of December 31, 2018 were as follows:
($ in millions)
Operating
Year
Leases
2019
$
13.0

2020
10.5

2021
7.8

2022
6.9

2023
5.5

Thereafter
37.8

Total
$
81.5
XML 85 R39.htm IDEA: XBRL DOCUMENT v3.19.3
Segment Information (Tables)
 9 Months Ended
Sep. 30, 2019
Segment Reporting [Abstract]  
Segment Information
The following table presents information about our reportable segments, reconciled to consolidated totals:

 
Three Months Ended
September 30,
 
Nine Months Ended
September 30,
($ in millions)
2019
 
2018
 
2019
 
2018
Net sales:
 
 
 
 
 
 
 
Proprietary Products
$
345.2

 
$
325.2

 
$
1,045.9

 
$
997.4

Contract-Manufactured Products
111.1

 
106.7

 
323.6

 
297.7

Intersegment sales elimination
(0.2
)
 
(0.2
)
 
(0.2
)
 
(0.2
)
Consolidated net sales
$
456.1

 
$
431.7

 
$
1,369.3

 
$
1,294.9

Operating profit (loss):
 
 
 
 
 
 
 
Proprietary Products
$
72.9

 
$
68.2

 
$
238.7

 
$
202.7

Contract-Manufactured Products
11.6

 
11.2

 
33.5

 
29.7

Corporate
(14.4
)
 
(16.3
)
 
(48.9
)
 
(50.1
)
Other unallocated items
(2.8
)
 
(2.3
)
 
(4.8
)
 
(7.8
)
Total operating profit
$
67.3

 
$
60.8

 
$
218.5

 
$
174.5

Interest expense
2.1

 
2.0

 
6.4

 
6.1

Interest income
(1.0
)
 
(0.5
)
 
(2.5
)
 
(1.4
)
Other nonoperating expense (income)
1.3

 
(1.8
)
 
0.2

 
(5.1
)
Income before income taxes
$
64.9

 
$
61.1

 
$
214.4

 
$
174.9
XML 87 R58.htm IDEA: XBRL DOCUMENT v3.19.3
Fair Value Measurements Level 3 (Details) - USD ($)
$ in Millions
 9 Months Ended 12 Months Ended
Sep. 30, 2019
Dec. 31, 2018
Level 3 Fair Value Measurements [Roll Forward]    
Balance, beginning of period $ 1.7 $ 4.9
Increase (decrease) in fair value recorded in earnings 0.4 (2.6)
Payments (0.3) (0.6)
Balance, end of period $ 1.8 $ 1.7
ZIP 88 0000105770-19-000045-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000105770-19-000045-xbrl.zip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�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
XML 90 R54.htm IDEA: XBRL DOCUMENT v3.19.3
Credit Facility (Details) - USD ($)
 9 Months Ended 12 Months Ended
Sep. 30, 2019
Dec. 31, 2018
Line of Credit Facility [Line Items]    
Unamortized debt issuance costs $ 500,000 $ 600,000
Revolving credit facility, Due 2024 [Member]    
Line of Credit Facility [Line Items]    
Line of Credit Facility, current borrowing capacity 300,000,000.0  
Line of Credit Facility, additional borrowing capacity 350,000,000.0  
Credit available for the issuance of letters of credit 30,000,000.0  
Line of Credit Facility, noncurrent 27,600,000  
Line of Credit Facility outstanding borrowings, Yen 4,600,000  
Line of Credit Facility outstanding borrowings, Euro 23,000,000.0  
Line of Credit Facility, unused commitment level 269,900,000  
Debt issuance costs $ 1,100,000 $ 600,000
Revolving credit facility, Due 2024 [Member] | London Interbank Offered Rate (LIBOR) [Member]    
Line of Credit Facility [Line Items]    
Debt instrument, stated interest rate 1.00%  
Revolving credit facility, Due 2024 [Member] | Fed Funds Effective Rate Overnight Index Swap Rate [Member]    
Line of Credit Facility [Line Items]    
Debt instrument, stated interest rate 50.00%  
Revolving credit facility, Due 2024 [Member] | Letter of Credit [Member]    
Line of Credit Facility [Line Items]    
Long-term Line of Credit $ 2,500,000  
Revolving credit facility, Due 2024 [Member] | Foreign Line of Credit [Member]    
Line of Credit Facility [Line Items]    
Credit facility is available for swing-line loans 20,000,000.0  
Revolving credit facility, Due 2024 [Member] | Domestic Line of Credit [Member]    
Line of Credit Facility [Line Items]    
Credit facility is available for swing-line loans $ 30,000,000.0  
Maximum [Member] | Revolving credit facility, Due 2024 [Member]    
Line of Credit Facility [Line Items]    
Ratio of debt to EBITDA 4.0  
Maximum [Member] | Revolving credit facility, Due 2024 [Member] | London Interbank Offered Rate (LIBOR) [Member]    
Line of Credit Facility [Line Items]    
Debt instrument, stated interest rate 137.50%  
Maximum [Member] | Revolving credit facility, Due 2024 [Member] | Base Rate [Member]    
Line of Credit Facility [Line Items]    
Debt instrument, stated interest rate 37.50%  
Minimum [Member] | Revolving credit facility, Due 2024 [Member]    
Line of Credit Facility [Line Items]    
Ratio of debt to EBITDA 3.5  
Minimum [Member] | Revolving credit facility, Due 2024 [Member] | London Interbank Offered Rate (LIBOR) [Member]    
Line of Credit Facility [Line Items]    
Debt instrument, stated interest rate 87.50%  
Minimum [Member] | Revolving credit facility, Due 2024 [Member] | Base Rate [Member]    
Line of Credit Facility [Line Items]    
Debt instrument, stated interest rate 0.00%  
XML 91 wst10q93019_htm.xml IDEA: XBRL DOCUMENT 0000105770 2019-01-01 2019-09-30 0000105770 2019-09-30 0000105770 2018-07-01 2018-09-30 0000105770 2018-01-01 2018-09-30 0000105770 2019-07-01 2019-09-30 0000105770 2018-12-31 0000105770 2017-12-31 0000105770 2018-09-30 0000105770 2019-04-01 0000105770 2019-01-01 2019-01-01 0000105770 wst:SmartDoseMember 2019-09-30 0000105770 wst:SmartDoseMember 2013-06-30 0000105770 2018-01-01 2018-12-31 0000105770 wst:ContractManufacturedCustomersMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2019-07-01 2019-09-30 0000105770 wst:BiologicsCustomersMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2018-07-01 2018-09-30 0000105770 wst:PharmaCustomersMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2018-07-01 2018-09-30 0000105770 wst:ContractManufacturedCustomersMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2018-01-01 2018-09-30 0000105770 wst:BiologicsCustomersMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2019-07-01 2019-09-30 0000105770 wst:PharmaCustomersMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2018-01-01 2018-09-30 0000105770 wst:ContractManufacturedCustomersMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2018-07-01 2018-09-30 0000105770 wst:PharmaCustomersMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2019-07-01 2019-09-30 0000105770 wst:GenericsCustomersMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2019-01-01 2019-09-30 0000105770 wst:PharmaCustomersMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2019-01-01 2019-09-30 0000105770 wst:GenericsCustomersMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2018-07-01 2018-09-30 0000105770 wst:GenericsCustomersMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2019-07-01 2019-09-30 0000105770 wst:BiologicsCustomersMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2018-01-01 2018-09-30 0000105770 wst:GenericsCustomersMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2018-01-01 2018-09-30 0000105770 wst:BiologicsCustomersMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2019-01-01 2019-09-30 0000105770 wst:ContractManufacturedCustomersMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2019-01-01 2019-09-30 0000105770 wst:ContractManufacturedProductsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2019-01-01 2019-09-30 0000105770 wst:StandardPackagingMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2019-01-01 2019-09-30 0000105770 wst:HighValueComponentsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2019-01-01 2019-09-30 0000105770 wst:ContractManufacturedProductsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2018-07-01 2018-09-30 0000105770 wst:HighValueComponentsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2018-01-01 2018-09-30 0000105770 wst:DeliveryDevicesMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2018-01-01 2018-09-30 0000105770 wst:HighValueComponentsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2018-07-01 2018-09-30 0000105770 wst:StandardPackagingMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2018-07-01 2018-09-30 0000105770 wst:StandardPackagingMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2019-07-01 2019-09-30 0000105770 wst:DeliveryDevicesMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2018-07-01 2018-09-30 0000105770 wst:DeliveryDevicesMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2019-01-01 2019-09-30 0000105770 wst:StandardPackagingMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2018-01-01 2018-09-30 0000105770 wst:ContractManufacturedProductsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2018-01-01 2018-09-30 0000105770 wst:HighValueComponentsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2019-07-01 2019-09-30 0000105770 wst:DeliveryDevicesMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2019-07-01 2019-09-30 0000105770 wst:ContractManufacturedProductsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2019-07-01 2019-09-30 0000105770 us-gaap:EMEAMember us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember 2019-01-01 2019-09-30 0000105770 srt:AsiaPacificMember us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember 2019-01-01 2019-09-30 0000105770 srt:AmericasMember us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember 2019-07-01 2019-09-30 0000105770 srt:AmericasMember us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember 2018-07-01 2018-09-30 0000105770 srt:AsiaPacificMember us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember 2019-07-01 2019-09-30 0000105770 srt:AmericasMember us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember 2018-01-01 2018-09-30 0000105770 us-gaap:EMEAMember us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember 2019-07-01 2019-09-30 0000105770 us-gaap:EMEAMember us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember 2018-07-01 2018-09-30 0000105770 srt:AmericasMember us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember 2019-01-01 2019-09-30 0000105770 srt:AsiaPacificMember us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember 2018-01-01 2018-09-30 0000105770 us-gaap:EMEAMember us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember 2018-01-01 2018-09-30 0000105770 srt:AsiaPacificMember us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember 2018-07-01 2018-09-30 0000105770 srt:MaximumMember 2019-01-01 2019-09-30 0000105770 us-gaap:AccountingStandardsUpdate201602Member 2019-01-01 0000105770 srt:MaximumMember 2019-09-30 0000105770 wst:SeniorCNotesDue2027Member 2018-12-31 0000105770 wst:Revolvingcreditfacilitydue2020Member 2018-12-31 0000105770 wst:SeniorBNotesDue2024Member 2019-09-30 0000105770 wst:SeniorCNotesDue2027Member 2019-09-30 0000105770 us-gaap:NotesPayableOtherPayablesMember 2018-12-31 0000105770 wst:Revolvingcreditfacilitydue2020Member 2019-09-30 0000105770 wst:SeniorNotesDue2022Member 2018-12-31 0000105770 us-gaap:NotesPayableOtherPayablesMember 2019-09-30 0000105770 wst:Revolvingcreditfacilitydue2024Member 2019-09-30 0000105770 wst:SeniorNotesDue2022Member 2019-09-30 0000105770 wst:SeniorBNotesDue2024Member 2018-12-31 0000105770 wst:Revolvingcreditfacilitydue2024Member 2018-01-01 2018-12-31 0000105770 us-gaap:FederalFundsEffectiveSwapRateMember wst:Revolvingcreditfacilitydue2024Member 2019-01-01 2019-09-30 0000105770 us-gaap:ForeignLineOfCreditMember wst:Revolvingcreditfacilitydue2024Member 2019-09-30 0000105770 srt:MinimumMember wst:Revolvingcreditfacilitydue2024Member 2019-01-01 2019-09-30 0000105770 us-gaap:LetterOfCreditMember wst:Revolvingcreditfacilitydue2024Member 2019-09-30 0000105770 srt:MaximumMember us-gaap:LondonInterbankOfferedRateLIBORMember wst:Revolvingcreditfacilitydue2024Member 2019-01-01 2019-09-30 0000105770 us-gaap:DomesticLineOfCreditMember wst:Revolvingcreditfacilitydue2024Member 2019-09-30 0000105770 srt:MinimumMember us-gaap:BaseRateMember wst:Revolvingcreditfacilitydue2024Member 2019-01-01 2019-09-30 0000105770 us-gaap:LondonInterbankOfferedRateLIBORMember wst:Revolvingcreditfacilitydue2024Member 2019-01-01 2019-09-30 0000105770 wst:Revolvingcreditfacilitydue2024Member 2019-01-01 2019-09-30 0000105770 srt:MaximumMember us-gaap:BaseRateMember wst:Revolvingcreditfacilitydue2024Member 2019-01-01 2019-09-30 0000105770 srt:MaximumMember wst:Revolvingcreditfacilitydue2024Member 2019-01-01 2019-09-30 0000105770 srt:MinimumMember us-gaap:LondonInterbankOfferedRateLIBORMember wst:Revolvingcreditfacilitydue2024Member 2019-01-01 2019-09-30 0000105770 currency:USD us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2019-09-30 0000105770 currency:JPY us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2019-09-30 0000105770 currency:USD us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:LongMember 2019-09-30 0000105770 currency:SGD us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2019-09-30 0000105770 currency:JPY us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:LongMember 2019-09-30 0000105770 currency:SGD us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:LongMember 2019-09-30 0000105770 us-gaap:NondesignatedMember 2019-01-01 2019-09-30 0000105770 us-gaap:CommodityOptionMember us-gaap:NondesignatedMember us-gaap:CostOfSalesMember 2018-01-01 2018-09-30 0000105770 us-gaap:NondesignatedMember 2019-07-01 2019-09-30 0000105770 us-gaap:CommodityOptionMember us-gaap:NondesignatedMember us-gaap:CostOfSalesMember 2019-07-01 2019-09-30 0000105770 us-gaap:CommodityOptionMember us-gaap:NondesignatedMember us-gaap:CostOfSalesMember 2019-01-01 2019-09-30 0000105770 us-gaap:NondesignatedMember 2018-01-01 2018-09-30 0000105770 us-gaap:CommodityOptionMember us-gaap:NondesignatedMember us-gaap:CostOfSalesMember 2018-07-01 2018-09-30 0000105770 us-gaap:NondesignatedMember 2018-07-01 2018-09-30 0000105770 wst:DebtYenDenominatedMember 2019-01-01 2019-09-30 0000105770 us-gaap:OptionMember 2017-11-22 0000105770 us-gaap:DebtMember 2019-01-01 2019-09-30 0000105770 currency:SGD us-gaap:ForwardContractsMember 2018-12-31 0000105770 us-gaap:OptionMember 2019-09-30 0000105770 currency:USD us-gaap:ForwardContractsMember 2018-12-31 0000105770 currency:EUR us-gaap:ForwardContractsMember 2018-12-31 0000105770 wst:DebtYenDenominatedMember 2019-09-30 0000105770 us-gaap:DebtMember 2019-09-30 0000105770 currency:SGD us-gaap:ForwardContractsMember 2019-09-30 0000105770 currency:USD us-gaap:ForwardContractsMember 2019-09-30 0000105770 us-gaap:FairValueHedgingMember 2019-07-01 2019-09-30 0000105770 us-gaap:CashFlowHedgingMember 2019-07-01 2019-09-30 0000105770 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember wst:NetSalesMember 2019-07-01 2019-09-30 0000105770 wst:ForeignCurrencyDenominatedDebtMember us-gaap:NetInvestmentHedgingMember us-gaap:ForeignCurrencyGainLossMember 2018-07-01 2018-09-30 0000105770 us-gaap:NetInvestmentHedgingMember 2018-07-01 2018-09-30 0000105770 us-gaap:ForeignExchangeContractMember us-gaap:FairValueHedgingMember us-gaap:ForeignCurrencyGainLossMember 2019-07-01 2019-09-30 0000105770 us-gaap:NetInvestmentHedgingMember 2019-07-01 2019-09-30 0000105770 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:CostOfSalesMember 2019-07-01 2019-09-30 0000105770 us-gaap:TreasuryLockMember us-gaap:CashFlowHedgingMember us-gaap:InterestExpenseMember 2019-07-01 2019-09-30 0000105770 wst:ForeignCurrencyDenominatedDebtMember us-gaap:NetInvestmentHedgingMember us-gaap:ForeignCurrencyGainLossMember 2019-07-01 2019-09-30 0000105770 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:CostOfSalesMember 2018-07-01 2018-09-30 0000105770 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember wst:NetSalesMember 2018-07-01 2018-09-30 0000105770 us-gaap:TreasuryLockMember us-gaap:CashFlowHedgingMember us-gaap:InterestExpenseMember 2018-07-01 2018-09-30 0000105770 us-gaap:CashFlowHedgingMember 2018-07-01 2018-09-30 0000105770 us-gaap:FairValueHedgingMember 2019-01-01 2019-09-30 0000105770 us-gaap:FairValueHedgingMember 2018-07-01 2018-09-30 0000105770 us-gaap:ForeignExchangeContractMember us-gaap:FairValueHedgingMember us-gaap:ForeignCurrencyGainLossMember 2019-01-01 2019-09-30 0000105770 us-gaap:ForeignExchangeContractMember us-gaap:FairValueHedgingMember us-gaap:ForeignCurrencyGainLossMember 2018-07-01 2018-09-30 0000105770 us-gaap:FairValueHedgingMember 2018-01-01 2018-09-30 0000105770 us-gaap:ForeignExchangeContractMember us-gaap:FairValueHedgingMember us-gaap:ForeignCurrencyGainLossMember 2018-01-01 2018-09-30 0000105770 us-gaap:CashFlowHedgingMember 2018-01-01 2018-09-30 0000105770 us-gaap:NetInvestmentHedgingMember 2019-01-01 2019-09-30 0000105770 us-gaap:TreasuryLockMember us-gaap:CashFlowHedgingMember us-gaap:InterestExpenseMember 2018-01-01 2018-09-30 0000105770 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:CostOfSalesMember 2019-01-01 2019-09-30 0000105770 wst:ForeignCurrencyDenominatedDebtMember us-gaap:NetInvestmentHedgingMember us-gaap:ForeignCurrencyGainLossMember 2019-01-01 2019-09-30 0000105770 us-gaap:TreasuryLockMember us-gaap:CashFlowHedgingMember us-gaap:InterestExpenseMember 2019-01-01 2019-09-30 0000105770 wst:ForeignCurrencyDenominatedDebtMember us-gaap:NetInvestmentHedgingMember us-gaap:ForeignCurrencyGainLossMember 2018-01-01 2018-09-30 0000105770 us-gaap:NetInvestmentHedgingMember 2018-01-01 2018-09-30 0000105770 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:CostOfSalesMember 2018-01-01 2018-09-30 0000105770 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember wst:NetSalesMember 2018-01-01 2018-09-30 0000105770 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember wst:NetSalesMember 2019-01-01 2019-09-30 0000105770 us-gaap:CashFlowHedgingMember 2019-01-01 2019-09-30 0000105770 us-gaap:FairValueInputsLevel2Member 2018-12-31 0000105770 us-gaap:FairValueInputsLevel1Member 2018-12-31 0000105770 us-gaap:FairValueInputsLevel3Member 2018-12-31 0000105770 us-gaap:FairValueInputsLevel3Member 2019-09-30 0000105770 us-gaap:FairValueInputsLevel2Member 2019-09-30 0000105770 us-gaap:FairValueInputsLevel1Member 2019-09-30 0000105770 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2019-07-01 2019-09-30 0000105770 us-gaap:InterestRateSwapMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2019-07-01 2019-09-30 0000105770 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2018-07-01 2018-09-30 0000105770 us-gaap:InterestRateSwapMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2019-01-01 2019-09-30 0000105770 us-gaap:TreasuryLockMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2018-07-01 2018-09-30 0000105770 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2018-01-01 2018-09-30 0000105770 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-01-01 2019-09-30 0000105770 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-07-01 2019-09-30 0000105770 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2018-01-01 2018-09-30 0000105770 us-gaap:TreasuryLockMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2019-07-01 2019-09-30 0000105770 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2019-01-01 2019-09-30 0000105770 us-gaap:ForeignExchangeContractMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2018-01-01 2018-09-30 0000105770 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2018-07-01 2018-09-30 0000105770 us-gaap:ForeignExchangeContractMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2019-07-01 2019-09-30 0000105770 us-gaap:TreasuryLockMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2018-01-01 2018-09-30 0000105770 us-gaap:ForeignExchangeContractMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2019-01-01 2019-09-30 0000105770 us-gaap:TreasuryLockMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2019-01-01 2019-09-30 0000105770 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2018-01-01 2018-09-30 0000105770 us-gaap:InterestRateSwapMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2018-07-01 2018-09-30 0000105770 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-09-30 0000105770 us-gaap:ForeignExchangeContractMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2018-07-01 2018-09-30 0000105770 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2018-07-01 2018-09-30 0000105770 us-gaap:InterestRateSwapMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2018-01-01 2018-09-30 0000105770 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2019-07-01 2019-09-30 0000105770 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2019-09-30 0000105770 us-gaap:AccumulatedTranslationAdjustmentMember 2019-01-01 2019-09-30 0000105770 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2018-12-31 0000105770 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2019-01-01 2019-09-30 0000105770 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2018-12-31 0000105770 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2019-09-30 0000105770 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-09-30 0000105770 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-01-01 2019-09-30 0000105770 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2019-01-01 2019-09-30 0000105770 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2018-12-31 0000105770 us-gaap:AccumulatedTranslationAdjustmentMember 2018-12-31 0000105770 us-gaap:AccumulatedTranslationAdjustmentMember 2019-09-30 0000105770 us-gaap:TreasuryStockMember 2019-01-01 2019-03-31 0000105770 us-gaap:RetainedEarningsMember 2019-03-31 0000105770 us-gaap:CommonStockMember 2019-01-01 2019-03-31 0000105770 2019-01-01 2019-03-31 0000105770 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-07-01 2019-09-30 0000105770 us-gaap:RetainedEarningsMember 2019-01-01 2019-03-31 0000105770 us-gaap:TreasuryStockMember 2019-04-01 2019-06-30 0000105770 2019-04-01 2019-06-30 0000105770 us-gaap:RetainedEarningsMember 2019-06-30 0000105770 us-gaap:CommonStockMember 2019-03-31 0000105770 us-gaap:RetainedEarningsMember 2019-07-01 2019-09-30 0000105770 us-gaap:CommonStockMember 2019-04-01 2019-06-30 0000105770 us-gaap:TreasuryStockMember 2019-06-30 0000105770 us-gaap:AdditionalPaidInCapitalMember 2019-04-01 2019-06-30 0000105770 2019-03-31 0000105770 us-gaap:CommonStockMember 2019-07-01 2019-09-30 0000105770 us-gaap:AdditionalPaidInCapitalMember 2019-06-30 0000105770 us-gaap:TreasuryStockMember 2018-12-31 0000105770 us-gaap:AdditionalPaidInCapitalMember 2019-03-31 0000105770 us-gaap:RetainedEarningsMember 2018-12-31 0000105770 us-gaap:RetainedEarningsMember 2019-09-30 0000105770 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-09-30 0000105770 us-gaap:CommonStockMember 2019-06-30 0000105770 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-03-31 0000105770 us-gaap:AdditionalPaidInCapitalMember 2019-09-30 0000105770 us-gaap:TreasuryStockMember 2019-09-30 0000105770 us-gaap:CommonStockMember 2019-09-30 0000105770 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-03-31 0000105770 us-gaap:AdditionalPaidInCapitalMember 2019-07-01 2019-09-30 0000105770 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-04-01 2019-06-30 0000105770 us-gaap:TreasuryStockMember 2019-07-01 2019-09-30 0000105770 us-gaap:CommonStockMember 2018-12-31 0000105770 2019-06-30 0000105770 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-03-31 0000105770 us-gaap:RetainedEarningsMember 2019-04-01 2019-06-30 0000105770 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-06-30 0000105770 us-gaap:TreasuryStockMember 2019-03-31 0000105770 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0000105770 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-12-31 0000105770 2018-03-31 0000105770 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-04-01 2018-06-30 0000105770 us-gaap:TreasuryStockMember 2018-01-01 2018-03-31 0000105770 2018-04-01 2018-06-30 0000105770 us-gaap:RetainedEarningsMember 2018-09-30 0000105770 us-gaap:RetainedEarningsMember 2018-06-30 0000105770 us-gaap:TreasuryStockMember 2017-12-31 0000105770 us-gaap:RetainedEarningsMember 2017-12-31 0000105770 us-gaap:RetainedEarningsMember 2018-03-31 0000105770 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-07-01 2018-09-30 0000105770 us-gaap:CommonStockMember 2018-06-30 0000105770 us-gaap:AdditionalPaidInCapitalMember 2018-01-01 2018-03-31 0000105770 us-gaap:TreasuryStockMember 2018-09-30 0000105770 2018-06-30 0000105770 us-gaap:TreasuryStockMember 2018-06-30 0000105770 us-gaap:TreasuryStockMember 2018-04-01 2018-06-30 0000105770 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-09-30 0000105770 2018-01-01 2018-03-31 0000105770 us-gaap:CommonStockMember 2018-04-01 2018-06-30 0000105770 us-gaap:RetainedEarningsMember 2018-07-01 2018-09-30 0000105770 us-gaap:RetainedEarningsMember 2018-01-01 2018-03-31 0000105770 us-gaap:AdditionalPaidInCapitalMember 2018-06-30 0000105770 us-gaap:CommonStockMember 2017-12-31 0000105770 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-06-30 0000105770 us-gaap:TreasuryStockMember 2018-07-01 2018-09-30 0000105770 us-gaap:TreasuryStockMember 2018-03-31 0000105770 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-01-01 2018-03-31 0000105770 us-gaap:CommonStockMember 2018-03-31 0000105770 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-12-31 0000105770 us-gaap:AdditionalPaidInCapitalMember 2018-04-01 2018-06-30 0000105770 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-03-31 0000105770 us-gaap:AdditionalPaidInCapitalMember 2018-07-01 2018-09-30 0000105770 us-gaap:AdditionalPaidInCapitalMember 2018-03-31 0000105770 us-gaap:AdditionalPaidInCapitalMember 2018-09-30 0000105770 us-gaap:CommonStockMember 2018-09-30 0000105770 us-gaap:CommonStockMember 2018-01-01 2018-03-31 0000105770 us-gaap:AdditionalPaidInCapitalMember 2017-12-31 0000105770 us-gaap:RetainedEarningsMember 2018-04-01 2018-06-30 0000105770 us-gaap:PerformanceSharesMember 2019-09-30 0000105770 us-gaap:PerformanceSharesMember 2019-01-01 2019-09-30 0000105770 us-gaap:RestrictedStockUnitsRSUMember 2019-01-01 2019-09-30 0000105770 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2019-07-01 2019-09-30 0000105770 us-gaap:PensionPlansDefinedBenefitMember 2018-07-01 2018-09-30 0000105770 us-gaap:PensionPlansDefinedBenefitMember 2019-07-01 2019-09-30 0000105770 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2018-07-01 2018-09-30 0000105770 us-gaap:OtherNonoperatingIncomeExpenseMember 2019-07-01 2019-09-30 0000105770 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2018-01-01 2018-09-30 0000105770 us-gaap:PensionPlansDefinedBenefitMember 2019-01-01 2019-09-30 0000105770 us-gaap:PensionPlansDefinedBenefitMember 2018-01-01 2018-09-30 0000105770 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2019-01-01 2019-09-30 0000105770 country:US us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2019-01-01 2019-09-30 0000105770 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-01-01 2018-09-30 0000105770 country:US 2019-01-01 2019-09-30 0000105770 us-gaap:ForeignPlanMember 2019-01-01 2019-09-30 0000105770 country:US us-gaap:PensionPlansDefinedBenefitMember 2018-01-01 2018-09-30 0000105770 country:US us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2018-01-01 2018-09-30 0000105770 us-gaap:ForeignPlanMember 2018-01-01 2018-09-30 0000105770 country:US us-gaap:PensionPlansDefinedBenefitMember 2019-01-01 2019-09-30 0000105770 country:US 2018-01-01 2018-09-30 0000105770 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-01-01 2019-09-30 0000105770 country:US us-gaap:PensionPlansDefinedBenefitMember 2019-07-01 2019-09-30 0000105770 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-07-01 2018-09-30 0000105770 country:US us-gaap:PensionPlansDefinedBenefitMember 2018-07-01 2018-09-30 0000105770 country:US us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2018-07-01 2018-09-30 0000105770 country:US us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2019-07-01 2019-09-30 0000105770 us-gaap:ForeignPlanMember 2018-07-01 2018-09-30 0000105770 country:US 2018-07-01 2018-09-30 0000105770 country:US 2019-07-01 2019-09-30 0000105770 us-gaap:ForeignPlanMember 2019-07-01 2019-09-30 0000105770 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-07-01 2019-09-30 0000105770 us-gaap:OtherNonoperatingIncomeExpenseMember 2019-01-01 2019-09-30 0000105770 wst:A2018RestructuringPlanMember 2018-01-01 2018-09-30 0000105770 wst:A2018RestructuringPlanMember 2019-07-01 2019-09-30 0000105770 wst:A2018RestructuringPlanMember 2019-01-01 2019-09-30 0000105770 wst:A2018RestructuringPlanMember 2018-07-01 2018-09-30 0000105770 wst:A2018RestructuringPlanMember 2019-09-30 0000105770 us-gaap:EmployeeSeveranceMember 2019-01-01 2019-09-30 0000105770 us-gaap:OtherRestructuringMember wst:A2018RestructuringPlanMember 2019-01-01 2019-09-30 0000105770 wst:AssetRelatedChargesMember wst:A2018RestructuringPlanMember 2019-09-30 0000105770 wst:AssetRelatedChargesMember wst:A2018RestructuringPlanMember 2019-01-01 2019-09-30 0000105770 wst:A2018RestructuringPlanMember 2018-12-31 0000105770 us-gaap:OtherRestructuringMember wst:A2018RestructuringPlanMember 2018-12-31 0000105770 us-gaap:EmployeeSeveranceMember 2018-12-31 0000105770 us-gaap:OtherRestructuringMember 2019-01-01 2019-09-30 0000105770 us-gaap:EmployeeSeveranceMember 2019-09-30 0000105770 us-gaap:OtherRestructuringMember wst:A2018RestructuringPlanMember 2019-09-30 0000105770 wst:AssetRelatedChargesMember wst:A2018RestructuringPlanMember 2018-12-31 0000105770 wst:AssetRelatedChargesMember 2019-01-01 2019-09-30 0000105770 wst:SmartDoseMember 2019-07-01 2019-09-30 0000105770 wst:SmartDoseMember 2019-01-01 2019-09-30 0000105770 srt:MaximumMember wst:A2018RestructuringPlanMember 2019-12-31 0000105770 wst:A2016RestructuringPlanMemberMember 2019-09-30 0000105770 wst:DeliverySystemsMember 2018-01-01 2018-09-30 0000105770 wst:DeliverySystemsMember 2018-07-01 2018-09-30 0000105770 wst:PackagingSystemsMember 2018-07-01 2018-09-30 0000105770 us-gaap:IntersegmentEliminationMember 2018-01-01 2018-09-30 0000105770 wst:CorporateAndEliminationsMember 2018-01-01 2018-09-30 0000105770 us-gaap:MaterialReconcilingItemsMember 2019-01-01 2019-09-30 0000105770 wst:PackagingSystemsMember 2019-01-01 2019-09-30 0000105770 wst:PackagingSystemsMember 2018-01-01 2018-09-30 0000105770 wst:DeliverySystemsMember 2019-07-01 2019-09-30 0000105770 wst:PackagingSystemsMember 2019-07-01 2019-09-30 0000105770 us-gaap:IntersegmentEliminationMember 2019-07-01 2019-09-30 0000105770 wst:DeliverySystemsMember 2019-01-01 2019-09-30 0000105770 us-gaap:MaterialReconcilingItemsMember 2019-07-01 2019-09-30 0000105770 wst:CorporateAndEliminationsMember 2019-07-01 2019-09-30 0000105770 wst:CorporateAndEliminationsMember 2019-01-01 2019-09-30 0000105770 us-gaap:IntersegmentEliminationMember 2019-01-01 2019-09-30 0000105770 wst:CorporateAndEliminationsMember 2018-07-01 2018-09-30 0000105770 us-gaap:MaterialReconcilingItemsMember 2018-01-01 2018-09-30 0000105770 us-gaap:IntersegmentEliminationMember 2018-07-01 2018-09-30 0000105770 us-gaap:MaterialReconcilingItemsMember 2018-07-01 2018-09-30 0000105770 2019-10-15 iso4217:EUR iso4217:USD shares utreg:MBbls iso4217:SGD shares pure iso4217:JPY iso4217:USD iso4217:USD wst:bbl wst:segment false --12-31 Q3 2019 0000105770 0.14 0.14 0.15 0.15 0.15 0.16 0.25 0.25 100000000 100000000 75300000 75300000 74100000 74000000 13400000 0.0382 0.0402 0.0367 0.00875 0.0382 0.0402 0.0367 2600000 -2700000 -100000 1000000 1500000 700000 0 100000 700000 700000 -1000000 3000000 3000000 0 0 0 0 1200000 1300000 10-Q true 2019-09-30 false 1-8036 WEST PHARMACEUTICAL SERVICES, INC. PA 23-1210010 530 Herman O. West Drive, Exton, PA 19341-0645 610 594-2900 Common Stock, par value $0.25 per share WST NYSE Yes Yes Large Accelerated Filer false false false 73990675 456100000 431700000 1369300000 1294900000 308300000 296100000 916800000 882700000 147800000 135600000 452500000 412200000 9300000 10100000 28700000 30500000 64800000 64900000 203700000 203200000 -6400000 200000 -1600000 -4000000.0 67300000 60800000 218500000 174500000 2100000 2000000.0 6400000 6100000 1000000.0 500000 2500000 1400000 -1300000 1800000 -200000 5100000 64900000 61100000 214400000 174900000 10900000 8000000.0 42500000 26500000 2300000 2100000 5900000 6500000 56300000 55200000 177800000 154900000 0.76 0.75 2.40 2.10 0.75 0.73 2.36 2.05 74000000.0 73900000 73900000 73900000 75500000 75700000 75300000 75400000 56300000 55200000 177800000 154900000 -23800000 -9500000 -20100000 -39100000 -2400000 200000 -2200000 -100000 3200000 -400000 1700000 2500000 -18200000 -10100000 -16200000 -36500000 38100000 45100000 161600000 118400000 396000000.0 337400000 316100000 288200000 230400000 214500000 61600000 54300000 1004100000 894400000 1779800000 1752700000 967700000 930700000 812100000 822000000.0 71300000 0 97400000 91200000 106600000 105800000 33800000 24700000 28700000 20300000 20000000.0 20500000 2174000000.0 1978900000 0 100000 145300000 130400000 2200000 2300000 72600000 64500000 19100000 9800000 9800000 0 86000000.0 76600000 335000000.0 283700000 195100000 196000000.0 10300000 13100000 46800000 56200000 63500000 0 35700000 33600000 686400000 582600000 0 0 18800000 18800000 268500000 282000000.0 1497300000 1353400000 -170400000 -154200000 126600000 103700000 1487600000 1396300000 2174000000.0 1978900000 177800000 154900000 74600000 76100000 2500000 2000000.0 18800000 14700000 1600000 800000 2700000 0 300000 500000 600000 4000000.0 16300000 28600000 260800000 215400000 88800000 74700000 18900000 0 -300000 -2500000 -107400000 -72200000 28000000.0 0 28000000.0 0 900000 0 33300000 31000000.0 25500000 25700000 4000000.0 3600000 83100000 70800000 -87800000 -72500000 -7000000.0 -9300000 58600000 61400000 337400000 235900000 396000000.0 297300000 Summary of Significant Accounting Policies<div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Basis of Presentation</span><span style="font-family:inherit;font-size:10pt;">: The condensed consolidated financial statements included in this report are unaudited and have been prepared in accordance with United States (“U.S.”) generally accepted accounting principles (“U.S. GAAP”) for interim financial reporting and U.S. Securities and Exchange Commission (“SEC”) regulations. The year-end condensed consolidated balance sheet data was derived from audited financial statements, but does not include all disclosures required by U.S. GAAP. Certain information and footnote disclosures normally included in annual financial statements prepared in accordance with U.S. GAAP have been condensed or omitted. In the opinion of management, these financial statements include all adjustments, which are of a normal recurring nature, necessary for a fair statement of the financial position, results of operations, cash flows and the change in equity for the periods presented. The condensed consolidated financial statements for the three and </span><span style="font-family:inherit;font-size:10pt;">nine months ended</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">September 30, 2019</span><span style="font-family:inherit;font-size:10pt;"> should be read in conjunction with the consolidated financial statements and notes thereto of West Pharmaceutical Services, Inc. and its majority-owned subsidiaries (which may be referred to as “West”, the “Company”, “we”, “us” or “our”) appearing in our Annual Report on Form 10-K for the year ended </span><span style="font-family:inherit;font-size:10pt;">December 31, 2018</span><span style="font-family:inherit;font-size:10pt;"> (the “</span><a href="http://www.sec.gov/Archives/edgar/data/105770/000010577019000012/wst10k12312018.htm" style="font-family:inherit;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2018 Annual Report</span></a><span style="font-family:inherit;font-size:10pt;">”). The results of operations for any interim period are not necessarily indicative of results for the full year.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In April 2019, we acquired the business of our distributor in South Korea for </span><span style="font-family:inherit;font-size:10pt;"><span>$18.9 million</span></span><span style="font-family:inherit;font-size:10pt;">. As a result of the acquisition, we recorded inventories, property, plant and equipment, goodwill and a customer relationships intangible asset of </span><span style="font-family:inherit;font-size:10pt;"><span>$4.5 million</span></span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;"><span>$0.6 million</span></span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;"><span>$2.6 million</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$11.2 million</span></span><span style="font-family:inherit;font-size:10pt;">, respectively. The goodwill was recorded within our Proprietary Products reportable segment. The results of this acquisition have been included in our condensed consolidated financial statements since the acquisition date. </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">As of April 1, 2017, our consolidated financial statements exclude the results of our Venezuelan subsidiary. Please refer to Note 15, </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Other Expense</span><span style="font-family:inherit;font-size:10pt;">, to the consolidated financial statements in our </span><a href="http://www.sec.gov/Archives/edgar/data/105770/000010577019000012/wst10k12312018.htm" style="font-family:inherit;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2018 Annual Report</span></a><span style="font-family:inherit;font-size:10pt;"> for further discussion.</span></div> <div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Basis of Presentation</span><span style="font-family:inherit;font-size:10pt;">: The condensed consolidated financial statements included in this report are unaudited and have been prepared in accordance with United States (“U.S.”) generally accepted accounting principles (“U.S. GAAP”) for interim financial reporting and U.S. Securities and Exchange Commission (“SEC”) regulations. The year-end condensed consolidated balance sheet data was derived from audited financial statements, but does not include all disclosures required by U.S. GAAP. Certain information and footnote disclosures normally included in annual financial statements prepared in accordance with U.S. GAAP have been condensed or omitted. In the opinion of management, these financial statements include all adjustments, which are of a normal recurring nature, necessary for a fair statement of the financial position, results of operations, cash flows and the change in equity for the periods presented. The condensed consolidated financial statements for the three and </span><span style="font-family:inherit;font-size:10pt;">nine months ended</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">September 30, 2019</span><span style="font-family:inherit;font-size:10pt;"> should be read in conjunction with the consolidated financial statements and notes thereto of West Pharmaceutical Services, Inc. and its majority-owned subsidiaries (which may be referred to as “West”, the “Company”, “we”, “us” or “our”) appearing in our Annual Report on Form 10-K for the year ended </span><span style="font-family:inherit;font-size:10pt;">December 31, 2018</span><span style="font-family:inherit;font-size:10pt;"> (the “</span><a href="http://www.sec.gov/Archives/edgar/data/105770/000010577019000012/wst10k12312018.htm" style="font-family:inherit;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2018 Annual Report</span></a><span style="font-family:inherit;font-size:10pt;">”). The results of operations for any interim period are not necessarily indicative of results for the full year.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In April 2019, we acquired the business of our distributor in South Korea for </span><span style="font-family:inherit;font-size:10pt;"><span>$18.9 million</span></span><span style="font-family:inherit;font-size:10pt;">. As a result of the acquisition, we recorded inventories, property, plant and equipment, goodwill and a customer relationships intangible asset of </span><span style="font-family:inherit;font-size:10pt;"><span>$4.5 million</span></span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;"><span>$0.6 million</span></span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;"><span>$2.6 million</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$11.2 million</span></span><span style="font-family:inherit;font-size:10pt;">, respectively. The goodwill was recorded within our Proprietary Products reportable segment. The results of this acquisition have been included in our condensed consolidated financial statements since the acquisition date. </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">As of April 1, 2017, our consolidated financial statements exclude the results of our Venezuelan subsidiary. Please refer to Note 15, </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Other Expense</span><span style="font-family:inherit;font-size:10pt;">, to the consolidated financial statements in our </span><a href="http://www.sec.gov/Archives/edgar/data/105770/000010577019000012/wst10k12312018.htm" style="font-family:inherit;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2018 Annual Report</span></a><span style="font-family:inherit;font-size:10pt;"> for further discussion.</span></div> 18900000 4500000 600000 2600000 11200000 New Accounting Standards<div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Recently Adopted Standards</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In August 2018, the SEC adopted a final release which would eliminate or modify certain disclosure requirements that are redundant, outdated, or duplicative of U.S. GAAP or other regulatory requirements. Among other changes, the amendments provide that disclosure requirements related to the analysis of shareholders’ equity are expanded for interim purposes. An analysis of the changes in each caption of shareholders’ equity presented in the balance sheet must be provided in a note or separate statement, as well as the amount of dividends per share for each class of shares. We provided this disclosure beginning in the first quarter of 2019. Please refer to Note 12, </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Shareholders</span><span style="font-family:inherit;font-size:10pt;">’</span><span style="font-family:inherit;font-size:10pt;font-style:italic;"> Equity</span><span style="font-family:inherit;font-size:10pt;">.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In June 2018, the Financial Accounting Standards Board (“FASB”) issued guidance which expands the scope of accounting for share-based payment arrangements to include share-based payment transactions for acquiring goods and services from nonemployees. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2018. Early adoption was permitted. We adopted this guidance as of January 1, 2019, on a prospective basis. The adoption did not have a material impact on our financial statements.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In February 2018, the FASB issued guidance to address a specific consequence of the Tax Cuts and Jobs Acts (the “2017 Tax Act”) by allowing a reclassification from accumulated other comprehensive income (loss) to retained earnings for stranded tax effects resulting from the 2017 Tax Act’s reduction of the U.S. federal corporate income tax rate. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2018. Early adoption was permitted. We adopted this guidance as of January 1, 2019, on a prospective basis, but elected to not reclassify from accumulated other comprehensive income (loss) to retained earnings the stranded tax effects resulting from the 2017 Tax Act’s reduction of the U.S. federal corporate income tax rate.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In August 2017, the FASB issued guidance which expands and refines hedge accounting for both nonfinancial and financial risk components and aligns the recognition and presentation of the effects of the hedging instrument and the hedged item in the financial statements. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2018. Early adoption was permitted. We adopted this guidance as of January 1, 2019, on a prospective basis. The adoption did not have a material impact on our financial statements.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In February 2016, the FASB issued guidance on the accounting for leases, Accounting Standards Codification (“ASC”) Topic 842 (“ASC 842”). This guidance requires lessees to recognize lease assets and lease liabilities on the balance sheet and to expand disclosures about leasing arrangements, both qualitative and quantitative. In terms of transition, the guidance requires adoption based upon a modified retrospective approach. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2018. Early adoption was permitted. We adopted this guidance as of January 1, 2019, using the modified retrospective approach that allows companies to apply ASC 842 as of the effective date and on a prospective basis. Please refer to Note 6, </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Leases</span><span style="font-family:inherit;font-size:10pt;">, for additional information.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Standards Issued Not Yet Adopted</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In April 2019, the FASB issued guidance which clarifies and improves areas of guidance related to the new credit losses, hedging, and recognition and measurement standards. This guidance is effective for the same fiscal years in which the original standards are effective or, if already implemented, annual periods beginning after the issuance of this guidance. Early adoption is permitted. We believe that the adoption of this guidance will not have a material impact on our financial statements. </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In August 2018, the FASB issued guidance to align the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software (and hosting arrangements that include an internal-use software license). The accounting for the service element of a hosting arrangement that is a service contract is not affected by this update. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2019. Early adoption is permitted, including adoption in any interim period. We believe that the adoption of this guidance will not have a material impact on our financial statements.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In August 2018, the FASB issued guidance which modifies the disclosure requirements for defined benefit pension plans and other postretirement plans. The guidance removes disclosures that no longer are considered cost beneficial, clarifies the specific requirements of disclosures, and adds disclosure requirements identified as relevant. This guidance is effective for fiscal years ending after December 15, 2020. Early adoption is permitted. We believe that the adoption of this guidance will not have a material impact on our financial statements.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In August 2018, the FASB issued guidance which modifies the disclosure requirements on fair value measurements by removing, modifying, or adding certain disclosures. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2019. Early adoption is permitted. We believe that the adoption of this guidance will not have a material impact on our financial statements.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In June 2016, the FASB issued guidance which provides financial statement users with more decision-useful information about the expected credit losses on financial instruments and other commitments held by a reporting entity at each reporting date. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2019. Early adoption is permitted. We believe that the adoption of this guidance will not have a material impact on our financial statements.</span></div> <div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Recently Adopted Standards</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In August 2018, the SEC adopted a final release which would eliminate or modify certain disclosure requirements that are redundant, outdated, or duplicative of U.S. GAAP or other regulatory requirements. Among other changes, the amendments provide that disclosure requirements related to the analysis of shareholders’ equity are expanded for interim purposes. An analysis of the changes in each caption of shareholders’ equity presented in the balance sheet must be provided in a note or separate statement, as well as the amount of dividends per share for each class of shares. We provided this disclosure beginning in the first quarter of 2019. Please refer to Note 12, </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Shareholders</span><span style="font-family:inherit;font-size:10pt;">’</span><span style="font-family:inherit;font-size:10pt;font-style:italic;"> Equity</span><span style="font-family:inherit;font-size:10pt;">.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In June 2018, the Financial Accounting Standards Board (“FASB”) issued guidance which expands the scope of accounting for share-based payment arrangements to include share-based payment transactions for acquiring goods and services from nonemployees. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2018. Early adoption was permitted. We adopted this guidance as of January 1, 2019, on a prospective basis. The adoption did not have a material impact on our financial statements.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In February 2018, the FASB issued guidance to address a specific consequence of the Tax Cuts and Jobs Acts (the “2017 Tax Act”) by allowing a reclassification from accumulated other comprehensive income (loss) to retained earnings for stranded tax effects resulting from the 2017 Tax Act’s reduction of the U.S. federal corporate income tax rate. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2018. Early adoption was permitted. We adopted this guidance as of January 1, 2019, on a prospective basis, but elected to not reclassify from accumulated other comprehensive income (loss) to retained earnings the stranded tax effects resulting from the 2017 Tax Act’s reduction of the U.S. federal corporate income tax rate.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In August 2017, the FASB issued guidance which expands and refines hedge accounting for both nonfinancial and financial risk components and aligns the recognition and presentation of the effects of the hedging instrument and the hedged item in the financial statements. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2018. Early adoption was permitted. We adopted this guidance as of January 1, 2019, on a prospective basis. The adoption did not have a material impact on our financial statements.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In February 2016, the FASB issued guidance on the accounting for leases, Accounting Standards Codification (“ASC”) Topic 842 (“ASC 842”). This guidance requires lessees to recognize lease assets and lease liabilities on the balance sheet and to expand disclosures about leasing arrangements, both qualitative and quantitative. In terms of transition, the guidance requires adoption based upon a modified retrospective approach. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2018. Early adoption was permitted. We adopted this guidance as of January 1, 2019, using the modified retrospective approach that allows companies to apply ASC 842 as of the effective date and on a prospective basis. Please refer to Note 6, </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Leases</span><span style="font-family:inherit;font-size:10pt;">, for additional information.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Standards Issued Not Yet Adopted</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In April 2019, the FASB issued guidance which clarifies and improves areas of guidance related to the new credit losses, hedging, and recognition and measurement standards. This guidance is effective for the same fiscal years in which the original standards are effective or, if already implemented, annual periods beginning after the issuance of this guidance. Early adoption is permitted. We believe that the adoption of this guidance will not have a material impact on our financial statements. </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In August 2018, the FASB issued guidance to align the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software (and hosting arrangements that include an internal-use software license). The accounting for the service element of a hosting arrangement that is a service contract is not affected by this update. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2019. Early adoption is permitted, including adoption in any interim period. We believe that the adoption of this guidance will not have a material impact on our financial statements.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In August 2018, the FASB issued guidance which modifies the disclosure requirements for defined benefit pension plans and other postretirement plans. The guidance removes disclosures that no longer are considered cost beneficial, clarifies the specific requirements of disclosures, and adds disclosure requirements identified as relevant. This guidance is effective for fiscal years ending after December 15, 2020. Early adoption is permitted. We believe that the adoption of this guidance will not have a material impact on our financial statements.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In August 2018, the FASB issued guidance which modifies the disclosure requirements on fair value measurements by removing, modifying, or adding certain disclosures. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2019. Early adoption is permitted. We believe that the adoption of this guidance will not have a material impact on our financial statements.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In June 2016, the FASB issued guidance which provides financial statement users with more decision-useful information about the expected credit losses on financial instruments and other commitments held by a reporting entity at each reporting date. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2019. Early adoption is permitted. We believe that the adoption of this guidance will not have a material impact on our financial statements.</span></div> Revenue<div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:13px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table presents the approximate percentage of our net sales by market group:</span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.57264957264957%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:49%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Three Months Ended<br/>September 30,</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Nine Months Ended<br/>September 30,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Biologics</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>26</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>21</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>25</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>21</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Generics</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>20</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>21</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>20</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>21</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Pharma</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>30</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>34</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>31</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>35</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Contract-Manufactured Products</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>24</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>24</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>24</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>23</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>100</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>100</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>100</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>100</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:13px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table presents the approximate percentage of our net sales by product category: </span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.57264957264957%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:49%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Three Months Ended<br/>September 30,</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Nine Months Ended<br/>September 30,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">High-Value Components</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>42</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>41</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>43</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>42</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Standard Packaging</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>28</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>31</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>29</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>32</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Delivery Devices</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Contract-Manufactured Products</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>24</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>24</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>24</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>23</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>100</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>100</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>100</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>100</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:13px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table presents the approximate percentage of our net sales by geographic location: </span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.57264957264957%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:49%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Three Months Ended<br/>September 30,</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Nine Months Ended<br/>September 30,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Americas</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>48</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>51</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>48</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>48</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Europe, Middle East, Africa</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>44</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>41</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>44</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>44</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Asia Pacific</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>100</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>100</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>100</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>100</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:13px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Contract Assets and Liabilities</span></div><div style="line-height:120%;padding-bottom:13px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table summarizes our contract assets and liabilities, excluding contract assets included in accounts receivable, net:</span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:86%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">($ in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Contract assets, December 31, 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Contract assets, September 30, 2019</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Change in contract assets - increase (decrease)</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Deferred income, December 31, 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(33.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Deferred income, September 30, 2019</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(30.9</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Change in deferred income - decrease (increase)</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:13px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The decrease in deferred income during the </span><span style="font-family:inherit;font-size:10pt;">nine months ended</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">September 30, 2019</span><span style="font-family:inherit;font-size:10pt;"> was primarily due to the recognition of revenue of </span><span style="font-family:inherit;font-size:10pt;"><span>$79.3 million</span></span><span style="font-family:inherit;font-size:10pt;">, including </span><span style="font-family:inherit;font-size:10pt;"><span>$18.0 million</span></span><span style="font-family:inherit;font-size:10pt;"> of revenue that was included in deferred income at the beginning of the year, and </span><span style="font-family:inherit;font-size:10pt;"><span>$2.7 million</span></span><span style="font-family:inherit;font-size:10pt;"> in other adjustments, partially offset by additional cash payments of </span><span style="font-family:inherit;font-size:10pt;"><span>$79.5 million</span></span><span style="font-family:inherit;font-size:10pt;"> received in advance of satisfying future performance obligations.</span></div><div style="line-height:120%;padding-bottom:13px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The majority of the performance obligations within our contracts are satisfied within one year or less. Performance obligations satisfied beyond one year include those relating to a nonrefundable customer payment of </span><span style="font-family:inherit;font-size:10pt;"><span>$20.0 million</span></span><span style="font-family:inherit;font-size:10pt;"> received in June 2013 in return for the exclusive use of the SmartDose</span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">®</sup></span><span style="font-family:inherit;font-size:10pt;"> technology platform within a specific therapeutic area. As of </span><span style="font-family:inherit;font-size:10pt;">September 30, 2019</span><span style="font-family:inherit;font-size:10pt;">, there was </span><span style="font-family:inherit;font-size:10pt;"><span>$5.9 million</span></span><span style="font-family:inherit;font-size:10pt;"> of unearned income related to this payment, of which </span><span style="font-family:inherit;font-size:10pt;"><span>$0.9 million</span></span><span style="font-family:inherit;font-size:10pt;"> was included in other current liabilities and </span><span style="font-family:inherit;font-size:10pt;"><span>$5.0 million</span></span><span style="font-family:inherit;font-size:10pt;"> was included in other long-term liabilities. The unearned income is being recognized as income on a straight-line basis over the remaining term of the agreement. The agreement does not include a future minimum purchase commitment from the customer.</span></div><div style="line-height:120%;padding-bottom:13px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Supply Chain Financing</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We have entered into supply chain financing agreements with certain banks, pursuant to which we offer for sale certain accounts receivable to such banks from time to time, subject to the terms of the applicable agreements. These transactions result in a reduction in accounts receivable, as the agreements transfer effective control over, and credit risk related to, the receivables to the banks. These agreements do not allow for recourse in the event of uncollectibility, and we do not retain any interest in the underlying accounts receivable once sold. As of </span><span style="font-family:inherit;font-size:10pt;">September 30, 2019</span><span style="font-family:inherit;font-size:10pt;">, we derecognized </span><span style="font-family:inherit;font-size:10pt;"><span>$7.9 million</span></span><span style="font-family:inherit;font-size:10pt;"> of accounts receivable under these agreements. Discount fees related to the sale of such accounts receivable on our condensed consolidated income statements for the </span><span style="font-family:inherit;font-size:10pt;">nine months ended</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">September 30, 2019</span><span style="font-family:inherit;font-size:10pt;"> were not material.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:13px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Voluntary Recall</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">On January 24, 2019, we issued a voluntary recall of our Vial2Bag</span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">®</sup></span><span style="font-family:inherit;font-size:10pt;"> product line due to reports of potential unpredictable or variable dosing under certain conditions. Our fourth quarter 2018 results included an </span><span style="font-family:inherit;font-size:10pt;"><span>$11.3 million</span></span><span style="font-family:inherit;font-size:10pt;"> provision for product returns, recorded as a reduction of sales, partially offset by a reduction in cost of goods sold reflecting our inventory balance for these devices at December 31, 2018. During the </span><span style="font-family:inherit;font-size:10pt;">three</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">nine months ended</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">September 30, 2019</span><span style="font-family:inherit;font-size:10pt;">, we recorded a net adjustment of </span><span style="font-family:inherit;font-size:10pt;"><span>$0.9 million</span></span><span style="font-family:inherit;font-size:10pt;"> and a net provision of </span><span style="font-family:inherit;font-size:10pt;"><span>$4.9 million</span></span><span style="font-family:inherit;font-size:10pt;">, respectively, for potential inventory returns from our customers and related in-house inventory, partially offset by a reduction in our provision for product returns. We continue to work to get the products back on the market.</span></div> <div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:13px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table presents the approximate percentage of our net sales by market group:</span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.57264957264957%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:49%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Three Months Ended<br/>September 30,</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Nine Months Ended<br/>September 30,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Biologics</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>26</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>21</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>25</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>21</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Generics</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>20</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>21</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>20</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>21</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Pharma</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>30</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>34</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>31</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>35</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Contract-Manufactured Products</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>24</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>24</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>24</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>23</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>100</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>100</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>100</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>100</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:13px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table presents the approximate percentage of our net sales by product category: </span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.57264957264957%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:49%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Three Months Ended<br/>September 30,</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Nine Months Ended<br/>September 30,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">High-Value Components</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>42</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>41</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>43</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>42</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Standard Packaging</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>28</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>31</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>29</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>32</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Delivery Devices</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Contract-Manufactured Products</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>24</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>24</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>24</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>23</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>100</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>100</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>100</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>100</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:13px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table presents the approximate percentage of our net sales by geographic location: </span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.57264957264957%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:49%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Three Months Ended<br/>September 30,</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Nine Months Ended<br/>September 30,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Americas</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>48</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>51</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>48</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>48</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Europe, Middle East, Africa</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>44</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>41</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>44</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>44</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Asia Pacific</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>100</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>100</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>100</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>100</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 0.26 0.21 0.25 0.21 0.20 0.21 0.20 0.21 0.30 0.34 0.31 0.35 0.24 0.24 0.24 0.23 1 1 1 1 0.42 0.41 0.43 0.42 0.28 0.31 0.29 0.32 0.06 0.04 0.04 0.03 0.24 0.24 0.24 0.23 1 1 1 1 0.48 0.51 0.48 0.48 0.44 0.41 0.44 0.44 0.08 0.08 0.08 0.08 1 1 1 1 <div style="line-height:120%;padding-bottom:13px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table summarizes our contract assets and liabilities, excluding contract assets included in accounts receivable, net:</span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:86%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">($ in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Contract assets, December 31, 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Contract assets, September 30, 2019</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Change in contract assets - increase (decrease)</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Deferred income, December 31, 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(33.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Deferred income, September 30, 2019</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(30.9</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Change in deferred income - decrease (increase)</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 9100000 9400000 300000 33400000 30900000 2500000 79300000 18000000.0 2700000 79500000 20000000.0 5900000 900000 5000000.0 7900000 11300000 900000 4900000 Net Income Per Share<div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table reconciles the shares used in the calculation of basic net income per share to those used for diluted net income per share:</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.57264957264957%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:49%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Three Months Ended<br/>September 30,</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Nine Months Ended<br/>September 30,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net income</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>56.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>55.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>177.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>154.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Weighted average common shares outstanding</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>74.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>73.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>73.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>73.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Dilutive effect of equity awards, based on the treasury stock method</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Weighted average shares assuming dilution</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>75.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>75.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>75.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>75.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">During the </span><span style="font-family:inherit;font-size:10pt;">three months ended</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">September 30, 2019</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;">, there were </span><span style="font-family:inherit;font-size:10pt;"><span>0.1 million</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>0.1 million</span></span><span style="font-family:inherit;font-size:10pt;"> shares, respectively, from stock-based compensation plans not included in the computation of diluted net income per share because their impact was antidilutive. There were </span><span style="font-family:inherit;font-size:10pt;"><span>0.3 million</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>0.4 million</span></span><span style="font-family:inherit;font-size:10pt;"> antidilutive shares outstanding during the </span><span style="font-family:inherit;font-size:10pt;">nine months ended</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">September 30, 2019</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;">, respectively.</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In February 2019, we announced a share repurchase program for calendar-year 2019 authorizing the repurchase of up to </span><span style="font-family:inherit;font-size:10pt;"><span>800,000</span></span><span style="font-family:inherit;font-size:10pt;"> shares of our common stock from time to time on the open market or in privately-negotiated transactions as permitted under the Securities Exchange Act of 1934 Rule 10b-18. The number of shares repurchased and the timing of such transactions depended on a variety of factors, including market conditions. There were no shares purchased during the </span><span style="font-family:inherit;font-size:10pt;">three months ended</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">September 30, 2019</span><span style="font-family:inherit;font-size:10pt;">. During the </span><span style="font-family:inherit;font-size:10pt;">nine months ended</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">September 30, 2019</span><span style="font-family:inherit;font-size:10pt;">, we purchased </span><span style="font-family:inherit;font-size:10pt;"><span>800,000</span></span><span style="font-family:inherit;font-size:10pt;"> shares of our common stock under the now-completed program at a cost of </span><span style="font-family:inherit;font-size:10pt;"><span>$83.1 million</span></span><span style="font-family:inherit;font-size:10pt;">, or an average price of </span><span style="font-family:inherit;font-size:10pt;"><span>$103.89</span></span><span style="font-family:inherit;font-size:10pt;"> per share.</span></div> <div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table reconciles the shares used in the calculation of basic net income per share to those used for diluted net income per share:</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.57264957264957%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:49%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Three Months Ended<br/>September 30,</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Nine Months Ended<br/>September 30,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net income</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>56.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>55.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>177.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>154.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Weighted average common shares outstanding</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>74.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>73.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>73.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>73.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Dilutive effect of equity awards, based on the treasury stock method</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Weighted average shares assuming dilution</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>75.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>75.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>75.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>75.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 56300000 55200000 177800000 154900000 74000000.0 73900000 73900000 73900000 1500000 1800000 1400000 1500000 75500000 75700000 75300000 75400000 100000 100000 300000 400000 800000 800000 83100000 103.89 Inventories<div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Inventories are valued at the lower of cost (on a first-in, first-out basis) and net realizable value. Inventory balances were as follows:</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:71%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">($ in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">September 30, <br/>2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">December 31, <br/>2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Raw materials</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>99.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>90.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Work in process</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>38.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>42.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Finished goods</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>92.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>81.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>230.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>214.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> <div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Inventories are valued at the lower of cost (on a first-in, first-out basis) and net realizable value. Inventory balances were as follows:</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:71%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">($ in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">September 30, <br/>2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">December 31, <br/>2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Raw materials</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>99.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>90.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Work in process</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>38.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>42.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Finished goods</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>92.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>81.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>230.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>214.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 99200000 90400000 38300000 42200000 92900000 81900000 230400000 214500000 Leases<div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Adoption of ASC 842</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">On January 1, 2019, we adopted ASC 842, using the modified retrospective approach that allows companies to apply ASC 842 as of the effective date and on a prospective basis. As a result, we were not required to adjust our comparative period financial information for effects of ASC 842 or present the new required lease disclosures for periods prior to the date of adoption. As of </span><span style="font-family:inherit;font-size:10pt;">September 30, 2019</span><span style="font-family:inherit;font-size:10pt;">, we had operating leases primarily related to land, buildings, and machinery and equipment, with lease terms through 2047. Certain of our operating leases include options to extend the lease term for up to </span><span style="font-family:inherit;font-size:10pt;"><span>five years</span></span><span style="font-family:inherit;font-size:10pt;">, and certain of our operating leases include options to terminate the leases within one year. We had no finance leases as of </span><span style="font-family:inherit;font-size:10pt;">September 30, 2019</span><span style="font-family:inherit;font-size:10pt;">.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">As a result of our adoption of ASC 842, we recorded operating lease right-of-use assets of </span><span style="font-family:inherit;font-size:10pt;"><span>$71.0 million</span></span><span style="font-family:inherit;font-size:10pt;"> and operating lease liabilities of </span><span style="font-family:inherit;font-size:10pt;"><span>$73.1 million</span></span><span style="font-family:inherit;font-size:10pt;"> for operating leases where we are the lessee in our condensed consolidated balance sheet as of January 1, 2019. The operating lease right-of-use assets are initially measured at cost, which comprises the initial amount of the lease liability adjusted for lease payments made at or before the lease commencement date, plus any initial direct costs incurred less any lease incentives received. The operating lease right-of-use assets are subsequently measured throughout the lease term at the carrying amount of the lease liability, plus initial direct costs, plus (minus) any prepaid (accrued) lease payments, less the unamortized balance of lease incentives received. Lease expense for lease payments is recognized on a straight-line basis over the lease term. The operating lease liabilities are initially measured at the present value of the unpaid lease payments at the lease commencement date.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Judgments used in applying ASC 842 include determining: i) whether a contract is, or contains, a lease; ii) the discount rate to be used to discount the unpaid lease payments to present value; iii) the lease term; and iv) the lease payments. We determine if a contract is, or contains, a lease at contract inception. A lease exists when a contract conveys to the customer the right to control the use of identified property, plant, or equipment for a period of time in exchange for consideration. The definition of a lease embodies two conditions: 1) there is an identified asset in the contract that is land or a depreciable asset (i.e., property, plant, and equipment); and 2) the customer has the right to control the use of the identified asset. ASC 842 requires a lessee to discount its unpaid lease payments using the interest rate implicit in the lease or, if that rate cannot be readily determined, its incremental borrowing rate. As all of our operating leases do not provide an implicit rate, we use our incremental borrowing rate based on the </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">information available at commencement date in determining the present value of lease payments. Our incremental borrowing rate for a lease is the rate of interest we would have to pay on a collateralized basis to borrow an amount equal to the lease payments under similar terms. The lease term for all of our operating leases includes the noncancellable period of the lease plus any additional periods covered by either a lessee option to extend (or not to terminate) the lease that the lessee is reasonably certain to exercise, or an option to extend (or not to terminate) the lease controlled by the lessor. Lease payments included in the measurement of the operating lease right-of-use assets and lease liabilities are comprised of fixed payments (including in-substance fixed payments), variable payments that depend on an index or rate, and the exercise price of a lessee option to purchase the underlying asset if the lessee is reasonably certain to exercise.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The components of lease expense were as follows:</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.57264957264957%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:59%;"/><td style="width:1%;"/><td style="width:18%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:18%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">($ in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Three Months Ended<br/>September 30, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Nine Months Ended<br/>September 30, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Operating lease cost</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Short-term lease cost</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Variable lease cost</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total lease cost</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>12.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Lease expense for the </span><span style="font-family:inherit;font-size:10pt;">three</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">nine months ended</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">September 30, 2018</span><span style="font-family:inherit;font-size:10pt;"> was </span><span style="font-family:inherit;font-size:10pt;"><span>$3.3 million</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$10.4 million</span></span><span style="font-family:inherit;font-size:10pt;">, respectively.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Supplemental information related to leases was as follows:</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.57264957264957%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:59%;"/><td style="width:1%;"/><td style="width:18%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:18%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">($ in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Three Months Ended<br/>September 30, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Nine Months Ended<br/>September 30, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cash paid for amounts included in the measurement of lease liabilities:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Operating cash flows from operating leases</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Right-of-use assets obtained in exchange for new operating lease liabilities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">As of </span><span style="font-family:inherit;font-size:10pt;">September 30, 2019</span><span style="font-family:inherit;font-size:10pt;">, the weighted average remaining lease term for operating leases was </span><span style="font-family:inherit;font-size:10pt;"><span>11.8</span></span><span style="font-family:inherit;font-size:10pt;"> years, and the weighted average discount rate was </span><span style="font-family:inherit;font-size:10pt;"><span>3.76%</span></span><span style="font-family:inherit;font-size:10pt;">.</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Maturities of lease liabilities as of </span><span style="font-family:inherit;font-size:10pt;">September 30, 2019</span><span style="font-family:inherit;font-size:10pt;"> were as follows:</span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.14529914529915%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:78%;"/><td style="width:1%;"/><td style="width:20%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">($ in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Operating</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Year</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Leases</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2019 (remaining three months)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2020</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>12.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2021</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>10.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2022</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2023</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Thereafter</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>48.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>89.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Less: imputed lease interest</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(16.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total lease liabilities</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>73.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Maturities of future minimum rental payments under non-cancelable operating leases as of December 31, 2018 were as follows:</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.14529914529915%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:78%;"/><td style="width:1%;"/><td style="width:20%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">($ in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Operating</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Year</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Leases</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>13.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2020</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>10.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2021</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2022</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2023</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Thereafter</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>37.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>81.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Practical Expedients and Exemptions </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We have elected to adopt the leasing package of practical expedients, which allows us to not retroactively reassess: i) any expired or existing contracts containing leases under the new definition of a lease; ii) the lease classification for any expired or existing leases; and iii) initial direct costs for any expired or existing leases. We have also elected to adopt practical expedients around land easements, the combination of lease and non-lease components, and the portfolio approach relating to discount rates. These practical expedients were applied consistently to all leases. </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We have elected not to recognize operating lease right-of-use assets and operating lease liabilities for all short-term leases (leases with an initial lease term of </span><span style="font-family:inherit;font-size:10pt;"><span>12 months</span></span><span style="font-family:inherit;font-size:10pt;"> or less). We recognize the lease payments associated with our short-term leases as an expense over the lease term.</span></div> P5Y 71000000.0 73100000 <div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The components of lease expense were as follows:</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.57264957264957%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:59%;"/><td style="width:1%;"/><td style="width:18%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:18%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">($ in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Three Months Ended<br/>September 30, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Nine Months Ended<br/>September 30, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Operating lease cost</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Short-term lease cost</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Variable lease cost</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total lease cost</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>12.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 3400000 9700000 100000 500000 800000 2300000 4300000 12500000 3300000 10400000 <div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Supplemental information related to leases was as follows:</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.57264957264957%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:59%;"/><td style="width:1%;"/><td style="width:18%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:18%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">($ in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Three Months Ended<br/>September 30, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Nine Months Ended<br/>September 30, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cash paid for amounts included in the measurement of lease liabilities:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Operating cash flows from operating leases</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Right-of-use assets obtained in exchange for new operating lease liabilities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 3200000 9400000 300000 8400000 P11Y9M18D 0.0376 <div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Maturities of lease liabilities as of </span><span style="font-family:inherit;font-size:10pt;">September 30, 2019</span><span style="font-family:inherit;font-size:10pt;"> were as follows:</span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.14529914529915%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:78%;"/><td style="width:1%;"/><td style="width:20%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">($ in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Operating</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Year</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Leases</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2019 (remaining three months)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2020</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>12.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2021</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>10.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2022</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2023</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Thereafter</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>48.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>89.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Less: imputed lease interest</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(16.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total lease liabilities</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>73.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 3400000 12000000.0 10200000 8300000 7700000 48100000 89700000 16400000 73300000 of December 31, 2018 were as follows:<div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.14529914529915%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:78%;"/><td style="width:1%;"/><td style="width:20%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">($ in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Operating</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Year</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Leases</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>13.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2020</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>10.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2021</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2022</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2023</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Thereafter</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>37.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>81.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 13000000.0 10500000 7800000 6900000 5500000 37800000 81500000 P12M Affiliated Companies<div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">At </span><span style="font-family:inherit;font-size:10pt;">September 30, 2019</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">December 31, 2018</span><span style="font-family:inherit;font-size:10pt;">, the aggregate carrying amount of our investment in affiliated companies that are accounted for under the equity method was </span><span style="font-family:inherit;font-size:10pt;"><span>$84.0 million</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$77.8 million</span></span><span style="font-family:inherit;font-size:10pt;">, respectively, and the aggregate carrying amount of our investment in affiliated companies that are not accounted for under the equity method was </span><span style="font-family:inherit;font-size:10pt;"><span>$13.4 million</span></span><span style="font-family:inherit;font-size:10pt;"> at both period-ends. We have elected to record these investments, for which fair value was not readily determinable, at cost, less impairment, adjusted for subsequent observable price changes. We test these investments for impairment whenever circumstances indicate that the carrying value of the investments may not be recoverable. </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Our purchases from, and royalty payments made to, affiliates totaled </span><span style="font-family:inherit;font-size:10pt;"><span>$33.0 million</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$85.2 million</span></span><span style="font-family:inherit;font-size:10pt;">, respectively, for the </span><span style="font-family:inherit;font-size:10pt;">three</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">nine months ended</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">September 30, 2019</span><span style="font-family:inherit;font-size:10pt;">, as compared to </span><span style="font-family:inherit;font-size:10pt;"><span>$16.3 million</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$64.0 million</span></span><span style="font-family:inherit;font-size:10pt;">, respectively, for the same periods in 2018. As of </span><span style="font-family:inherit;font-size:10pt;">September 30, 2019</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">December 31, 2018</span><span style="font-family:inherit;font-size:10pt;">, the payable balance due to affiliates was </span><span style="font-family:inherit;font-size:10pt;"><span>$24.3 million</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$12.9 million</span></span><span style="font-family:inherit;font-size:10pt;">, respectively. The majority of these transactions related to a distributorship agreement with Daikyo Seiko, Ltd. (“Daikyo”) that allows us to purchase and re-sell Daikyo products. </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Sales to affiliates were </span><span style="font-family:inherit;font-size:10pt;"><span>$2.2 million</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$6.9 million</span></span><span style="font-family:inherit;font-size:10pt;">, respectively, for the </span><span style="font-family:inherit;font-size:10pt;">three</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">nine months ended</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">September 30, 2019</span><span style="font-family:inherit;font-size:10pt;">, as compared to </span><span style="font-family:inherit;font-size:10pt;"><span>$3.0 million</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$8.0 million</span></span><span style="font-family:inherit;font-size:10pt;">, respectively, for the same periods in 2018. As of </span><span style="font-family:inherit;font-size:10pt;">September 30, 2019</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">December 31, 2018</span><span style="font-family:inherit;font-size:10pt;">, the receivable balance due from affiliates was </span><span style="font-family:inherit;font-size:10pt;"><span>$1.4 million</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$1.6 million</span></span><span style="font-family:inherit;font-size:10pt;">, respectively.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Please refer to Note 6, </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Affiliated Companies</span><span style="font-family:inherit;font-size:10pt;">, to the consolidated financial statements in our </span><a href="http://www.sec.gov/Archives/edgar/data/105770/000010577019000012/wst10k12312018.htm" style="font-family:inherit;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2018 Annual Report</span></a><span style="font-family:inherit;font-size:10pt;"> for additional details.</span></div> 84000000.0 77800000 13400000 33000000.0 85200000 16300000 64000000.0 24300000 12900000 2200000 6900000 3000000.0 8000000.0 1400000 1600000 Debt<div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table summarizes our long-term debt obligations, net of unamortized debt issuance costs and current maturities. The interest rates shown in parentheses are as of </span><span style="font-family:inherit;font-size:10pt;">September 30, 2019</span><span style="font-family:inherit;font-size:10pt;">.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.14529914529915%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:71%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">($ in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">September 30, <br/>2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">December 31, <br/>2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Note payable, due December 31, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Credit Facility, due October 15, 2020</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>28.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Credit Facility, due March 28, 2024 (0.875%)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>27.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Series A notes, due July 5, 2022 (3.67%)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>42.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>42.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Series B notes, due July 5, 2024 (3.82%)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>53.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>53.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Series C notes, due July 5, 2027 (4.02%) </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>73.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>73.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>195.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>196.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Less: unamortized debt issuance costs</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total debt</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>195.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>196.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Less: current portion of long-term debt</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Long-term debt, net</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>195.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>196.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In March 2019, we entered into a new senior unsecured, multi-currency revolving credit facility agreement (the “Credit Agreement”) that replaced our prior revolving credit facility, which was scheduled to expire in October 2020. The Credit Agreement, which expires in March 2024, contains a senior unsecured, multi-currency revolving credit facility (the “Credit Facility”) of </span><span style="font-family:inherit;font-size:10pt;"><span>$300.0 million</span></span><span style="font-family:inherit;font-size:10pt;">, with sublimits of up to </span><span style="font-family:inherit;font-size:10pt;"><span>$30.0 million</span></span><span style="font-family:inherit;font-size:10pt;"> for swing line loans for domestic borrowers in U.S. Dollars (“USD”) and a </span><span style="font-family:inherit;font-size:10pt;"><span>$20.0 million</span></span><span style="font-family:inherit;font-size:10pt;"> swing line loan for our German Holding Company and up to </span><span style="font-family:inherit;font-size:10pt;"><span>$30.0 million</span></span><span style="font-family:inherit;font-size:10pt;"> for the issuance of standby letters of credit, which Credit Facility may be increased from time-to-time by the greater of </span><span style="font-family:inherit;font-size:10pt;"><span>$350.0 million</span></span><span style="font-family:inherit;font-size:10pt;"> and earnings before interest, taxes, depreciation and amortization (“EBITDA”) for the preceding twelve month period in the aggregate through an increase in the Credit Facility, subject to the satisfaction of certain conditions. Borrowings under the Credit Facility bear interest at either the base rate (the per annum interest rate of the highest of the Prime Rate, the Federal Funds Rate plus </span><span style="font-family:inherit;font-size:10pt;"><span>50</span></span><span style="font-family:inherit;font-size:10pt;"> basis points or the daily London Interbank Offered Rate (“LIBOR”), plus </span><span style="font-family:inherit;font-size:10pt;"><span>1.00%</span></span><span style="font-family:inherit;font-size:10pt;">) or at the applicable LIBOR rate, plus a tiered margin based on the ratio of our net consolidated debt to our modified EBITDA, ranging from </span><span style="font-family:inherit;font-size:10pt;"><span>0</span></span><span style="font-family:inherit;font-size:10pt;"> to </span><span style="font-family:inherit;font-size:10pt;"><span>37.5</span></span><span style="font-family:inherit;font-size:10pt;"> basis points for base rate loans and </span><span style="font-family:inherit;font-size:10pt;"><span>87.5</span></span><span style="font-family:inherit;font-size:10pt;"> to </span><span style="font-family:inherit;font-size:10pt;"><span>137.5</span></span><span style="font-family:inherit;font-size:10pt;"> basis points for LIBOR rate loans. The Credit Agreement contains financial covenants providing that we shall not permit the ratio of our net consolidated debt to our modified EBITDA to be greater than </span><span style="font-family:inherit;font-size:10pt;"><span>3.5</span></span><span style="font-family:inherit;font-size:10pt;"> to 1; provided that, no more than three times during the term of the Credit Agreement, upon the occurrence of a qualified acquisition for each of our four fiscal quarters immediately following such qualified acquisition, the ratio shall be increased to </span><span style="font-family:inherit;font-size:10pt;"><span>4.0</span></span><span style="font-family:inherit;font-size:10pt;"> to 1. The Credit Agreement also contains customary limitations on liens securing our indebtedness, fundamental changes (mergers, consolidations, liquidations and dissolutions), asset sales, distributions and acquisitions. As of </span><span style="font-family:inherit;font-size:10pt;">September 30, 2019</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">December 31, 2018</span><span style="font-family:inherit;font-size:10pt;">, total unamortized debt issuance costs of </span><span style="font-family:inherit;font-size:10pt;"><span>$1.1 million</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$0.6 million</span></span><span style="font-family:inherit;font-size:10pt;">, respectively, were recorded in other noncurrent assets and are being amortized as additional interest expense over the term of the Credit Facility. A portion of these costs relate to our prior revolving credit facility.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">At </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">September 30, 2019</span><span style="font-family:inherit;font-size:10pt;">, we had </span><span style="font-family:inherit;font-size:10pt;"><span>$27.6 million</span></span><span style="font-family:inherit;font-size:10pt;"> in outstanding long-term borrowings under the Credit Facility, of which </span><span style="font-family:inherit;font-size:10pt;"><span>$4.6 million</span></span><span style="font-family:inherit;font-size:10pt;"> was denominated in Japanese Yen (“Yen”) and </span><span style="font-family:inherit;font-size:10pt;"><span>$23.0 million</span></span><span style="font-family:inherit;font-size:10pt;"> was denominated in Euro. These borrowings, together with outstanding letters of credit of </span><span style="font-family:inherit;font-size:10pt;"><span>$2.5 million</span></span><span style="font-family:inherit;font-size:10pt;">, resulted in a borrowing capacity available under the Credit Facility of </span><span style="font-family:inherit;font-size:10pt;"><span>$269.9 million</span></span><span style="font-family:inherit;font-size:10pt;"> at </span><span style="font-family:inherit;font-size:10pt;">September 30, 2019</span><span style="font-family:inherit;font-size:10pt;">. Please refer to Note 9, </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Derivative Financial Instruments</span><span style="font-family:inherit;font-size:10pt;">, for a discussion of the foreign currency hedges associated with the Credit Facility.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Please refer to Note 9, </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Debt</span><span style="font-family:inherit;font-size:10pt;">, to the consolidated financial statements in our </span><a href="http://www.sec.gov/Archives/edgar/data/105770/000010577019000012/wst10k12312018.htm" style="font-family:inherit;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2018 Annual Report</span></a><span style="font-family:inherit;font-size:10pt;"> for additional details regarding our debt agreements.</span></div> <div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table summarizes our long-term debt obligations, net of unamortized debt issuance costs and current maturities. The interest rates shown in parentheses are as of </span><span style="font-family:inherit;font-size:10pt;">September 30, 2019</span><span style="font-family:inherit;font-size:10pt;">.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.14529914529915%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:71%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">($ in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">September 30, <br/>2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">December 31, <br/>2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Note payable, due December 31, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Credit Facility, due October 15, 2020</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>28.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Credit Facility, due March 28, 2024 (0.875%)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>27.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Series A notes, due July 5, 2022 (3.67%)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>42.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>42.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Series B notes, due July 5, 2024 (3.82%)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>53.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>53.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Series C notes, due July 5, 2027 (4.02%) </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>73.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>73.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>195.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>196.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Less: unamortized debt issuance costs</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total debt</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>195.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>196.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Less: current portion of long-term debt</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Long-term debt, net</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>195.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>196.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 0 100000 0 28600000 27600000 42000000.0 42000000.0 53000000.0 53000000.0 73000000.0 73000000.0 195600000 196700000 500000 600000 195100000 196100000 0 100000 195100000 196000000.0 300000000.0 30000000.0 20000000.0 30000000.0 350000000.0 0.50 0.0100 0 0.375 0.875 1.375 3.5 4.0 1100000 600000 27600000 4600000 23000000.0 2500000 269900000 Derivative Financial Instruments<div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Our ongoing business operations expose us to various risks, such as fluctuating interest rates, foreign currency exchange rates and increasing commodity prices. To manage these market risks, we periodically enter into derivative financial instruments, such as interest rate swaps, options and foreign exchange contracts for periods consistent with, and for notional amounts equal to or less than, the related underlying exposures. We do not purchase or hold any derivative financial instruments for investment or trading purposes. All derivatives are recorded in our condensed consolidated balance sheet at fair value.</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Foreign Exchange Rate Risk</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We have entered into forward exchange contracts, designated as fair value hedges, to manage our exposure to fluctuating foreign exchange rates on cross-currency intercompany loans. As of </span><span style="font-family:inherit;font-size:10pt;">September 30, 2019</span><span style="font-family:inherit;font-size:10pt;">, the total amount of these forward exchange contracts was Singapore Dollar (“SGD”) </span><span style="font-family:inherit;font-size:10pt;"><span>601.5 million</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$13.4 million</span></span><span style="font-family:inherit;font-size:10pt;">. As of </span><span style="font-family:inherit;font-size:10pt;">December 31, 2018</span><span style="font-family:inherit;font-size:10pt;">, the total amount of these forward exchange contracts was </span><span style="font-family:inherit;font-size:10pt;"><span>€10.0 million</span></span><span style="font-family:inherit;font-size:10pt;">, SGD </span><span style="font-family:inherit;font-size:10pt;"><span>601.5 million</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$13.4 million</span></span><span style="font-family:inherit;font-size:10pt;">. </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In addition, we have entered into several foreign currency contracts, designated as cash flow hedges, for periods of up to eighteen months, intended to hedge the currency risk associated with a portion of our forecasted transactions denominated in foreign currencies. As of </span><span style="font-family:inherit;font-size:10pt;">September 30, 2019</span><span style="font-family:inherit;font-size:10pt;">, we had outstanding foreign currency contracts to purchase and sell certain pairs of currencies, as follows:</span></div><div style="line-height:120%;text-align:left;padding-left:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.14529914529915%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:33%;"/><td style="width:21%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:21%;"/><td style="width:1%;"/><td style="width:21%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(in millions)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="4" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Sell</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Currency</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Purchase</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">USD</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Euro</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">USD</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>39.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>34.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Yen</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,921.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>31.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>20.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">SGD</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>31.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>18.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">At </span><span style="font-family:inherit;font-size:10pt;">September 30, 2019</span><span style="font-family:inherit;font-size:10pt;">, a portion of our debt consisted of borrowings denominated in currencies other than USD. We have designated our </span><span style="font-family:inherit;font-size:10pt;"><span>€21.0 million</span></span><span style="font-family:inherit;font-size:10pt;"> (</span><span style="font-family:inherit;font-size:10pt;"><span>$23.0 million</span></span><span style="font-family:inherit;font-size:10pt;">) Euro-denominated borrowings under our Credit Facility as a hedge of our net investment in certain European subsidiaries. A cumulative foreign currency translation gain of </span><span style="font-family:inherit;font-size:10pt;"><span>$0.6 million</span></span><span style="font-family:inherit;font-size:10pt;"> pre-tax (</span><span style="font-family:inherit;font-size:10pt;"><span>$0.5 million</span></span><span style="font-family:inherit;font-size:10pt;"> after tax) on this debt was recorded within accumulated other comprehensive loss as of </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">September 30, 2019</span><span style="font-family:inherit;font-size:10pt;">. We have also designated our </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;"><span>¥500.0 million</span></span><span style="font-family:inherit;font-size:10pt;"> (</span><span style="font-family:inherit;font-size:10pt;"><span>$4.6 million</span></span><span style="font-family:inherit;font-size:10pt;">) Yen-denominated borrowings under our Credit Facility as a hedge of our net investment in Daikyo. At </span><span style="font-family:inherit;font-size:10pt;">September 30, 2019</span><span style="font-family:inherit;font-size:10pt;">, there was a cumulative foreign currency translation loss of </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;"><span>$0.5 million</span></span><span style="font-family:inherit;font-size:10pt;"> pre-tax (</span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;"><span>$0.4 million</span></span><span style="font-family:inherit;font-size:10pt;"> after tax) on this Yen-denominated debt, which was also included within accumulated other comprehensive loss.</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Commodity Price Risk</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Many of our proprietary products are made from synthetic elastomers, which are derived from the petroleum refining process. We purchase the majority of our elastomers via long-term supply contracts, some of which contain clauses that provide for surcharges related to fluctuations in crude oil prices. The following economic hedges did not qualify for hedge accounting treatment since they did not meet the highly effective requirement at inception.</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">From November 2017 through July 2019, we purchased several series of call options for a total of </span><span style="font-family:inherit;font-size:10pt;"><span>301,326</span></span><span style="font-family:inherit;font-size:10pt;"> barrels of crude oil to mitigate our exposure to such oil-based surcharges and protect operating cash flows with regards to a portion of our forecasted elastomer purchases. </span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">As of </span><span style="font-family:inherit;font-size:10pt;">September 30, 2019</span><span style="font-family:inherit;font-size:10pt;">, we had outstanding contracts to purchase </span><span style="font-family:inherit;font-size:10pt;"><span>107,909</span></span><span style="font-family:inherit;font-size:10pt;"> barrels of crude oil from October 2019 to December 2020, at a weighted-average strike price of </span><span style="font-family:inherit;font-size:10pt;"><span>$71.15</span></span><span style="font-family:inherit;font-size:10pt;"> per barrel.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Effects of Derivative Instruments on Financial Position and Results of Operations</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Please refer to Note 10, </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Fair Value Measurements</span><span style="font-family:inherit;font-size:10pt;">, for the balance sheet location and fair values of our derivative instruments as of </span><span style="font-family:inherit;font-size:10pt;">September 30, 2019</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">December 31, 2018</span><span style="font-family:inherit;font-size:10pt;">.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table summarizes the effects of derivative instruments designated as fair value hedges on the condensed consolidated statements of income:</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.14529914529915%;border-collapse:collapse;text-align:left;"><tr><td colspan="18"/></tr><tr><td style="width:27%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:25%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Amount of Loss (Gain) Recognized in Income for the </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Amount of Gain Recognized in Income for the</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Three Months Ended<br/>September 30,</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Nine Months Ended<br/>September 30,</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Location on Statement of Income</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">($ in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Fair Value Hedges:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Foreign currency hedge contracts</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(5.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(3.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other expense (income)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(5.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(3.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We recognize in earnings the initial value of forward point components on a straight-line basis over the life of the fair value hedge.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following tables summarize the effects of derivative instruments designated as fair value, cash flow, and net investment hedges on other comprehensive income (“OCI”) and earnings, net of tax:</span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.57264957264957%;border-collapse:collapse;text-align:left;"><tr><td colspan="18"/></tr><tr><td style="width:27%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:25%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Amount of (Loss) Gain Recognized in OCI for the</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Amount of Loss (Gain) Reclassified from Accumulated OCI into Income for the</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Location of Loss (Gain) Reclassified from Accumulated OCI into Income</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Three Months Ended<br/>September 30,</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Three Months Ended<br/>September 30,</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">($ in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Fair Value Hedges</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Foreign currency hedge contracts</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Times_New_Roman;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Times_New_Roman;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Times_New_Roman;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Times_New_Roman;font-size:10pt;"><span>2.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Times_New_Roman;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Times_New_Roman;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other expense (income)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Cash Flow Hedges:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Foreign currency hedge contracts</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net sales</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Foreign currency hedge contracts</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.5</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.2</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cost of goods and services sold</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Forward treasury locks</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Interest expense</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Net Investment Hedges:</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Foreign currency-denominated debt</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other expense (income)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.57264957264957%;border-collapse:collapse;text-align:left;"><tr><td colspan="18"/></tr><tr><td style="width:27%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:25%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Amount of Gain (Loss) Recognized in OCI for the</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Amount of (Gain) Loss Reclassified from Accumulated OCI into Income for the</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Location of (Gain) Loss Reclassified from Accumulated OCI into Income</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Nine Months Ended<br/>September 30,</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Nine Months Ended<br/>September 30,</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">($ in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Fair Value Hedges</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Foreign currency hedge contracts</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Times_New_Roman;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Times_New_Roman;font-size:10pt;"><span>(3.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Times_New_Roman;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other expense (income)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(3.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Cash Flow Hedges:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Foreign currency hedge contracts</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net sales</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Foreign currency hedge contracts</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.5</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cost of goods and services sold</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Forward treasury locks</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Interest expense</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Net Investment Hedges:</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Foreign currency-denominated debt</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other expense (income)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table summarizes the effects of derivative instruments not designated as hedges on the condensed consolidated statements of income:</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.14529914529915%;border-collapse:collapse;text-align:left;"><tr><td colspan="18"/></tr><tr><td style="width:27%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:25%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Amount of Loss Recognized in Income for the</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Amount of Loss (Gain) Recognized in Income for the </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Three Months Ended<br/>September 30,</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Nine Months Ended<br/>September 30,</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Location on Statement of Income</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">($ in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Commodity call options</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cost of goods and services sold</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">For the three and </span><span style="font-family:inherit;font-size:10pt;">nine months ended</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">September 30, 2019</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2018</span><span style="font-family:inherit;font-size:10pt;">, there was no material ineffectiveness related to our hedges.</span></div> 601500000 13400000 10000000.0 601500000 13400000 As of <span style="font-family:inherit;font-size:10pt;">September 30, 2019</span><span style="font-family:inherit;font-size:10pt;">, we had outstanding foreign currency contracts to purchase and sell certain pairs of currencies, as follows:</span><div style="line-height:120%;text-align:left;padding-left:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.14529914529915%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:33%;"/><td style="width:21%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:21%;"/><td style="width:1%;"/><td style="width:21%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(in millions)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="4" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Sell</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Currency</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Purchase</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">USD</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Euro</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">USD</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>39.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>34.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Yen</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,921.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>31.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>20.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">SGD</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>31.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>18.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 39300000 0 34200000 5921100000 31800000 20200000 31900000 18700000 4300000 21000000.0 23000000.0 -600000 -500000 500000000.0 4600000 -500000 -400000 301326 107909 71.15 <div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table summarizes the effects of derivative instruments designated as fair value hedges on the condensed consolidated statements of income:</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.14529914529915%;border-collapse:collapse;text-align:left;"><tr><td colspan="18"/></tr><tr><td style="width:27%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:25%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Amount of Loss (Gain) Recognized in Income for the </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Amount of Gain Recognized in Income for the</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Three Months Ended<br/>September 30,</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Nine Months Ended<br/>September 30,</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Location on Statement of Income</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">($ in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Fair Value Hedges:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Foreign currency hedge contracts</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(5.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(3.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other expense (income)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(5.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(3.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We recognize in earnings the initial value of forward point components on a straight-line basis over the life of the fair value hedge.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following tables summarize the effects of derivative instruments designated as fair value, cash flow, and net investment hedges on other comprehensive income (“OCI”) and earnings, net of tax:</span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.57264957264957%;border-collapse:collapse;text-align:left;"><tr><td colspan="18"/></tr><tr><td style="width:27%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:25%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Amount of (Loss) Gain Recognized in OCI for the</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Amount of Loss (Gain) Reclassified from Accumulated OCI into Income for the</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Location of Loss (Gain) Reclassified from Accumulated OCI into Income</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Three Months Ended<br/>September 30,</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Three Months Ended<br/>September 30,</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">($ in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Fair Value Hedges</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Foreign currency hedge contracts</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Times_New_Roman;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Times_New_Roman;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Times_New_Roman;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Times_New_Roman;font-size:10pt;"><span>2.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Times_New_Roman;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Times_New_Roman;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other expense (income)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Cash Flow Hedges:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Foreign currency hedge contracts</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net sales</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Foreign currency hedge contracts</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.5</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.2</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cost of goods and services sold</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Forward treasury locks</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Interest expense</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Net Investment Hedges:</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Foreign currency-denominated debt</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other expense (income)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.57264957264957%;border-collapse:collapse;text-align:left;"><tr><td colspan="18"/></tr><tr><td style="width:27%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:25%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Amount of Gain (Loss) Recognized in OCI for the</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Amount of (Gain) Loss Reclassified from Accumulated OCI into Income for the</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Location of (Gain) Loss Reclassified from Accumulated OCI into Income</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Nine Months Ended<br/>September 30,</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Nine Months Ended<br/>September 30,</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">($ in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Fair Value Hedges</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Foreign currency hedge contracts</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Times_New_Roman;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Times_New_Roman;font-size:10pt;"><span>(3.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Times_New_Roman;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other expense (income)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(3.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Cash Flow Hedges:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Foreign currency hedge contracts</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net sales</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Foreign currency hedge contracts</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.5</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cost of goods and services sold</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Forward treasury locks</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Interest expense</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Net Investment Hedges:</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Foreign currency-denominated debt</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other expense (income)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table summarizes the effects of derivative instruments not designated as hedges on the condensed consolidated statements of income:</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.14529914529915%;border-collapse:collapse;text-align:left;"><tr><td colspan="18"/></tr><tr><td style="width:27%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:25%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Amount of Loss Recognized in Income for the</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Amount of Loss (Gain) Recognized in Income for the </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Three Months Ended<br/>September 30,</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Nine Months Ended<br/>September 30,</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Location on Statement of Income</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">($ in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Commodity call options</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cost of goods and services sold</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 4300000 -2000000.0 -5000000.0 -3400000 4300000 -2000000.0 -5000000.0 -3400000 -600000 2900000 -600000 2900000 700000 100000 -300000 0 600000 -500000 -200000 -100000 0 0 100000 100000 1300000 -400000 -400000 0 700000 200000 0 0 700000 200000 0 0 3900000 -3300000 3900000 -3300000 1000000.0 200000 -700000 800000 1100000 900000 -500000 400000 0 0 200000 200000 2100000 1100000 -1000000.0 1400000 500000 700000 0 0 500000 700000 0 0 100000 0 300000 -500000 100000 0 300000 -500000 Fair Value Measurements<div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The following fair value hierarchy classifies the inputs to valuation techniques used to measure fair value into one of three levels:</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><span style="font-family:inherit;font-size:10pt;">•</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;text-decoration:underline;">Level 1</span><span style="font-family:inherit;font-size:10pt;">: Unadjusted quoted prices in active markets for identical assets or liabilities.</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><span style="font-family:inherit;font-size:10pt;">•</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;text-decoration:underline;">Level 2</span><span style="font-family:inherit;font-size:10pt;">: Inputs other than quoted prices that are observable for the asset or liability, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active.</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><span style="font-family:inherit;font-size:10pt;">•</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;text-decoration:underline;">Level 3</span><span style="font-family:inherit;font-size:10pt;">: Unobservable inputs that reflect the reporting entity’s own assumptions.</span></div></td></tr></table><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following tables present the assets and liabilities recorded at fair value on a recurring basis:</span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:41%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance at</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Basis of Fair Value Measurements</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">($ in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">September 30, <br/>2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Level 1</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Level 2</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Level 3</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;text-decoration:underline;">Assets:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Deferred compensation assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Foreign currency contracts</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>13.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>13.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Commodity call options</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>23.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>13.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;text-decoration:underline;">Liabilities:</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Contingent consideration</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Deferred compensation liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>11.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>11.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Foreign currency contracts</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>13.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>11.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:41%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance at</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Basis of Fair Value Measurements</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">($ in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">December 31, <br/>2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Level 1</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Level 2</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Level 3</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;text-decoration:underline;">Assets:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Deferred compensation assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Foreign currency contracts</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>15.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;text-decoration:underline;">Liabilities:</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Contingent consideration</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Deferred compensation liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Foreign currency contracts</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>11.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Deferred compensation assets are included within other noncurrent assets and are valued using a market approach based on quoted market prices in an active market. The fair value of our foreign currency contracts, included within other current and other noncurrent assets, as well as other current and other long-term liabilities, is valued using an income approach based on quoted forward foreign exchange rates and spot rates at the reporting date. The fair value of our commodity call options, included within other current and other noncurrent assets, is valued using a market </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">approach. The fair value of our contingent consideration, included within other current and other long-term liabilities, is discussed further in the section related to Level 3 fair value measurements. The fair value of deferred compensation liabilities is based on quoted prices of the underlying employees’ investment selections and is included within other long-term liabilities. Please refer to Note 9, </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Derivative Financial Instruments</span><span style="font-family:inherit;font-size:10pt;">, for further discussion of our derivatives.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Level 3 Fair Value Measurements</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The fair value of the contingent consideration liability related to the SmartDose technology platform (the “SmartDose contingent consideration”) was initially determined using a probability-weighted income approach, and is revalued at each reporting date or more frequently if circumstances dictate. Changes in the fair value of this obligation are recorded as income or expense within other expense (income) in our condensed consolidated statements of income. The significant unobservable inputs used in the fair value measurement of the SmartDose contingent consideration are the sales projections, the probability of success factors, and the discount rate. Significant increases or decreases in any of those inputs in isolation would result in a significantly lower or higher fair value measurement. As development and commercialization of the SmartDose technology platform progresses, we may need to update the sales projections, the probability of success factors, and the discount rate used. This could result in a material increase or decrease to the SmartDose contingent consideration.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table provides a summary of changes in our Level 3 fair value measurements:</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:86%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">($ in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance, December 31, 2017</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Decrease in fair value recorded in earnings</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2.6</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Payments</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance, December 31, 2018</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Increase in fair value recorded in earnings</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Payments</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.3</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance, September 30, 2019</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Other Financial Instruments</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We believe that the carrying amounts of our cash and cash equivalents and accounts receivable approximate their fair values due to their near-term maturities. </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The estimated fair value of long-term debt is based on quoted market prices for debt issuances with similar terms and maturities and is classified as Level 2 within the fair value hierarchy. At </span><span style="font-family:inherit;font-size:10pt;">September 30, 2019</span><span style="font-family:inherit;font-size:10pt;">, the estimated fair value of long-term debt was </span><span style="font-family:inherit;font-size:10pt;"><span>$204.4 million</span></span><span style="font-family:inherit;font-size:10pt;"> compared to a carrying amount of </span><span style="font-family:inherit;font-size:10pt;"><span>$195.1 million</span></span><span style="font-family:inherit;font-size:10pt;">. At </span><span style="font-family:inherit;font-size:10pt;">December 31, 2018</span><span style="font-family:inherit;font-size:10pt;">, the estimated fair value of long-term debt was </span><span style="font-family:inherit;font-size:10pt;"><span>$192.6 million</span></span><span style="font-family:inherit;font-size:10pt;"> and the carrying amount was </span><span style="font-family:inherit;font-size:10pt;"><span>$196.0 million</span></span><span style="font-family:inherit;font-size:10pt;">.</span></div> <div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following tables present the assets and liabilities recorded at fair value on a recurring basis:</span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:41%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance at</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Basis of Fair Value Measurements</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">($ in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">September 30, <br/>2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Level 1</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Level 2</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Level 3</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;text-decoration:underline;">Assets:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Deferred compensation assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Foreign currency contracts</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>13.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>13.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Commodity call options</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>23.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>13.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;text-decoration:underline;">Liabilities:</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Contingent consideration</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Deferred compensation liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>11.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>11.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Foreign currency contracts</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>13.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>11.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:41%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance at</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Basis of Fair Value Measurements</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">($ in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">December 31, <br/>2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Level 1</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Level 2</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Level 3</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;text-decoration:underline;">Assets:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Deferred compensation assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Foreign currency contracts</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>15.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;text-decoration:underline;">Liabilities:</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Contingent consideration</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Deferred compensation liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Foreign currency contracts</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>11.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 9900000 9900000 13200000 13200000 100000 100000 23200000 9900000 13300000 1800000 1800000 11400000 11400000 200000 200000 13400000 11400000 200000 1800000 8700000 8700000 6500000 6500000 15200000 8700000 6500000 1700000 1700000 9800000 9800000 200000 200000 11700000 9800000 200000 1700000 <div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table provides a summary of changes in our Level 3 fair value measurements:</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:86%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">($ in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance, December 31, 2017</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Decrease in fair value recorded in earnings</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2.6</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Payments</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance, December 31, 2018</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Increase in fair value recorded in earnings</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Payments</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.3</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance, September 30, 2019</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 4900000 -2600000 600000 1700000 400000 300000 1800000 204400000 195100000 192600000 196000000.0 Accumulated Other Comprehensive Loss <div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table presents the changes in the components of accumulated other comprehensive loss, net of tax, for the </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">nine months ended</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">September 30, 2019</span><span style="font-family:inherit;font-size:10pt;">:</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="20"/></tr><tr><td style="width:29%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:17%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:7%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">($ in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(Losses) gains on</span></div><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">derivatives</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;text-align:center;">Unrealized gains </span></div><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;text-align:center;">on investment </span></div><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;text-align:center;">securities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Defined benefit</span></div><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">pension and other </span></div><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">postretirement plans</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Foreign </span></div><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">currency </span></div><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">translation</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance, December 31, 2018</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(40.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(113.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(154.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other comprehensive income (loss) before reclassifications</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(20.1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(13.5</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Amounts reclassified out</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(4.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other comprehensive income (loss), net of tax</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.7</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.2</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(20.1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(16.2</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance, September 30, 2019</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(38.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(133.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(170.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">A summary of the reclassifications out of accumulated other comprehensive loss is presented in the following table: </span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="19"/></tr><tr><td style="width:34%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:6%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:6%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:6%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:6%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:29%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">($ in millions)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Three Months Ended<br/>September 30,</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Nine Months Ended<br/>September 30,</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Location on Statement of Income</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Detail of components</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2018</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Gains (losses) on derivatives:</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Foreign currency contracts</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.8</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net sales</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Foreign currency contracts</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cost of goods and services sold</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Foreign currency contracts</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(4.3</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other expense (income)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Forward treasury locks</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Interest expense</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total before tax</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(3.8</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1.8</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Tax expense</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net of tax</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Amortization of defined benefit pension and other postretirement plans:</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Prior service credit</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(a)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Actuarial gains (losses)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(a)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Settlements</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(a)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total before tax</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Tax expense</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net of tax</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total reclassifications for the period, net of tax</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(4.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(a) These components are included in the computation of net periodic benefit cost. Please refer to Note 14, </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Benefit Plans</span><span style="font-family:inherit;font-size:10pt;">, for additional details.</span></div> <div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table presents the changes in the components of accumulated other comprehensive loss, net of tax, for the </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">nine months ended</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">September 30, 2019</span><span style="font-family:inherit;font-size:10pt;">:</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="20"/></tr><tr><td style="width:29%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:17%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:7%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">($ in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(Losses) gains on</span></div><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">derivatives</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;text-align:center;">Unrealized gains </span></div><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;text-align:center;">on investment </span></div><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;text-align:center;">securities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Defined benefit</span></div><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">pension and other </span></div><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">postretirement plans</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Foreign </span></div><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">currency </span></div><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">translation</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance, December 31, 2018</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(40.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(113.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(154.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other comprehensive income (loss) before reclassifications</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(20.1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(13.5</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Amounts reclassified out</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(4.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other comprehensive income (loss), net of tax</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.7</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.2</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(20.1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(16.2</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance, September 30, 2019</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(38.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(133.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(170.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> -400000 400000 -40400000 -113800000 -154200000 6000000.0 0 600000 -20100000 -13500000 4300000 0 -1600000 0 2700000 1700000 0 2200000 -20100000 -16200000 1300000 400000 -38200000 -133900000 -170400000 <div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">A summary of the reclassifications out of accumulated other comprehensive loss is presented in the following table: </span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="19"/></tr><tr><td style="width:34%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:6%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:6%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:6%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:6%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:29%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">($ in millions)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Three Months Ended<br/>September 30,</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Nine Months Ended<br/>September 30,</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Location on Statement of Income</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Detail of components</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2018</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Gains (losses) on derivatives:</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Foreign currency contracts</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.8</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net sales</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Foreign currency contracts</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cost of goods and services sold</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Foreign currency contracts</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(4.3</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other expense (income)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Forward treasury locks</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Interest expense</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total before tax</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(3.8</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1.8</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Tax expense</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net of tax</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Amortization of defined benefit pension and other postretirement plans:</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Prior service credit</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(a)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Actuarial gains (losses)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(a)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Settlements</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(a)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total before tax</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Tax expense</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net of tax</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total reclassifications for the period, net of tax</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(4.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(a) These components are included in the computation of net periodic benefit cost. Please refer to Note 14, </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Benefit Plans</span><span style="font-family:inherit;font-size:10pt;">, for additional details.</span></div> 300000 100000 800000 -800000 -300000 0 -800000 700000 4300000 0 -5000000.0 0 100000 100000 300000 300000 -3800000 0 6300000 -1800000 -1300000 0 2000000.0 -400000 -2500000 0 4300000 -1400000 -100000 -500000 -400000 -1600000 200000 -200000 200000 -1000000.0 -2700000 -2700000 -2400000 300000 -2100000 600000 -600000 0 -500000 100000 -1800000 300000 -1600000 500000 -4300000 300000 2700000 -900000 Shareholders<span style="font-family:inherit;font-size:10pt;">’</span><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> Equity</span><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table presents the changes in shareholders’ equity for the </span><span style="font-family:inherit;font-size:10pt;">nine months ended</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">September 30, 2019</span><span style="font-family:inherit;font-size:10pt;">:</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.69135802469135%;border-collapse:collapse;text-align:left;"><tr><td colspan="30"/></tr><tr><td style="width:29%;"/><td style="width:6%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:5%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:6%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:7%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:5%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:5%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:6%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Common Shares Issued</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Common Stock</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Capital in Excess of Par Value</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Number of Treasury Shares</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Treasury Stock</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Retained earnings</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Accumulated other comprehensive loss</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">($ in millions)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Balance, December 31, 2018</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>75.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>18.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>282.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(103.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,353.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(154.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,396.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net income</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>55.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>55.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Activity related to stock-based compensation</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(3.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>14.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>10.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Shares purchased under share repurchase program</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(83.1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(83.1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Dividends declared ($0.15 per share)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(10.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(10.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other comprehensive income, net of tax</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Balance, March 31, 2019</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>75.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>18.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>278.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(172.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,398.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(153.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,369.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net income</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>66.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>66.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Activity related to stock-based compensation</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(5.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>24.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>19.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Dividends declared ($0.15 per share)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(11.4</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(11.4</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other comprehensive income, net of tax</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance, June 30, 2019</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>75.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>18.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>273.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(147.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,452.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(152.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,445.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Net income</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>56.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>56.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Activity related to stock-based compensation</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(4.9</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.3</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>21.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>16.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Dividends declared ($0.16 per share)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(11.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(11.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other comprehensive loss, net of tax</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(18.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(18.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance, September 30, 2019</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>75.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>18.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>268.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(126.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,497.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(170.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,487.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table presents the changes in shareholders’ equity for the </span><span style="font-family:inherit;font-size:10pt;">nine months ended</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">September 30, 2018</span><span style="font-family:inherit;font-size:10pt;">:</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.69135802469135%;border-collapse:collapse;text-align:left;"><tr><td colspan="30"/></tr><tr><td style="width:29%;"/><td style="width:6%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:5%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:6%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:7%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:5%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:5%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:6%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Common Shares Issued</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Common Stock</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Capital in Excess of Par Value</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Number of Treasury Shares</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Treasury Stock</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Retained earnings</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Accumulated other comprehensive loss</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">($ in millions)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance, December 31, 2017</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>75.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>18.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>309.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(109.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,178.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(117.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,279.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Effect of modified retrospective application of a new accounting standard</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>11.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>11.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net income</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>43.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>43.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Activity related to stock-based compensation</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.8</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Shares purchased under share repurchase program</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(47.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(47.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Dividends declared ($0.14 per share)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(10.4</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(10.4</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other comprehensive income, net of tax</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>21.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>21.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance, March 31, 2018</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>75.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>18.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>308.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(149.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,222.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(95.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,305.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net income</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>56.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>56.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Activity related to stock-based compensation</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(3.8</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.2</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>16.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>12.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Shares purchased under share repurchase program</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(22.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(22.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Dividends declared ($0.14 per share)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(20.9</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(20.9</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other comprehensive loss, net of tax</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(47.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(47.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance, June 30, 2018</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>75.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>18.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>304.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(155.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,258.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(143.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,281.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net income</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>55.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>55.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Activity related to stock-based compensation</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(21.9</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.6</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>47.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>25.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Dividends declared ($0.15 per share)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other comprehensive loss, net of tax</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(10.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(10.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance, September 30, 2018</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>75.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>18.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>282.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(108.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,312.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(153.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,351.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> <div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table presents the changes in shareholders’ equity for the </span><span style="font-family:inherit;font-size:10pt;">nine months ended</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">September 30, 2019</span><span style="font-family:inherit;font-size:10pt;">:</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.69135802469135%;border-collapse:collapse;text-align:left;"><tr><td colspan="30"/></tr><tr><td style="width:29%;"/><td style="width:6%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:5%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:6%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:7%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:5%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:5%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:6%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Common Shares Issued</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Common Stock</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Capital in Excess of Par Value</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Number of Treasury Shares</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Treasury Stock</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Retained earnings</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Accumulated other comprehensive loss</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">($ in millions)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Balance, December 31, 2018</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>75.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>18.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>282.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(103.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,353.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(154.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,396.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net income</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>55.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>55.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Activity related to stock-based compensation</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(3.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>14.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>10.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Shares purchased under share repurchase program</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(83.1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(83.1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Dividends declared ($0.15 per share)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(10.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(10.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other comprehensive income, net of tax</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Balance, March 31, 2019</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>75.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>18.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>278.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(172.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,398.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(153.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,369.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net income</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>66.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>66.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Activity related to stock-based compensation</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(5.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>24.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>19.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Dividends declared ($0.15 per share)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(11.4</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(11.4</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other comprehensive income, net of tax</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance, June 30, 2019</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>75.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>18.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>273.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(147.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,452.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(152.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,445.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Net income</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>56.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>56.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Activity related to stock-based compensation</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(4.9</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.3</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>21.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>16.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Dividends declared ($0.16 per share)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(11.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(11.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other comprehensive loss, net of tax</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(18.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(18.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance, September 30, 2019</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>75.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>18.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>268.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(126.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,497.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(170.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,487.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 75300000 18800000 282000000.0 1200000 -103700000 1353400000 -154200000 1396300000 55400000 55400000 0 0 -3500000 -200000 14200000 10700000 800000 83100000 83100000 -10600000 10600000 800000 800000 75300000 18800000 278500000 1800000 -172600000 1398200000 -153400000 1369500000 66100000 66100000 0 0 -5100000 -200000 24800000 19700000 -11400000 11400000 1200000 1200000 75300000 18800000 273400000 1600000 -147800000 1452900000 -152200000 1445100000 56300000 56300000 0 0 -4900000 -300000 21200000 16300000 -11900000 11900000 -18200000 -18200000 75300000 18800000 268500000 1300000 -126600000 1497300000 -170400000 1487600000 <div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table presents the changes in shareholders’ equity for the </span><span style="font-family:inherit;font-size:10pt;">nine months ended</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">September 30, 2018</span><span style="font-family:inherit;font-size:10pt;">:</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.69135802469135%;border-collapse:collapse;text-align:left;"><tr><td colspan="30"/></tr><tr><td style="width:29%;"/><td style="width:6%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:5%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:6%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:7%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:5%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:5%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:6%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Common Shares Issued</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Common Stock</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Capital in Excess of Par Value</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Number of Treasury Shares</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Treasury Stock</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Retained earnings</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Accumulated other comprehensive loss</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">($ in millions)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance, December 31, 2017</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>75.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>18.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>309.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(109.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,178.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(117.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,279.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Effect of modified retrospective application of a new accounting standard</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>11.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>11.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net income</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>43.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>43.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Activity related to stock-based compensation</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.8</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Shares purchased under share repurchase program</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(47.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(47.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Dividends declared ($0.14 per share)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(10.4</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(10.4</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other comprehensive income, net of tax</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>21.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>21.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance, March 31, 2018</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>75.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>18.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>308.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(149.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,222.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(95.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,305.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net income</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>56.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>56.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Activity related to stock-based compensation</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(3.8</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.2</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>16.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>12.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Shares purchased under share repurchase program</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(22.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(22.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Dividends declared ($0.14 per share)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(20.9</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(20.9</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other comprehensive loss, net of tax</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(47.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(47.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance, June 30, 2018</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>75.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>18.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>304.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(155.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,258.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(143.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,281.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net income</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>55.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>55.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Activity related to stock-based compensation</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(21.9</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.6</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>47.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>25.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Dividends declared ($0.15 per share)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other comprehensive loss, net of tax</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(10.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(10.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance, September 30, 2018</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>75.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>18.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>282.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(108.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,312.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(153.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,351.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 75200000 18800000 309300000 1300000 -109100000 1178200000 -117300000 1279900000 11400000 11400000 43600000 43600000 100000 0 -800000 -100000 8000000.0 7200000 500000 47900000 47900000 10400000 10400000 21500000 21500000 75300000 18800000 308500000 1700000 -149000000.0 1222800000 -95800000 1305300000 56100000 56100000 0 0 -3800000 -200000 16000000.0 12200000 300000 22900000 22900000 20900000 20900000 -47900000 -47900000 75300000 18800000 304700000 1800000 -155900000 1258000000.0 -143700000 1281900000 55200000 55200000 -21900000 -600000 47200000 25300000 500000 500000 -10100000 -10100000 75300000 18800000 282800000 1200000 -108700000 1312700000 -153800000 1351800000  Stock-Based Compensation<div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The West Pharmaceutical Services, Inc. 2016 Omnibus Incentive Compensation Plan (the “2016 Plan”) provides for the granting of stock options, stock appreciation rights, restricted stock awards and performance awards to employees and non-employee directors. A committee of the Board of Directors determines the terms and conditions of awards to be granted. Vesting requirements vary by award. At </span><span style="font-family:inherit;font-size:10pt;">September 30, 2019</span><span style="font-family:inherit;font-size:10pt;">, there were </span><span style="font-family:inherit;font-size:10pt;"><span>3,110,708</span></span><span style="font-family:inherit;font-size:10pt;"> shares remaining in the 2016 Plan for future grants.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">During the </span><span style="font-family:inherit;font-size:10pt;">nine months ended</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">September 30, 2019</span><span style="font-family:inherit;font-size:10pt;">, we granted </span><span style="font-family:inherit;font-size:10pt;"><span>345,400</span></span><span style="font-family:inherit;font-size:10pt;"> stock options at a weighted average exercise price of </span><span style="font-family:inherit;font-size:10pt;"><span>$102.59</span></span><span style="font-family:inherit;font-size:10pt;"> per share based on the grant-date fair value of our stock to employees under the 2016 Plan. The weighted average grant date fair value of options granted was </span><span style="font-family:inherit;font-size:10pt;"><span>$24.53</span></span><span style="font-family:inherit;font-size:10pt;"> per share as determined by the Black-Scholes option valuation model using the following weighted average assumptions: a risk-free interest rate of </span><span style="font-family:inherit;font-size:10pt;"><span>2.3%</span></span><span style="font-family:inherit;font-size:10pt;">; expected life of </span><span style="font-family:inherit;font-size:10pt;"><span>5.6</span></span><span style="font-family:inherit;font-size:10pt;"> years based on prior experience; stock volatility of </span><span style="font-family:inherit;font-size:10pt;"><span>22.5%</span></span><span style="font-family:inherit;font-size:10pt;"> based on historical data; and a dividend yield of </span><span style="font-family:inherit;font-size:10pt;"><span>0.7%</span></span><span style="font-family:inherit;font-size:10pt;">. Stock option expense is recognized over the vesting period, net of forfeitures.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">During the </span><span style="font-family:inherit;font-size:10pt;">nine months ended</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">September 30, 2019</span><span style="font-family:inherit;font-size:10pt;">, we granted </span><span style="font-family:inherit;font-size:10pt;"><span>82,646</span></span><span style="font-family:inherit;font-size:10pt;"> stock-settled performance share unit (“PSU”) awards at a weighted average grant-date fair value of </span><span style="font-family:inherit;font-size:10pt;"><span>$102.59</span></span><span style="font-family:inherit;font-size:10pt;"> per share to eligible employees. These awards are earned based on the Company’s performance against pre-established targets, including annual growth rate of revenue and return on invested capital, over a specified performance period. Depending on the achievement of the targets, recipients of stock-settled PSU awards are entitled to receive a certain number of shares of common stock. Shares earned under PSU awards may vary from </span><span style="font-family:inherit;font-size:10pt;"><span>0%</span></span><span style="font-family:inherit;font-size:10pt;"> to </span><span style="font-family:inherit;font-size:10pt;"><span>200%</span></span><span style="font-family:inherit;font-size:10pt;"> of an employee’s targeted award. The fair value of stock-settled PSU awards is based on the market price of our stock at the grant date and is recognized as expense over the performance period, adjusted for estimated target outcomes and net of forfeitures.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">During the </span><span style="font-family:inherit;font-size:10pt;">nine months ended</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">September 30, 2019</span><span style="font-family:inherit;font-size:10pt;">, we granted </span><span style="font-family:inherit;font-size:10pt;"><span>11,631</span></span><span style="font-family:inherit;font-size:10pt;"> stock-settled restricted share unit (“RSU”) awards at a weighted average grant-date fair value of </span><span style="font-family:inherit;font-size:10pt;"><span>$112.49</span></span><span style="font-family:inherit;font-size:10pt;"> per share to eligible employees. These awards are earned over a specified performance period. The fair value of stock-settled RSU awards is based on the market price of our stock at the grant date and is recognized as expense over the vesting period, net of forfeitures. </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total stock-based compensation expense was </span><span style="font-family:inherit;font-size:10pt;"><span>$5.4 million</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$18.8 million</span></span><span style="font-family:inherit;font-size:10pt;"> for the </span><span style="font-family:inherit;font-size:10pt;">three</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">nine months ended</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">September 30, 2019</span><span style="font-family:inherit;font-size:10pt;">, respectively. For the </span><span style="font-family:inherit;font-size:10pt;">three</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">nine months ended</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">September 30, 2018</span><span style="font-family:inherit;font-size:10pt;">, stock-based compensation expense was </span><span style="font-family:inherit;font-size:10pt;"><span>$5.3 million</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$14.7 million</span></span><span style="font-family:inherit;font-size:10pt;">, respectively.</span></div> 3110708 345400 102.59 24.53 0.023 P5Y7M6D 0.225 0.007 82646 102.59 0 2 11631 112.49 5400000 18800000 5300000 14700000 Benefit Plans<div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The components of net periodic benefit cost for the </span><span style="font-family:inherit;font-size:10pt;">three months ended</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">September 30</span><span style="font-family:inherit;font-size:10pt;"> were as follows:</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="24"/></tr><tr><td style="width:33%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Pension benefits</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other retirement benefits</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">($ in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2019</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2018</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2019</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2018</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2019</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Service cost</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Interest cost</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Expected return on assets</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(3.1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(3.9</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(3.1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(3.9</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Amortization of prior service credit</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Recognized actuarial losses (gains)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.7</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.7</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.2</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Settlements</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net periodic benefit cost</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="24"/></tr><tr><td style="width:33%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Pension benefits</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other retirement benefits</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">($ in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">U.S. plans</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">International plans</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net periodic benefit cost</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The components of net periodic benefit cost for the </span><span style="font-family:inherit;font-size:10pt;">nine months ended</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">September 30</span><span style="font-family:inherit;font-size:10pt;"> were as follows:</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="24"/></tr><tr><td style="width:33%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Pension benefits</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other retirement benefits</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">($ in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Service cost</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Interest cost</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Expected return on assets</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(8.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(11.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(8.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(11.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Amortization of prior service credit</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1.1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.5</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.5</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.4</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1.6</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Recognized actuarial losses (gains)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Settlements</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net periodic benefit cost</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"> </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="24"/></tr><tr><td style="width:33%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Pension benefits</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other retirement benefits</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">($ in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">U.S. plans</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">International plans</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net periodic benefit cost</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">During the </span><span style="font-family:inherit;font-size:10pt;">three</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">nine months ended</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">September 30, 2019</span><span style="font-family:inherit;font-size:10pt;">, we recorded a </span><span style="font-family:inherit;font-size:10pt;"><span>$2.7 million</span></span><span style="font-family:inherit;font-size:10pt;"> pension settlement charge within other nonoperating expense (income), as we determined that normal-course lump-sum payments for each of our U.S. qualified and non-qualified defined benefit pension plans exceeded the threshold for settlement accounting under U.S. GAAP for the year. Effective January 1, 2019, except for interest crediting, benefit accruals under these defined benefit pension plans ceased.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">During the </span><span style="font-family:inherit;font-size:10pt;">three</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">nine months ended</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">September 30, 2019</span><span style="font-family:inherit;font-size:10pt;">, we contributed </span><span style="font-family:inherit;font-size:10pt;"><span>$2.6 million</span></span><span style="font-family:inherit;font-size:10pt;"> to our U.S. qualified defined benefit pension plan.</span></div> <div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The components of net periodic benefit cost for the </span><span style="font-family:inherit;font-size:10pt;">three months ended</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">September 30</span><span style="font-family:inherit;font-size:10pt;"> were as follows:</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="24"/></tr><tr><td style="width:33%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Pension benefits</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other retirement benefits</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">($ in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2019</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2018</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2019</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2018</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2019</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Service cost</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Interest cost</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Expected return on assets</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(3.1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(3.9</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(3.1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(3.9</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Amortization of prior service credit</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Recognized actuarial losses (gains)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.7</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.7</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.2</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Settlements</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net periodic benefit cost</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="24"/></tr><tr><td style="width:33%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Pension benefits</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other retirement benefits</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">($ in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">U.S. plans</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">International plans</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net periodic benefit cost</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The components of net periodic benefit cost for the </span><span style="font-family:inherit;font-size:10pt;">nine months ended</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">September 30</span><span style="font-family:inherit;font-size:10pt;"> were as follows:</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="24"/></tr><tr><td style="width:33%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Pension benefits</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other retirement benefits</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">($ in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Service cost</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Interest cost</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Expected return on assets</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(8.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(11.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(8.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(11.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Amortization of prior service credit</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1.1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.5</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.5</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.4</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1.6</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Recognized actuarial losses (gains)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Settlements</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net periodic benefit cost</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"> </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="24"/></tr><tr><td style="width:33%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Pension benefits</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other retirement benefits</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">($ in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">U.S. plans</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">International plans</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">—</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net periodic benefit cost</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 400000 2600000 0 0 400000 2600000 1900000 2300000 100000 100000 2000000.0 2400000 3100000 3900000 3100000 3900000 100000 -300000 -200000 -200000 -100000 -500000 -500000 -900000 700000 700000 200000 -200000 -2700000 0 -2700000 0 2500000 1600000 -800000 -800000 1700000 800000 2000000.0 1000000.0 -800000 -800000 1200000 200000 500000 600000 500000 600000 2500000 1600000 -800000 -800000 1700000 800000 1100000 8100000 0 0 1100000 8100000 6800000 7000000.0 200000 200000 7000000.0 7200000 8900000 11700000 8900000 11700000 100000 -1100000 -500000 -500000 -400000 -1600000 -1600000 -2800000 1800000 1800000 200000 -1000000.0 -2700000 -2700000 0 3400000 5100000 -2100000 -2100000 1300000 3000000.0 1900000 3500000 -2100000 -2100000 -200000 1400000 1500000 1600000 1500000 1600000 3400000 5100000 -2100000 -2100000 1300000 3000000.0 -2700000 2600000 Other Expense (Income) <div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other expense (income) consists of:</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.57264957264957%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:49%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Three Months Ended<br/>September 30,</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Nine Months Ended<br/>September 30,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">($ in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Restructuring and related charges:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Severance and post-employment benefits</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Asset-related charges</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other charges</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total restructuring and related charges</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Argentina currency devaluation</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Development and licensing income</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Contingent consideration</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other items</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(3.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(4.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total other expense (income)</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Restructuring and Related Charges</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In February 2018, our Board of Directors approved a restructuring plan designed to realign our manufacturing capacity with demand. These changes are expected to be implemented over a period of up to twenty-four months from the date of approval. The plan will require restructuring and related charges of approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$16.0 million</span></span><span style="font-family:inherit;font-size:10pt;">. Since its approval, we have recorded </span><span style="font-family:inherit;font-size:10pt;"><span>$12.6 million</span></span><span style="font-family:inherit;font-size:10pt;"> in restructuring and related charges associated with this plan.</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">During the </span><span style="font-family:inherit;font-size:10pt;">three months ended</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">September 30, 2019</span><span style="font-family:inherit;font-size:10pt;">, we recorded </span><span style="font-family:inherit;font-size:10pt;"><span>$1.8 million</span></span><span style="font-family:inherit;font-size:10pt;"> in restructuring and related charges associated with this plan, consisting of </span><span style="font-family:inherit;font-size:10pt;"><span>$0.6 million</span></span><span style="font-family:inherit;font-size:10pt;"> for severance charges, </span><span style="font-family:inherit;font-size:10pt;"><span>$0.1 million</span></span><span style="font-family:inherit;font-size:10pt;"> for non-cash asset write-downs associated with the discontinued use of certain equipment, and </span><span style="font-family:inherit;font-size:10pt;"><span>$1.1 million</span></span><span style="font-family:inherit;font-size:10pt;"> for other non-cash charges. During the </span><span style="font-family:inherit;font-size:10pt;">three months ended</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">September 30, 2018</span><span style="font-family:inherit;font-size:10pt;">, we recorded </span><span style="font-family:inherit;font-size:10pt;"><span>$1.2 million</span></span><span style="font-family:inherit;font-size:10pt;"> in restructuring and related charges associated with this plan, consisting of </span><span style="font-family:inherit;font-size:10pt;"><span>$0.1 million</span></span><span style="font-family:inherit;font-size:10pt;"> for severance charges, </span><span style="font-family:inherit;font-size:10pt;"><span>$0.4 million</span></span><span style="font-family:inherit;font-size:10pt;"> for non-cash asset write-downs associated with the discontinued use of certain equipment, and </span><span style="font-family:inherit;font-size:10pt;"><span>$0.7 million</span></span><span style="font-family:inherit;font-size:10pt;"> for other non-cash charges.</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">During the </span><span style="font-family:inherit;font-size:10pt;">nine months ended</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">September 30, 2019</span><span style="font-family:inherit;font-size:10pt;">, we recorded </span><span style="font-family:inherit;font-size:10pt;"><span>$3.8 million</span></span><span style="font-family:inherit;font-size:10pt;"> in restructuring and related charges associated with this plan, consisting of </span><span style="font-family:inherit;font-size:10pt;"><span>$2.2 million</span></span><span style="font-family:inherit;font-size:10pt;"> for severance charges, </span><span style="font-family:inherit;font-size:10pt;"><span>$0.1 million</span></span><span style="font-family:inherit;font-size:10pt;"> for non-cash asset write-downs associated with the discontinued use of certain equipment, and </span><span style="font-family:inherit;font-size:10pt;"><span>$1.5 million</span></span><span style="font-family:inherit;font-size:10pt;"> for other non-cash charges. During the </span><span style="font-family:inherit;font-size:10pt;">nine months ended</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">September 30, 2018</span><span style="font-family:inherit;font-size:10pt;">, we recorded </span><span style="font-family:inherit;font-size:10pt;"><span>$6.7 million</span></span><span style="font-family:inherit;font-size:10pt;"> in restructuring and related charges associated with this plan, consisting of </span><span style="font-family:inherit;font-size:10pt;"><span>$3.4 million</span></span><span style="font-family:inherit;font-size:10pt;"> for severance charges, </span><span style="font-family:inherit;font-size:10pt;"><span>$0.8 million</span></span><span style="font-family:inherit;font-size:10pt;"> for non-cash asset write-downs associated with the discontinued use of certain equipment, and </span><span style="font-family:inherit;font-size:10pt;"><span>$2.5 million</span></span><span style="font-family:inherit;font-size:10pt;"> for other non-cash charges.</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table presents activity related to our restructuring obligations related to our 2018 restructuring plan:</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.78632478632478%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:45%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">($ in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Severance</span></div><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">and benefits</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Asset-related charges</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other charges</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance, December 31, 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Charges</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cash payments</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Non-cash asset write-downs</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1.6</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance, September 30, 2019</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">On February 15, 2016, our Board of Directors approved a restructuring plan designed to repurpose several of our production facilities in support of growing high-value proprietary products and to realign operational and commercial activities to meet the needs of our new market-focused commercial organization. Our remaining restructuring obligations related to the 2016 restructuring plan as of </span><span style="font-family:inherit;font-size:10pt;">September 30, 2019</span><span style="font-family:inherit;font-size:10pt;"> were </span><span style="font-family:inherit;font-size:10pt;"><span>$0.2 million</span></span><span style="font-family:inherit;font-size:10pt;">.</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Other Items</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">During the </span><span style="font-family:inherit;font-size:10pt;">three</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">nine months ended</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">September 30, 2019</span><span style="font-family:inherit;font-size:10pt;">, we recorded a charge of </span><span style="font-family:inherit;font-size:10pt;"><span>$1.0 million</span></span><span style="font-family:inherit;font-size:10pt;"> as a result of the continued devaluation of Argentina’s currency. During the </span><span style="font-family:inherit;font-size:10pt;">three</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">nine months ended</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">September 30, 2018</span><span style="font-family:inherit;font-size:10pt;">, we recorded a charge of </span><span style="font-family:inherit;font-size:10pt;"><span>$1.1 million</span></span><span style="font-family:inherit;font-size:10pt;"> related to the classification of Argentina’s economy as highly inflationary under U.S. GAAP as of July 1, 2018. </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">During both the </span><span style="font-family:inherit;font-size:10pt;">three</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">nine months ended</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">September 30, 2019</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;">, we recorded development income of </span><span style="font-family:inherit;font-size:10pt;"><span>$0.2 million</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$0.6 million</span></span><span style="font-family:inherit;font-size:10pt;">, respectively, related to a nonrefundable customer payment of </span><span style="font-family:inherit;font-size:10pt;"><span>$20.0 million</span></span><span style="font-family:inherit;font-size:10pt;"> received in June 2013 in return for the exclusive use of the SmartDose technology platform within a specific therapeutic area. Please refer to Note 3, </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Revenue</span><span style="font-family:inherit;font-size:10pt;">, for additional information.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Contingent consideration represents changes in the fair value of the SmartDose contingent consideration. Please refer to Note 10, </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Fair Value Measurements</span><span style="font-family:inherit;font-size:10pt;">, for additional details. </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other items consist of foreign exchange transaction gains and losses, gains and losses on the sale of fixed assets, and miscellaneous income and charges. Other items changed by </span><span style="font-family:inherit;font-size:10pt;"><span>$6.2 million</span></span><span style="font-family:inherit;font-size:10pt;"> for the </span><span style="font-family:inherit;font-size:10pt;">three months ended</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">September 30, 2019</span><span style="font-family:inherit;font-size:10pt;">, as compared to the same period in </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;">, primarily as a result of foreign exchange transaction losses of </span><span style="font-family:inherit;font-size:10pt;"><span>$5.1 million</span></span><span style="font-family:inherit;font-size:10pt;"> during the </span><span style="font-family:inherit;font-size:10pt;">three months ended</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">September 30, 2019</span><span style="font-family:inherit;font-size:10pt;">, as compared to foreign exchange transaction gains of </span><span style="font-family:inherit;font-size:10pt;"><span>$2.7 million</span></span><span style="font-family:inherit;font-size:10pt;"> during the </span><span style="font-family:inherit;font-size:10pt;">three months ended</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">September 30, 2018</span><span style="font-family:inherit;font-size:10pt;">. Other items decreased by </span><span style="font-family:inherit;font-size:10pt;"><span>$1.0 million</span></span><span style="font-family:inherit;font-size:10pt;"> for the </span><span style="font-family:inherit;font-size:10pt;">nine months ended</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">September 30, 2019</span><span style="font-family:inherit;font-size:10pt;">, as compared to the same period in </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;">, primarily due to losses on the sale of fixed assets during the </span><span style="font-family:inherit;font-size:10pt;">nine months ended</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">September 30, 2019</span><span style="font-family:inherit;font-size:10pt;">.</span></div> <div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other expense (income) consists of:</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.57264957264957%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:49%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Three Months Ended<br/>September 30,</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Nine Months Ended<br/>September 30,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">($ in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Restructuring and related charges:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Severance and post-employment benefits</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Asset-related charges</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other charges</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total restructuring and related charges</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Argentina currency devaluation</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Development and licensing income</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Contingent consideration</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other items</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(3.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(4.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total other expense (income)</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 600000 100000 2200000 3400000 100000 400000 100000 800000 1100000 700000 1500000 2500000 1800000 1200000 3800000 6700000 1000000.0 1100000 1000000.0 1100000 200000 200000 600000 600000 100000 200000 400000 800000 -3700000 2500000 3000000.0 4000000.0 -6400000 200000 -1600000 -4000000.0 16000000.0 12600000 1800000 600000 100000 1100000 1200000 100000 400000 700000 3800000 2200000 100000 1500000 6700000 3400000 800000 2500000 <div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table presents activity related to our restructuring obligations related to our 2018 restructuring plan:</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.78632478632478%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:45%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">($ in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Severance</span></div><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">and benefits</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Asset-related charges</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other charges</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance, December 31, 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Charges</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cash payments</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Non-cash asset write-downs</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1.6</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance, September 30, 2019</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 2300000 0 0 2300000 2200000 100000 1500000 3800000 2000000.0 0 0 2000000.0 0 100000 1500000 1600000 2500000 0 0 2500000 200000 1000000.0 1100000 200000 600000 20000000.0 -6200000 5100000 -2700000 -1000000.0 Income Taxes<div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The tax provision for interim periods is determined using the estimated annual effective consolidated tax rate, based on the current estimate of full-year earnings before taxes, adjusted for the impact of discrete quarterly items.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The provision for income taxes was </span><span style="font-family:inherit;font-size:10pt;"><span>$10.9 million</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$8.0 million</span></span><span style="font-family:inherit;font-size:10pt;"> for the </span><span style="font-family:inherit;font-size:10pt;">three months ended</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">September 30, 2019</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;">, respectively, and the effective tax rate was </span><span style="font-family:inherit;font-size:10pt;"><span>16.8%</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>13.1%</span></span><span style="font-family:inherit;font-size:10pt;">, respectively. The provision for income taxes was </span><span style="font-family:inherit;font-size:10pt;"><span>$42.5 million</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$26.5 million</span></span><span style="font-family:inherit;font-size:10pt;"> for the </span><span style="font-family:inherit;font-size:10pt;">nine months ended</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">September 30, 2019</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;">, respectively, and the effective tax rate was </span><span style="font-family:inherit;font-size:10pt;"><span>19.8%</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>15.1%</span></span><span style="font-family:inherit;font-size:10pt;">, respectively.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">During the </span><span style="font-family:inherit;font-size:10pt;">three</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">nine months ended</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">September 30, 2019</span><span style="font-family:inherit;font-size:10pt;">, we recorded a tax benefit of </span><span style="font-family:inherit;font-size:10pt;"><span>$1.0 million</span></span><span style="font-family:inherit;font-size:10pt;"> due to the impact of federal law changes enacted during the quarter. During the </span><span style="font-family:inherit;font-size:10pt;">three</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">nine months ended</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">September 30, 2018</span><span style="font-family:inherit;font-size:10pt;">, we recorded a net tax charge of </span><span style="font-family:inherit;font-size:10pt;"><span>$0.4 million</span></span><span style="font-family:inherit;font-size:10pt;"> and a net tax benefit of </span><span style="font-family:inherit;font-size:10pt;"><span>$4.1 million</span></span><span style="font-family:inherit;font-size:10pt;">, respectively, for the </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">estimated impact of the 2017 Tax Act. Please refer to Note 16, </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Income Taxes</span><span style="font-family:inherit;font-size:10pt;">, to the consolidated financial statements in our </span><a href="http://www.sec.gov/Archives/edgar/data/105770/000010577019000012/wst10k12312018.htm" style="font-family:inherit;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2018 Annual Report</span></a><span style="font-family:inherit;font-size:10pt;"> for further discussion.</span></div> 10900000 8000000.0 0.168 0.131 42500000 26500000 0.198 0.151 -1000000.0 400000 -4100000 Commitments and Contingencies<div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">From time to time, we are involved in product liability matters and other legal proceedings and claims generally incidental to our normal business activities. We accrue for loss contingencies when it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. While the outcome of current proceedings cannot be accurately predicted, we believe their ultimate resolution should not have a material adverse effect on our business, financial condition, results of operations or liquidity.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">There have been no significant changes to the commitments and contingencies included in our </span><a href="http://www.sec.gov/Archives/edgar/data/105770/000010577019000012/wst10k12312018.htm" style="font-family:inherit;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2018 Annual Report</span></a><span style="font-family:inherit;font-size:10pt;">.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">On January 1, 2019, we adopted ASC 842. Please refer to Note 6, </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Leases</span><span style="font-family:inherit;font-size:10pt;">, for additional information.</span></div> Segment Information<div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Our business operations are organized into </span><span style="font-family:inherit;font-size:10pt;"><span>two</span></span><span style="font-family:inherit;font-size:10pt;"> reportable segments, Proprietary Products and Contract-Manufactured Products. Our Proprietary Products reportable segment offers proprietary packaging, containment and drug delivery products, along with analytical lab services, to biologic, generic and pharmaceutical drug customers. Our Contract-Manufactured Products reportable segment serves as a fully integrated business, focused on the design, manufacture, and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We evaluate the performance of our segments based upon, among other things, segment net sales and operating profit. Segment operating profit excludes general corporate costs, which include executive and director compensation, stock-based compensation, adjustments to annual incentive plan expense for over- or under-attainment of targets, certain pension and other retirement benefit costs, and other corporate facilities and administrative expenses not allocated to the segments. Also excluded are items that we consider not representative of ongoing operations. Such items are referred to as other unallocated items and generally include restructuring and related charges, certain asset impairments and other specifically-identified income or expense items.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table presents information about our reportable segments, reconciled to consolidated totals:</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.57264957264957%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:49%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Three Months Ended<br/>September 30,</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Nine Months Ended<br/>September 30,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">($ in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net sales:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Proprietary Products</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>345.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>325.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,045.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>997.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Contract-Manufactured Products</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>111.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>106.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>323.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>297.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Intersegment sales elimination</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Consolidated net sales</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>456.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>431.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,369.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,294.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Operating profit (loss):</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Proprietary Products</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>72.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>68.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>238.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>202.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Contract-Manufactured Products</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>11.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>11.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>33.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>29.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Corporate</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(14.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(16.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(48.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(50.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other unallocated items</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2.3</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(4.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(7.8</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total operating profit</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>67.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>60.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>218.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>174.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Interest expense</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Interest income</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other nonoperating expense (income)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(5.1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Income before income taxes</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>64.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>61.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>214.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>174.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The intersegment sales elimination, which is required for the presentation of consolidated net sales, represents the elimination of components sold between our segments.</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other unallocated items during the </span><span style="font-family:inherit;font-size:10pt;">three</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">nine months ended</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">September 30, 2019</span><span style="font-family:inherit;font-size:10pt;"> consisted of </span><span style="font-family:inherit;font-size:10pt;"><span>$1.8 million</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$3.8 million</span></span><span style="font-family:inherit;font-size:10pt;">, respectively, in restructuring and related charges. In addition, during the </span><span style="font-family:inherit;font-size:10pt;">three</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">nine months ended</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">September 30, 2019</span><span style="font-family:inherit;font-size:10pt;">, other unallocated items included a charge of </span><span style="font-family:inherit;font-size:10pt;"><span>$1.0 million</span></span><span style="font-family:inherit;font-size:10pt;"> as a result of the continued devaluation of Argentina’s currency. Other unallocated items during the </span><span style="font-family:inherit;font-size:10pt;">three</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">nine months ended</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">September 30, 2018</span><span style="font-family:inherit;font-size:10pt;"> consisted of </span><span style="font-family:inherit;font-size:10pt;"><span>$1.2 million</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$6.7 million</span></span><span style="font-family:inherit;font-size:10pt;">, respectively, in restructuring and related charges. In addition, during the three and nine months ended September 30, 2018, other unallocated items included a charge of </span><span style="font-family:inherit;font-size:10pt;"><span>$1.1 million</span></span><span style="font-family:inherit;font-size:10pt;"> related to the classification of Argentina’s economy as highly inflationary under U.S. GAAP as of July 1, 2018. Please refer to Note 15, </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Other Expense (Income)</span><span style="font-family:inherit;font-size:10pt;">, for further discussion of these items.</span></div> 2 <div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table presents information about our reportable segments, reconciled to consolidated totals:</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.57264957264957%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:49%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Three Months Ended<br/>September 30,</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Nine Months Ended<br/>September 30,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">($ in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net sales:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Proprietary Products</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>345.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>325.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,045.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>997.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Contract-Manufactured Products</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>111.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>106.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>323.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>297.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Intersegment sales elimination</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Consolidated net sales</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>456.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>431.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,369.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,294.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Operating profit (loss):</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Proprietary Products</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>72.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>68.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>238.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>202.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Contract-Manufactured Products</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>11.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>11.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>33.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>29.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Corporate</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(14.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(16.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(48.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(50.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other unallocated items</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2.3</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(4.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(7.8</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total operating profit</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>67.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>60.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>218.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>174.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Interest expense</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Interest income</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other nonoperating expense (income)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(5.1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Income before income taxes</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>64.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>61.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>214.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>174.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 345200000 325200000 1045900000 997400000 111100000 106700000 323600000 297700000 -200000 -200000 -200000 -200000 456100000 431700000 1369300000 1294900000 72900000 68200000 238700000 202700000 11600000 11200000 33500000 29700000 -14400000 -16300000 -48900000 -50100000 -2800000 -2300000 -4800000 -7800000 67300000 60800000 218500000 174500000 2100000 2000000.0 6400000 6100000 1000000.0 500000 2500000 1400000 -1300000 1800000 -200000 5100000 64900000 61100000 214400000 174900000 1800000 3800000 1000000.0 1200000 6700000 1100000 Subsequent Event<div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">On October 15, 2019, we entered into an Amendment Agreement (the “Amendment”) with Daikyo, amending certain commercial agreements between the parties in order to make each party’s rights under such agreements exclusive. The Amendment amends the Amended and Restated Technology Exchange and CrossLicense Agreement and Distributorship Agreements, each dated and effective January 18, 2017, as modified by the Letter Agreement dated and effective July 2, 2018. In addition, on October 16, 2019, we announced that we increased our ownership interest in Daikyo to </span><span style="font-family:inherit;font-size:10pt;"><span>49%</span></span><span style="font-family:inherit;font-size:10pt;">. We believe that the increase in ownership interest will not have a material impact on our financial statements.</span></div> 0.49 These components are included in the computation of net periodic benefit cost. Please refer to Note 14, Benefit Plans, for additional details.

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�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htm IDEA: XBRL DOCUMENT v3.19.3
Leases Lease Weighted Average (Details)
Sep. 30, 2019
Lease Cash Flow and Supplemental Information [Abstract]  
Weighted average remaining lease term 11 years 9 months 18 days
Weighted average discount rate 3.76%